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Thesis Abstract  
Introduction 
Rates of surgery vary considerably across the UK. Many assume that this on the one hand 
exposes residents of certain UK regions to unnecessary surgical risks, and on the other 
hand prevents those of neighbouring regions from receiving important surgical care. 
Nowhere is this more apparent than for tonsillectomy – an operation that involves 
removing the tonsils in patients suffering with severe recurring sore throats. With 40,000 
tonsillectomies per year, it is one of the most common operations in the NHS, but 
remarkably, tonsillectomies are done seven times more frequently in some UK regions 
than in others. Despite national efforts to reduce these differences (e.g. re-education 
programmes for ENT surgeons, creation of national guidance on how to manage recurring 
sore throat, and financial penalties locally imposed to restrict high numbers of surgeries) 
this disparity has only got worse over the past 17 years. I undertook my research to 
examine the causes of these differences in more detail, to guide future policies.  
Aims 
The aim of my thesis was to develop a better understanding of the drivers of regional 
tonsillectomy rate variation by quantifying regional variation of tonsillectomy rates in 
relation to regional demands, and by exploring the role of professional uncertainty and 
treatment preference on the treatment chosen. 
Objectives 
The objectives were to establish the: 
A. Rate and regional variation of self-reported sore throat and help seeking 
behaviour in the community; 
B. Rate and regional variation of recurring sore throat in primary care; 
C. Rate and regional variation of tonsillectomy in secondary care, after adjusting for 
local rates of recurring sore throat; 
D. Constructs of clinical decision making and thereby ascertain which concepts were 
most likely to be related to surgical rate variation; 
E. Role of surgeon and patient decisional uncertainty on the treatment chosen for 
recurring tonsillitis; 
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F. Role of surgeon and patient treatment preference on the treatment chosen for 
recurring tonsillitis; 
Methods 
By using the largest UK population based study of upper respiratory symptoms and 
primary-secondary care linked medical record databases, I was able to investigate 
regional surgical rate variations across the entire patient-disease pathway: from sore 
throat in the community (used as a surrogate marker for tonsillitis), through recurrent 
sore throat consultations in primary care and finally tonsillectomy in hospitals. Following 
systematic review and thematic analysis of patient focus groups, I designed an instrument 
to elicit patient and surgeon preference. By undertaking the largest observational study 
of decision-making in adults with recurring tonsillitis, I was able to investigate the role of 
both patient and surgeon treatment preference and decisional uncertainty on treatment 
choice.  
Results 
My results suggest: 
A. There is considerable variation in the incidence of self-reported severe sore throat 
between regions. However, once patient risk factors are accounted for there is no 
statistical evidence for disparity between regions. In those who self-report a 
severe sore throat there is also a degree of regional variation in the rate of 
relevant consultations for sore throat symptoms, however, once disease 
characteristics were accounted for, this regional disparity disappears.  
B. There is regional disparity in recurring sore throat consultations in primary care, 
however, once patient characteristics are accounted for, this regional variation 
reduces considerably. 
C. Similarly, there is regional disparity in tonsillectomy rates; this variation reduces 
considerably once patient characteristics are accounted for. 
D. In the literature concepts related to shared-decision-making are strongly inter-
related and often poorly defined. Decisional uncertainty and treatment 
preference are amongst the best described, most measurable, and most 
appropriate constructs to investigate in a study of surgical rate variation.   
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E. Decisional uncertainty, either patient’s or surgeon’s, was found to have no role to 
play in the treatment chosen during a consultation for recurring sore throat. 
F. Patients’ treatment preferences did not influence their treatment chosen, but 
surgeons’ treatment preferences did.  
Discussion 
There are three key findings of my thesis. Firstly, regional rate of consultation for sore 
throat – which was used as a proxy for the underlying tonsillitis rate in the population 
throughout – was mirrored in the regional rate of tonsillectomy. This implies the regional 
tonsillectomy rate variations reflect regional variations in the ‘need’ of the population. 
Secondly, regional tonsillectomy rate variations are greater for children than adults. 
Finally, treatment decisions for adults with recurring tonsillitis are more influenced by 
surgeon’s treatment preferences than patient preferences or severity.   
There is a strong culture within the NHS of addressing variations of all kinds as a means 
of increasing healthcare quality and decreasing cost. There are currently metrics of 
variation across almost every aspect of care, however few of these account for patient 
characteristics to the extent that this thesis has, meaning that the initiatives may be a 
waste of effort at best and harmful at worst.  
The work presented in my thesis uses a unique set of mixed methods to demonstrate the 
complexity of regional tonsillectomy rate variation, which too frequently has been 
investigated using poorly controlled cross-sectional studies and reduced to soundbites 
like the “Surgical Signature”. Whilst my study shows “surgical signature” is important, it 
fails to describe the true complexity of the variation observed. My study sheds more light 
on the complexity of this variation and provides a plausible reason as to why the policies 
to reduce tonsillectomy rate variations may have failed. This mixed methods approach 
could be used more broadly to inform discussions under regional surgical rate variations. 
Most importantly, the findings in this thesis also demonstrate where future policy could 
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Patient perspective 
The inception of this project was informed by concerns from patients with recurring 
tonsillitis who were convened for Patient Public Involvement process of a tonsillectomy 
trial application. The patients reported great variation in treatments for recurring 
tonsillitis and suggested studying why the process of receiving a tonsillectomy varied so 
greatly. 
Personal Perspective 
Below I present some reflections of my personal experience during the PhD. Since many 
key decisions are made before the PhD even starts, they are not always made explicit in 
the chapters that follow. They relate to the weeks of deliberate thinking before a 
methodology becomes a study, when other potential methodologies are buried and 
forgotten. I found these decisions to be amongst the most difficult to take and convey in 
the thesis. At the inception of my PhD I had weekly meetings with Dr Sarah Smith and 
Prof Andrew Hayward, where we discussed the aims and potential methodological 
approaches that I had explored through MSc modules in social epidemiology or through 
private reading. These were supplemented with 3 weekly “all supervisors” meetings 
where I presented the potential strengths and weaknesses of different methodologies.  I 
also had the advantage of presenting my plans to supervisors on the epidemiology 
modules I undertook and the conferences I attended. These conversations helped me 
centre my investigations so they could be informative, but also provide future options to 
effect a change.  
I began this journey because my personal experience of working in different regions of 
the country as a surgical trainee did not agree with the strongly held academic view that 
there is a strong ‘surgical signature’ effect that results in high tonsillectomy rates in some 
regions and not in others. So this was an extremely personal journey that began from my 
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personal experience, but required me to acknowledge and address the biases resulting 
from personal experiences to really investigate the issues.   
When I reviewed the evidence base, I noted that studies had rarely accounted for 
differences in underlying disease burden between regions and whilst professional 
uncertainty and surgeon preference were thought to be the main drivers of variation, 
there was little proof that these factors influenced medical decisions.  
An ideal thesis would have allowed me to investigate these variations at all levels of the 
patient pathway, from tonsillitis in the community, to GP consultations for tonsillitis and 
recurring tonsillitis, outpatient referrals for recurring tonsillitis and tonsillectomies at 
hospital and local health authority policies for tonsillectomy. Additionally, an 
investigation into decision making for treatments of recurring tonsillitis, would have 
allowed me to look at the decision-making from multiple visits in primary care through to 
the surgeon-patient interaction when the final treatment decision was made.  
However, tonsillitis has no objective test and was poorly diagnosed and coded in primary 
care records. , Additionally, patients may experience tonsillitis but not recognise their 
illness as such or even consult for their symptoms.. There was considerable heterogeneity 
in the codes used to diagnose tonsillitis in primary care and poor coding for specialist 
referrals for recurring tonsillitis. Additionally, due to data safety regulations rules around 
re-identification of pseudo-anonymised data, analysing patient data mapped to hospitals 
and local health care trusts was not permitted. Finally, a study of decision making in 
primary care where only a small proportion of consultations relate to tonsillitis would 
have required ineffective resource allocation over a considerable length of time.  
Therefore, pragmatically, I chose to investigate severe sore throat in the community and 
in primary care, instead of tonsillitis. Using a sensitive definition of my cases (and treating 
sore throat as a surrogate marker of tonsillitis) ensured that I did not misinterpret 
variations in the manner people define and diagnose tonsillitis with variations in the 
incidence of tonsillitis. Whilst I could not investigate variations at the level of the hospital 
due to data safety restrictions, I was able to investigate them at the level of 10 larger 
health care regions. This allowed me a first step to developing a better understanding of 
tonsillectomy rate variation, without which, future studies would not be able to request 
information on hospital identities.  
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Since the role of decision-making in recurring tonsillitis had not been investigated directly 
at all in relation to regional tonsillectomy rate variation, I felt a well-targeted large 
observational study would be more valuable than a small qualitative study, in the first 
instance, especially if the goal was to inform on regional tonsillectomy rate variation. It 
would highlight areas that could be targeted more directly in future studies. Most of the 
evidence concludes that surgical signature is responsible for regional variation in 
tonsillectomy rate. I decided to study decision making during the consultation between 
ENT surgeon and patient. However, it was still unclear what I should study during the 
shared decision making process that occurs during that consultation and so I had to 
unpack the conceptual frameworks of shared decision making with the aim of finding a 
concept that was most likely related to regional surgical rate variation. I chose decisional 
uncertainty and surgeon and patient preference as they were most likely related to 
regional tonsillectomy rate variation, compared to other conceptual frameworks, based 
on the available, but weak, evidence. This decision was based on the assumption that 
uncertain surgeons are more likely to base their decisions on their personal preferences; 
therefore, if the assumption was not valid it may have led to uninformative findings. 
However, if the conceptual framework I identified was related to regional tonsillectomy 
rate variation it would be more amenable to a targeted intervention to improve the 
situation.  
Finally, there was no specific instrument available to elicit preferences in the treatment 
of recurring tonsillitis. Rather than simplifying preference for surgery into a visual 
analogue scale that lacked validity – which had been done frequently in the realm of 
orthopaedic surgery - I chose to develop a new instrument based on the available 
evidence. I generated this instrument based on a systematic review and qualitative 
analysis of patient focus groups. This took me considerably longer, but I believe it allowed 
me to create an instrument that could be used in the future, based on a more valid 
representation of the underlying construct being measured.    
Overall, I gained an in-depth knowledge of data management, advanced epidemiology, 
analysis of person level data and multivariable modelling, decision analysis, systematic 
reviews and an introduction into qualitative methods. I was the Chief Investigator in the 
largest multi-centre portfolio study of surgical decision making to date and gained 
invaluable experiences in this sphere.  
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research that justifies study of decision making in regional varaitions of 





A&E  Accident & Emergency 
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CI  Confidence interval 
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CCG  Clinical Commissioning Group 
CPRD  Clinical Practice Research Datalink 
DART  Decision-making for Adults with Recurring Tonsillitis study 
DoH  Department of Health 
EHR  Electronic Health Record 
GP  General Practice 
HES  Hospital Episode Statistics 
HRQoL  Health-related quality of life 
IMD  Index of Multiple Deprivation 
IRR  Incidence Rate Ratio 
ISAC  Independent Scientific Advisory Committee 
MINAP  Myocardial Ischaemia National Audit Project 
NHS  National Health Service 
NICE  National Institute for Health and Care Excellence 
NNT  Number Needed to Treat 
ONS  Office of National Statistics 
OR  Odds Ratio 
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PARTT  Preferences in Adults with Recurring Tonsillitis Tool 
RCS  Royal College of Surgeons 
RR  Relative Risk 
SIGN  Scottish Intercollegiate Guideline Network 
SCV  Systematic Component of Variation 
UCL  University College London 
URTI  Upper respiratory tract infection  
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Glossary of commonly used terms 
A & E: Accident and Emergency department - a medical treatment facility specialising in 
emergency medicine, the acute care of patients who present without prior appointment; 
either by their own means or by that of an ambulance. The emergency department is usually 
found in a hospital.    
Baseline biosociodemographics data: For participants of FluWatch a baseline visit was made 
to the household at enrolment, during which a research nurse assisted families with a series 
of laptop-based surveys collecting information on basic demographics, health and chronic 
illness, respiratory hygiene, household structure and relationships, accommodation, contacts 
and activities. From the third season onwards, these baseline data were self-completed by 
participants using a bespoke online survey. 
BMI: Body Mass Index approximates adiposity by comparing weight to height (weight in 
kilograms over height in metres squared). However, it does not differentiate lean mass from 
fat mass.  
Completed weeks analysis: Analyses in FluWatch were undertaken in all weeks where there 
was a completed household weekly status report (see household weekly status report) 
attached to their household for that week, even if there no individual patient illness data for 
that week.  
CALIBER: Clinical research using bespoke database of electronic patient medical records. 
CALIBER links the world’s largest primary care database (see CPRD below) with secondary 
care health data (see HES below) 
CCG: Clinical Commissioning Groups were originally created to cover a population of around 
100,000 UK residents each and were given a yearly budget based on the population size and 
predicted health care need. The main remit of the CCG was to ensure the most efficient use 
of their residents’ healthcare fund. 
CPRD: Clinical Practice Research Datalink – a governmental, not-for-profit research service, 
that collects primary care medical records data from over 5 million active patient records (and 
over 13 million overall) drawn from approximately 650 primary care practices in the UK. The 
diagnosis and management of patients attending their GP is coded using READ codes (see 
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READ codes) and stored in electronic medical records which are sent to CPRD for 
anonymization. The primary purpose of coding is for routine clinical use and not research.  
Daily Illness report: Participants of FluWatch were asked to complete a daily health diary 
during days of respiratory illness. The diary requested information on illness onset date, 
temperature and presence and severity of symptoms such as feeling feverish, headache, 
muscle aches, cough and sore throat. Diaries also collected data on contact patterns and 
activities before and during illness, including consultations and antibiotic use. 
FluWatch: Cohort study to investigate community burden of influenza and associated medical 
consultations, run over 6 seasons between 2006-2011 
GP: General Practice – a primary health care service located in the community to improve the 
health of local residents through health promotion, surveillance, screening, deployment of 
vaccination programmes, disease treatment and medical condition management.  There are 
7,875 General Practices in England with 57.2 million registered patients. 
HES: Hospital Episode Statistics - HES is a data warehouse containing details of all admissions, 
outpatient appointments and A&E attendances at NHS hospitals in England. This data is 
collected during a patient's time at hospital and is submitted to allow hospitals to be paid for 
the care they deliver. HES data is designed to enable secondary use, that is use for non-clinical 
purposes, of this administrative data. Diagnostic data is coded using the ICD-10 system (ICD-
10), whereas procedures are coded using the OPCS4 system (see OPCS4). The CALIBER dataset 
of combined CPRD-HES data only had access to inpatient HES records from January 1997.   
Household weekly status report: The lead member of every household in the FluWatch study 
was actively contacted every week with automated telephone calls to assess the presence or 
absence of respiratory illness in each household member.  
HPA: Health Protection Agency - a non-departmental public body set up by the UK 
government in 2003 to protect the public in England from threats to their health from 
infectious diseases and environmental hazards. In 2013, the HPA became part of Public Health 
England, a new executive agency of the Department of Health (DoH).  
HSB: Help Seeking Behaviour – a series of well-ordered and purposeful cognitive and 
behavioural steps, each leading to specific types of solutions, depending upon the person's 
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recognition, insight and dimension of the problem and resources available for problem 
resolution. In FluWatch we measured HSB by asking patients if they sought help for their 
symptoms and asking which of the following avenues of help was sought: Pharmacist, GP (see 
GP), NHS Direct (see NHS Direct), hospital, A & E (see A&E), Other. 
ICD-10: 10th revision of the International Statistical Classification of Diseases and Related 
Health Problems (ICD), a medical classification list by the World Health Organization (WHO). 
It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social 
circumstances, and external causes of injury or diseases. It has been mandated for use in the 
UK since 1995 and is used for coding health encounters experienced at secondary care level. 
IMD: Index of multiple deprivation - is a UK government qualitative study of deprived areas 
in England. Categorising geographically on areas with similar social characteristics and 
population of around 1500 people the team calculated an index of deprivation for these 
geographical units based on income, employment, health deprivation and disability, 
education skills and training, barriers to housing and services, crime and living Environment. 
In my analyses, I used quintiles of this index to estimate if the participant lived in the most 
deprived fifth or the least deprived fifth of the country.  
MINAP: Myocardial Ischaemia National Audit Project – a national registry of patients 
admitted to hospitals in England and Wales with acute coronary syndromes (ACS), established 
in 1998 to provide participating hospitals with a common mechanism for auditing 
performance against standards defined in the National Service Framework for Coronary Heart 
Disease. 
Need: In relation to healthcare the term ‘need’ is defined as the population who could benefit 
from a treatment 
NHS Direct: Health advice and information service provided by the National Health Service 
(NHS), established in March 1998 for residents and visitors in England. The nurse-led 
telephone information service provided healthcare advice 24 hours a day, every day of the 
year through telephone contact. It was discontinued on 31 March 2014. 
19 
 
Obesity: Large weight in relation to height. If patient weight to height ratio (see Body Mass 
Index) is more than 20% of expected then they are defined as obese (specifically defined as 
BMI≥30 kg/m2). Obesity is a strong risk factor for many other conditions, including tonsillitis 
OPCS4: The procedural classification used by clinical coders within National Health Service 
(NHS) hospitals based on the earlier Office of Population Censuses and Surveys Classification 
of Surgical Operations and Procedures (4th revision) 
ONS: Office of National Statistics which provides information on deaths and social deprivation 
OSA: Obstructive Sleep apnoea, a syndrome defined by obstruction of upper airways during 
sleep. The blocked airway results in lower blood oxygen levels and greater pressures exerted 
on the heart. Patients complain of poor sleep and daytime tiredness. Severe OSA can lead to 
heart failure. Many factors have been shown to be related to the occurrence of this syndrome 
from obesity (BMI > 30) to large tonsils. Surgical intervention can be advocated for OSA 
clinically when symptoms are severe and interfere with daytime behaviour, e.g. increased day 
time tiredness or poor concentration. Tonsillectomy is the most common surgical procedure 
undertaken for this syndrome in children. 
PCT: Primary Care Trust, see CCG 
Poor responders: Participants of FluWatch from households that responded to less than 70% 
of all household weekly status reports (see Household weekly status report) during the period 
they were enrolled in the study. 
Population density: In the FluWatch study the population density of the participants’ region 
of residence was calculated based on their post code as urban for postcodes that mapped to 
cities or towns or rural for postcodes that mapped to villages or hamlets.  
READ code: Standard clinical terminology system used in General Practice in the United 
Kingdom. It supports detailed clinical encoding of multiple patient phenomena including: 
occupation; social circumstances; ethnicity and religion; clinical signs, symptoms and 
observations; laboratory tests and results; diagnoses; diagnostic, therapeutic or surgical 
procedures performed; and a variety of administrative items. This is the coding system used 
by practices that are associated with CPRD.  
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Recurring sore throat phenotype: Any patient who has 3 or more sore throat consultations 
(see sore throat consultation) within a year, with each consultation being more than 21 days 
apart from each other (discussed in chapter 2). 
Recurring tonsillitis: Defined by SIGN as 7 episodes of tonsillitis within 12 months/5 episodes 
a year over 24 months/ 3 episodes a year over 36 months. Also see tonsillitis 
Sore throat consultations: A collection of READ codes (see READ codes) that describe 
potential patient consultations in primary care that were related to sore throat infection. 
Used in CALIBER study to assess the burden of sore throat in primary care.  
Sore throat infection: Acute episode of symptoms self-reported by a patient as moderate or 
severe sore throat for two or more consecutive days, in absence of a cough, with no 
respiratory tract symptoms in preceding 7 days. Illness was considered resolved when 
participant was free of symptoms for 2 days or more.  
SCV: Systematic Component of Variation measures the degree of variation between regions. 
The SCV is an adaptation of the proportional hazards model.  The method described subtracts 
the random error (estimated through generalised linear models above) from the estimated 
total variance to calculate the systematic component of variation. This measure allows 
comparisons of variability between regions but makes few assumptions about the nature of 
the variation and allows for appropriate amounts of sampling variation in the data. It has been 
suggested that variations giving SCVs greater than 3 are likely to be due largely to differences 
in practice style or medical discretion, and that high variation is described by a SCV of between 
5.4 and 10.0, with SCVs greater than 10 being very high variation. 
Tonsils: lymphoid tissue situated at the back of the throat and are often the first point of 
contact our lymphatic system has with bacteria and microbes humans ingest and inhale. 
Tonsillectomy: A surgical procedure undertaken under general anaesthesia to remove 
palatine tonsils. Most commonly undertaken for patients with recurring tonsillitis (see 
recurring tonsillitis), but also be undertaken for patients with obstructive sleep apnoea (see 
OSA), or suspected tonsillar cancer.  
Tonsillitis: Infectious inflammation of palatine tonsils. Symptoms include severe sore throat, 
feeling feverish, pain on swallowing food and tenderness in the upper neck. Examination 
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shows exudate on tonsils, temperature above 38°C and swollen glands in upper neck. 
Commonly caused by viruses and bacteria. If bacterial, can be complicated by localised 
abscess, or non-suppurative conditions from acute rheumatic fever to glomerulonephritis. 
Treated with painkillers and rest. If symptoms severe can be managed with a delayed 
antibiotic prescription. Can become recurrent in certain groups. Also see recurrent tonsillitis.  
UCL: University College London - a public research university in London, England, and a 
constituent college of the federal University of London. It is the largest postgraduate 
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In this chapter, I have used historical context to define the importance of regional 
tonsillectomy rate variation. I have critically evaluated studies, specific to tonsillectomy and 
then surgery in general, to present two current theories of what drives regional tonsillectomy 
rate variation. Subsequently I have summarised strategies that have been employed to 
directly reduce regional tonsillectomy rate variation. Finally, I have outlined evidence from 
multiple disparate sources (health economics, decision analysis, healthcare equity science) 
and summarised two preparatory studies I had undertaken to define key reasons why these 
strategies may have failed. I have concluded this chapter with the aim and objectives of my 
thesis and an overview of thesis architecture
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Introduction to tonsils, tonsillectomy and regional tonsillectomy rate variations 
Tonsils are lymphoid tissue situated at the back of the throat (Figure 1 Tonsils) and are often 
the first point of contact our lymphatic system has with bacteria and microbes that we ingest 
and inhale. Tonsils produce antibodies that help fight against bacteria and T-cells that attack 
cells infected with viruses(1).  
 
Figure 1 Tonsils. 
 This diagram shows the location of pharyngeal tonsils, which are lymphoid tissue, ideally located to be the first line of defence 





Figure 2 Tonsillectomy. 
 This diagram shows one method of removing the tonsils surgically – tonsillectomy – which is a procedure undertaken most 
commonly when patients suffer from recurring infections of the tonsils.  
 
Occasionally the tonsils, and supporting lymphatic tissue, fail to prevent a throat infection 
(pharyngitis) and can indeed become infected themselves (tonsillitis), causing a pain in the 
throat that gets worse on swallowing solids and liquids. Sore throats are the second most 
frequent respiratory infection seen in primary care (2). While in many cases sore throat is 
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relatively minor and self-limiting, a significant number of patients have recurrent episodes of 
sore throat with illness, and loss of education or earnings(3-8). In those patients, tonsils can 
be surgically removed by a procedure called a tonsillectomy Figure 2 Tonsillectomy. 
Tonsillectomy is amongst the top 20 most performed operations in England (9) with more 
than 46,000 undertaken each year. This intervention was most commonly used to treat 
recurring tonsillitis. However, in recent years, obstructive sleep apnoea may have become a 
more frequent indication, in children at least (10). 
Variation in tonsillectomy rates has been investigated and publicly reported since the 1930’s, 
originally in the UK but subsequently in many other developed countries (11-15). The rapid 
rise in use of tonsillectomy in the paediatric population following the First World War was 
probably a key reason as to why so many epidemiological studies used tonsillectomy to 
investigate geographical surgical rate variation. Epidemiological studies summarised by 
Glover suggested that one third to one half of all children received this operation before the 
age of 15 in UK and USA in the 1930s – with nearly 6 times the number of children receiving 
this operation at its peak compared to modern times (16).  
Glover’s (16) seminal paper, published in 1938, investigated geographical variation in 
adenotonsillectomy rates of children 5-14 years old across England and Wales (using school 
medical records). He found that tonsillectomy rates varied threefold between geographical 
regions, even when these regions were adjacent. Ever since, regional tonsillectomy rate 
variation has continued to be topical and controversial. 
Bloor (17) undertook an investigation between two socio-demographically similar regions in 
Scotland known to have wide variation in tonsillectomy rates in children 15 and under. He 
analysed all referrals received by the ENT departments, between 1961-1970, and showed that 
referral rates were not statistically different between regions, but tonsillectomy rates were 
different.   
A retrospective observational study of surgical admissions to the Oxford region, UK (18), 
showed that paediatric tonsillectomy rates varied widely between regions in Oxford. In 
response, Suleman used NHS Hospital Episode Statistics (HES) data to calculate tonsillectomy 
rates in patients under 15 years across  380 local authorities over the years 2000-2005(19). 
In addition, he extracted similar figures from BUPA, the UK’s largest private provider covering 
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40% of England’s private medical practice. He found up to 7-fold difference in tonsillectomy 
rates between regions. There was no correlation between the rates of NHS and private 
tonsillectomy; a low NHS tonsillectomy rate within a region did not mean that the private rate 
was greater.  
In 2009 the UK Government commissioned the King’s fund(20) to undertake an investigation 
of healthcare variation. They also reported a 7-fold disparity in paediatric tonsillectomy rates 
between the highest and lowest utilising regions. Compared to other procedures they 
reported that tonsillectomy remained amongst the five procedures with the highest 
geographical variation.  Not only has high regional tonsillectomy rate variation been noted 
within other countries (11-15) , but also between countries and types of health care systems 
(21).  
 
What do we think is driving regional tonsillectomy rate variation?  
Historical evidence from survey, epidemiological and qualitative studies has suggested that 
regional variations in tonsillectomy rates may, in part, be related to “professional 
uncertainty” amongst surgeons of how to manage the condition which then allows regionally 
aligned surgeon treatment preference - “the surgical signature” - to drive the treatment 
decision.  
Professional uncertainty in the management of recurring tonsillitis 
The first sign that there was professional uncertainty in the management of recurring 
tonsillitis came from a study of paediatric tonsillectomy in the USA. In 1954, Bakwin 
(22)randomly sampled 1,000 children, 11 years of age, from the public schools of New York 
City. He noted that 61 per cent had already received a tonsillectomy. The remaining 39 per 
cent were examined by a group of surgeons who selected 45 per cent of these for 
tonsillectomy and selected the remainder for non-surgical treatment. The children that were 
selected for non-surgical management were then re- examined by another group of surgeons, 
who recommended for tonsillectomy 46 per cent of those remaining. The authors 
commented that 935 out of the 1,000 children would have had a tonsillectomy if they had 
followed this pathway and concluded that there was no clinical consensus amongst surgeons 
as to who would benefit from the surgery (22).  
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This was  backed up by Bloor’s (23) qualitative study of 6 ENT surgeons from a high 
tonsillectomy-, and 5 from a low tonsillectomy-rate region in Scotland, who undertook 493 
sequential consultations with patients (15 years and under) referred with recurrent sore 
throat. He reported considerable variation in decision-making and concluded variation in 
tonsillectomy rates was due to the variation in the interpretation of an incomplete evidence 
base.  
The theory of professional uncertainty driving regional tonsillectomy rate variations was 
further supported from observational studies around other surgical procedures that 
demonstrated greater variation for procedures for which there was a professional uncertainty 
on how cases should be managed, compared to similar procedures where management had 
been standardised  (17,24-26). For example, there was low regional variation in paediatric 
herniorraphy compared to paediatric appendicectomy (24) and low regional variation in hip 
fracture surgery compared to hip replacement surgery (27). Qualitative and observational 
studies of surgical management of breast cancer and osteoarthritis, amongst other 
conditions, led to a better understanding of professional uncertainty (discussed below).  
By critically evaluating the broader evidence base around professional uncertainty I have 
identified three scenarios that have been found associated with professional uncertainty: 1. 
Conditions that have equipoise across treatments (e.g. management of early breast cancer 
where modified radical mastectomy has equivocal survival to breast conserving surgery (28-
30); 2. Conditions for which there is no consensus amongst surgeons about how patients 
should be managed, e.g. breast cancer (31,32)) 3. Conditions for which there is insufficient 
evidence about outcomes, e.g. Meniere’s disease (33,34). Conditions that fulfilled any of 
these criteria have in the past been defined as ‘preference-sensitive’ since ‘best treatment’ 
could only be defined as the treatment that performed best on the outcomes important to 
that individual patient (24,35).  Wennberg suggested that when there was no consensus on 
how to manage a condition there was greater opportunity to consider non-medical factors, 
such as surgeon preferences and social norms. 
This theory may have a part to play in explaining why certain procedures were more prone to 
regional surgical rate variation compared to others. It did not, however, explain patterns of 
variation in surgical practice for the same condition – that is if there was uncertainty in the 
evidence for a management of a specific condition then all surgeons in all regions would be 
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exposed to that uncertainty. It would fail to explain why uncertain surgeons in some regions 
were more prone to surgical intervention than their counterparts in a neighbouring region. A 
further theory was developed to explain this observation – this theory was based on the idea 
of surgeon treatment preference and was coined the “Surgical Signature”.  
Surgeon treatment preference 
Evidence for surgeon treatment preference influencing regional surgical rates originally came 
from a “natural experiment”. Whilst Glover (16) was investigating regional paediatric 
tonsillectomy rates in English boroughs, he noted that Hornsey had a higher rate of 
tonsillectomy than all neighbouring regions. Half way through his observation window a new 
school district surgeon was appointed at Hornsey. Within a year, the rates of tonsillectomy in 
the district dropped by a factor of ten, and remained low for years afterwards. Glover 
attributed the drop in rates to the change in “surgeon opinion” embodied in the different 
practice styles of the two different surgeons. He concluded that geographical variations were 
due to the surgeon’s preference towards the operation. In addition, whilst this may have 
helped explain the regional variation seen in paediatric tonsillectomy rates across school 
districts that were each administered by a single surgeon, it did not explain the high 
tonsillectomy rate variation across bigger geographical units that were administered by 
multiple surgeons. Wright (36) argued that through processes of attraction and retention, 
practice styles tended to cluster, resulting in geographically based patterns of variation 
amongst a larger number of surgeons.  Chassin (37) suggested that the authoritative nature 
of continued medical education, which was often regionally based, promoted geographical 
alignment in surgeon treatment preference. However, the surgical signature hypothesis did 
not explain the observation that surgeons had previously changed their behaviour, within 
whole regions, suddenly for non-medical reasons (e.g. changes in the remuneration system) 
(38).  
What has been tried to reduce regional tonsillectomy rate variation? 
Whilst tonsillectomy rates were the first surgical procedure found to have such large variation 
between regions, it soon became evident that this was part of a larger issue (39-41).  The 
issue of regional healthcare variation became popularised in the media as the “post code 
lottery” (42-44), and was broadly publicised as source of social injustice with certain 
populations being prevented from having necessary treatments or other populations being 
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exposed to unnecessary surgery. From a policy perspective, Government bodies saw the same 
regional surgical rate variation as a source of inefficiency. In fact, a report commissioned by 
the UK Department of Health in 2009 found that up to £700 million could be saved by de-
commissioning operations that had high regional variations (45). NHS England created 
RightCare in 2009, a national programme devoted to reducing practice variations and 
securing value for the NHS. It produced atlases of practice variation, including tonsillectomy, 
and guided local health authorities towards prioritising treatments to prevent under- or 
overuse. Public health officials started reporting large differences in standardised mortality 
rates, which were up to three times greater in some regions of England compared to others 
(46), and they argued that regional surgical rate variations were tied into the bigger issue of 
healthcare inequity – that is a failure to provide equal healthcare to those who had equal 
need.  
The Evidence Based Medicine movement (EBM) grew in direct response to variation in health 
care (47). Three major consequences of this movement included building the knowledge base 
for implementation and knowledge translation through promotion of high level research 
(48), the establishment of the Cochrane Collaboration(49), which was tasked with the 
collation and summarising of evidence from clinical trials, building national and international 
infrastructures for developing and updating clinical practice guidelines(50).  
Specific to tonsillectomy, multiple randomised controlled trials were initiated to evaluate the 
effectiveness of this surgery for the treatment of children  (3,51-53) (52) and adults (5,7) 
with recurring tonsillitis.  The Cochrane collaborative recently updated  a meta-analysis of the 
above randomised controlled trials(54) and concluded that whilst in children 
(adeno)tonsillectomy resulted in a reduction of 0.6 sore throat episodes (95% confidence 
interval -1 to -0.1) in the first post-operative year,  there was insufficient evidence with 
regards to adults to guide clinical decisions. In parallel to this, the National Institute of Health 
Research (NIHR) Health Technology Assessment (HTA) programme commissioned a 
randomised controlled trial assessing the effectiveness of tonsillectomy in adults with 
recurrent tonsillitis, which is ongoing (55). A better understanding of the risks and 
complications of tonsillectomy came following on from the National Prospective 
Tonsillectomy Audit, which was undertaken by the Royal College of Surgeons in 2005. The 
audit included 33,921 tonsillectomies and found a total primary and secondary bleeding rate 
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of 3% and 0.9% returned to theatre for arrest of haemorrhage(56). With the results of these 
papers a better understanding of potential benefits and risks of tonsillectomy was now 
developed.  
Based on the above evidence the Scottish Intercollegiate Guidelines Network (SIGN) 
generated GP referral advice and ENT criteria for tonsillectomy(57). This guidance was 
endorsed by ENTUK. Tonsillectomy was advocated on children and adults if: 
• sore throats were due to acute tonsillitis AND 
• the episodes of sore throat were disabling and prevent normal functioning AND 
• 7 or more well documented, clinically significant, adequately treated sore throats in 
the preceding year OR 
• 5 or more such episodes in each of the preceding two years OR 
• 3 or more such episodes in each of the preceding three years 
Shortly after the release of the guidelines a survey of ENT surgeons showed that whilst many 
had criticisms, 84% of respondents reported following the guidelines(58). 
Yet despite this growing evidence better defining benefits and risks of tonsillectomy, 
development of national guidance and high compliance reported by ENT surgeons, the King’s 
Fund (20) and the NHS RightCare programme (59) reported in 2011 that regional variation in 
tonsillectomy rates increased and got worse in their rankings.  
 
What are the potential reasons that we have failed to reduce regional tonsillectomy 
rate variation? 
 
Following on from critical evaluation of the published work around regional surgical rate 
variation, I have hypothesised three potential drivers of why regional tonsillectomy 
variation has failed to reduce despite the above strategies:  
1. Regional surgical rate variation is a response to regional need (e.g. rates of recurring 
tonsillitis are different between regions) 
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2. Regional surgical rate variation is a component of shared decision making (e.g. 
regional differences in the way the medical consultation is conducted encourage 
treatment decisions to align with regional norms) 
3. Regional surgical rate variation is a response to regional healthcare infrastructure (e.g. 
regional healthcare policy encourages differences in tonsillectomy rates between 
regions) 
 
Regional surgical rate variation is a response to regional need 
Regional surgical rate variation may be a marker of a healthcare system that is adaptable to 
the ‘need’ of the local populations.  The term ‘need’ is defined as the population who could 
benefit from a treatment (60) and has historically been divided into three broad categories: 
1. The true incidence of surgically treatable disease, which may be related to demographic, 
environmental and lifestyle factors  
2. How frequently sub-clinical disease is detected with medical testing, which may relate to 
help seeking behaviour such as GP consultation  




Variation related to true incidence of disease 
It may seem obvious that as numbers of people who may benefit from surgery increases, so 
does the rate of surgery. This phenomenon becomes apparent for conditions that are easily 
diagnosed, always detected and recorded, unlikely to be falsely recorded, and for which the 
only treatment is surgery (i.e. there is little room for choice or preference). A good example 
is hip fractures, which all require hospitalisation and there is only one agreed treatment: Open 
reduction and internal fixation (61). Rates of hip fracture surgery in Hawaii are at least 60% 
lower than elsewhere in the US because fewer patients have hip fractures (62). For diseases 
that are not as easily recorded (e.g. ischaemic heart disease), the incidence can be inferred 
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through risk factors. For example, the North of England has markedly higher rates of all types 
of cardiovascular interventions than other regions of the country, driven by much higher 
prevalence of cardiovascular risk factors, such as hypertension (63), diabetes (64,65), and 
smoking (66), and therefore, higher incidence of ischaemic heart disease. In the case of 
tonsillitis, it is still unclear how regional rates of tonsillectomy relate to regional rates of 
tonsillitis.  
II. Variation related to differences in disease detection 
Even when the true prevalence of disease varies little by geography, the number of surgically 
treatable patients could vary according to regional differences in diagnostic testing of patients 
with asymptomatic or subclinical disease. For example, while there is little evidence that the 
true incidence of prostate cancer varies widely within countries, rates of prostate specific 
antigen (PSA) screening—the most common means by which this disease is detected—differ 
markedly. These variations in screening are strongly correlated with variations in prostatic 
biopsy and resection rates (67). Lu-Yao and colleagues found that PSA screening rates 
differed five-fold between two North American cities and suggested that this may have 
contributed to the five-fold difference in prostatectomy rates between the two(68). Specific 
to tonsillectomy, most tonsillitis cases can be safely managed in the community and so 
detection requires a patient to present to their General Practitioner (GP) or other health care 
provider, therefore, detection rates of tonsillitis are highly influenced by consultation rate for 
sore throat. Studies have shown that GP consultation for acute respiratory infections varies 
with patient characteristics such as age, sex (69) (70-72) marital status(73), family size 
(73,74), education level (75)and social class (76), all factors that are also known to vary 
between regions.  In the case of tonsillitis, it is still unclear how regional rates of GP 
consultation for tonsillitis relate to regional rates of tonsillectomy.  
III. Variation related to patient choice 
Finally, differences in patients’ willingness to undergo surgery may play a part in regional 
variation in procedure rates. Hawker et al. conducted a study in patients with hip and knee 
osteoarthritis residing in two areas of Canada, one with low and the other with higher rates 
of hip and knee arthroplasty. For patients judged clinically appropriate for surgery, the 
investigators then presented patients with detailed information about the nature of and risks 
and benefits of joint replacement. Only 8·5% of patients in the low-rate area expressed that 
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they were “definitely willing” to have surgery, while 14·9% of patients in the high-rate area 
expressed that preference(77).  There is growing evidence from survey studies to suggest 
that patients in high surgical areas may have a higher preference for surgery than those in 
low surgery areas (78-80). Other studies suggest that patient preference for surgery may vary 
by patient characteristics known to vary between regions, for example age and gender (81-
84), ethnicity (85-88), English language fluency (89), education level (90) and socioeconomic 
status (91). However, these studies ask about hypothetical willingness to undergo surgery, 
which may not be reflective of decisions reached in a real consultation. Additionally, 
measurement of willingness for treatment based on selecting an ordinal value on a spectrum 
from “definitely not willing to have to treatment”, through to “definitely willing to have 
treatment”, is less reliable since it uses a single question to measure a complicated construct. 
Studies have used willingness-for-surgery as a surrogate for patient-preference-for-surgery 
since the latter has historically been difficult to elicit in a reliable and efficient manner.  In the 
case of tonsillitis, there is no instrument that measures treatment preference and it is still 
unclear how regional rates of tonsillectomy relate to regional preferences towards 
tonsillectomy or non-surgical management of recurring tonsillitis.  
 
“Need” in relation to tonsillectomy 
The difficulty of relating regional tonsillectomy rate variation to regional variation in ‘need’ 
for tonsillectomy comes from three main issues:  
(1) Tonsillitis can be managed conservatively without medical intervention, and so the true 
incidence of the disease has to be measured in the community, not health care settings, to 
prevent underestimation of the disease burden. Monitoring short lived infections in the 
community, and resulting increases in consultation rate for sore throat has been notoriously 
difficult given the number of people that need to be included in a cohort and followed up 
intensively for long periods of time to truly estimate the community incidence of a condition.  
(2) Diagnosis and medical management of tonsillitis is most frequently undertaken and 
therefore recorded in primary care, while treatment of recurring tonsillitis (tonsillectomy) 
takes place and is recorded in secondary care. There is no official national linkage between 
primary and secondary healthcare datasets. Whilst patients in the UK have a unique health 
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code that identifies them in both primary and secondary care, government attempts to link 
and centralise health records across all settings have not been successful.   
(3) There is more than one way to treat recurring tonsillitis and so variations may reflect 
patient choice – which has historically been very difficult to measure. Measures such as visual 
analogue scores have issues with reliability as they use a single question to approximate a 
complicate concept, whilst using interview techniques based on standard gamble or time-
trade off are labour and time intensive.  
In part because “need” for tonsillectomy is so difficult to ascertain, previous studies of 
regional tonsillectomy rate variation have just assumed that the “need” for tonsillectomy 
does not vary between regions.   
 
Regional surgical rate variation is a component of shared decision making 
The surgical consultation is the key setting where decisions are finalised about a patient 
having surgery or not. There is good qualitative evidence suggesting that aspects of this 
decision-making process varies with factors that are known to vary between regions. For 
example, the amount of information given during a consultation varied according to patient 
characteristics such as age (92), gender (93), social class (94) (95) , educational status (96) 
and ethnicity (97), as well as surgeon characteristics such as income, social class background, 
political ideology (98) and race (99). Similar evidence exists regarding type and detail of 
information. This was partly thought to relate to the doctor’s stereotyped perception of 
patients’ needs (99)  and partly to do with information seeking behaviour that was more 
common to certain patient groups (94) (97) (93). Whilst these early studies suggested that 
variations in population and surgeon characteristics may influence the shared decision 
making process there was no previous research that directly examined the role of the surgical 
decision-making process (or components therein) on treatments chosen and therefore, 
regional surgical rate variation.   
Studies of patient decision aids may have indirectly investigated this association between the 
medical decision-making process and regional surgical rate variation. Patient decision aids are 
tools that help patients make difficult decisions based on the most recent medical evidence 
and patients’ personal treatment preferences.  
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In a collaboration with researchers at Johns Hopkins Medical School, I undertook a systematic 
review of studies reporting on the use surgery-related patient decision aids and its effect on 
the treatment choice (100). We found 17 studies that were relevant to our research question. 
Most studies (n=10) showed that patient decision aids influenced patients’ treatment 
preference. Nine found that exposure to a decision aid was likely to change patient treatment 
decisions away from surgery (e.g. 26 – 38 % reduction of patients choosing joint-replacement 
surgery), whilst one showed an increase in numbers of patients choosing surgery (change in 
those choosing laminectomy to treat lumbar disc herniation went from 26.7% to 35.8%). 
Whilst our review suggests that factors within the consultation may have a role in treatment 
decision, and therefore, surgical rate variations, there was insufficient evidence to 
understand which part of shared treatment decision was most related to the change in 
regional surgical rates.  
This has been difficult to investigate because as in other conditions, the surgical consultation 
is a complicated shared decision making process that contains multiple interconnected 
concepts. There is little understanding of which concept could lead treatment decisions to 
line up with regional norms, and even less understanding of how accurately these concepts 
can be measured.   
 
Regional surgical rate variation is a response to regional healthcare infrastructure (supply 
sensitive variations) 
 
Supply-sensitive variations have been traditionally described in relation to chronic conditions 
where the use of service (e.g. hospitalisations, diagnostic tests, Intensive Care utilisation) 
varies in direct proportion to the capacity of the system (number of acute beds, number of 
physicians, number of Intensive Care beds etc.) (101). Whilst supply sensitive variations could 
result in regional variations in elective surgery, there has been no published evidence to 
suggest such an association.  
Measuring regional differences in capacity for tonsillectomy is difficult as it may relate to the 
number of beds, numbers of other ENT surgeries being undertaken by a department, number 
and type of surgeries being undertaken by other surgical specialties reducing access to 
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theatre space, number of clinics running, number of specialists and local policies that promote 
or prevent access for tonsillectomy. Whilst his has never been measured, there is some 
evidence using the number of ENT surgeons per capita as a surrogate marker for capacity that 
suggests capacity does not vary between regions. Specifically, there does not appear to be a 
correlation between the number of ENT specialists within each country and number of 
paediatric tonsillectomies between those countries (e.g. USA has the same number of ENT 
specialists per 100,000 population but has less than half the rate of tonsillectomies compared 
to Netherlands)(21).  
Whilst the number of specialists available may not drive regional variations in tonsillectomy 
rates, there may be a role for regional health care policies.  
Within the National Health Service, the Government funds health services through regionally 
based local health authorities – called Clinical Commissioning Groups (CCGs). The CCGs were 
originally created to cover a population of around 100,000 UK residents each and were given 
a yearly budget based on the population size and predicted health care need. The main remit 
of the CCG was to ensure the most efficient use of their residents’ healthcare fund. To 
facilitate this, the Government provided guidance as to how they could prioritise, or ‘ration’, 
treatments to allow most efficient use of their funds for their local populations’ needs – called 
commissioning guidance. Therefore, review of the funding infrastructure within the NHS 
suggested a potential role for regionally based “rationing” of services (commissioning 
guidance) in the regional tonsillectomy rate variation. As there was no published evidence on 
the relationship between local rationing (commissioning guidance) and local tonsillectomy 
rates, and to better understand regional rationing policies, I sent out a Freedom of 
Information request to all 211 CCGs. I asked if they had any published commissioning 
guidance in relation to tonsillectomy, and if they had, what were its contents and when it was 
placed into action. I received responses from 189 CCGs (89% response rate).  
All CCGs had commissioning guidance for whom should receive a tonsillectomy – that is 
rationing tonsillectomy to those who would have maximal benefit. However, review of the 
actual guidance documents showed that different CCGs had used different criteria to define 
who would gain maximal benefit. For example, some regions (11%) required patients to have 
attended their GP for seven episodes of tonsillitis in the preceding 12 months, whilst others 
(89%) just required patients to confirm themselves that they had suffered seven episodes of 
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tonsillitis in 12 months. Some requested that a microbiological swab prove that the tonsillitis 
was caused by Streptococcus (full responses through correspondence). This meant some 
regional systems allowed access to tonsillectomy more than others. However, there was no 
data to show whether the local commissioning guidance were related the rates of 
tonsillectomy.  
Rationale for this thesis 
Regional surgical rate variations are important to address for Public Health, as our current 
healthcare system may be exposing certain groups of our population to unnecessary surgery, 
whilst preventing others from receiving necessary treatment. I have shown above that 
tonsillectomy is not only one of the most common operations undertaken in this country, it 
also has one of the highest rates of regional variation, despite national strategies undertaken 
to reduce this.  Developing a better understanding of the drivers of regional tonsillectomy 
rate variation therefore may help guide future health policy in the broader context of regional 
surgical variation. Whilst I have shown there are many aspects of regional tonsillectomy rate 
variation that remain poorly defined I have focused my thesis on areas where there is 
preliminary evidence to suggest a link to regional variation, to provide a better understanding 
of this finding. The need for tonsillectomy is determined in part by recurring tonsillitis and in 
community sore throat incidence. The review of regional tonsillectomy-rate-variation 
research shows that there has never been a specific investigation into the regional variation 
in proxy measures of ‘need’ for tonsillectomy. There has only been an assumption that ‘need’ 
must be same from region to region. And whilst decisions that lead to tonsillectomy may start 
from the patient seeking help for their first episode of tonsillitis, through to decisions made 
by the GP to refer the patient whose tonsillitis becomes recurrent to a specialist (or not), 
there is considerable literature implying that regional tonsillectomy rate variation is the result 
of region specific surgeon practice styles (the ‘surgical signature’ hypothesis). Despite this 
body of evidence there has never been a study that investigates the ENT specialist-patient 
medical encounter to see how it affects the treatment decisions of patients with recurring 
tonsillitis and refute or further support this hypothesis.  
Aim  
The aim of my thesis was to develop a better understanding of the drivers of regional 
tonsillectomy rate variation by quantifying regional variation of tonsillectomy rates in relation 
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to regional demands, and by exploring the role of professional uncertainty and treatment 
preference on the treatment chosen. 
Objectives 
The objectives were to establish the: 
A. Rate and regional variation of self-reported sore throat and in the rate of relevant 
consultations for sore throat in the community; 
B. Rate and regional variation of recurring sore throat in primary care; 
C. Rate and regional variation of tonsillectomy in secondary care, after adjusting for local 
rates of recurring sore throat; 
D. Constructs of clinical decision making and thereby ascertain which concepts were 
most likely to be related to surgical rate variation; 
E. Role of surgeon and patient decisional uncertainty on the treatment chosen for 
recurring tonsillitis; 




To address these objectives, I have separated my thesis into two sections:  
Epidemiological studies quantifying regional variation in tonsillectomy rates in relation to 
regional ‘need’.  
Decision-making study investigating the potential role of professional uncertainty and 
treatment preference on the treatment chosen. Please see Figure 3 Thesis architecture 
Part I is separated into three chapters (Chapters 2-4).  
In Chapter 2, I have summarised the cohorts used in the upcoming studies (FluWatch and 
CALIBER) and why I used them, how I defined outcomes, co-variates, and potential sources of 
bias.  
In Chapter 3, I have reported a population study analysing self-reported moderate-severe 
sore throat illnesses in the community, and resulting help-seeking behaviour. This chapter 
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investigated regional variation in sore throat incidence and in the rate of relevant 
consultations for sore throat after accounting for local population risk factors (Objective A).  
In Chapter 4, I have reported a study that used linked primary and secondary care healthcare 
records to investigate regional variations in recurring sore throat (Objective B) and 
tonsillectomy rates (Objective C) after accounting for local population risk factors, as a proxy 
for demand.  
Part II is separated in three chapters (chapters 5-7).  
In Chapter 5, I have evaluated the main concepts in clinical decision-making, and the 
instruments available to measure these concepts, with a particular focus on those that may 
be involved in surgical rate variation (Objective D).  
In Chapter 6, I have summarised the development of a novel instrument to measure potential 
treatment preferences for adults with recurring tonsillitis (Objective F).  
In Chapter 7, I have reported the decision-making study investigating the role of decisional 
uncertainty and treatment preferences in relation to the treatment chosen for adults 
presenting to ENT clinics with recurring tonsillitis (Objectives E & F).  
In Chapter 8, I have brought together my results from both parts together in a discussion of 






























1. Introduction  
What is the Importance and relevance of regional surgical rate 
variation? 




2. Creating electronic cohorts 
What are the Flu Watch and CALIBER 
databases and why are we using them? 
 
3. How much variation occurs before people 
see a health care professional?  
Is there regional variation in the incidence or 
sore throat in the community? 
Is there regional variation in help seeking 
behaviour for sore throat?  
4. How much variation occurs once a patient 
meets a health care professional? 
Is there regional variation in consultation rates 
for sore throat and recurring sore throat in 
primary care?  
 
Is there regional variation in tonsillectomy 
rates once we accounted for regional variation 




5. Conceptual frameworks of shared decision 
making and a review of the available instruments 
What are the key concepts within shared decision 
making that may contribute to regional 
tonsillectomy rate variation? 
How reliable and valid are the instruments that 
measure these concepts? 
  
  
6.Development of a new instrument of patient 
preferences in recurring tonsillitis 
What evidence do we have about outcomes of 
tonsillectomy? 
Which outcomes are most important to patients? 
 
  
7. A cohort study to investigate the role 
uncertainty and preferences in explaining 
tonsillectomy variation  
 
Is decisional uncertainty related the decision to 
have a tonsillectomy? 





What does this thesis add? 
What are the limitations? 




CHAPTER TWO: Creating electronic cohorts from the FluWatch study 















In this chapter, I have summarised the FLUWATCH and CALIBER programmes and the 
preparatory work I did in this thesis. I have outlined and highlighted key components of data 
management that were necessary to align existing datasets towards answering the aims of 
my thesis. I phenotyped dependent and independent variables to ensure I was measuring 
valid risk factors and outcomes. I evaluated the impact of poor data quality and summarised 






This chapter discusses two existing data sources: The FluWatch study cohort and the Clinical 
research using LInked Bespoke studies and Electronic Health Resources (CALIBER) database 
of electronic patient medical records. Since the FluWatch study was a population-based study 
of upper respiratory illness, its resulting database provided an ideal source of information of 
sore throat infections in the community and associated rate of sore throat consultations, 
allowing me to address objective A (Rate and regional variation of self-reported sore throat 
and help seeking behaviour in the community). CALIBER linked the largest primary care 
database in the world (Clinical Practice Research Database - CPRD) with secondary care 
hospital data (Hospital Episode Statistics - HES) to provide an ideal source of information on 
recurring sore throat management in primary care and secondary care, allowing me to 
address objectives B (Rate and regional variation of recurring sore throat in primary care) and 
C (Rate and regional variation of tonsillectomy in secondary care, after adjusting for local rates 
of recurring sore throat).  
FLUWATCH: Introduction 
FluWatch was a collaboration between epidemiologists at the Centre for Infectious Disease 
Epidemiology at University College London (UCL), virologists and mathematical modellers 
from the Health Protection Agency (HPA, now Public Health England), immunologists at the 
Medical Research Council (MRC) Human Immunology Unit at Oxford University and the MRC 
General Practice Research Framework (GPRF). It was created to estimate community burden 
of influenza and influenza-like illnesses, generate up-to-date knowledge of demographic, 
social and behavioural factors affecting influenza transmission, measure antibody and T cell 
immune responses to influenza and to use knowledge generated to inform modelling 
parameters. Funded by the MRC it began recruitment in 2006, however, when the H1N1 
pandemic arose in 2009 further funding was secured jointly from the MRC and Wellcome 
Trust, allowing continued follow-up and an expansion in cohort size. Additional study aims 
were to inform the national and international response to the current and future pandemics. 
Specific objectives were to examine clinical profiles of illness, estimate population infection 




Although focused on influenza, the study collected data on all respiratory illnesses 
experienced by cohort members, making it ideal for the study of the community burden of 
sore throat infections and related consultation behaviour.  
 
FLUWATCH: Cohort 
Households were recruited from registers of 146 volunteer general practices (GP) across 
England, who formed part of the MRC GPRF or (from the 2009 pandemic onwards) the 
Primary Care Research Network (PCRN). Participants were selected from GP lists by 
computer-based random number generation. GPs sent invitation letters inviting the randomly 
selected person and their household to participate. This meant that larger households, such 
as those with children were more likely to be enrolled.  
To be eligible to participate, the whole household had to agree to take part in follow-up over 
the coming winter, with adults aged ≥ 16 years agreeing to have blood samples taken. 
Exclusion criteria included household size > 6 people, individuals with terminal illness, severe 
mental illness or incapacity and heavy involvement in other ongoing research. GPs reviewed 
invitation lists and removed anyone meeting these criteria, before sending letters. Cohorts 
were recruited to allow follow-up of participants over six influenza seasons—the 2006/07, 
2007/08 and 2008/09 periods of seasonal influenza circulation, the summer and winter waves 
of the 2009 pandemic and the first post-pandemic season 2010/11. From season 3 (2008/09) 
onwards, previous participants were invited to take part again. 
In season 1, invitation letters were sent to 2300 households from 42 practices, and 602 
individuals from 243 households agreed to participate. In subsequent seasons the response 
rate was not monitored as practices (rather than the university study team) sent the invitation 
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Table 1). Compared with the English population, young adults, non-White ethnic groups, 
people living in socially deprived areas and those living in the North of England, West 
Midlands and London were under-represented in the FluWatch cohort (102,103) (for full 
breakdown of FluWatch Cohort please see Appendix A Table 35)  
Table 1 Numbers recruited by season of FluWatch Cohort. 
This table shows the numbers of GP practices used, households recruited and patients recruited through the 6 waves of 
recruitment, n=7,360.  
 
FLUWATCH: Data collected 
Baseline data 
A baseline visit was made to the household at enrolment, during which a research nurse 
assisted families with a series of laptop-based surveys collecting information on basic 
demographics, health and chronic illness, respiratory hygiene, household structure and 
relationships, accommodation, contacts and activities – baseline biosociodemographics 
data. From the third season onwards, these baseline data were self-completed by participants 
using a bespoke online survey. Overall, 7360 patients were initially consented to participate 
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Once participants had enrolled they were actively contacted every week with automated 
telephone calls to assess the presence or absence of respiratory illness in each household 
member – household weekly status report. For each respiratory illness, participants were 
reminded to fill in a prospective paper illness diary – daily illness report. The diary requested 
information on illness onset date, temperature and presence and severity of symptoms such 
as feeling feverish, headache, muscle aches, cough and sore throat. Diaries also collected data 
on contact patterns and activities before and during illness, including help seeking behaviour 
and antibiotic use. This information was completed by proxy for children. 
From the third season onwards (November 2008-March 2011), FluWatch household weekly 
status report was extracted through emails and SMS that directed participants to a custom 
built website for survey completion, if anyone in their household had suffered an illness in 
the preceding week. Participants were provided with laminated wipe-clean charts at home to 
record daily illness reports as a memory aid for when they completed the online survey. In 
the final season the EQ5D3L generic health related quality of life measure was added to the 
questionnaire and was completed during every illness.  605 participants were lost to follow 
before their first household weekly status report.  Therefore, there were 6755 participants 
for which there was illness data, over six influenza seasons. Please refer to Appendix B – Flu 
Watch data management – for a detailed explanation of how 2 data files were merged to 






FLUWATCH: Data quality 
Since I was planning to undertake research on a dataset created from daily self-reported 
symptoms from members of the public there were three key issues that needed to be 
considered with regards to the quality of the data: Representativeness, validity and 
completeness. 
The FluWatch dataset has pseudo-anonymised identifiers and did not identify the patients’ 
location except at a crude level (ten regions of England).  
Representativeness 
The FluWatch study was limited by the difficulty in obtaining a fully representative sample 
because, although selection was random, acceptance rates were low. To overcome known 
issues of non-representativeness, analyses reported in my thesis were weighted using ONS 
census data to ensure results represented the age and regional structure of the 
country{Statistics:2004vm}. I did not weight on ethnic origin or social deprivation because 
zero numbers in some groups would have led to instability of weighted measures. 
Additionally, the method of recruitment meant that larger households (up to a limit of 6 
people) were more likely to be recruited. To overcome this, analyses in my thesis, were 
weighted to the inverse of family size. Weighting was undertaken in line with previous work 
done on this cohort(102-104). 
Validity  
Understanding valid relationships between risk factors and outcomes requires an 
appreciation of the potential nature of the association, based on the available evidence. To 
improve the validity of this study considerable effort was placed on defining outcomes, 
categorising risk factors based on the available evidence and developing a conceptual model 
of potential associations. 
Defining outcomes 
Sore throat and all associated symptoms (described in the above section) were reported as 




A sore throat infection  
Since my objective in this study was to investigate regional variations in tonsillectomy rates 
in relation regional variations in the underlying disease burden for tonsillectomy, the ideal 
measure would have been a community measure of bacterial tonsillitis. However, there 
remains considerable heterogeneity between clinical signs and symptoms of all acute sore 
throat infections with no objective measure of bacterial tonsillitis currently available. There 
is currently no available data on the relationship between acute sore throat infections and 
tonsillitis. In fact, there is disagreement even amongst GPs following history and physical 
exam on the diagnosis and coding of tonsillitis (105).  Therefore, since I had no way to 
accurately and reliably measure tonsillitis in the community I chose to use symptoms that 
most closely approximated bacterial tonsillitis from the available evidence – that is moderate-
severe sore throat on 2 or more consecutive days, associated fever, and absence of a cough. 
This approximated CENTOR criteria for the diagnosis of bacterial tonsillitis(106), but did not 
include white spots on the tonsils or tender neck lymph nodes – neither of which had been 
measured in the original Flu Watch study. An episode of sore throat infection was assumed 
to have ended safely when the participant was free from symptoms for two days or more. 
A new episode was recorded after at least seven days without symptoms. A sensitivity 
analysis was conducted extending this to 14 and 21 symptom free days (see Table 2 Sensitivity 
analysis when using differing definitions of new sore throat illness.) Since there was little 
difference in the incidence of sore throat, irrespective of the disease-free interval used, I 










Each episode >7 days apart 3337 735315 4.22(3.89-4.62) <0.001 
Each episode >14 days apart 3230 735315 4.11(3.77-4.49)  <0.001 
Each episode >21 days apart 3135 735315 4.00(3.66-4.34) <0.001 




This table demonstrates the number of sore throat illnesses captured when using varying definitions of a new sore throat – 
either 7, 14 or 21 days after the previous episode finished. 
Categorising risk factors 
Age was categorised into preschool (0-4 years), school age (5-15) adolescence and young 
adult (16-24), early adulthood (25-44), middle age (45-64) and retirement age (>65) as upper 
respiratory tract infections have been shown to be different in these groups (2,107,108). 
Ethnicity was defined as white British and other (small numbers of non-white ethnicities 
precluded further meaningful sub classification). Postcode was used to define three different 
variables: 1. Participants’ geographical region in England (North, West Midlands, East 
Midlands and East of England, London, South East and South West); 2. Population density 
(defined as urban for postcodes that mapped to cities or towns or rural for postcodes that 
mapped to villages or hamlets) and 3. Index of multiple deprivation (categorised into national 
quintiles: IMD1 describing the most deprived quintile and IMD5 describing the least deprived 
quintile). Patients were defined as vaccinated if they had received the influenza vaccination 
specific to the current influenza season. Health utility/status was measured using the EQ5D-
3L questionnaire, which consisted of five dimensions (mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression), each with 3 levels of functioning (no problems, 




Conceptual models were created to help guide analyses as well as inform the discussion. 
Therefore, two models were developed to help 1. Identify causes of sore throat in the 
community (Figure 4 Conceptual model of sore throat infections.) and 2. Identify causes of 
GP consultation in those with sore throats (Figure 5 Conceptual model GP consultations for 
sore throat infections.).  
1. It was considered that sore throat could be due to infectious or non-infectious causes (e.g. 
acid reflux).  It was considered that infectious causes required contact with the infection and 




to infection could be mediated by hygiene and by immunity. I note that these mechanisms 
(contact patterns, hygiene, immunity and non-infectious causes of sore throat) were not 
directly measured.  All other risk factors were hypothesised to work through these 
mechanisms.   Age, gender and social deprivation were assumed to potentially affect all 
mechanisms. Chronic illness was assumed to act through all mechanisms apart from hygiene.  
Smoking was assumed to act through immunity and non-infectious causes.  Urban/Rural 
status and the number of people in the household were assumed to largely act through 
contact patterns. 
2. The likelihood of consultation was assumed to be potentially mediated by health service 
accessibility, characteristics of the acute illness, underlying vulnerabilities that may increase 
overall level of health concern, personalities and social norms.  Except for characteristics of 
the acute illness I did not have direct measurements for any of these mechanisms.  Age, 
gender and socioeconomic status were assumed to potentially affect all mechanisms.  Chronic 
illness was assumed to act through influencing course of disease and overall level of health 
concern. Population density was assumed to act through health service accessibility.  Ethnicity 
was assumed to act through cultural norms.  The characteristics of pain, loss of usual activity, 
loss of ability to self-care, reduced ability to go out, ear pain and duration of symptoms, were 




















Figure 4 Conceptual model of sore throat infections.  
This is a conceptual model of factors that could lead to sore throat infections. Using the infectious disease model, sore throat infections were thought to be propagated by 





GP consultation for sore throat 
Health service 
accessibility 












Loss of usual activity 
Loss of usual activity 
Loss of mobility 
Pop. Density 
 
Figure 5 Conceptual model GP consultations for sore throat infections. 
This is a conceptual model of factors that could lead to GP consultation for sore throat. The likelihood of a patient seeking a consultation was thought to be dependent on underlying vulnerabilities, social 




Completeness and missing data 
Household weekly status report responses were obtained from 88.4% in seasons 1 -2, which 
increased after the introduction of email and online surveys in season 3 to more than 92%. 
Poor responders were classified as participants from households that responded to less than 
70% of all household weekly status reports during the period they were enrolled in the study. 
Using these criteria, only 12.4% of households were classified as poor responders. Patients 
were considered lost to follow up if there was baseline data but no weekly status reports or 
the ultimate four weeks (or more) of weekly status reports were missing: 8.2% (605 
participants) were considered lost to follow up.   
Sensitivity analyses (see Table 3 Sensitivity analysis of missing data.) were undertaken to 
explore the impact of missing data. In one analysis, I assumed that weeks with a missing 
household status weekly report were weeks of no illness (assumed disease absence analysis), 
whilst in another analysis I excluded these weeks from analysis (completed weeks analysis).  
Completed weeks analysis showed a sore throat rate of 3.99(3.77-4.23)/1000-person days 
whilst analysis assuming that weeks with missing household status weekly reports were 
weeks with no illness (assumed disease absence analysis) showed a sore throat incidence of 
3.45(3.26-3.65)/1000 person days. Restricting analysis to good responders, by removing poor 










Non-reported weeks excluded 3337 735315 3.99(3.61-4.41) <0.001 
Including all weeks in study 3337 818445 3.45(3.12-3.81) <0.001 
Good reporters only 2600 587548 3.88(3.50-4.29) <0.001 
Poor reporters only 737 230897 2.43(2.01-2.85) <0.001 
Table 3 Sensitivity analysis of missing data. 
This table shows a sensitivity analysis of sore throat infections depending on whether missing weeks were excluded, 




Univariable logistic analyses were undertaken to assess which characteristics were associated 
with being from a household categorised as poor responders (Table 4 Characteristics of poor 
responders.). Non-whites, smokers, living in regions greater deprivation, living in rural 
regions, being young, having chronic illness and not being vaccinated were factors that were 
more likely to be associated with poor responders.     
 
Good responders Poor 
responders 
Odds Ratio P>Z 
Males 4177 1259 1.01(0.93-1.10) 0.772 
Females 4638 1416 1 
 
Non white 2067 125 0.67(0.54-0.84) <0.001 
White 7758 317 1 
 
Smoker 467 202 0.70(0.59-0.83) <0.001 
Non-Smoker 6789 2057 1 
 
IMD Quin 1 150 264 0.41(0.33-0.51) <0.001 
IMD Quin 2 360 799 0.52(0.45-0.60) 
IMD Quin 3 711 2373 0.78(0.69-0.88) 
IMD Quin 4 722 2450 0.79(0.70-0.89) 
IMD Quin 5 634 2713 1 
Urban 1717 860 1.36(1.24-1.49) <0.001 
Rural 5114 3485 1 
Age 
    
0-4 years 533 228 0.64(0.53-0.77) <0.001 
5-13 years 1077 363 0.81(0.69-0.95) 
14-24 years 663 256 0.71(0.59-0.84) 
25-44 years 1827 649 0.77(0.67-0.88) 
44-64 years 3103 738 1.15(1.01-1.31) 
>65 years 1612 441 1 
Chronic illness 1363 480 0.83(0.74-0.93) 0.001 
No medical problems 7010 2039 1 
Vaccinated 2152 575 1.19(1.08-1.33) 
 
Not vaccinated 6390 2039 1 0.001 
Table 4 Characteristics of poor responders. 




Completed weeks (completed weeks analysis) of all responders was chosen as the data from 
which further analyses were undertaken as it provided greater power, whilst giving no 
difference in sore throat rates. It was also free from the assumption that weeks with missing 
household status weekly reports were disease free weeks (assumed disease absence 
analysis). I therefore, report univariable and multivariable analysis based on the completed 
weeks of all responders. In multivariable analyses, the role of being defined as a good or poor 
responder was assessed for its impact in the prediction of sore throat.  
Summary 
In summary, I used the FluWatch database to study community incidence of sore throat. 
FluWatch is the largest UK based population study using patient self-report of upper 
respiratory infections to date. Any issues with representativeness of the cohort, were 
addressed by weighting analyses. Sore throat illness was defined as moderate to severe sore 
throat reported on 2 or more consecutive days, in the absence of a cough, with a fever 
reported on any day; recurrence of sore throat illness as sore throat illness with no symptoms 
in preceding seven days. Considering this was a long-term study where patients were asked 
to complete daily health diary cards during periods of illness, completeness of the data set 
was good with more than 80% good responders (>70% response rate to weekly illness 
reports). I decided to control for whether someone was a good or poor responder rather than 







CALIBER (Clinical research using LInked Bespoke studies and Electronic Health Resources) is a 
database of linked routinely collected electronic health records (EHR) from England(109), 
comprising data from primary care (Clinical Practice Research Datalink, CPRD)(109), hospital 
admissions (Hospital Episode Statistics, HES)(110), the Myocardial Ischaemia National Audit 
Project (MINAP)(111) and the national death registry at the Office for National Statistics 
(ONS).  
In addition, CALIBER contains small-area indices of deprivation from ONS (Index Of Multiple 
Deprivation, IMD) linked by the patient’s postcode(112). The IMD is a score calculated for 
each patient’s neighbourhood based on social indices such as income, education, and 
employment. 
The data sources complement each other in providing different types of information about a 
patient’s medical history longitudinally, illustrated with a cardiovascular disease example in 
Figure 6 Data linkage principles in CALIBER. 
 
Figure 6 Data linkage principles in CALIBER. 





The CALIBER dataset has GP records from 1988 to 2010, but does not include routine 
information on attendance in hospital outpatients or accident and emergency departments.  
The CALIBER dataset has pseudo-anonymised identifiers and does not identify a patient’s or 
general practice’s location except at a very crude level (one of 10 regions in England). Further 
descriptions of the datasets utilised in the subsequent chapters; CPRD, HES and ONS are 
detailed below.  
Access to data 
Access to CALIBER data operates by a ‘safe haven’ model with datasets stored and analysed 
securely and only aggregate data exportable(113). CALIBER researchers are provided with 
pseudonymised data (i.e., identifiers such as date of birth, name and address removed) and 
must commit to not disclosing any information that may be able to identify a patient. Whilst 
the free text associated with coded data is not routinely available to researchers, it can be 
requested (with a cost for manual anonymisation) and has been used for validation 
studies(114). 
Ethical and scientific approval 
CPRD has Multi-centre Research Ethics Committee approval for all purely observational 
research using its linked EHRs (CPRD, HES, ONS)(115).  
The CALIBER dataset comprises CPRD data linked to HES, ONS and MINAP by a trusted third 
party with the final dataset held in a pseudonymised form. In addition, the CALIBER record 
linkage study has had separate ethical approval (09/H0810/16).  
Although direct identifiers such as name and date of birth are not contained within the data, 
the amount of information about individual patients is quite detailed so it is treated as 
sensitive. Prior to data release, individual studies using CALIBER must be approved by the 
CPRD Independent Scientific Advisory Committee (ISAC). This study was granted individual 





CALIBER: Data collected 
Primary care data: Clinical Practice Research Datalink (CPRD) 
CPRD is an ongoing primary care database of anonymised medical records from general 
practitioners, with coverage of over 11.3 million patients from 674 practices in the UK 
(England, Wales, Scotland and Northern Ireland)(116). It represents one of the largest 
databases of longitudinal medical records from primary care in the world.  
The population of active patients (alive and currently registered) on July 2013 was 4.4 million 
(6.9% of the UK population) and is broadly representative in terms of age, sex and ethnicity 
of the total UK population. The CPRD is therefore a rich source of health data for research, 
including data on demographics, symptoms, tests, diagnoses, therapies, health-related 
behaviours and referrals to secondary care. 
Clinical encounters are entered onto the CPRD database using READ codes. READ terminology 
is a structured hierarchy of both medical and non-medical terms covering several areas 
including categories for signs and symptoms, diagnoses, investigations, treatment and 
therapies, drugs and appliances, occupations and administrative processes. They therefore 
offer a comprehensive list of clinical terms that can be used to describe the care and 
treatment of patients.  
Information in the CPRD is recorded in several tables, which can be linked by the 
pseudonymised patient identifier to build up a complete picture of a patient’s healthcare 
experience.  
Patients – one row per patient, with demographic details such as year of birth, date of death 
and registration dates.  
Practices – one row per practice, giving details such as region of the UK and the date when 
the practice achieved ‘up-to-standard data’ (Described further below).  
Consultations – each patient episode is considered a ‘consultation’ and all data are entered 
in consultations (face-to-face, telephone or administrative). This table allows diagnoses and 
prescriptions entered in the same consultation to be identified.  




Events –Each event is linked to a single consultation and an event date, a medical dictionary 
code (READ code), product dictionary code (Multilex) and/or associated information in free 
text.  
Clinical – READ coded diagnoses entered by the GP with additional data such as observations  
Referrals – referrals to secondary care, with the indication recorded as a READ code  
Immunisations – records of immunisations  
Therapy – prescriptions  
Test – results of laboratory tests, each with a READ code  
Secondary care data: Hospital Episode Statistics (HES) 
Hospital Episode Statistics (HES) is a database warehouse containing details of all admissions, 
procedures, outpatient appointments and Accident & Emergency (A&E) attendances at NHS 
hospitals in England(109,111,113). It is a records-based system that covers all NHS trusts in 
England, including acute hospitals, primary care trusts and mental health trusts with 
information on each hospitalisation stored as a large collection of separate records (one for 
each period of care) in a secure data warehouse. This data is collected during a patient’s time 
at hospital and utilised to allow hospitals to be paid for the care they deliver. Currently, in the 
CALIBER dataset, only information on admissions and procedures from HES is available.  
Data on diagnoses are logged using the ICD-10 coding system whilst information on 
procedures is stored using the OPCS4 coding system(117,118). ICD-10 is the 10th revision of 
the World Health Organization’s medical classification system(119). It contains codes for 
diseases, signs, symptoms, abnormal findings, complaints, social circumstances, and external 
causes of injury or disease. OPCS-4 is the coding system for operations, procedures and 
interventions performed during inpatient stays, day case surgery and some outpatient 
treatments in NHS hospitals (119). Patients are identified by their NHS number in the same 





Death registry & deprivation: Office of National Statistics (ONS) 
The death registry for England and Wales curated by the Office for National Statistics (ONS) 
includes the date of death and the causes entered on the death certificate. A single underlying 
cause of death is allocated according to the WHO ICD-10 algorithm based on the information 
recorded on the death certificate, likely causal sequence and ICD selection rules (120).  
Deaths in England and Wales have been coded using ICD-10 since 2001 and ICD-9 in previous 
years. Due to a change in the rules for selecting the underlying cause from ICD-9 to ICD-10, 
the causes of deaths are not directly comparable between 2001 onwards and previous years.  
The Index of Multiple Deprivation (IMD) is a composite measure of deprivation calculated by 
ONS using indicators for super output areas (postcode areas). It covers the following domains; 
(i) Income, (ii) Employment, (iii) Health and disability, (iv) Education, skills and training, (v) 
Barriers to housing and services, (vi) Crime and (vii) Living environment (121).  
Data management  
See Appendix C CALIBER Data management - Figure C 1 Merging cohort data with co-variate 
data, Figure C 2 Creating main cohort/denominator file, Figure C 3 Creating platform files for 
analyses. 
Since my objective in this study was to investigate regional variations in tonsillectomy rates 
in relation regional variations in the underlying disease burden for tonsillectomy, the ideal 
measure would have been a primary care measure of bacterial tonsillitis. However, there 
remains considerable heterogeneity between clinical signs and symptoms of all acute sore 
throat infections with no objective measure of bacterial tonsillitis currently available. There 
is disagreement even amongst GPs following history and physical exam on the diagnosis and 
coding of tonsillitis (105).  Therefore, since I had no way to accurately and reliably measure 
tonsillitis in the primary care I chose to use a sensitive measure that included all sore throat 
consultations, assuming that the ratio of sore throat consultations to tonsillitis consultations 
did not vary from region to region.  
Data were provided as comma separated value files, on a secure server. Files were separated 
by cohorts of pre-defined medical co-morbidities, two cohort files that had basic patient 




rank, ethnicity, date of leaving the practice, date of death), a file with all sore throat 
consultations (using codes defined in the process above), and a file with all tonsillectomies.  
I undertook several steps that allowed these various files to be converted into the final six 
platform files that were ready for analysis. The steps are outlined in the flow diagram below 
and described as text in the following paragraphs.  
Within the CALIBER cohort, that had patients from 1988 to 2010, there were 4,703,547 
patients, 2,891,511 sore throat consultations and 29,578 tonsillectomies (not necessarily for 
recurring tonsillitis on each occasion) recorded. However, I restricted our cohort so that 
inclusion began from 1st January 1997, as this was the date HES data was linked to CPRD. 
Furthermore, I restricted our cohort so that each patient could only enter following the date 
their GP practice was deemed to be up to standard practice (UTS). This was to ensure high 
quality data were used for analyses. Approximately 400,000 patients were dropped as they 
did not meet these two basic requirements.  
Sore throat consultations that occurred on the same day (104,362) or within 21 days of the 
previous sore throat consultation (210,423) were dropped to ensure I was measuring 
different illnesses. Had I changed the definition to 14 days or 7 days I would have removed 
169,060 or 104,630 consultations, respectively. However, given that an average sore throat 
lasts for seven days (FluWatch) and a follow up consultation can be scheduled for two weeks 
after the first to ensure the symptoms have resolved, I felt that 21-day washout after the first 
consultation would ensure that review consultations could not falsely inflate the rate of 
consultations for active episodes of sore throat.  
Whilst there were 29,578 tonsillectomies reported within CALIBER more than 1500 were 
duplicated entries due to the use of additional codes. Therefore, only 28,046 patients had 
undergone a tonsillectomy within our cohort. The sore throat consultation and tonsillectomy 
files were merged and then added to the cohort file that had dates of entry and exit from our 
cohort. Consultations and tonsillectomies that occurred on dates that were outside the period 
of risk defined in our cohort were excluded. Therefore, more than 1.14 million sore throat 
consultations and 10,764 tonsillectomies were removed. There were 3,560,864 patients in 




I added a variable that defined recurrence as having three sore throat consultations within a 
year (each sore throat consultation being 21days apart from each other) and restricted to 
tonsillectomies that had received an ICD-10 code for recurring tonsillitis. 16,618 had received 
a tonsillectomy for ICD-10 code of recurring tonsillitis. 
 
Three files were created to separate the outcomes of interest (sore throat consultation, 
recurring sore throat consultations and tonsillectomy for recurring sore throat).  
Files were further divided by age, into children (15 years and younger) and adults (16 years to 
44 years old. This age range was chosen because above the age of 44 the risk of tonsillectomy 
is very low, however the number of years added to the denominator is substantial, resulting 
in a falsely inflated denominator. These six files formed the platform files from which our data 





CALIBER: data quality 
Representativeness 
When compared with the UK census in 2011 (122,123)) CPRD patients are broadly 
representative of the UK population in terms of age and sex (109). Patients are also 
comparable to the UK census in terms of ethnicity(124), and comparable to the Health Survey 
for England for body mass index distribution in most patient subgroups(125). However, the 
CPRD may not be representative of all practices in the UK based on geography and size(126). 
There are also certain patient groups that are missing from primary care records, such as 
prisoners, private patients, some residential homes and the homeless.  
 
Validity and misclassification  
Validity in this context describes how well a specific code (or combination of codes) used 
pragmatically in routine healthcare records describes the presence of a specific diagnosis 
needed for research purposes. Conversely, it also relates to how well the absence of a code 
(or a combination of codes) in the routine healthcare record predicts the absence of a specific 
diagnosis needed for research purposes. CALIBER researchers need to rely on READ codes 
that GPs have assigned to consultations or ICD-10 codes that hospital coders have assigned 
to hospitalisations. In routine practice, clinicians may not have applied the strict case 
definitions when allocating diagnostic codes that are defined by researchers. If this happens 
it is termed misclassification. 
Misclassification can occur in the selection of the patient population, exposure, confounders 
and outcomes. It is commonly categorized as either non-differential or differential 
misclassification. For example, in non-differential exposure misclassification, the 
misclassification is deemed unrelated to the occurrence or presence of disease. In contrast, if 
the misclassification of exposure is different for those with and without disease, it is 
differential.  Misclassification can have a large impact on how well we can predict for a disease 
from the code, and therefore affect the sensitivity, specificity, positive and negative predictive 
values. Even small changes in sensitivity and specificity can have large impact on the 




Studies that have explored the validity of diagnoses on CPRD have shown high positive 
predictive values. In fact, a systematic review of CPRD validation studies noted that diagnoses 
were generally reliable(128). And, where evaluated these studies have also shown an 
incidence of disease that is comparable to other UK datasets(129-133). However, these 
studies rarely describe other components of validity such as negative predictive value, 
sensitivity or specificity.  
Numerous epidemiological studies have been performed using HES with validation studies 
confirming that HES records on RTIs appear to be both reliable and complete (108). However, 
due to its primary purpose as an administrative dataset, caution is advised when undertaking 
studies due to its research utility being limited by data accuracy at illness level and limitations 
of the ICD-10 coding system. In fact, an audit study investigating the validity of codes in HES 
for surgical patients, when compared to patients’ complete hospital records, demonstrated 
that at least one change was required in 55% of cases.  However, only 17% of primary 
diagnoses required changing(134).  When looking more specifically at HES coding of surgical 
procedures, 12% of coded operations required revision(135).  In a similar study where the 
authors looked more specifically at HES coding for otolaryngological admissions and 
procedures they reported that primary diagnoses and procedures were incorrect 13% of the 
time (136). These studies were primarily aimed at reporting lost hospital earning through 
inaccurate coding and may have a different priority when suggesting primary codes for 
diagnosis and operations. Additionally, personal correspondence from the authors of these 
studies has shown that coding error increased with complexity of admission and operations. 
Indeed, there was little coding error for patients admitted electively for a tonsillectomy 
(personal correspondence). Therefore, the evidence suggests good validity and little 
misclassification in the use of tonsillectomy codes to depict patients who underwent 
tonsillectomy.  
The implications of CPRD misclassification in our study can be seen in the following two 
examples: 1. Since the use of antibiotics in primary care is now highly scrutinised due to 
bacterial resistance, it is possible that General Practitioners wishing to prescribe antibiotics 
for their patients with upper respiratory infections may be more likely to code their 




infection may reduce the specificity in detecting patients with bacterial tonsillitis. 2. 
Alternatively, GPs may code all patients with upper respiratory tract infections (including 
tonsillitis) as ‘sore throat’, for ease. Using only the bacterial tonsillitis code to define tonsillitis 
would miss cases and reduce sensitivity. Indeed, there is evidence that there is considerable 
variation amongst coding practices for GPs, especially for sore throat illnesses (137,138). To 
reduce the risk of misclassification it was important to have an appropriate definition of my 
outcome of interest (phenotype) and a robust method that would allow the identification of 
READ codes that identified my outcome of interest (phenotyping). This process is detailed 
below.  
Sore throat consultation phenotype 
Since my objective in this study was to investigate regional variations in tonsillectomy rates, 
and the underlying disease burden for tonsillectomy, variations in coding practice could 
greatly influence my conclusions. The underlying disease burden in this case related to 
recurring tonsillitis (57). However, we know this that there is variation in how GPs diagnose 
tonsillitis (105) and how they define recurrence of tonsillitis (139). Therefore, if a very 
specific definition of underlying disease burden was used (e.g. “recurrent streptococcal 
tonsillitis”) then variations in coding practice may be more readily interpreted as variation in 
underlying disease burden. However, if a very sensitive definition of underlying disease 
burden was used (all codes that could be related to recurrent tonsillitis, such as ‘sore throat’) 
then variations in coding practice would be diluted, but conclusions may be harder to reach. 
Therefore, I chose to use sore throat (which includes tonsillitis) variation as a surrogate 
marker for tonsillitis variation, which assumes that the ‘ratio’ of sore throat to tonsillitis is the 
same across the geographical entities you compare. It is an assumption which is however 
sensitive to help-seeking for sore throat being the same across the land.  Additionally since 
here is higher number of sore throat consultations than tonsillitis consultation modelling is 
relatively more robust to small number issues than it would have been if I had gone out for 
tonsillitis. 
 I opted, in the end, to use a sensitive measure of disease burden underlying tonsillectomy, 
which describes the overall rate of all consultations for sore throat infections, rather than 




unreasonable, as the ratio of sore throat to tonsillitis is likely to be the same across the various 
geographical regions which are compared in the thesis. The sore throat phenotype also 
includes tonsillitis. This meant that the specificity of my case definition – acute sore throat 
consultations - was low when measuring bacterial tonsillitis resulting in many non-true cases 
being included, potentially diluting variations in the recurrent tonsillitis. Having an increased 
number of sore throat consultations included may be beneficial, however, as it results in my 
modelling being more robust to small number issues and variation due to chance. To 
investigate if my definition of sore throat infection was valid I cross referenced the incidence 
of sore throat calculated using this phenotype definition CALIBER and compared it the 
predicted incidence of sore throat to my population study that had detailed information 
about rate of consultations for sore throat illnesses. 
Recurring sore throat phenotype 
Whilst our definition of sore throat consultations was broad and not specific to consultations 
of bacterial tonsillitis, I decided to opt for a more specific definition of recurring sore throat, 
which may relate more accurately to patients who were at risk of a tonsillectomy. National 
guidelines advocate referral to ENT to consider a tonsillectomy if a patient has 3 episodes of 
tonsillitis a year for 3 years, 5 episodes a year for 2 years or 7 episodes a year for one year(57). 
However, I was cognisant that not every sore throat requires primary care consultation, 
especially now that national guidelines discourage the overuse of antibiotics for throat 
infections(140). Therefore, GPs and ENT surgeons often judge the frequency of sore throat 
recurrence based on the patients’ recall rather than documented evidence of consultations. I 
undertook a sensitivity analysis to assess the impact of defining recurring sore throat as 3 or 
more versus 5 or more sore throat consultations over a year. I assessed which definition could 
sensitively and specifically detect those that had a tonsillectomy for recurring tonsillitis. 
Whilst both definitions had high specificity, defining recurrence at 5 or more sore throat 
consultations in one year produced an extremely low sensitivity (3.5%) (see Table 5 Sensitivity 
analysis for definition of recurring sore throat). I therefore, chose to define recurrence at 3 or 
more sore throat consultations within a year, with each consultation being more than 21 days 




illness lasted 7 days (interquartile range 4-10days, and therefore 21 days was considered 







undertaken not in 
this group 
Total patients who 
meet definition of 
recurrence 
Sensitivity Specificity 
>2 episodes a years 7040 9578 45,443 42% 98.9% 
>4 episodes a year 585 16033 1260 3.5% 99.9% 
Table 5 Sensitivity analysis for definition of recurring sore throat. 
 This table shows that using a definition of more than 2 GP sore throat consultations (based on READ codes on CPRD) more 
sensitively identifies patients who had a tonsillectomy for recurring tonsillitis (based on ICD-10 codes on HES) than 3 or more 
GP sore throat consultations (n=45,443). 
Tonsillectomy phenotype 
The majority, but not all, tonsillectomies are undertaken for recurring tonsillitis. The 
procedure is also indicated for cancer and obstructive sleep apnoea. Therefore, it was 
important to identify patients who had tonsillectomy for recurring tonsillitis. Additionally, all 
tonsillectomies in England are undertaken under anaesthesia and in a secondary care setting. 
Patients who have a procedure receive an OPCS4 code and the indication for their procedure 
is recorded as their diagnoses with ICD-10 codes. For these reasons, I used the HES database 
to identify patients who had undergone tonsillectomy, and then restricted patients to those 
who had received an ICD-10 code for tonsillitis as their primary diagnosis.   
 
Phenotyping code lists 
As part of the phenotyping process, codes of interest (e.g., diagnostic, symptom, medications) 
needed to be identified and listed according to the relevant source dataset terminology (e.g., 
selecting all READ terms for sore throat infections to assess sore throat infection consultations 
in primary care). There are thousands of potential terms per terminology, with a varying 




Code lists were developed by an iterative process which involves searching for terms in the 
dictionaries, combining selections of terms to derive a final set of chosen terms, and assigning 
a category to these terms.  
In CALIBER, the production of code lists is assisted by the use of; (1) the CALIBER Data Portal, 
a web portal for researchers to access descriptions of contributed CALIBER clinical phenotypes 
(phenotypes), the underlying development process and code lists of Read, ICD-10 or OPCS 
codes used to define them and (2) R packages created by Dr Anoop Shah; the R 
CALIBERcodelist package(141). This is illustrated in the Figure 7 Process for generating a code 
list using the R CALIBERcodelists package. 
 
Figure 7 Process for generating a code list using the R CALIBERcodelists package 
This diagram demonstrates how multiple codes, across code libraries, received during routine medical care can be phenotyped 
to reliability represent a medical condition. 
 
1. Decide which source dictionaries to use, e.g. READ, ICD-10 and/or OPCS 
2. Create a selection of terms from source dictionaries (e.g., all terms containing the 
word ‘throat’ or all ICD-10 codes beginning with ‘I10’). Combine selections using 
Boolean operators such as AND, OR or NOT to identify exactly which terms are of 
interest. 
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1. Decide which source dictionaries to use, e.g. Read, ICD-10 and/or OPCS.
2. Create a selection of terms from the source dictionaries. e.g. all terms containing the word ‘angina’,
or all ICD-10 codes beginning with ‘I20’. Combine selections using Boolean operators such as AND,
OR or NOT o identify exactly which terms are of inte st.
3. Allocate a category to terms in a particular selection, e.g. ‘history of angina’.
4. Set the metadata for the codelists under construction (version number, category descriptions, author
name, date). Extract the Read, ICD-10 and OPCS codelists and save them in a standard ﬁle format.
5. Ask clinicians and epidemiologists to review the codelists and suggest any changes. Also it may
be useful to validate the codelist by exploring CALIBER data, e.g. comparing myocardial infarction
records extracted using a Read codelist versus records in MINAP. The algorithm can be changed and
the results compared with the previous version if necessary.
6. Approved codelists with documentation can be shared on the CALIBER data portal (section 3.7 on
page 61) for use in subsequent studies.
developed by the CALIBER data manager to automatically extract records of interest
from the CALIBER master database. All codelists stored on the data portal have a version
number in order to track which versions of each codelist were used for a particular project.
4.3.6 Phenotyping algorithms
The phenotype of an individual is the set of observable characteristics about that person,
which may include clinical measurements such as height and blood pressure, or disease
states such as diabetes or coronary artery disease. In electronic health record research,
one is interested in studying the phenotype but the information about the phenotype is
what is recorded in the electronic health record. It is crucial to understand the process by
which information about a subject enters the record in order to be able to interpret it and





3. Allocate a category to terms in a particular selection, e.g. ‘Sore throat’ 
4. Set the metadata for the code lists under construction (version number, category 
descriptions, author name, date). Extract the READ, ICD-10 and OPCS code lists and 
save in a standard format. 
5. Undertake a consensus meeting with clinicians and epidemiologists to review the code 
lists and suggest any changes. The algorithm may be iteratively changed with results 
compared with previous versions if necessary. 
6. Approved code lists with documentation can be shared on the CALIBER data portal for 
use in subsequent studies 
In CALIBER, sore throats can be classified using either diagnostic or symptom codes, each of 
which has potential limitations:  
Diagnoses codes: Assuming the patient and/or healthcare professional know what type of 
sore throat the patient has, it can theoretically be coded using the specific READ or ICD-10 
code. However, some codes are ambiguous, for example ‘throat pain’ could have infectious, 
inflammatory, neuropathic or traumatic causes. In our case, I would only be concerned with 
infectious causes of sore throat, which if they were to become recurrent a tonsillectomy may 
be recommended. In addition, some patients may have conflicting diagnostic codes issued on 
the same day.  
Symptom codes: In contrast to diagnostic codes, these are usually more ambiguous and may 
range from ‘sore throat’ to ‘cough’ and ‘fever’. Based on clinical knowledge, sore throat in a 
child can be classified as either laryngitis or tonsillitis (i.e., URTIs). In contrast, cough could 
either be an URTI or LRTI whilst fever, a sensitive marker for an infection, is more non-specific 
and may be a possible RTI.   
In developing the algorithm, I reviewed a previously published code list for identifying sore 
throat infections in UK primary and secondary care datasets(2,142,143). I used this list to 
add to my search terms and as final check against my code list to ensure no codes had been 
omitted.  
Diagnostic and symptom codes were searched through the READ and ICD-10 dictionaries 




“larynx*” were used. The programme returned all codes that contain the search term as a 
prefix or suffix as well as codes that were ontologically similar.  
The initial search with these terms returned 267 codes that contained the search terms and 
a further 689 that were similar ontologically. Review of the ontologically similar codes 
provided additional search terms: “uvul*”, “quinsy”, “fauces” “upper respiratory” and 
“mouth”. The search was reinitiated with both the primary and additional search terms. This 
returned 898 codes that contained the search terms and 2687 ontologically similar. The 
ontologically similar codes were initially searched to ensure there were no missed terms that 
could be used on a further search. Since there were no new search terms the iteration was 














The reviewers (NM, LM and MM) were asked to short list the extensive list to codes that could 
be used as a marker for consultations that related to acute sore throat infections, that could 
be treated with a tonsillectomy should they become recurrent. They were allowed to mark 
codes as definite exclude, definite include and unsure. The task was undertaken on excel and 
once complete the two files were merged. All codes that both reviewers had marked as 
definite exclude were dropped (2956 codes excluded). 79 codes were marked by both 
reviewers as definite include. All codes where reviewers disagreed, or were marked by either 
reviewer as unsure disagreed were discussed. 550 were marked as unsure by one or both 
reviewers, or were marked differently by reviewers.  Consensus was reached between 
reviewers on 532 codes, with a 30 further codes added to the list of inclusions.  For eighteen 
codes where consensus could not be reached a third senior ENT doctor was asked for his 
opinion, and codes were included or excluded depending on the majority vote (2 or more 
reviewers). The process is illustrated in Figure 8 Generating a sore throat codelist. For a full 
codelist please see Appendix U - Sore throat codes.  
79 codes added 
30 codes added 
2 codes added 
111 codes selected to 
define sore throat 
Figure 8 Generating a sore throat codelist 
. This diagram shows I searched for codes of interest using key search terms that were revised and search reiterated based on 




These code lists were subsequently discussed and finalised at a consensus meeting that 
consisted of an ENT surgeon (Anne Schilder), a biostatistician (Hannah Evans) and an 
infectious diseases epidemiologist (Andrew Hayward). One hundred and eleven codes were 
classified as either “Probable” (n=30) or “Possible” (n=81), in relation to whether they 
described codes for consultations about acute sore throat infections, that could be treated 
with a tonsillectomy should they become recurrent.  Codes that were “Probable” accounted 
for less than 10% of all codes used and had very low sensitivity (<4%) for detecting patients 
who went on to receive a OPCS4 code for tonsillectomy associated with an ICD-10 code for 
recurring tonsillitis. Additionally, it was known that there was heterogeneity in the coding of 
sore throat illnesses by GPs (105). And finally, tonsillectomy may actually be of benefit for 
recurring sore throat infections, other than bacterial tonsillitis. For all of these reasons,  I 
chose to use a sensitive code list of sore throat consultations – that is all 111 codes. 
Analysis of the FluWatch dataset showed that median sore throat illness lasted 7 days 
(interquartile range 4-10days), and therefore 21 days was considered more than sufficient to 
define a second illness. This ensured that I did not mislabel surveillance checks on previous 
illnesses as a new throat infection. I undertook a sensitivity analysis using a 7, 14, and 28 day 
wash out period, but since there was no change in the overall incidence I chose the more 
conservative period of 21 days. 
This procedure was repeated for codes that would relate to tonsillectomy on OPCS4 coding 
and tonsillitis related diagnoses on ICD-10. This procedure was relatively simple as there were 
only 3 OPCS codes for tonsillectomy (F34..) and 8 (J03/J35) ICD-10 codes for tonsillitis related 
conditions.  
Categorising co-variates 
Age was categorised into preschool (0-4 years), early school (5-15) adolescence and young 
adult (16-24), early adulthood (25-44). Adults over the age of 45 were rarely at risk of 
recurring sore throat (only 2% of those with one sore throat consultation go on to have 2 
more within a year) or tonsillectomy for recurring sore throat (less than 10% of all 
tonsillectomies, but more than 50% of the time at risk), therefore, I removed them from 





Table 6 The role of age in recurring sore throat and tonsillectomy. 
This diagram demonstrates the number of sore throat consultations as recorded on CPRD compared to tonsillectomies for 
recurring tonsillitis recorded on HES by age group. As can be seen those over 44 account for half of the time at risk but less 
than 10 percent of all tonsillectomies, (n=1,440,002 person years). 
 
  
Ethnicity was defined by ONS census categories into White British, Indian, Black African, Black 
Caribbean, Black other, Bangladeshi, Pakistani, Other Asian, Chinese, Mixed, Other, Unknown. 
Participants’ geographical region was categorised by the 10 geographically based Strategic 
Health Authorities that manage local health care: North East, North West, Yorkshire & The 
Humber, East Midlands, West Midlands, East of England, South West, South Central, London 
and South East Coast. Social deprivation (categorised into national quintiles based on the 
index of multiple deprivation: IMD1 describing the most deprived quintile and IMD5 
describing the least deprived quintile).  
Code lists for the following conditions (that is potential risk factors for sore throats, recurring 













n (% of those 
who had sore 
throat) 
Total number 
of patients who 
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throats in those 









tons who had 
less than 3 GP 
sore throat 
consultations 
0-4 347,734 117443 4871 (6%) 1254 (36%) 6.09(5.89-6.28) 11 
5-15 2,253,956 358790 13385 (9%) 6396 (45%) 4.67(4.58-4.76) 35 
16-24 2,360,050 267991 12,726 (7%) 4274 (38%) 4.30(4.20-4.39) 35 
25-44 5,347,471 432555 10,381 (4%) 3490 (29%) 3.57(3.48-3.66) 41 
>44 1.06107 263223 4080(2%) 1204 (23%) 2.27(2.17-2.37) 68 




Health Informatics using the same methodology I have used to develop the sore throat code 
list. Code lists were stored on a secure server with a file that explained how they were 
developed and the final do file that could be run to generate them again. Below is a list of 
how I categorised other potential risk factors for analysis.  
Respiratory illness was classified based on published literature as a child having ever been 
given the diagnosis of asthma (any code starting H33) (144) or an adult having been given the 
diagnosis of asthma (any code starting H33) (145) or chronic obstructive pulmonary disease 
(a specific COPD code, more than one prescription of a COPD medication and 
spirometry)(146).  Obesity was classified based on published literature (125) and was defined 
on body mass index greater than 29, recorded at least once during their window of 
observation. Obstructive sleep apnoea was diagnosed for any patient that received codes for 
this condition during their window of observation. HIV status was classified as positive if the 
patient had ever received the code. I did not use AIDs defining illness to define HIV status in 
the absence of a HIV positive test result. Eating disorder was defined based on published 
literature(147). Cases were identified if they had received the diagnosis of “Anorexia 
Nervosa”, “Bulimia Nervosa” or “Eating disorder unspecified”, “Atypical AN” or “Atypical BN” 
during their window of observation.  Alcohol consumption was measured in adults only and 
based on previously published literature(148): Non-drinkers were patients who had codes 
such as “teetotaller”, “non-drinker”, “stopped drinking alcohol” and “ex-drinker”, Mild-
moderate drinker was used to classify those that had received codes such as “drinks rarely”, 
“drinks occasionally”, “alcohol intake within recommended sensible limits”, “light drinker” 
”drank within daily and/or weekly recommended sensible drinking limits for the UK”, and 
heavy drinkers were classified as those who received codes such as “alcohol intake above 
recommended sensible drinking limits”, “hazardous alcohol use” and “exceeded daily and/or 
weekly sensible drinking limits.” Smoking status was defined based on published literature 
into non-, ex- and current smoker(149). Diabetes: Patients were classified as being diabetic 
if they received at least 1 prescription for a noninsulin antidiabetic drug (NIAD) (150) during 
their window of observation. Hypertension: Patients were classified as being hypertensive if 




blood pressure measurements within one year, or patient received 2 blood pressure lowering 
medications within one year (113). 
 
Completeness and missing data 
Whereas misclassification is important for the case definition, missing data are more relevant 
to co-variates in the study. Missing data are common in large datasets, collected over long 
periods of time (151). Additionally, when a dataset is created for record keeping in busy 
clinical practice, missing data may be more likely than in cohort studies that are dedicated to 
the creation of a research-ready database (152). Since CPRD is the largest database of 
primary care in the world, collected for routine medical records, missing data are expected. 
There are two mechanisms that keep missing data down. The first is routine data quality 
checks: Practices participating in CPRD are assigned an “up-to-standard” date by CPRD 
custodians based on acceptable standards on ten practice-based measures of quality, 
completeness and representativeness. Once deemed “up-to-standard”, their data is marked 
as suitable for longitudinal data research. Conventionally, clinical data from patients are 
restricted from the date their practice were deemed “up-to-standard”. Practice data are 
checked once delivered to CPRD for data quality issues. Any practices submitting poor data is 
provided feedback and if coding practices are not rectified, data from their practice are 
subsequently removed from CPRD (114). The second relates to the introduction in 2004 of a 
national incentive payment program for GPs that encouraged better record keeping of key 
data items (for example smoking status and the delivery of services to key patient groups). 
This resulted in a large drop in missing data (109).  
Nevertheless, the issue of missing data needs careful consideration as incorrect assumptions 
of their underlying mechanisms could have a big impact on the conclusions reached. Data can 
be classified as missing completely at random (MCAR), missing at random (MAR) and missing 
not at random (MNAR) (153). Three examples are shown below of how the different 
mechanisms of missingness could occur in a study examining tonsillitis rates through patients 
who received READ codes of tonsillitis in CPRD: 1. Tonsillitis codes could be MCAR if all CPRD 




complete chance, and not based on their own characteristics or the way tonsillitis is coded.  
2. Tonsillitis codes could be MAR if they were recorded more frequently in children than in 
adults, as adults frequently present with more than one symptom.  Therefore, in adults, 
tonsillitis cases were missed at random. In this case, the chance of missing cases of tonsillitis 
did not depend itself on the presence of tonsillitis but on another patient characteristic – i.e. 
age. 3. If adults with tonsillitis were more likely to attend Accident and Emergency, or walk-
in centres, then cases missed from CPRD could be described as MNAR.  Unfortunately, the 
assumptions that differentiate the mechanisms of missingness are difficult to ascertain. 
Multiple strategies exist for reducing bias produced by missing data and be divided into 
deletion methods and imputation methods.   
Deletion methods 
There are two deletion methods available, listwise and pairwise deletions. Both are more 
applicable if the data are assumed to be missing completely at random.  
Listwise deletion or complete case analysis restricts analyses to patients who have data 
available on all variables, i.e. have no missing data. This allows for comparability across 
analyses, but reduces statistical power and produces biased results if data are not MCAR, e.g. 
investigations into the relationship of age and tonsillitis would be restricted to patients who 
have no missing data on any variables (including smoking). If, however, smoking status was 
more likely to be missing in adults than in children and all patients with missing smoking status 
were excluded, the association between age and tonsillitis would be biased.  
Pairwise deletion or available case analysis restricts analyses to cases in which variables of 
interest are present. This allows maximum use of data available, but prevents comparison 
across analyses as each analysis related to a slightly different sample, e.g. investigations into 
the relationship of age and tonsillitis, would be restricted to cases that had no missing data 
for tonsillitis or age only. Patients who had missing smoking status but had data on age and 
tonsillitis would still be included. Whilst this method makes fewer assumptions on the 
mechanisms of missingness and allows the use of as many cases as possible, we cannot 





Imputing, or replacing, missing data can be divided into single or multiple imputation 
methods. Imputing methods are especially valuable when data are assumed to be missing at 
random.  
Single imputation methods include replacing missing data with the nearest value(154) or field 
average (mean, mode, median)(155). This method can be supplemented with adjusting for 
missingness, by creating a variable that is positive when the data field was initially missing. 
These methods reduce variability within the variable and may weaken correlation between 
the imputed variable and others. Alternatively, missing field can be replaced by a regression 
value, or one that is predicted based on the relationship of the outcome of interest and a 
second variable. For example, if height varied with age and one height recording was missed 
in a child’s clinical records, the missing field could be imputed based on a regression model 
between the observed correlation between his height and age. However, this method 
overestimates model fit and weakens variance. Overall, single imputation models introduce 
false precision, by reducing the obvious uncertainty of the missed variable, and they ignore 
associations of the missing variable with the whole dataset, therefore, they are not ideal for 
inference.  
Multiple imputation methods, builds on regression imputation, and involves filling in each 
missing value with several plausible values, based on many other variables, in a way that 
reflects the uncertainty about them and their relationship to the overall database. This results 
in the creation of multiple datasets, which are each analysed individually, and the estimates 
of the missing values are combined to produce a likely value for the missing field. This method 
allows for uncertainty inherent to the variables’ missingness and a more accurate 
measurement of the relationship of the missing variable to other variables in the data set.  
However, multiple imputation greatly adds to the complexity of the modelling and there is 
considerable room for error in the manner the model is specified(156).  
In our analysis co-variates appeared to be missing at random after adjusting sore throat 




following basic tests (Associations between polymyalgia rheumatica and giant cell arteritis 
and 12 cardiovascular diseases(157,158)).  
I used a mixed approach to deal with missing covariates since most variables in the full dataset 
had a degree of missingness. I felt that within our cohort of children and young adults (0-45 
years old) a missing code was more likely to represent the absence of a disease rather than 
missed diagnosis for conditions that were not actively being routinely measured in our 
population (e.g. atrial fibrillation, heart failure, hypertension, multiple sclerosis, cirrhosis, 
cardiac valve abnormalities, endocarditis, Parkinson’s, COPD, diabetes, dialysis, liver 
pathology, renal disease, respiratory disease and heart valve diseases). It would not be 
appropriate to impute diagnoses of these chronic conditions as I did not believe they were 
missing at random (as absence of disease is not actively recorded).  
Obesity was considered a key co-variate. Obesity was strongly associated with obstructive 
sleep apnoea, which can be another indication for tonsillectomy, mostly in children but also 
occasionally in adults as part of more complicated airway surgery.  Additionally, obesity can 
also be associated with gastro-oesophageal reflux disease that results in non-infectious sore 
throat. For these reasons it was considered an important condition to control for in the 
assessing the impact of sore throat infections on tonsillectomy. Smoking was considered as 
key co-variate as smoking can be related to poor oral hygiene and increased risk of infections.  
though to be Missing data in other co-variates (obesity and smoking status – see Table 7 Table 
of missingness in key co-variates.) were evaluated through a sensitivity analysis comparing 
the effect of complete cases and best case (missing is absence of disease) and imputation on 
overall model. Multiple imputation was implemented using the M algorithm  in  the  statistical  
package  Stata  13.1,  to  replace  missing  values  in  exposure  and  risk  factor variables. Ten 
multiply imputed datasets were generated, and Poisson models were fitted to each dataset. 
Coefficients were combined using Rubin’s rules.  The Kolmogorov Smirnov test was used to 
compare the distribution of observed versus imputed log transformed covariates.  
Results from analysis evaluating risk factors for sore throat from multiply imputed dataset 
were compared to those created from complete cases and best case. Since the direction of 
the effect of the covariates on the outcome was unaltered between analyses I chose to 




were unlikely to record BMIs for all of their young patients I assumed that they would if their 
patient was obese.  
Since the effect of smoking on sore throat was altered depending on whether I used complete 
case or best case I decided to use complete cases as I felt it did not assume that patients with 





Smoking status 31 
IMD score 1 
Table 7 Table of missingness in key co-variates. 
This table shows the percentage of patients in CALIBER dataset that have missing codes for key co-variates: obesity, smoking 
status and IMD. 
Summary 
In summary, CPRD and thus CAILBER is representative of the UK national population, but is 
missing certain groups such as the homeless and prisoners. Validity in CPRD and HES is 
generally good and misclassification is low. For our study, I chose a sensitive definition to 
calculate underlying disease burden of tonsillectomy (i.e. all sore throat infections) to reduce 
the impact of misclassification and variation in coding by GPs. Completeness of data in 
CALIBER is better following the introduction of national data recording quality incentives. 
Missing data for co-variates are most likely missing at random and therefore, I undertook 
multiple imputation to investigate the impact of missingness in our analyses. The multiple 
imputation dataset was used to investigate co-variates associated with sore throat and 
tonsillectomy. Sensitivity analysis showed similar results between multiply imputed dataset 
and available case dataset. Therefore, the systematic component of variation was calculated 




CHAPTER THREE: Is there regional variation in the incidence of sore 













In this chapter I have presented the results of a longitudinal population based study of self-
reported sore throat and help seeking-behaviour. This study determined the incidence of sore 
throat more robustly than ever before at 4.22 sore throat episodes (95% CI: 3.86-4.61) per 
1000-person-days. Specific to children, population density, age and the presence of chronic 
illness were identified as predictors of sore throat in the community. Population density, age, 
duration of illness and fever were identified as predictors of help seeking behaviour for sore 
throat.  For adults, age, gender, household size and smoking status were identified as 
predictors of sore throat, and EQ5D index score the only predictor of help seeking behaviour 
for sore throat. Importantly, this study demonstrated that whilst there is regional variation in 
sore throat incidence, both for adults and children, once the above factors are accounted for, 





Whilst previous epidemiological studies have shown considerable variation in tonsillectomy 
rates, both between countries (159)) and regions within a country (16,17,19,20), they have 
failed to investigate the incidence of sore throat, or help seeking behaviour (HSB) for sore 
throat (primary care consultation), across those same regions. In part, this is related to the 
difficulty in capturing acute illness information at population level on a large enough scale to 
inform our understanding of regional healthcare variations. Therefore, it is uncertain whether 
the variation in tonsillectomy rates are a warranted response to the regional disparities in 
disease burden (community sore throat infections) and HSB (GP consultation for sore throat), 
or whether there is systematic bias between regions that exposes patients to inequity in the 
management of recurring sore throats. The only previous UK based population study of sore 
throat was conducted on 198 pregnant women more than 3 decades ago, and it was 
conducted in Lambeth only. The study was not powered to assess predictors of sore throat. 
And whilst this study did assess help-seeking behaviour for sore throat (i.e. if the patient went 
to the GP), it was not on a large enough scale to accurately calculate predictors of GP 
consultation, and due to the local nature of the study could not assess regional differences in 
GP consultation. Therefore, there are no generalisable data about the incidence, predictors 
or regional differences in community sore throat. Nor are there data on the rate, predictors 
and regional differences in GP consultation for those with sore throat.  
Objective  
The objective of this chapter was to quantify regional tonsillectomy rate variation in relation 
to regional variation of self-reported sore throat and help-seeking behaviour in the 
community (objective A).  
Research questions 
I addressed this objective through the following 8 questions:  
1. What is the incidence rate of sore throat in the community? 
2. Is there a regional difference in the incidence of sore throat? 




4. How much variation in sore throat exists once these population characteristics are 
accounted for? 
5. In people who have a sore throat, who seeks medical advice? 
6. Is there a difference in the rate of GP consultation in those with sore throat between 
regions? 
7. What are the predictors of GP consultation in those with sore throat? 
8. How much variation in GP consultation persists once disease and population 
characteristics are accounted for? 
Methodology 
The analyses used the FluWatch dataset described in Chapter 2. I have provided a detailed 
explanation of the FluWatch cohort, variables and missing data in chapter 2.  Dependent and 
independent variables were defined in line with published evidence around sore throat. 
Missing data were managed by only analysing data for weeks where the household survey 
lead had responded with a completed weekly illness report.  
 
Weighting  
Since the survey was oversampled in the Southwest of England and under-sampled in those 
between 0-15 years I weighted analyses to age and regional structure of England to give 
locally and nationally representative estimates. The final weight also accounted for the 
method of sampling through households (that is participants from a larger household had a 
greater chance of being sampled compared to those from smaller households). Models used 
to estimate the incidence of sore throat and GP consultation rate for sore throat were 
weighted to make survey data more nationally representative. 
Modelling  
Analyses were undertaken separately for children (15 years and younger) and adults (16 years 
and over), as the epidemiology and risk factors for sore throat in these populations was known 





On the first analysis I used self-reported sore throat as my main outcome variable. This 
outcome has been defined earlier in chapter 2. But in summary it relates to any self-reported 
moderate-severe sore throat over at least two consecutive days, with an associated fever in 
the absence of a cough.   
Since participants could report more than one sore throat during their time at risk, logistic 
models were less appropriate. General linear models (GLM) were used to quantify the rate 
and predictors of sore throat, as they allowed repeated counts and could account for 
disparities in the time at risk. I assessed how different models predicted dispersion of the data 
and the participants that never reported sore throats. Whilst the mean and variance were 
similar, negative binomial models could predict variance more closely to the observed data 
than Poisson models.  Poisson models predicted the rate of participants who never reported 
a sore throat better than negative binomial models. However, both Poisson and Negative 
Binomial multivariable models showed no difference in the direction of variable effects and 
therefore, Poisson models were used in the sections that follow. All analyses were conducted 
on the whole FluWatch cohort, children (n=1414) and adults (n=5946), separately. 
On the second analysis I used sore throat GP consultation as my main outcome variable. This 
outcome was defined as self-reported GP consultation for sore throat infection.  Since help 
seeking behaviour data were only available in the final three influenza seasons (May 2009-
March 2011), analyses for rates and predictors of GP sore throat consultation were restricted 
to these periods.  Logistic models were used to describe predictors of help seeking behaviour 
during self-reported sore throat illnesses (a binary outcome). All analyses were conducted on 
self –reported sore throat illnesses (defined above), for children (n=433) and adults (n=1760) 
separately. 
As participants could report more than one sore throat or health care contact I clustered data 
to the level of the participant in all analyses. Conceptually, it seemed logical that patterns of 
disease may be clustered by region. To investigate this I also clustered data at the level of the 
GP. A multi-level model, clustering at patient and GP level, was found to more accurately 




Therefore, I used multi-level (patient and general practice level) models to evaluate clinical 
and sociodemographic determinants of sore throat and GP consultation amongst those with 
sore throat.  
Exposure Variables 
Exposure variables are defined in chapter 2. In summary, I used age, ethnicity, participants’ 
geographical region, population density (urban versus rural), quintiles of index of multiple, 
Influenza vaccination status, and health utility/status index and subdomains scores.Exposure 
variables that were associated with the outcome with a p value of <=0.1, on univariable 
analysis, were considered for inclusion in multivariable regression models with an a priori 
decision to include age and gender regardless of the association.  Additional variables were 
included initially starting with variables that had the most number of plausible mechanisms 
of action and then adding those with fewer plausible mechanisms (as per our conceptual 
model described in chapter 2). Akaike’s information criteria (AIC) (160) for sequential models 
was noted and the probability that each model could reduce the information loss as 
compared to the model with lowest AIC was calculated. Exposure variables were added 
sequentially and hierarchically, as random effects to the appropriate level, if they improved 
the model fit. The model was retained if it had a high probability of reducing information loss. 
I undertook tests for interaction between variables if both variables were independently 
related to the outcome and had a biologically plausible interdependent relationship to 
outcome. Once a full multi-level multivariable model had been created, region was added to 
the model to see if geography was still important after accounting for population and disease 
level predictors of sore throat, recurring sore throat and tonsillectomy rates.  
Models developed to predict the incidence of sore throat and GP consultation rates were 
used to calculate the systematic component of variation (SCV).  The SCV measures the degree 
of variation between regions. Other methods, such as extremal quotients, standard deviation 
and coefficient from variation were not used because they are greatly affected by differences 
in population size between regions. The SCV is an adaptation of the proportional hazards 
model.  The method described(161) subtracts the random error (estimated through 
generalised linear models above) from the estimated total variance to calculate the 




regions but makes few assumptions about the nature of the variation and allows for 
appropriate amounts of sampling variation in the data. It has been suggested that variations 
giving SCVs greater than 3 are likely to be due largely to differences in practice style or medical 
discretion, and that high variation is described by a SCV of between 5.4 and 10.0, with SCVs 
greater than 10 being very high variation (162). Bevan et al (163)identified high variation as 
healthcare resource groups (HRGs) with an SCV greater than 6.6, the SCV for hip replacement. 
All statistical analyses were undertaken on Stata SE 13.1. 
 
Results 
There were 3337 sore throat illnesses and 735315 days at risk, amongst 7360 participants. 
Using a Poisson model and weighting the sample to reflect the local age-sex structure and 
sampling method I calculated the incidence of moderate-severe sore throat episodes as 
4.22(95% CI: 3.86-4.61) per 1000-person-days. The median duration of sore throat illness was 
7 days (interquartile range 4-10 days). There were 2193 sore throat illnesses self-reported in 
the seasons where help seeking behaviour was collected (May 2009- March 2011). 
Approximately ten percent of these illnesses resulted in GP consultation (n=215), and of these 
more than half took antibiotics (n=121).  
Results hereafter are described in children (0-15 years, n=1414) and adults (16 years and 
older, n=5946) separately.  
Children 
Sore throat 
See Table 8 Incidence and predictors of sore throats in children. 
The weighted incidence of sore throat in children (n=1414) was 4.23(95%CI 3.65-4.90) 
episodes per 1000 person days. Univariable Poisson analyses of measured variables on the 
incidence of sore throat in children are shown in Table 8; participants who were of school age 
were more likely to report a sore throat compared to those who were of preschool age 
(Incidence Rate Ratio – IRR - 1.23). Further analysis showed that sore throat was more likely 




medical issues (IRR1.32), belonging to the least socially deprived groups (IRR1.39), belonging 
to a family who are good responders (IRR1.44) and in those living in some regions of England 
(e.g. South West compared to London IRR 1.45). Therefore, univariable analyses suggested 
there was regional variation in sore throat.  
On multilevel multivariable Poisson modelling the following variables were found to be 
independently related to the risk of reporting a moderate-severe sore throat episode, even 
after clustering individuals to their General Practice and adjusting for the effects of other 
significant variables: Child age (e.g. school age compared to preschool age children - adjusted 
IRR – aIRR - 1.18); living in regions of higher population density (aIRR 1.29), presence of 
chronic medical issues (aIRR 1.31) and being from a family who are good responders (aIRR 
1.26). Once these variables were accounted for there was no statistical association between 
region and sore throat incidence. 
Systematic component of variation (SCV) was calculated as 2.76, suggesting that after 
accounting for loco-regional population differences between regions there was very little 












IRR (95% CI) P-value Adjusted IRR (95% CI) P-value 
    Univariable analysis Multivariable analysis 




Females 338 63598 4.66 1 1 




White 591 114465 5.16 1 - 




Urban residence 297 46458 6.39 1.34(1.15-1.55) 1.29(1.07-1.57) 




Not vaccinated 599 119710 5.00 1 - 




Healthy 592 112629 5.26 1 1 




Least deprived: IMD 5 192 37278 5.15 1 - 




5-15 years 545 102120 4.61 1.23(1.03-1.47) 1.18(0.97-1.44) 




Good responder 515 92653 4.74 1.41(1.01-1.97) 1.26(1.04-1.52) 








Table 8 Incidence and predictors of sore throats in children. 
This table demonstrates the incidence and risk of self-reporting a severe sore throat infection (moderate-severe sore throat pain on 2 or more days with fever and no cough) amongst key patient 
variables, amongst the whole paediatric cohort of FluWatch. It shows the results of univariable and multivariable multi-level Poisson analyses that investigate which of these factors are actually 
related to self-reporting a sore throat infection in children. The final multi-level Poisson model, presented in this table, clustered at level of patient and practice, with exposure variables as random 
effects, denominator was 125,498 person-days from 1398 children.  
 
 
4 people in household 367 69360 5.29 1.17(0.95-1.44) - 
5 people in household 158 30900 5.11 1.13(0.89-1.44) - 
6 people in household 49 8480 5.78 1.28(0.91-1.78) - 




West Midlands 44 9345 4.71 0.84(0.61-1.57) 0.85(0.55-1.32) 
East and East Midlands 217 40976 5.30 0.95(0.79-1.13) 0.95(0.74-1.21) 
London 37 9542 3.88 0.69(0.49-0.98) 0.81(0.52-1.26) 
South East 58 15402 3.77 0.67(0.51-0.89) 0.69(0.46-1.03) 




Help seeking behaviour  
There were 433 sore throat illnesses reported in children during the seasons when help 
seeking behaviour was monitored. More than one fifth (n=98) resulted in health contacts 
being initiated, with GP consultation being the most common form of health contact (n=62) 
– see Table 9 Types of help seeking behaviour in children with sore throat. 
 
Type of health contact % of all health contacts (n) 
GP consultation 63% (62) 
GP phone call 15% (15) 
Accident and Emergency 5% (5) 
Hospital 4% (4) 
Other including NHS Direct/pharmacists/Urgent 
referral centres etc,. 
12% (12) 
Table 9 Types of help seeking behaviour in children with sore throat. 
This table shows what proportion of children who have self-report a sore throat seek help from these healthcare venues, n= 
98 health contacts. 
 
Univariable analyses (see Table 10 Rate and predictors of GP consultation in children with 
self-reported sore throat.) showed that the following factors were related to consultation 
amongst those with sore throat: Being preschool age compared to be school age (Odds Ratio 
– OR - 3.33), living in rural regions (OR2.56), increasing days of illness (OR1.11), reporting 
severe pain compared to moderate pain (OR23.75), reporting severe earache compared to no 
earache (OR 3.34) and reporting high fever compared to no fever (OR 9.55). There was no 
regional difference in GP consultation rate of children who had reported a sore throat.   
Multivariable analysis (see Table 10 Rate and predictors of GP consultation in children with 
self-reported sore throat.) showed that being preschool age compared to school age 
(adjusted odds ratio – aOR - 2.27), living in rural regions (aOR 2.86), increasing days of sore 
throat illness (aOR 1.16) and reporting a high fever compared to no fever (aOR 5.32) were all 




Systematic component of variation was calculated as 1.86, suggesting that after accounting 
for loco-regional population differences between regions there was very little disparity in the 




Variable GP visits 
Total sore throats in 
this category 
% OR 95 p Adjusted OR 95 P 




Well 49 376 13% 1 - 




5-15  years 38 346 11% 0.31(0.16-0.59) 0.44(0.18-1.03) 




Male 35 225 16% 1.19(0.63-2.22) 1.31(0.63-2.70) 




Urban 16 190 8% 0.39(0.20-0.76) 0.35(0.14-0.87) 




White 52 388 13% 1 - 
Duration (days) 62 433 14% 1.11(1.05-1.16) <0.001 1.16(1.08-1.24) <0.001 
Severe pain 10 15 67% - 
<0.001 
- 
- Moderate pain 6 64 9% 0.04(0.01-0.19) - 
Mild pain 0 13 - - - 
Severe earache 12 37 32% 3.34(1.48-7.76) 
0.01 
- 
- Mild earache 6 47 13% 0.96(0.34-2.72) - 
No earache 44 330 13% 1 - 




Table 10 Rate and predictors of GP consultation in children with self-reported sore throat.  
This table demonstrates the rate and risk factors of GP consultation in those with those who have already reported a sore throat illness (from start of symptoms to 21days following resolution) 
in children. It shows the results of univariable and multivariable multi-level logistic analyses that investigate which of these factors are actually related to self-reporting a sore throat infection in 
children.Multi-level logistic regression clustered at the level of patient and practice, with exposure variables added as random effects, using denominator of 318 sore throat infections.  
 
IMD 5 (Least deprived) 25 156 16% 1 - 
No fever 11 162 7% 1 
<0.001 
1 
0.004 Mild fever 25 115 22% 3.99(1.72-9.28) 3.47(1.40-8.61) 
High fever 16 39 41% 9.55(3.46-26.38) 5.32(1.69-16.75) 




Bad reporters 8 63 13% 1.03(0.39-2.63) - 




West Midlands 4 23 17% 1.37(0.35-5.33) 1.17(0.35-3.84) 
East and East Midlands 26 183 14% 1.10(0.53-2.31) 1.84(0.68-5.00) 
London 8 23 35% 3.48(1.18-10.27) 2.72(0.69-10.68) 
South East 3 31 10% 0.70(0.14-3.59) 2.14(0.29-15.89) 






See Table 11 Incidence and predictors of sore throats in adult. 
The weighted incidence of sore throat in adults (16 years and older, n=5946) was 4.22(95%CI 
3.85-4.63) episodes per 1000 person days. Univariable Poisson analyses of measured 
variables on the incidence of sore throat in adults are seen in Table 11 Incidence and 
predictors of sore throats in adult.; participants who were 25-44 years old were more likely 
to report a sore throat compared to 16-24 year olds (OR1.29). Further analyses showed that 
sore throat was more likely in females (IRR 1.33), those not suffering chronic illness (IRR 1.16), 
living in households of 4 people compared to households of 2 people (IRR 1.24), being a non-
smoker (OR 1.53), being from a family of good reporters (IRR1.37) and those who lived in 
some regions (e.g. London compared to those who lived in the south west of England (IR 
1.27)). Univariable analysis suggests there is regional variation in sore throat incidence.    
On multilevel multivariable Poisson modelling (Table 11 Incidence and predictors of sore 
throats in adult.) the following variables were found to be independently related to the risk 
of reporting a moderate-severe sore throat episode, even after clustering individuals to their 
General Practice and adjusting for the effects of other significant variables: Female gender 
(adjusted OR 1.33); non-white ethnicity (aOR 1.33), being vaccinated against influenza that 
season (aOR 1.19), being 25-44 years compared to 16-24 years old (aOR 1.23), living in a 
household of 4 people instead of 2 people (aOR 1.05), non-smokers (aOR 1.54) and being from 
a family of good reporters (aOR 1.18). Once these variables were accounted for there was no 
statistical association of region on sore throat incidence. 
Systematic component of variation was calculated as 1.2, suggesting that after accounting for 
measured sociodemographic factors between regions there was very little disparity in the 












IRR P-value IRR P-value 
    Univariable analysis Multivariable analysis 




Females 1584 315715 4.61 1 1 




White 2330 497036 4.53 1 1 




Urban residence 1061 226526 4.83 1.03(0.94-1.12) - 




Not vaccinated 1862 422014 4.16 1 1 




Healthy 2133 446987 4.62 1 - 




Least deprived: IMD 5 787 163003 4.58 1 - 




<0.001 25-44 years 755 133926 5.48 1.20.9(1.08-1.53) 1.22(1.02-1.46) 




65 years and over 473 149716 2.98 0.72(0.58-0.87) 0.62(0.50-0.77) 




2 people in household 1306 316360 4.05 1 1 
3 people in household 430 94133 4.44 1.11(0.99-1.24) 1.01(0.88-1.15) 
4 people in household 538 105037 4.98 1.24(1.11-1.39) 1.05(0.92-1.20) 
5 people in household 164 32312 4.79 1.23(1.03-1.46) 1.04(0.86-1.27) 
6 people in household 19 6664 3.05 0.69(0.43-1.12) 0.41(0.24-0.71) 




Smoker 139 47346 2.94 0.65(0.53-0.78) 0.60(0.50-0.73) 




Good reporter 2085 438001 4.76 1.37(1.24-1.52) 1.18(0.91-1.53) 




West Midlands 170 39403 3.96 1.03(0.86-1.23) 1.01(0.81-1.26) 
East and East Midlands 801 166131 4.44 1.15(1.04-1.28) 1.10(0.96-1.26) 
London 180 34018 4.69 1.27(1.06-1.51) 1.26(1.03-1.55) 
South East 366 83467 4.29 1.05(0.92-1.20) 0.97(0.80-1.16) 
South West 874 209026 4.21 1 1 
Table 11 Incidence and predictors of sore throats in adult.   
This table demonstrates the incidence and risk of self-reporting a severe sore throat infection (moderate-severe sore throat pain on 2 or more days with fever and no cough) amongst key patient 
variables, amongst the whole adult cohort of FluWatch. It shows the results of univariable and multivariable Poisson analyses that investigate which of these factors are actually related to self 
reporting a sore throat infection in children. The final multi-level Poisson model, presented in this table, clustered at level of patient and practice, with all exposure variables as random effects, 




Help seeking behaviour  
There were 1760 sore throat illnesses reported in adults during seasons when help seeking 
behaviour was monitored. Twelve percent (n=212) resulted in help seeking behaviour, with 
most adults with sore throat choosing to see their GP (72%) see Table 12 Types of help seeking 
behaviour in adults with sore throat.  
Table 12 Types of help seeking behaviour in adults with sore throat.  
This table shows what proportion of adults who have self-report a sore throat seek help from these healthcare venues, n = 
212 health contacts. 
 
Univariable analyses (see Table 13 Rates and predictors of adult GP consultation for sore 
throat.) showed the following variables were related to the risk of GP consultation during a 
sore throat illness: Female gender (OR 1.52), chronic medical issues (OR 2.06), increasing days 
of illness (OR1.11) and severe earache compared to no earache (OR 5.22).  In addition, 
reduced health related quality of life, measured either using the EQ5D-3L index score (OR 
0.98) or its five domains (mobility, self-care, usual activities, pain and anxiety – see Table 13 
Rates and predictors of adult GP consultation for sore throat. for full results) were all related 
to increased risk of GP consultation.  Adults in the North of England had more than 3.5 times 
the odds of GP consultation for sore throat compared to adults in the South East of England.   
Multivariable analysis (see Table 13 Rates and predictors of adult GP consultation for sore 
throat.) showed that the only predictor of GP consultation for sore throat in adults was 
reduction in health-related quality of life, as measured by the composite EQ5D index score 
(aOR 0.98). After accounting for health-related quality of life no other variables were 
significantly related to GP consultation, including region of England.  
Type of health contact % of all health contacts (n) 
GP consultation 72% (153) 
GP phone call 20% (42) 
Accident and Emergency 3% (7) 
Hospital 2% (5) 
Other including NHS Direct/pharmacists/Urgent 





Systematic component of variation was calculated as 4.5, suggesting that after accounting for 
differences in measured sociodemographics between regions, there was very little disparity 





Variable GP visits 
Total sore throats in 
this category 
% OR p Adjusted OR P 




Well 111 1460 8% 1 - 




25-44  years 35 500 7% 0.55(0.27-1.13) 0.29(0.05-1.77) 
45-64 years 76 820 9% 0.74(0.37-1.46) 0.66(0.12-3.53) 
>65 years 29 334 9% 0.69(0.33-1.45) 0.55(0.09-3.40) 




Male 47 699 7% 0.66(0.45-0.97) 0.60(0.29-1.26) 




Urban 64 714 9% 1.04(0.72-1.50) - 




White 143 1640 9% 1 - 
Duration (days) 153 1760 9% 1.11(1.09-1.14) <0.001 - - 
EQ5D Index score 153 1760 9% 0.98(0.97-0.99) <0.001 0.98(0.97-0.99) <0.001 
No problems with mobility 28 296 9% 1 
0.0 4 
- - 
Some problems with 
mobility 
10 51 20% 2.32(1.04-5.16) - - 
Confined to bed 12 32 38% 5.7(2.29-14.21) - - 




Some problems washing and 
dressing 
5 15 33% 4.04(1.25-13.07) - - 
Unable to wash/dress 6 8 75% 24.23(4.11-142.88) - - 
No problems with usual 
activities 
9 175 5% 1 
0.001 
- - 
Some problems with usual 
activities 
25 155 16% 3.55(1.45-8.73) - - 
Unable to perform usual 
activities 
16 49 33% 8.89(1.45-8.73) - - 
Severe pain 12 37 32% 8.52(1.90-38.18) 
0.01 
- 
- Moderate pain 34 267 13% 2.61(0.75-9.07) - 
Mild pain 4 75 5% 1 - 
No anxiety 29 286 10% 1 
0.02 
- - 
Moderate anxiety 19 85 22% 2.63(1.33-5.20) - - 
Extreme Anxiety 2 8 25% 2.95(0.32-26.92) - - 
Severe earache 34 131 26% 5.22(3.21-8.48) 
<0.001 
- 
- Mild earache 33 209 16% 2.78(1.78-4.36) - 
No earache 86 1354 6% 1 - 




IMD 2 10 142 7% 0.72(0.36-1.44) - 
IMD 3 48 479 10% 1.03(0.66-1.61) - 




IMD 5 (Least deprived) 55 574 10% 1 - 




Bad reporters 11 148 7% 1 - 




West Midlands 9 93 10% 0.62(0.28-1.37) 0.73(0.15-3.57) 
East and East Midlands 55 669 8% 0.51(0.30-0.87) 0.85(0.29-2.53) 
London 9 132 7% 0.43(0.18-1.01) 1.52(0.39-5.88) 
South East 9 192 5% 0.28(0.12-0.64) 0.11(0.01-0.94) 
South West 45 502 9% 0.56(0.31-0.99) 0.45(0.13-1.56) 
Table 13 Rates and predictors of adult GP consultation for sore throat.  
This table demonstrates the rate and risk factors of GP consultation in those with those who have already reported a sore throat illness (from start of symptoms to 21days following resolution) 
in children. It shows the results of univariable and multivariable multi-level logistic analyses that investigate which of these factors are actually related to self-reporting a sore throat infection in 








This study demonstrated that the incidence of moderate-severe sore throat episodes, 
weighted to represent the national population, was 4.22/1000 person years in England. 
Univariable analyses showed that there was a statistically different incidence of sore throat 
between six regions of England surveyed for both children and adults. Multi-level 
multivariable models showed that age, chronic ill health and population density were 
predictors of sore throat episodes in children, whereas age, gender, ethnicity, smoking status, 
household size and influenza vaccination status were predictors of sore throats in adults. 
After accounting for loco-regional population characteristics, there was no difference in the 
incidence of sore throat in adults or children between regions, as measured by the systematic 
component of variation or multilevel multivariable models.  
Fourteen percent of all sore throat episodes resulted in help seeking behaviour, most of which 
were GP consultations (10% of all sore throat episodes). Univariable analyses showed that 
there was a statistically different rate of GP consultation in both children and adults, 
separately, between the 6 regions of England surveyed. Multilevel multivariable models 
showed that age, population density, duration of sore throat and presence of fever were 
predictors of GP consultation in children, whereas reduction in health-related quality of life 
was the only predictor of GP consultation in adults. After accounting for loco-regional 
population characteristics there was no difference in the rate of GP consultation for sore 
throat between regions, as measured by the systematic component of variation or multilevel 
multivariable models.  
Whilst this study showed that there is substantial regional variation in the incidence and GP 
consultation for sore throat, these disparities appear to be related to differences in 
population characteristics between regions.  It is plausible that these variations in disease 
occurrence and consultation behaviour may contribute to regional variations in tonsillectomy 
rates. Strategies that aim to reduce regional variation in tonsillectomy rates may consider 
educating the public about appropriate sore throat management. That is sore throat 




patients who have red-flag symptoms should seek help from their GP (e.g. Lock jaw, neck 
swelling, difficulty breathing etc.,)(164-166).  
Strengths and weaknesses 
This is the largest population-based survey of sore throat to date, weighted to represent the 
national population. In addition, it is the only study of regional patterns of sore throat 
incidence to date. The prospective nature of data collection, through daily health diaries and 
weekly telephone calls, reduced recall bias inherent to retrospective interview studies. This 
survey method also allowed us to reduce our missing data (14% missing weekly status 
reports). Sensitivity analyses of different ways of accounting for our missing data showed no 
change in our conclusions. In contrast to electronic health care record studies, I could 
accurately assess the role of sore throat severity and associated symptoms in relation to help 
seeking behaviour. This study has two limitations. Firstly, very young children, residents of 
Northern England and those of lowest socio-economic status were under-represented in the 
study population. Therefore, the survey was weighted to allow the incidence to be more 
representative of local and national populations. Secondly, one year of data collection was 
conducted in a pandemic influenza outbreak year when there was considerable media 
coverage, which may have increased symptom vigilance and increased consultation 
behaviour. The third weakness is that variation can occur at a number of sublevels, however 
only variation at the level of GPs and 6 large regions was able to be analysed due to a lack of 
data availability. In the future analyses should attempt to study smaller scale variations. 
Relation to published literature  
Sore throat 
The only other prospective population based study in England was undertaken in Lambeth in 
1974 on 198 women, aged 20-44, who were asked to keep a prospective health diary for 28-
days each. During the observation period 90 sore throat episodes were reported (annual sore 
throat incidence of 5.9 (95% CI 4.7-7.3) sore throat episodes per person-year) with 33 
subsequent GP consultations (37% (95% CI 25-51%) consultation rate. However, since this 
was a small study in a select population it is difficult to draw meaningful comparisons. Our 




infections (103,104,108,167) that the majority of sore throats, are managed safely in the 
community.  
Help seeking behaviour 
I found that GP consultation for sore throat was predicted by young age. Studies of all 
respiratory infections also confirm that young age is a major driver for primary care use in UK 
(69) with qualitative studies showing that parents’ decision to bring their children to the GP 
is influenced by perceived threat, disease severity, the perceived benefits of consulting, and 
an expectation of assessment, information, advice or treatment (69-72,168). Our study also 
found duration of sore throat and presence of fever were related to GP consultation in 
children. Explanations for these results can be offered from qualitative research into people 
with acute sore throat(169) and respiratory tract infections (167) showing that people most 
commonly seek help from their GP for perceived symptom severity and non-resolution of 
symptoms.  
Whilst GP consultation is only one type of help seeking behaviour, it is pertinent to our overall 
study of tonsillectomy, since a patient is almost exclusively referred for a tonsillectomy 
through primary care. Whilst several models of help seeking behaviour have been described 
in the literature (170,171), a framework of outcome and health behaviour has been 
proposed (172) that encompasses several social-cognition models. The Shaw model 
describes that the experience of symptoms and the subsequent health behaviour are based 
on an individual's appraisal of the symptom as being a health threat, followed by an 
assessment of the severity of the health threat and the formation of behavioural intentions. 
Appraisal of symptom severity is dependent on (a) impact of symptoms on routines of life; (b) 
an appraisal of coping resources mediated by personality, locus of control, social support, 
preferred coping styles, expectations and self-efficacy; and (c) individual differences such as 
age, gender, social status and ethnicity (which reflect wider cultural influences). Since a sore 
throat is a common and self-limiting illness, it is reasonable to think that help seeking was 
initiated when the perceived symptom severity was beyond the patient’s personal coping 




In children, our study showed that GP consultation for sore throat was predicted by very 
young age. Epidemiological studies confirm that very young age is a major driver for primary 
care use in UK(69). Qualitative studies have shown that very young children are perceived as 
vulnerable and there is more frequent delegation of care(70-72). In addition, I found markers 
of disease severity such as fever and increasing duration were also strong predictors of GP 
consultation in children. Qualitative studies have shown that parents’ decision to bring their 
children to the GP is influenced by perceived threat, disease severity, the perceived benefits 
of consulting, and an expectation of assessment, information, advice or treatment (69-
72,168). Therefore, it is likely that parents in our study chose to consult their GP when the 
perceived threat of the sore throat illness was beyond their coping strategies. Children 
residing in rural areas were more likely to consult their GP than children with similar disease 
severity in urban areas. Since there was a lower incidence of sore throat in rural regions, 
parents may have been less exposed to these illnesses and perceive them with more threat. 
Alternatively, despite the potential need to travel further in rural areas there could have been 
easier access to services in rural areas that aren’t burdened with over population, which in 
turn may have lowered the threshold for consultation. Further qualitative studies may help 
answer this question. 
In adults, our study showed that GP consultation for sore throat was predicted by lower self-
reported health status (as measured by the EQ-5D 3L). Low health status, may have meant 
that respondents had difficulty coping with mobility, usual activities, self-care, or reported 
high pain, or anxiety. This index score, therefore, may be associated with a high perception 
of threat or an exhaustion of coping strategies. Hence according to the framework of help 
seeking behaviour EQ5D may be a good surrogate measure of perceived symptom severity. A 
sore throat specific health related quality of life score may improve our understanding of this 
relationship. 
Implications and future work 
This is the first study of regional disparities in sore throat disease burden. It shows that there 
is considerable variation in the incidence and help seeking behaviour for sore throat between 
six regions of England, both for children and adults. However, the variations in disease burden 




density, chronic illnesses, influenza vaccination status and smoking status. After controlling 
for these characteristics there was no measurable variation in GP consultation rates for sore 
throats between regions.  Unfortunately, studies of geographical practice variations rarely 
have the granularity in their data to account for such characteristics and therefore, may 
inadvertently overestimate the unwarranted variation in treatment rates. Whilst I have 
shown in this data that there is no variation in GP consultation rates between regions, after 
accounting for local population characteristics, the overall number of participants who 
consulted a GP is low and further work needs to be undertaken to corroborate our findings 





CHAPTER FOUR: Is there variation in the incidence of recurring sore 














In this chapter, I have summarised the results of a large retrospective electronic cohort study 
of sore throat following health care contact: That is of sore throat consultations in primary 
care, recurring sore throat as defined by consultations in primary care, and tonsillectomy 
rates in secondary care. I was able to undertake these investigations following linkage of 
primary and secondary care databases. These investigations demonstrated that whilst there 
was substantial variation in the rates of sore throat, recurring sore throat and tonsillectomy 
between the 10 regions of England, once regional population characteristics were accounted 






Previous epidemiological studies have shown considerable variation in tonsillectomy rates, 
both between countries (159)) and regions within a country (16,17,19,20). This observation 
has since been noted for many other surgical conditions(17,24-26) (27) (28-30) (31,32)) 
(33-35) and considerable effort has gone into reducing regional surgical rate variation, 
broadly described within the evidence based medicine movement(47). Unfortunately, and 
specific to tonsillectomy, the regional surgical rate variation persists (20). There is now a 
growing body of evidence, summarised and categorised in chapter one, that comes from 
public health and decision analysis studies suggesting regional healthcare variations are a 
direct response to the regional variations in healthcare ‘need’(61) (62) (63) (64,65), (66) 
(67) (68,69) (70-72) (77) (78-80) (81-84) (85-88) (89) (90) (91).  However, this 
information has not been described in relation to regional tonsillectomy rate variations. This 
may partly relate to the fact that records for tonsillitis, and recurring tonsillitis diagnoses are 
kept in primary care databases where the condition is most frequently managed. In contrast, 
tonsillectomy is undertaken, and recorded, solely in secondary health care setting. 
Historically, there has not been any linkage of health care information between these settings 
on a large enough scale to describe regional surgical rate variations. This means relating 
regional tonsillectomy rate variations to regional incidence of recurring tonsillitis (key 
component of ‘need’ for tonsillectomy) has never been undertaken. In fact, the previous 
chapter has shown that there is considerable unadjusted regional variation in the occurrence 
of sore throat in the community and rate of help seeking behaviour – implying a potential role 
for regional variation in ‘need’. We do not yet know how the disparities in community sore 
throat and help seeking behaviour are related to tonsillectomy rate variation.  
  
Aims 
Therefore, in this chapter I aimed to investigate regional variations in the primary care 
consultations for sore throat and recurring sore throat and their relationship to geographical 






I attempted to achieve my aims by answering 3 main questions, separately for sore throat, 
recurring sore throat and tonsillectomy:  
A. Is there regional variation in sore throat/recurring sore throat/tonsillectomy rates? 
B. What are the predictors of sore throat/recurring sore throat/tonsillectomy rates?  
C. How much regional disparity persists once these predictors of sore throat/recurring 
sore throat/tonsillectomy are accounted for?  
Methodology 
The study used the CALIBER database, which is broadly representative of the national cohort 
and as such have comparable characteristics in terms of age, gender and socioeconomic 
status(113,173).  
I divided the CALIBER dataset into children (preschool-0-4 and school 5-15 years old) and 
adults (young adults 16-24 and early adulthood 25-44 years) as there was evidence to suggest 
that the epidemiology and management of sore throat was different in these populations. 
Finally, adults over the age of 44 were rarely at risk of recurring sore throat or tonsillectomy 
for recurring sore throat, therefore, I removed them from analyses as I felt that would 
artificially and inappropriately inflate the denominator (see Table 14 Sore throat, recurring 
sore throat and tonsillectomies by age group.).  









Patients with recurring 
sore throat 
n (% of those who had sore 
throat) 
Total number of patients who had 
tonsillectomy for recurring tonsillitis 
0-4 347,734 4871 (6%) 1108 
5-15 2,253,956 13385 (9%) 3170 
16-24 2,360,050 12,726 (7%) 1675 
25-44 5,347,471 10,381 (4%) 981 
>44 1.06107 4080(2%) 106 
Total 
number 
2.10107 45,443 7040 
Table 14 Sore throat, recurring sore throat and tonsillectomies by age group.  
This table demonstrates that only 2%   of adults over the age of 44 go from having one sore throat to being defined as those 
with recurring sore throat (3 consultations in less than 1 year).  They also account for less than 2% of all the tonsillectomies 





Similarly to the study described in Chapter 3, since participants could visit their GP more than 
once during their time at risk, logistic models were less appropriate. General linear models 
(GLM) were used to quantify the rate and predictors of sore throat, as they allowed repeated 
counts and could account for disparities in the time at risk. GLM models were also used to 
calculate the incidence of recurring sore throat and tonsillectomy rates in the cohort as they 
accounted for variations in time at risk. I assessed how different models (Poisson, Zero-
inflated Poisson and Negative binomial) predicted dispersion of the data and the participants 
that never reported sore throats. Poisson modelled our dataset best and was therefore used 
for all analyses.  
Outcome variables 
For the first set of analyses the outcome variable was GP sore throat consultation. For more 
detailed information on how this variable was defined please refer to chapter 2. In summary, 
it was defined as any GP consultation that was coded with any one or more of the 111 sore 
throat READ codes defined in Appendix U. GP sore throat consultation was used as a surrogate 
marker for GP tonsillitis consultation, with the assumption that the proportion of sore throat 
consultations that are actually tonsillitis will not vary from region to region. The entire 
CALIBER cohort was used as study denominator, with children (denominator 3.0million 
person-years at risk) and adults (denominator 7.7million person-years at risk) analysed 
separately, and time at risk censored for 21 days around a sore throat consultation, as it was 
not felt that patients were at risk of a new sore throat infection. As participants could attend 
their GP more than once with a sore throat I clustered data to the level of the participant in 
these analyses. In addition, further clustering of patients to general practices, and general 
practices to regions was found to better describe the data on likelihood ratio test against a 
single level model. Therefore, I used multi-level (patient, general practice and regional level) 
models to evaluate clinical and sociodemographic determinants of sore throat GP 
consultation. 
In the second set of analyses the outcome variable was recurring sore throat. This was defined 
as any patient who had 3 or more GP sore throat consultations (defined above) in 12months 




when a patient becomes defined as having recurring sore throat. Children (denominator 
2.9million person-years at risk) and adults (denominator 7.6million person-years at risk) were 
analysed separately.   
In the final set of analyses, tonsillectomy was the outcome variable. Since not all 
tonsillectomies are done for recurring tonsillitis, and hospitals do not use ICD-10 codes for 
diagnosis reliably, the outcome was defined as any patient with recurring GP sore throat 
consultations (defined above) who went on to receive an OPCS code for tonsillectomy.  
The entire CALIBER cohort was used as study denominator, with children (denominator 
2.6million person-years at risk) and adults (denominator 7.7million person-years at risk) 
analysed separately, and time-at-risk censored once a patient received a tonsillectomy. 
Since patients were not able to have more than one diagnosis of recurring sore throat or one 
tonsillectomy, analyses that had these variables as the main outcome were clustered at the 
level of general practice and region only. Exposure Variables Definitions of exposure variables 
are provided in chapter 2. In summary, I used the following variables: Ethnicity; Geographical 
region (10 geographically based Strategic Health Authorities that manage local health care); 
Social deprivation (categorised into national quintiles based on the index of multiple 
deprivation; Respiratory disease in children as asthma an adult having been given the 
diagnosis of asthma or chronic obstructive pulmonary disease; Obesity (body mass index 
greater than 29, recorded at least once during their window of observation); Obstructive 
sleep apnoea; HIV status; Eating disorder; Alcohol consumption (Non-drinkers, Mild-
moderate drinker, Heavy drinkers); Smoking status (non-, ex- and current smoker); Diabetes; 
and Hypertension. 
Exposure variables that were associated with the outcome with a p value of <=0.1, on 
univariable analysis, were considered for inclusion in multivariable regression models with an 
a priori decision to include age, gender and ethnicity as patient characteristics, and social 
deprivation (since IMD is calculated by postcode), regardless of the association.  Additional 
variables were included initially starting with variables that had the most number of plausible 
mechanisms of action and then adding those with fewer plausible mechanisms. Exposure 




level, if they improved the model fit. Akaike’s information criteria (AIC) (160) for sequential 
models were noted and the probability that each model could reduce the information loss as 
compared to the model with lowest AIC was calculated. The model was retained if it had a 
high probability of reducing information loss. I undertook tests for interaction between 
variables if both variables were independently related to the outcome and had a biologically 
plausible interdependent relationship to outcome. Once a full multi-level multivariable model 
had been created, region was added to the model to see if geography was still important after 
accounting for population and disease level predictors of sore throat, recurring sore throat 
and tonsillectomy rates.  
Models developed to predict the GP sore throat consultation rates, incidence of recurring 
sore throat and tonsillectomy rates were used to calculate the systematic component of 
variation (SCV).  The SCV is described in chapter 3. The SCV was calculated using all variables 
found to be significant in multi-level multi-model testing.  
All statistical analyses were undertaken in Stata SE 13.1. 
Results 
Our cohort consisted of 3,560,864 patients making up more than 21 million person-years of 
follow up. Within our cohort there were 1,440,002 sore throat consultations 
(68.0/1000person-years) and 16,618 tonsillectomies (7.9 tonsillectomies for 10,000person 
years of follow up), both of which are comparable to the expected levels(2,174). The sore 
throat consultation rate observes in CPRD was around half the expected sore throat 
consultation rate as predicted by the FluWatch study (around 154 consultations/1000 patient 
year). However, FluWatch did not have full person years but winter seasons only.  
A quarter of patients in our cohort – all ages - (n=861,600) saw their GP at least once for a 
sore throat (mean: 1.67 consultations per patient seeing their GP at least once with sore 
throat). Five percent of those who had consulted for a sore throat once (n=45,443) went on 
to have recurring sore throat (3 sore throat consultations within a 12-month period). Sixteen 
percent (n=7040) of patients with recurring sore throat went on to have a tonsillectomy. Table 




months) and tonsillectomy rate by age category. From this point forward all analyses will be 




There were 410,477 sore throat consultations over 2,456,253 person years of observation 
giving a sore throat consultation rate of 167/1000person years (95% CI 166-168) (comparable 
to predicted paediatric consultation rate based on FluWatch 200/1000 person years). 18,256 
children suffered with recurring sore throat, giving an annual incidence of 6.9/1000 person-
years (95%CI 6.76-6.96). Whilst 7849 children were recorded as having a tonsillectomy for 
recurring tonsillitis, only 3361 met our definition of recurring sore throat (3 sore throat 
consultations in 12 months).   
Sore throat  
See Table 15 Multi-variable models of sore throat consultation in children. 
Univariable analysis showed a small amount of variation in the rate of sore throat consultation 
by geographical region (Residents of East Midlands had 33% more chance of having a sore 
throat consultation compared to residents from the North East). Please see Appendix D for 
univariable analyses. Running the Systematic Component Variation (SCV) model without 
adjustment of population characteristics showed the SCV value of 4.2.  
Multi-level multivariable Poisson modelling showed the following factors were more likely to 
be related to GP sore throat consultation in children: Very young age (0-4 years: adjusted 
incidence rate ratio – aIRR – 1.81), female gender (aIRR 1.24), ethnicity (e.g. white ethnicity 
compared to Black African – aIRR 1.62), lower deprivation score (least deprived compared to 
most deprived aIRR 1.11), chronic respiratory illness (aIRR1.79), obesity (aIRR 2.00), eating 
disorders (aIRR 1.88), and HIV (aIRR 1.30).  
After controlling for all the above factors there was very slightly less variation in sore throat 
incidence between the 10 regions of England (Residents of East Midlands now had 32% more 




there was more unaccounted variation between general practices within regions than 
between the regions themselves. The multilevel model revealed that there was 5 times more 
unaccounted variation at the general practice level compared to the region level (variance 
0.003 vs 0.015, respectively). The above multilevel multivariable model was used to calculate 
a new systematic component of variation (adjusted SCV). The adjusted SCV score of 1.2 





Characteristic Multivariable analysis 
 Adjusted IRR P 
Gender   
Male 1  
Female 1.24(1.23-1.26) <0.001 
Age category   
0-4 years 1  
5-15 years 0.55(0.55-0.56) <0.001 
Ethnic origin   
White British 1 <0.001 
Indian 0.87(0.82-0.93)  
Black African 0.63(0.59-0.68)  
Black Caribbean 0.68(0.62-0.74)  
Black other 0.69(0.63-0.75)  
Bangladeshi 1.01(0.90-1.13)  
Pakistani 0.96(0.91-1.02)  
Other Asian 0.82(0.75-0.89)  
Chinese 0.72(0.62-0.82)  
Mixed 0.67(0.63-0.71)  
Other 0.85(0.81-0.89)  
Unknown 0.92(0.90-0.93)  
Social Deprivation   
Least deprived 1  
Most deprived 0.94(0.92-0.96) <0.001 
Respiratory illness   
Absent 1  




Table 15 Multi-variable models of sore throat consultation in children. 
 This table shows the risk factors associated with sore throat consultation, amongst all children in the CALIBER cohort 
(denominator=3.0million person years). Multivariable model is based on the Poisson distribution. Multivariable models are 
multi-level and include random effects. 
Obstructive sleep apnoea   
Absent 1 <0.001 
Present 1.79(1.76-1.81)  
Obesity   
Not coded 1  
Obese 2.00(1.93-2.08) <0.001 
HIV status   
HIV negative 1  
HIV positive 1.30(1.17-1.45) <0.001 
Eating disorder   
Absent 1  
Eating disorder 1.88(1.76-2.01) <0.001 
Practice region   
North East 1  
North West 1.23(1.15-1.32)  
Yorkshire & The Humber 1.14(1.06-1.23)  
East Midlands 1.32(1.22-1.42)  
West Midlands 1.37(1.27-1.47)  
East of England 1.24(1.16-1.34)  
South West 1.07(0.99-1.15)  
South Central 1.07(0.99-1.15)  
London 1.17(1.09-1.26)  




Recurring sore throat  
See Table 16 Multi-variable models of recurring sore throat in children. 
Univariable analysis showed a moderate amount of variation in the incidence of recurring 
sore throat rates by geographical region (Residents of East Midlands had 86% more chance of 
having recurring sore throat compared to residents from the North East). Running the SCV 
model without adjustment of population characteristics showed the SCV value of 4.8. 
Multilevel multivariable Poisson modelling showed the following factors were more likely to 
be related to children defined as suffering from recurring sore throat:  Very young age (0-4 
compared to 5-15 years: aIRR 1.56), female gender (aIRR 1.40), ethnicity (e.g. white ethnicity 
compared to Black African – aIRR 2.38), lower deprivation score (least deprived compared to 
most deprived aIRR 1.12), chronic respiratory illness (aIRR2.03), obstructive sleep apnoea 
(aIRR 2.10), obesity (aIRR 2.00) and eating disorders (aIRR2.30).  
After controlling for all the above factors there was less variation in recurring sore throat rates 
between the 10 regions of England (Residents of East Midlands now had 65% increased risk 
of a recurring sore throat compared to Residents of the North East). There was more 
unaccounted variation between general practices within regions than between the regions 
themselves. The multilevel model revealed that there was four times more unaccounted 
variance at the level of the general practice compared to the level of the region (0.54 vs 0.12, 
respectively). The above multilevel multivariable model was used to calculate the systematic 
component of variation. The adjusted SCV score of 1.8 showed that much of the regional 




Risk Factors Multivariable model 
 Adjusted IRR P 
Gender   
Male 1 <0.001 
Female 1.40(1.36-1.45)  
Age category   
0-4 years 1 <0.001 
5-15 years 0.64(0.62-0.67)  
Ethnic origin   
White British 1 <0.001 
Indian 0.67(0.55- 0.82)  
Black African 0.42(0.33- 0.54)  
Black Caribbean 0.50(0.38- 0.67)  
Black other 0.61(0.47- 0.81)  
Bangladeshi 1.12(0.84-1.48)  
Pakistani 0.90(0.76- 1.06)  
Other Asian 0.70(0.54- 0.90)  
Chinese 0.38(0.21- 0.68)  
Mixed 0.45(0.37- 0.55)  
Other 0.79(0.68- 0.92)  
Unknown 0.83(0.80- 0.87)  
Social Deprivation   
Least deprived 1 <0.001 
Most deprived 0.89(0.84-.094)  
Respiratory illness   
Absent 1 <0.001 
Present 2.03(1.95-2.10)  
Obstructive sleep apnoea   
Absent 1 <0.001 




Obesity   
Not coded 1 <0.001 
Obese 2.31(2.12-2.53)  
Eating disorder   
Absent 1 <0.001 
Eating disorder 2.30(1.95-2.70)  
Practice region   
North East 1 <0.001 
North West 1.41(1.11- 1.78)  
Yorkshire & The Humber 1.42(1.13-1.79)  
East Midlands 1.65(1.31-2.08)  
West Midlands 1.68(1.33- 2.13)  
East of England 1.49(1.17- 1.88)  
South West 1.11(0.88- 1.41)  
South Central 1.01(0.79- 1.28)  
London 1.29(1.01- 1.63)  
South East Coast 1.49(1.18- 1.89)  
Table 16 Multi-variable models of recurring sore throat in children.  
This table shows the risk factors associated with recurring sore throat consultation, amongst all children in the CALIBER cohort 
(denominator=2.9million person-years). Multivariable models are based on the Poisson distribution. Multivariable models are 






See Table 17 Multi-variable models of tonsillectomy in children. 
Univariable analysis showed considerable variation in tonsillectomy rates by geographical 
region (Residents of East Midlands had 290% more chance of a tonsillectomy compared to 
residents from the North East). Running the SCV model without adjustment of population 
characteristics showed the SCV value of 8.8. 
Multilevel multivariable Poisson modelling of tonsillectomy rates in all children showed the 
following factors were more likely to be related to receiving a tonsillectomy:  School age (5-
15 years compared to 0-4 years: aIRR – 5.34), female gender (aIRR 1.10), ethnicity (e.g. white 
ethnicity compared to Black African – aIRR 1.40), lower deprivation score (least deprived 
compared to most deprived aIRR 1.47), chronic respiratory illness (aIRR1.50), obstructive 
sleep apnoea (aIRR 10.99), obesity (aIRR 1.96) and eating disorders (aIRR1.54).  
After controlling for all the above factors there was still variation in tonsillectomy rates 
between the 10 regions of England (Residents of East Midlands had aIRR 3.04 for a 
tonsillectomy consultation compared to Residents of the North East). The multilevel model 
revealed that there was more variance unaccounted for at the level of the general practices 
within regions compared to between regions (variance 0.38 vs 0.23, respectively). The final 
multilevel multivariable model was used to calculate the systematic component of variation. 
The SCV score of 2.25 showed that there was little disparity between regional tonsillectomy 
rates after controlling for regional population characteristics.  
Describing this more intuitively Table 18 shows that whilst the numbers of tonsillectomies 





Characteristic Multivariable analysis 
 Adjusted IRR P 
Gender   
Male 1 <0.001 
Female 1.10(1.05-1.16)  
Age category   
0-4 years 1 <0.001 
5-15 years 5.34(4.64-6.15)  
Ethnic origin   
White British 1 <0.001 
Indian 0.86(0.66-1.13)  
Black African 0.71(0.52-0.97)  
Black Caribbean 0.50(0.34-0.74)  
Black other 0.86(0.62-1.20)  
Bangladeshi 0.61(0.35-1.06)  
Pakistani 1.01(0.80-1.28)  
Other Asian 0.94(0.65-1.34)  
Chinese 0.47(0.21-1.04)  
Mixed 0.92(0.73-1.16)  
Other 0.89(0.73-1.08)  
Unknown 0.62(0.58-0.66)  
Social Deprivation   
Least deprived 1 <0.001 
Most deprived 0.68(0.62-0.74)  
Respiratory illness   
Absent 1 <0.001 
Present 1.50(1.42-1.59)  
Obstructive sleep apnoea   




Present 10.99(9.7-12.40)  
Obesity   
Not coded 1 <0.001 
Obese 1.96(1.66-2.30)  
HIV status   
HIV negative -  
HIV positive -  
Eating disorder   
Absent 1 0.01 
Eating disorder 1.54(1.13-2.12)  
Practice region   
North East 1 <0.001 
North West 1.92(1.30-2.84)  
Yorkshire & The Humber 1.80(1.20-2.69)  
East Midlands 3.04(2.04-4.54)  
West Midlands 2.01(1.35-2.97)  
East of England 2.27 (1.53-3.36)  
South West 1.72(1.16-2.55)  
South Central 1.77(1.19-2.63)  
London 1.87(1.26-2.78)  
South East Coast 2.75(1.86-4.08)  
 Table 17 Multi-variable models of tonsillectomy in children.  
This table shows the risk factors associated with tonsillectomy, amongst all children in the CALIBER cohort 
(denominator=2.6million person-years). Univariable and Multivariable models are based on the Poisson distribution. 






Table 18Table of numbers and proportions of children with recurring sore throat who then receive tonsillectomy, by region 
Practice region Children with 
recurring sore 





North East 105 24 23% 
North West 3,699 1065 29% 
Yorkshire & The 
Humber 
1,026 289 28% 
East Midlands 983 358 36% 
West Midlands 3,174 747 24% 
East of England 2,935 818 28% 
South West 2,241 667 30% 
South Central 1,884 566 30% 
London 2,552 620 24% 
South East Coast 2,413 770 32% 






There were 766,302 sore throat consultations over 8,268,459 person years of observation 
giving a sore throat consultation rate of 92.7/1000 person years (95% CI 92.5-92.9). 20,423 
adults went on to have recurring sore throat giving an annual incidence of 2.67/1000person 




recurring tonsillitis, only 3568 were in our cohort of adults with recurring sore throat (3 sore 
throat consultations in 12 months).   
 
Sore throat  
See Table 19 Multivariable models of Sore throat in adults 16-44 years old. 
Univariable analysis showed a small amount of variation in the rate of sore throat consultation 
by geographical region (Residents of East Midlands had 24% more chance of having a sore 
throat consultation compared to residents from the North East). Running the SCV model 
without adjustment of population characteristics showed the SCV value of 3.4. 
Multi-level multivariable Poisson modelling showed the following factors were more likely to 
be related to GP sore throat consultation in adults (16-44years): Young age (16-24 years: aIRR  
1.45), female gender (aIRR 1.75), ethnicity (e.g. white ethnicity compared to Black African – 
aIRR 1.20), low deprivation score (least deprived compared to most deprived aIRR 1.09), 
presence of chronic respiratory illness (aIRR1.26), diagnosis of obstructive sleep apnoea (aIRR 
1.45), obesity (aIRR 1.45), HIV (aIRR 1.37), being a non-drinker compared to heavy drinker 
(aIRR 1.54), being an active smoker (aIRR 1.10), being diabetic (aIRR 1.20) and being 
hypertensive (aIRR1.40).  
After controlling for all the above factors there was less variation in sore throat incidence 
between the 10 regions of England (Residents of East Midlands had 18% greater risk of a sore 
throat consultation compared to Residents of the North East). However, much of the variation 
was seen to occur between general practices rather than regions. The multilevel model 
revealed that there was 4 times more unaccounted variation at the general practice level 
compared to the region level (variance 0.003 vs 0.012, respectively).  
The above multilevel multivariable model was used to calculate the systematic component of 
variation. The adjusted SCV score of 1.7 showed that much of the regional disparity in sore 







 Adjusted IRR P 
Gender   
Male 1 <0.001 
Female 1.75(1.71-1.79)  
Age category   
16-24 years 1 <0.001 
25-44 years 0.51(0.49-0.52)  
Ethnic origin   
White British 1 <0.001 
Indian 1.06(0.98-1.14)  
Black African 0.83(0.72-0.95)  
Black Caribbean 0.87(0.79-0.97)  
Black other 0.85(0.75-0.95)  
Bangladeshi 1.12(0.97-1.29)  
Pakistani 1.22(1.13-1.32)  
Other Asian 0.97(0.86-1.10)  
Chinese 0.78(0.68-0.90)  
Mixed 0.80(0.71-0.89)  
Other 0.99(0.93-1.05)  
Unknown 0.96(0.93-0.98)  
Social Deprivation   
Least deprived 1 0.01 
Most deprived 1.09(1.00-1.19)  
Respiratory illness   
Absent 1 <0.001 




Obstructive sleep apnoea   
Absent 1 <0.001 
Present 1.45(1.31-1.61)  
Obesity   
Not coded 1 <0.001 
Obese 1.45(1.26-1.43)  
HIV status   
HIV negative 1 <0.001 
HIV positive 1.37(1.24-1.51)  
Alcohol   
Non-drinker 1 <0.001 
Mild-Moderate drinker 1.03(0.99-1.07)  
Heavy drinker 0.65(0.60-0.71)  
Smoking   
Non-Smoker 1 <0.001 
Ex-smoker 1.17(1.14-1.21)  
Smoker 1.10(1.08-1.12)  
Diabetes   
No Diabetes coded 1 <0.001 
Diabetes coded 1.20(1.15-1.26)  
Hypertension   
No hypertension coded 1 <0.001 
Hypertension coded 1.44(1.39-1.50)  
Practice region   
North East 1 0.01 
North West 1.13(0.84-1.52)  
Yorkshire & The Humber 1.07(0.77-1.49)  
East Midlands 1.18(0.86-1.61)  




East of England 1.14(0.83-1.54)  
South West 1.12(0.82-1.52)  
South Central 0.98(0.72-1.32)  
London 0.97(0.71-1.31)  
South East Coast 0.99(0.73-1.36)  
Table 19 Multivariable models of Sore throat in adults 16-44 years old.  
This table shows the risk factors associated with recurring sore throat consultation, amongst all adults 16-44 years old in the 
CALIBER cohort 1997-2010, denominator is 7.7 million person-years. Multivariable models are based on the Poisson 




Recurring sore throat  
See Table 20 Multi-variable models of recurring sore throat in adults (16-44 years old). 
Univariable analysis showed a moderate amount of variation in the incidence of recurring 
sore throats between geographical regions (Residents of East Midlands had 50% more chance 
of having recurring sore throat compared to residents from the North East). Running the SCV 
model without adjustment of population characteristics showed the SCV value of 4.2. 
Multilevel multivariable Poisson modelling showed the following factors were more likely to 
be related to adults (16-44years) defined as suffering from recurring sore throat (3 GP sore 
throat consultations within 12 months): Young age (16-24 years: aIRR 1.52), female gender 
(aIRR 1.98), ethnicity (e.g. white ethnicity compared to Black African – aIRR 1.47), chronic 
respiratory illness (aIRR 1.53), obstructive sleep apnoea (aIRR 1.82), obesity (aIRR 1.55), being 
a non-drinker compared to a heavy drinker (aIRR 2.08), being an active smoker (aIRR1.12), 
and being hypertensive (aIRR 1.26).   
After controlling for all the above factors there was still variation in the incidence of recurring 
sore throats between the 10 regions of England (e.g. Residents of East Midlands had a 54% 
increased risk for recurring sore throat compared to Residents of the North East). However, 
much of the variation was seen to occur between general practices rather than regions. The 
multilevel model revealed that there was 3 times more unaccounted variation at the general 
practice level compared to the region level (variance 0.14 vs 0.45, respectively). The final 
multilevel multivariable model was used to calculate the systematic component of variation. 
The adjusted SCV score of 2.1 showed that much of the regional disparity in sore throat can 




Characteristic Multivariable analysis 
 Adjusted IRR P 
Gender   
Male 1 <0.001 
Female 1.98(1.82-2.15)  
Age category   
16-24 years 1 <0.001 
25-44 years 0.66(0.61-0.71)  
Ethnic origin   
White British 1 0.004 
Indian 0.95(0.74-1.23)  
Black African 0.68(0.44-1.03)  
Black Caribbean 0.61(0.45-0.83)  
Black other 0.78(0.58-1.03)  
Bangladeshi 1.14(0.75-1.73)  
Pakistani 1.18(0.99-1.40)  
Other Asian 1.04(0.74-1.45)  
Chinese 0.69(0.43-1.13)  
Mixed 0.92(0.69-1.24)  
Other 0.82(0.65-1.05)  
Unknown 0.89(0.82-0.96)  
Respiratory illness   
Absent 1 <0.001 
Present 1.53(1.44-1.63)  
Obstructive sleep apnoea   
Absent 1 <0.001 
Present 1.82(1.34-2.48)  




Not coded 1 <0.001 
Obese 1.55(1.40-1.71)  
Alcohol   
Non-drinker 1 <0.001 
Mild-Moderate drinker 0.94(0.87-1.01)  
Heavy drinker 0.48(0.40-0.58)  
Smoking   
Non-Smoker 1 0.003 
Ex-smoker 1.06(0.96-1.17)  
Smoker 1.12(1.06-1.18)  
Hypertension   
No hypertension coded 1 <0.001 
Hypertension coded 1.26(1.13-1.41)  
Practice region   
North East 1 0.002 
North West 1.28(0.87-1.90)  
Yorkshire & The Humber 1.23(0.79-1.92)  
East Midlands 1.54(1.02-2.31)  
West Midlands 1.44(0.98-2.10)  
East of England 1.19(0.80-1.78)  
South West 1.18(0.79-1.78)  
South Central 0.89(0.60-1.32)  
London 1.01(0.67-1.51)  
South East Coast 1.03(0.69-1.54)  
Table 20 Multi-variable models of recurring sore throat in adults (16-44 years old). 
 This table shows the risk factors associated with recurring sore throat consultation, amongst all adults 16-44 years old in 
the CALIBER cohort, denominator= 7.6million person-years. Multivariable models are based on the Poisson distribution. 





See Table 21  Multi-variable models of tonsillectomy in adult. 
Univariable analysis showed a small amount of variation in the rate of tonsillectomies 
between geographical regions (Residents of East Midlands had 21% more chance of having a 
tonsillectomy compared to residents from the North East). Running the Systematic 
Component Variation (SCV) model without adjustment of population characteristics showed 
the SCV value of 5.3. 
Multilevel multivariable Poisson modelling in all adults (16-44 years) within the full CALIBER 
cohort showed the following factors predicted a tonsillectomy:  Young age (16-24 years: aIRR 
– 6.25), female gender (aIRR 1.39), ethnicity (e.g. white ethnicity compared to Black African – 
aIRR 2.50), chronic respiratory illness (aIRR 1.18), obstructive sleep apnoea (aIRR 2.59), 
obesity (aIRR 1.58), being a non-drinker compared to heavy drinker (aIRR 1.64) and being an 
active smoker (aIRR 1.30).  
After controlling for all the above factors there was no variation in tonsillectomy rates 
between the 10 regions of England. Additionally, much of the variation was seen to occur 
between general practices rather than regions. The multilevel modelled revealed that there 
was comparable unaccounted variation between the general practice level and the region 
level (variance 0.24 vs 0.27, respectively). The above multilevel multivariable model was used 
to calculate the systematic component of variation. The adjusted SCV score of 2.91 showed 
that much of the regional disparity in tonsillectomy rates can be predicted by regional 
characteristics.    A more intuitive way to evaluate the role of ‘need’ on regional tonsillectomy 
rate variation is displayed in table 21. In this table, the raw tonsillectomy rates over 10 regions 
can be seen, but also the tonsillectomy rates as a proportion of the population with recurring 
sore throat infections.    And whilst there is great disparity between regions in the number of 
tonsillectomies undertaken, the proportion of tonsillectomies from a population of those with 




Characteristic Multivariable analysis 
 Adjusted IRR P 
Gender   
Male 1 <0.001 
Female 1.39(1.24-1.55)  
Age category   
16-24 years 1 <0.001 
25-44 years 0.16(0.14-0.17)  
Ethnic origin   
White British 1 <0.001 
Indian 0.85(0.54-1.34)  
Black African 0.40(0.23-0.69)  
Black Caribbean 0.66(0.37-1.18)  
Black other 0.53(0.28-0.99)  
Bangladeshi 1.63(1.01-2.64)  
Pakistani 0.85(0.52-1.40)  
Other Asian 1.16(0.50-2.72)  
Chinese 0.57(0.21-1.52)  
Mixed 0.79(0.50-1.27)  
Other 0.57(0.39-0.85)  
Unknown 0.79(0.70-0.89)  
Social Deprivation   
Least deprived 1 0.67 
Most deprived 1.06(0.92-1.22)  
Respiratory illness   
Absent 1 <0.001 
Present 1.18(1.07-1.29)  
Obstructive sleep apnoea   




Present 2.59(1.59-4.23)  
Obesity   
Not coded 1 <0.001 
Obese 1.58(1.39-1.80)  
Alcohol   
Non-drinker 1 <0.001 
Mild-Moderate drinker 1.26(1.14-1.40)  
Heavy drinker 0.61(0.47-0.78)  
Smoking   
Non-Smoker 1 <0.001 
Ex-smoker 1.45(1.24-1.69)  
Smoker 1.30(1.20-1.42)  
Practice region   
North East 1 0.38 
North West 0.88(0.57-1.38)  
Yorkshire & The Humber 0.97(0.59-1.59)  
East Midlands 1.23(0.75-2.02)  
West Midlands 0.91(0.59-1.40)  
East of England 0.92(0.59-1.45)  
South West 0.89(0.58-1.39)  
South Central 0.90(0.56-1.42)  
London 0.78(0.50-1.22)  
South East Coast 0.86(0.54-1.35)  
Table 21  Multi-variable models of tonsillectomy in adult. 
This table shows the risk factors associated with tonsillectomy, amongst all adults 16-44 years old in the CALIBER cohort, 
denominator=7.7million person-years. Multivariable models are based on the Poisson distribution. Multivariable models are 





Once the above factors are accounted for there is <0.001 of the variance left unexplained at 
the level of region, and 0.23 of the variance still unexplained at the level of the general 
practice. 
 
Practice region Adults with 
recurring sore 





North East 128 63 49% 
North West 3,541 1317 37% 




East Midlands 978 338 35% 
West Midlands 3,130 886 28% 
East of England 2,948 904 31% 
South West 2,507 910 36% 
South Central 2,019 673 33% 
London 2,246 597 27% 
South East Coast 1,970 710 36% 
Mean 2042 678 35% 
Table 22 Regional variations in tonsillectomy proportions for adults with recurring sore throat. 
This table shows the proportion of adults who go on to receive a tonsillectomy having presented with a recurring sore throat, 





























































4.2 4.8 8.8 3.4 4.2 5.3 
Adjusted 
SCV 
1.2 1.8 2.3 1.7 2.1 2.9 
Table 23 Different metrics of variation as measured across health care settings 
This  table shows the  different metrics used to measure variation for each of the subject types. The variation is greatly reduced 







I have shown that there is substantial unadjusted variation between regions e.g. in children 
there was up to 35% variation between regions in GP sore throat consultation (unadjusted 
SCV=4.2), 90% GP recurring sore throat consultation (unadjusted SCV= 4.8) and 290% 
tonsillectomy rates (unadjusted SCV=8.8). A wide range of risk factors for sore throat, 
recurring sore throat and tonsillectomy were identified. (see Table 23 Different metrics of 
variation as measured across health care settings). Once these patient variables were 
accounted for, geographical variations in sore throat, recurring sore throat and tonsillectomy 
rates reduced and SCV measurements based on these models suggested only minimal 
regional variation after adjusting for patient characteristics and regional patterns of recurring 
sore throat, with an adjusted SCV of 2.3 for tonsillectomy in children and 2.9 for tonsillectomy 
in adults.  
Strengths 
This is the first study to investigate the effect of patient level characteristics on regional 
variation of tonsillectomy rates. By using a dataset that linked primary and secondary care 
encounters, I was, for the first time, able to relate regional tonsillectomy rate variations to 
population predictors of regional sore throat disease burden in primary care. Firstly, I could 
reliably investigate geographical variations across the patient care pathway, from the initial 
sore throat consultation in primary care through to tonsillectomy in hospital. Secondly, I had 
a dataset that had more complete information on the tonsillectomy (secondary care 
database) linked to a dataset that had more complete information about patient socio-
demographics and co-morbidities (primary care database), allowing us the opportunity to 
understand the role of patient characteristics on regional tonsillectomy rate. Additionally, I 
used a multi-disciplinary team to define the codes that would phenotype our outcomes of 
interest in an iterative and transparent manner. Finally, the use of electronic health care 
records, which were collected as part of routine medical care, allowed for long follow up 
(mean follow up 6.8years) which would be expensive if the data were collected specifically 





would occur in a study setting. Finally, this is the first study that describes regional adult 
tonsillectomy rate variation, showing that the level of variation is substantially lower than in 
children (see Figure 9  Sore throat in the community to tonsillectomy in secondary care for 
children 5-15 years and Figure 10 Sore throat in the community to tonsillectomy in secondary 
care for adults 16-24).  
 




Figure 10 Sore throat in the community to tonsillectomy in secondary care for adults 16-24 
1679 self reported sore throats/1000pt years – from FluWatch (8% seek 
help)
142 GP sore throat consultations/1000pt years  (46% become recurrent) 
66 recurring sore throat patients/1000pt years (4% have tonsillectomy)
2.5 tonsillectomies/1000pt years
1559 self reported sore throats/1000pt years from FluWatch (7% seek 
help)
116 GP sore throat consultations/1000pt years (3% become recurrent) 








Whilst the use of electronic health care records had the advantages described above, it also 
had several disadvantages. Firstly, the database was not created with our research question 
in mind and so there were important pieces of information that I could not use since they 
were infrequently coded by GPs (e.g. the presence of a fever during a sore throat, severity of 
symptoms, referral to ENT, etc.). Additionally, whilst I could identify whether patients were 
part of the same GP and Strategic Health Authority, I did not have access to data that would 
allow us to identify the patient’s Primary Care Trust/Clinical Commissioning Group (PCT/CCG) 
or even Hospital Trust, which is where local policy is enacted. Therefore, it would not be 
possible to say anything about inter-hospital variation or even comparisons between localities 
that have differing local policies on tonsillectomy. Finally, our dataset did not include Accident 
and Emergency visits for sore throat and so could not measure all health service activity 
related to sore throat.  However, it must be noted from our FluWatch study that only a small 
proportion of patients seeking help for their sore throat attend A&E (3%), and so I did not 
expect the loss of this data to affect our overall conclusions.  
 
Findings in the context of published literature 
In response to a local study of regional variation in Oxford (19)  Suleman (19) (2010) 
undertook an analysis of regional variation in paediatric tonsillectomies using HES and private 
health insurer (BUPA) data from 2000-2005 and reported a 7-fold difference between Primary 
Care Trusts (now called Clinical Commissioning Groups). The King’s Fund published a report 
on regional surgical rate variation, using 2009-10 HES data they also reported a 7 fold 
difference in paediatric tonsillectomy rates between PCTSs (20). The Rightcare(175) 
programme have since done the same and reported a was a 5.2-fold difference between the 
PCT with the highest and lowest rates, based on 2011 HES data. Our data analysis showed 
that there was 3-fold difference in paediatric tonsillectomy rates between the regional levels 





Some of the difference between the literature and the results reported here may relate to 
the different geographical units assessed.  Due to pseudononymisation and patient re-
identification policy around linked primary and secondary care datasets I did not have access 
to data that would identify patient’s primary care trust or hospital. Studies described in the 
previous paragraph did not have access to individual patient data but only aggregate 
population data and so were able to discuss variations at local health authority level. 
Therefore, it is difficult to make direct comparisons between our study and the others 
described above, since they describe variations at different size geographical units. It would 
be expected that variation reduces when larger geographical units are analysed (e.g. strategic 
health authority compared to primary care trust) since the rates of outlier primary care trusts 
are more heavily diluted through regression to the mean. This is borne out in my results which 
show greater variations for GPs than regions. Our analysis showed that there were still large 
differences in tonsillectomy rates, even with a smaller dataset and analysis of larger 
geographical units. Most importantly my results demonstrate that whilst crude metrics of 
variation can provide measures of maximum variation, they may be misleading. In order to 
formally examine such apparent variation and it is essential to use SVC thresholds for 
categorisation.  
No previous study has described regional tonsillectomy rate variation in adults. It is unclear 
whether this is related to publication bias (with a greater likelihood to report high levels of 
variation than low levels of variation) or a perception that adult tonsillectomies are 
infrequent. Although adult tonsillectomy rates are substantially lower in adults than in 
children it must be noted that nearly half of all tonsillectomies done in our cohort were on 
adults.  
The King’s Fund reported a systematic component of variation of 8.4 in relation to paediatric 
tonsillectomy rate variation between local health authorities (20), which is comparable to 
unadjusted SCV of 8.8 that I report here. The systematic component of variation is a more 
robust measure of small-area variation, as it focuses on inter-regional disparities, after 
accounting for expected variation due to population characteristics. When I recalculated the 





tonsillectomy and clustering of patients to general practices) the SCV dropped to 2.25. Whilst 
the authors of the King’s Fund publication do not describe the underlying model of their SCV 
calculation, it is unlikely they had access to accurate patient level characteristics since they 
used an unlinked HES database in isolation.  
My FluWatch study (chapter 3), along with RightCare’ s Atlas of Practice Variation (59,176) 
adds further support to the hypothesis that regional tonsillectomy rate variation is 
substantially affected by regional ‘need’. My study of CALIBER data showed East Midlands 
had the highest rates of tonsillectomy, whilst North East England had the lowest rates. The 
variation between these two regions was most apparent in children (0-15 years old) and had 
an almost 300% difference in tonsillectomy rates between these regions, compared to adults 
(16-44years old) who had 20% difference between these regions. Regional patterns of 
recurring sore throat (3 primary care sore throat consultations in less than 12 months) 
showed residents of the East Midlands were more likely to have recurring sore throat 
compared to those in the North East of England (children 90% more likely and adults 50% 
more likely). These observations are corroborated by my FluWatch study (chapter 3) that 
showed regional patterns of community sore throat residents of East of England and East 
Midlands were more likely to self-report a sore throat compared to those in North England 
(children 3% and adults 14% more likely). Overall, regional patterns of sore throat in the 
community, and incidence of recurring sore throat in primary care all seem to vary in patterns 
that are similar to regional tonsillectomy rates. This holds across 3 separate databases: 
FluWatch, CPRD and HES. This suggests that a considerable component of regional variation 
in tonsillectomy rates may be present before the patient is seen in an ENT outpatients setting.  
Future work is also planned to investigate regional variation in other surgical procedures such 
as grommet insertions for otitis media with effusion as mechanisms that drive variations in 
other procedures may be different.  
Implications for policy 
Current strategies to reduce regional tonsillectomy rate variation may have failed to reduce 





variations in recurring sore throat, and potentially community incidence of sore throat. 
Regional tonsillectomy rate variations may be better described as a symptom of a deeper 
issue that allows for regional disparities in healthcare. Future policies should promote joined 
up strategies to reduce variation in care across the entire care pathway, from sore throat 
management in primary care through to surgical management with tonsillectomy in 
secondary care.  
A key component of the current Government policy to reduce regional surgical rate variations 
is to quantify and publicise variations through RightCare’s Atlases of Practice Variation 
(59,177,178). This allows local healthcare authorities to judge over- or underuse of 
treatments and make appropriate changes through prioritisation (rationing) strategies. 
However, these Atlases are based on unadjusted figures, taken at from aggregate HES data. 
As this study has shown, unadjusted regional rates of tonsillectomy, may distort true 
variations in tonsillectomy rates and result in ineffective use of commissioning guidance, 
which at best may have no effect on regional tonsillectomy rate variation, but at worse may 
prevent patients with recurring tonsillitis failing to receive appropriate treatment.  
Additionally, whilst the RightCare Atlas of Practice variation described regional paediatric 
tonsillectomy rate variation my freedom of information request showed local commissioning 
guidance applied to adult tonsillectomy also. This is the first study that has reported on 
regional adult tonsillectomy rate variation and has found there is very little variation in this 
group. Therefore, local policy aimed at this population may be unnecessary, and may, in fact, 





CHAPTER FIVE: Can aspects of the decision-making process 













In this chapter I have introduced possible alternative sources of variation in adult 
tonsillectomy by considering the variables that can be measured within the medical 
consultation.  The chapter provides an overview of the main conceptual frameworks of shared 
decision making –the most relevant description of the medical consultation between doctor 
and patient (i.e. decision support, information exchange, patient centredness, patient 
empowerment, decisional uncertainty, role preference, patient treatment preferences). It 
goes on to review the extent to which these key concepts can be measured, and explains the 
reasons for measuring decisional uncertainty and treatment preference in an observational 







Chapters 3 and 4 have shown that the rates of sore throat in the community and in primary 
care, along with tonsillectomy rates in secondary care change with factors that are known to 
vary between regions (specifically age, sex, ethnicity, presence of chronic medical diseases, 
number of people in the household, smoking status and population density).  Controlling for 
these population factors reduced regional tonsillectomy, recurring sore throat and 
community sore throat variations, with the SCV reducing from 8.8 to 2.3 in children’s 
tonsillectomy rates and 5.3 to 2.9 in adult’s tonsillectomy rates.  
The greatest evidence for regional variation comes from the concept of the “surgical 
signature”. The surgical signature refers to regional variations in surgical treatment, 
corresponding to the differences in surgeon preference for certain treatments. Yet, there is 
very little evidence for why shared decision making in one region leads to patients choosing 
tonsillectomy and others not. Some have suggested (39,40,60,179) that other factors, at the 
level of the individual patient, the individual doctor (physician/surgeon) or the interaction 
between the two during the medical consultation (collectively defined as the medical 
decision-making process) can also contribute to variation in tonsillectomy rates. Ideally, a 
study of decision making in relation to regional tonsillectomy rate variation would have 
examined variation at the level of GPs in primary care and hospital (surgical team). We do not 
know which part of the shared decision-making process could be related to decisions 
becoming regionally aligned. A better understanding of the conceptual frameworks leading 
to medical decision-making is required in order to target interventions aimed at reducing 
variation. Measuring decision making in primary care over several consultations would have 
been difficult conceptually, as well as practically. Before I embarked on a study to understand 
if any parts of the medical consultation for recurring tonsillitis had any role in regional 
tonsillectomy rate variation, I set out to understand which aspects of the medical decision-
making process are most likely influential and which aspects can be practically measured. As 
a first step this was most feasible in the consultation between surgeon and patient, which led 






Shared Decision-Making (SDM): Definition and key conceptual frameworks 
Since the time of Hippocrates, the medical consultation has followed a doctor-centred 
“paternalistic” model, defined as the doctor giving the patient selected information and 
encouraging the patient to consent to what the doctor considers best(180). However over 
the last half-century, due to a shift in focus of medicine from acute to chronic diseases (181), 
increase in the number of treatment options available(63) (182), and changes in society that 
have informed (183) and empowered individuals (184), there has been a move away from 
this model of decision-making, towards a more patient-centred approach, defined as shared 
decision-making (SDM).  
Charles and Gafni (185) originally described patient participation as shared decision-making 
(SDM), and defined it as a process that has 4 features: 
1. At least two participants: the doctor and patient; 
2. Information is shared; 
3. Both parties (doctors and patients) take steps to participate in the process of treatment 
decision-making;  
4. A treatment decision is made and both parties agree to the decision. 
SDM is now extensively taught to medical practitioners training and practicing in both  
primary (186), (187) and secondary care (188,189). In parallel, there has been a national 
campaign, aimed at the public, that encourages a change in the method of medical decision-
making, away from the traditional “paternalistic” model towards to a more shared 
approach(190). Whilst the popularity of SDM, has grown so has its definition. A recent review 
(191) found 161 different definitions for the process, suggesting that the term SDM is an 
“umbrella” term incorporating many different, specific concepts related to patient-centred 
decision making.  Conceptual frameworks (concepts or constructs) are definitions of abstract 
ideas, based on a structure of relationships between key-variables(192). There is a difference 
in technical language depending on the background and discipline of authors.  For this reason, 





Since concepts around the process of SDM have been developed independently of each other, 
it is unclear how these concepts relate to each other within the process of SDM. Further, 
there is little clarity about the names of these specific concepts since concepts are frequently 
referred to using different names. To understand more fully the range of concepts that are 
discussed in relation to SDM, and to what extent they may relate to one another to create 
the process of shared decision-making I undertook a review of the relevant conceptual 
frameworks.  Through brief review of the relevant literature (search terms in PubMed and 
PsychINFO: “shared decision making”, or “SDM”, or patient-centred decision-making” or 
“patient-centred decision-making” and “conceptual framework” or “concept*” or 
“construct”) I identified seven main concepts in relation to the processes of SDM: decisional 
support, patient centredness, information exchange, empowerment, decision uncertainty, 
role and treatment preference.  Each of these contains several separate elements and there 
is considerable overlap between them.  Below, I discuss the main conceptual frameworks that 









The Ottawa Decision Support Framework (
 
Figure 11) provides a structure to support patients through a medical decision, based on 
theories from general psychology (193) social psychology (194), decision analysis(195), 
decisional conflict(196), social support (197) and economic concepts regarding expectations 





decision by clarifying their need, providing facts and probabilities, clarifying their values, 
guiding them in deliberation and then finally helping facilitate their decision. 
 
Figure 11 Decision Support, my adaptation based on Ottawa decision support framework(199) 
The decision support framework gives a structure to support patients through making medical 
decisions above shows how the authors describe decision support from the patients’ 
decisional needs to a high-quality decision 
Information exchange 
Frederickson’s (200) framework (Figure 12) provides an in depth analysis of information 
exchange, building on Tuckett’s (201) five general statements of information sharing for the 
general  physician recognising that: (1) attending to the provision of information, reassurance 
and understanding are intrinsic and important parts of therapy; (2) the patient’s co-operation 
in carrying out advice cannot be taken for granted and information may be necessary for 
persuasion; (3) the outcome of medical treatment is multidimensional and subjective matter, 
thus the patient’s view is relevant; (4) individuals selectively seek help with symptoms that 
they experience and seek knowledge to deal with them; (5) patients are in a sense consumers 
of the medical service and require information and autonomy in decision making.   
Frederickson L (202) realised that the concept of information should extend beyond the mere 





expectations and anticipations of the patient and should be pervasive through the whole 
consultation.  
Frederickson described three key dimensions that exist for both patient and doctor 
separately: Input; Information exchange; and Outcomes. “Input” relates to the relative 
knowledge, orientation, perspectives, social norms and belief systems that exist within and 
around each agent, prior to the exchange. As part of the “exchange” process Frederickson 
(202) described the patient and doctor role introductions (203). They allowed for a fluid 
model of information flow to mimic the unpredictable flow of human interaction.  In addition 
to verbal communication they also felt that the concept of information exchange should not 
be limited to verbal exchange. Intrinsic to the concept of information exchange was the 
notion of information processing by the participants, and this subsumed the perception, 
selection, and understanding of informative items. Significant processing was necessary 
before any information available in a consultation could be utilised by those who received it 
(204). The process depicted in the model readily incorporated the patient-centred ideology 
of Levenstein et al. (205) and Middleton (206) with the information exchange involving 
exploration of doctor and patient agendas.  
Finally, “output” describes the full disclosure of treatments being considered and 
commitment to options offered by one another. Figure 12 below illustrates this process of 
information exchange. This construct is similar to the idea of knowledge transfer described 






Figure 12 Information exchange – diagram based on Fredericksson (200) 





Mead et al (208) derived a formal framework of ”patient-centredness” based on a review of 
conceptual and empirical literature regarding the doctor-patient relationship. The authors 
described five key dimensions of patient centredness (Figure 13 Patient centredness ) as the 
biopsychosocial perspective, patient-as-person; sharing power and responsibility; 
therapeutic alliance; and doctor-as-person perspectives. The biopsychosocial perspective, 
derived from work from (209), broadens the definition of illness from just the biomedical to 
include psychological and social aspects in a hierarchical manner. This model can best be 
understood with the example of a man who died suddenly of a heart attack at work. The 





taking nutrients to the heart. The biopsychological model would describe this situation as a 
stoic gentleman that has been having chest pain related to narrowing of his heart vessels for 
months and has refused to seek help, culminating in a complete blockage and a heart attack. 
The biopsychosocial model would describe this situation as stoic gentleman that has been 
having chest pain related to narrowing of his heart vessels for months and has refused to seek 
help, culminating in a complete blockage and a heart attack that could not be treated urgently 
enough due to lack of defibrillators at work. While the biopsychological model included a 
broader range of concepts than the biomedical model, Mead et al (208) felt that even the 
biopsychosocial model did not sufficiently describe the situation as it did not account for the 
patients’ perspective of illness. The patient-as-person, therefore, adds a biographical 
component, created to instil a sense of illness within the patient’s life setting. For example, in 
the above case it would provide information on how the patient viewed his symptoms, illness 
and death.  Mead added “sharing power and responsibility” to the conceptual framework of 
patient centredness based on Byrne and Long’s (210), analysis of audiotaped consultations.  
Byrne and Long described sharing power and responsibility as any process that results in 
recognition of patients’ needs and preferences in their treatment. Mead added “therapeutic 
alliance” based on new developments from Roth & Fonagy (211) to emphasise  certain 
aspects of the patient-doctor relationship : (a) the patient’s perception of the relevance and 
potency of interventions offered, (b) agreement over the goals of treatment, and (c) cognitive 
and affective components, such as the personal bond between doctor and patient and 
perception of the doctor as caring, sensitive and sympathetic. The final dimension added to 
this construct was doctor as person, to acknowledge doctor subjectivity was an inherent 
component of the patient-doctor interaction (212).  Mead suggests that five key definitions 
of patient centredness relate to each other through information exchange, but does not 
qualify the basis or types of interactions involved. Patient involvement is often used 
interchangeably with patient centredness. Whilst patient involvement was first described in 
1974 and formalised through the creation of community health councils, this term has also 





patients’ needs (213) . Currently it has since become synonymous with involving patients in 
all their health care decisions (214). 
Figure 13 Patient centredness below describes the potential contributors to patient 
centredness, which are divided into patient, doctor and consultation factors, all of which can 




Figure 13 Patient centredness 
This figure shows my adaptation of the components which contribute to patient centredness, based on theories by Mead 
{Mead:2000cb}  
Patient empowerment  
Opie (215) reviewed previous conceptual frameworks of patient empowerment over 
material circumstance (216), empowerment over social circumstance (217) and the method 
by which professionals can empower patients (218). The authors then undertook qualitative 
interviews to investigate how multidisciplinary teams could best be deployed to empower 
patients and their carers. Menon (219) built on these frameworks to describe empowerment 





Goal internalization of health ideals requires that patients see good health as their personal 
goal. Perceived competence relates to the patient’s management of various activities 
associated with health and health care. This requires patients to a) have the capability and 
knowledge required to maintain a healthy lifestyle, b) have the ability to manage minor 
ailments that do not require specialised medical assistance, and c) know when, where, and 
how to seek specialised medical assistance. Perceived control relates to controlling factors 
associated with maintaining good health. This frequently requires access, high quality of 
services and interaction with health care providers.  
Decisional uncertainty/conflict 
The concept of decisional uncertainty/conflict grew out of studies examining how people 
coped with stresses in World War II and culminated in the “conflict-theory model of decision 
making”- see Figure 14- (220). The authors felt that uncertainty/conflict was the result of an 
opportunity or need to change the status quo, insufficient knowledge about benefits and risks 
of continuing in status quo or undertaking the alternative, and insufficient time to evaluate 
and undertake a change.  
The five coping patterns identified when facing stresses of uncertainty/conflict were un-
conflicted adherence, un-conflicted change, defensive avoidance, hypervigilance and 
vigilance. Studies investigating physiological concomitants found that the greater the 
uncertainty/conflict the more marked the changes in heart rate and galvanic skin-response 
(221,222)  
 
Figure 14 Conflict-decision theory Adapted from Janis and Man (223) 





The model of uncertainty/conflict (Figure 14) describes the process required to appropriately 
reduce the uncertainty/conflict in a decision, i.e. 1. Information gathering about potential 
gains and losses from change in status quo; 2. Information gathering about gains and losses 
from alternatives; 3. Having sufficient time to undertake evaluation of above. Whilst the 
original model was created to understand decision-making in uncertainty, it was not until 
O’Connor {OConnor:1998hh} used the model to understand erratic health choices for breast 
cancer and vaccination that it was used to describe and evaluate how shared clinical decisions 
were undertaken.  Although the work of Janis and Mann (220) was seminal, modern 
neurobiological research on conflict and decision-making also considers heuristic processes 
rather than deliberate-rational processes alone(224).  
Role preference  
The idea of role preference originates in the work of Degner(225), who  undertook a 
qualitative study designed to investigate “What happens when treatment decisions are made 
for patients with life-threatening illnesses”. Degner used role and control preferences 
interchangeably throughout their article. The authors reported that whilst several factors 
influenced the way treatment decisions were made, the central factor appeared to be 
“control over the design of the treatment.” There were four main patterns of decision making: 
provider-controlled, patient-controlled, family-controlled and jointly controlled (225). This 
led the authors to a second question: “Do patients actually have preferences about the 
degree of control they actually want to exercise in treatment decision-making?” Analysis 
(using grounded theory) of consultation transcripts from first visits made by patients to two 
different cancer clinics revealed that patients fell into 3 categories: delegators (those that 
delegated the decision to the doctor), deliberators (those who wanted time to go away and 
think about the information before coming back and making the decision with their doctor) 
and decision makers (those that wanted to make their own treatment choices) – see Figure 
15.  In an effort to decide whether patients could differentiate their preferred roles in 
treatment decisions Degner asked 60 patients from oncology clinics to sort through 4 cards 
that represented potential roles (226)– see Figure 15. The authors reported that most 





differentiate amongst those who chose to share - Figure 15. Degner went further to show 
that preference for role in decision making was separate from preference for information 
regarding treatment options (225). Sutherland, Llewellyn-Thomas, Lockwood, Richler and Till 
(227) have since commented that need for information is related to the need to enhance 
psychological autonomy and is not necessarily related to a desire to assume responsibility for 
the treatment decision. Finally, Degner (228,229) used a survey studies of breast cancer 
patients to assess whether patients were able to differentiate between preferred decision 
roles and actual treatment roles. The studies showed that patients were able to differentiate 
between the two, and that patients who had been actively involved had a higher quality of 
life. Degner suggested that role preference was dependent on patients’ beliefs in the efficacy 
and benefits of self-care and should be communicated between patient and doctor. The term 
role preference is interchangeably used with control preferences throughout the literature.  
 
 
Figure 15 Role preference construct Adapted from Degner et al (230) 
This figure shows the different types of roles which patients may choose to take in a consultation.  
 
Patient treatment preference 
A key additional characteristic that patients bring to the clinical encounter is their preference 
for treatment. The psychological process that converts information gathered into a 
preference has historically been modelled using economic or psychological disciplines. 
Economic theory bases preference on utility, which is a measure of the satisfaction gained 
from the consumption of a good or service (231) – or in health care, the treatment decision. 
In psychology, preference is measured in the concept of attitude, which is defined as a 





or event (232).  Both of these models are based on the paradigm of a rational, individual 
decision maker and are concerned with two key processes: (1) An evaluation of an 
intervention in terms of its desirability or attractiveness and (2) A choice between alternative 
interventions based on that evaluation (233). Asking patients about their preferred 
treatment should initiate both processes. However, as complexity of information increases so 
does the probability that the respondent departs from the rational decision-making and 
employs simplifying heuristics to form a preference, and therefore, omits the evaluation 
phase (234). Preferences measured this way are not always stable with time (235,236).  
Review and inter-relatedness of conceptual frameworks 
All constructs related to the process of SDM and all frameworks described above aimed to 
understand patient and doctor collaboration. None of the constructs described the outcomes 
of SDM, such as satisfaction, or knowledge retained by the patient. Patient-centredness, 
empowerment, and decision support related more to the doctor’s role in the process. 
Information exchange included both patient and doctor’s roles. Role preference, decision 
uncertainty and treatment preference were more patient-orientated constructs (i.e. they 
related to patient’s role in SDM). Critical appraisal of each of the constructs above), suggested 
that there may be some conceptual overlap between constructs, although different terms 
were used to describe them. For example, conceptual definitions of decision support, 
decisional uncertainty and patient centredness all include information delivery, which is an 
integral part of the concept of information exchange.  
To investigate the interconnectedness of SDM constructs I examined each construct 
definition again to see if it could fit into the broader definition of any of the other constructs. 
I numbered key definitions of each construct and compared them to numbered key 
definitions from the remaining constructs. For example, “Patient involvement in decisions” 
was a key definition in the conceptual framework of Patient Involvement. I felt that this 
definition was related or similar to “value elicitation” in Decision Support, because if patients’ 
values are being elicited they are being involved in their decision. I also felt it was similar to 
“Discuss effect of problem on patient’s life” in Information Exchange, because by discussing 





treatment decision. By repeating this process across all key definitions of the seven 
conceptual frameworks I could hypothesize how the conceptual frameworks were related to 
each other.  The output of this process is summarised in Appendix V – Table of 
Interrelatedness of Concepts – and described in an example below the table.  This quantifiable 
process allowed me to create a representation of how the conceptual frameworks related to 
each other.  
I interpreted this table (Appendix V – Table of Interrelatedness of Concepts) as showing three 
constructs that were connected to nearly all other conceptual frameworks (patient 
involvement, decision support and information exchange). In contrast, there were four 
constructs that had little commonality between them (i.e. treatment preference, role 
preference, decisional uncertainty and empowerment). For example, neither empowerment 
nor role preference had any association with decisional uncertainty or treatment preference.  
I used an iterative discussion to develop a diagram of how all the constructs related to each 
other within the overall process of SDM. Part of this iterative discussion related to whether a 
construct was a smaller integral or a larger overarching construct. Through this process, I 
concluded that there were two large overarching constructs of SDM: patient involvement and 
decision support, each including several of five smaller constituent constructs: information 
exchange, role preference, patient empowerment, decisional uncertainty and treatment 
preference. Information exchange was the most inter-related of all constructs, having 
defining features in common with all six other constructs. Therefore, information exchange 
was described as a central construct, one that allowed all the other constructs to relate each 
another.  Figure 16 presents these inter-relationships diagrammatically.   
Summary 
All constructs discussed above have some foundation in theory that has been formalised into 
definitions using observational studies. Some definitions are broad and include many aspects 
of SDM (information exchange, patient centredness and decision support), whilst others are 
very specific to a small but integral part of SDM (role preference, treatment preference, 





constructs are more difficult to measure using questionnaire instruments.  Many of these 
constructs were defined before SDM was described and, therefore, there is considerable 
overlap between constructs, in the description of SDM.  
Given the inter-related nature of these constructs, care must be taken when choosing a 
construct to measure. In a study that is designed to investigate the role of the SDM on 
treatment chosen for recurring tonsillitis, measuring a small, discreetly defined construct (e.g. 
role preference) may provide results that are more readily interpretable and translatable into 
clinical practice (e.g. improve opportunities for patients to understand and state their 
preferred role in the decision). On the other hand, it may miss a large association between 
SDM and treatment chosen. Conversely, measuring a larger, indistinct construct (e.g. 
information exchange), may identify an association between the SDM and treatment chosen, 
but it may render interpretations difficult to translate into clinical practice (e.g. should one 
increase the amount of information, the type of information or the format the information is 
deployed in). Therefore, it is essential that I next considered how measureable these 
constructs were in the context of study that assesses shared decision making for adults with 
recurring tonsillitis. In the following section, I have examined existing questionnaire 
instruments that claim to measure constructs of the SDM process. The following chapter will 
focus on critical evaluation of methods for measuring treatment preferences and the 






Figure 16 Overlap of concepts of SDM.  
Uncertainty 
 Information gathering about gains and 
losses from change in status quo 
 Information gathering about gains and 
losses about alternatives 
 Time to evaluate above 
 
 Physician and patient roles, 
 Goals needs and expectations 
 Treatment options; 
 Explain cause of problems; 
 Explore patients ideas 
 Explore patients concerns; 
 Explore patients expectations;  
 Discuss effect of problem on patient’s life; 
 Explain treatment; 
 Assess patient characteristics 
for success; 
 Information delivery; 
 Value elicitation; 
 Support decision maker 
according to conflict; 





 Beliefs in the 
efficacy and benefits 
of self-care; 
 Choice of role 
decision making 





 The need to respect individuals 
decision making abilities and to 
recognise their capacity to make 
those decisions; 
 The need for workers to surrender 
their need for control and link in 
with support networks in a co-
operative and collaborative 
manner; 
 Identification of the power 
imbalances in relationship; 
 Awareness that the user may 
reject help offered; 
 Patient as person; 
 Explore all biopsychosocial causes; 
 Patient involvement in decisions; 
 Responsibility for non medical 
aspects of care; 
 Giving information to patients, 
 Form therapeutic alliance; 
 Share power and responsibility; 






Questionnaire instruments that measure constructs of SDM 
Having identified the key concepts that are relevant within the decision-making process 
(decision support, patient involvement, information exchange, role preference, 
empowerment, uncertainty and treatment preference); for those to be potentially useful in 
investigating variation they also need to be measurable.  To address this question I identified 
the existing questionnaire instruments that claimed to measure one of the above conceptual 
frameworks (or closely related) and critically appraised the psychometric properties of each 
using criteria with adapted from several well recognized sources (237-240).   
A review of the literature identified instruments that measure constructs of SDM (PubMed 
and PsychINFO were searched  using the search terms “shared decision making”, or “SDM” 
or “patient involvement” or “patient centred” or “patient centred” or “decision support” or 
“role preference” or “treatment preference” or “decisional uncertainty” or “decision 
uncertainty” or “decisional conflict” or “decision conflict” or “empowerment” or “information 
exchange” or “knowledge transfer” cross referenced with “instrument”, “tool”, “survey”, 
“questionnaire” and “measure”).  
Original search for instruments that measure constructs of SDM revealed questionnaires that 
could be divided into groups based on: 1) Whether they measured the process or outcome of 
SDM; and 2) The perspective they measured this from (patient, doctor, independent 
observer).  I focused on measures of decision making process itself (e.g. how much 
information exchange occurred during SDM), rather than satisfaction from the decision-
making ( e.g. how much satisfaction resulted from the information exchange that occurred 
during SDM). This is because studies have shown that patient decision satisfaction can be 
easily conflated with rapport with doctor or satisfaction from the treatment itself(241) ((242-
246) (247) (248)).  
I also restricted instruments by the perspective they used to measure their construct (i.e. 
doctor-reported, patient-reported or independent observer reported). Studies have shown 
that when a construct is evaluated from different perspectives the results are not 





Changing the perspective from which the measurement is made may slightly change the 
underlying construct being measured. Independent- observer based instruments miss 
information that is non-audible or is non- observable. Additionally, they do not take account 
of the perceptions of those who are involved in the process of understanding the nature of 
decisions, negotiating their role in the decision process, and acting to deliberate and decide. 
Additionally, nearly all constructs described above represented conceptualisations of SDM 
that were best reported from a patient’s perspective (e.g. how involved was the patient, had 
the patient described their preferred role, had the patient appropriately chosen their 
preferred treatment, etc.), and therefore patient reported instruments were more likely to 
align with the underlying construct. For all the above reasons, I focused on patient-reported 
instruments only.  
Scientific criteria are available for evaluating the psychometric rigour of rating scales (i.e. 
questionnaires). For example, gold-standard review criteria have been published to evaluate 
the scientific and practical aspects of health outcome measures(240). Guidelines for the 
development, testing and dissemination of health measures have also been produced(237-
240) see  Appendix W – Gold standard psychometric properties.  The psychometric properties 
reported in the main development paper for each of the identified instruments were 
compared with these gold standards (see Appendix W). If the properties had not been 
reported in the development paper, a further search was undertaken of the papers reporting 








I identified eleven questionnaires in total, six of which were self-reported. Each of these is 
described below and a critical evaluation of each is presented in Appendix X – Psychometric 
properties of SDM instruments and summarised below.    
Patient Perceived Involvement in Care Scale (PPICS) 
Patient Perceived Involvement in Care Scale (PPICS) (256) is an instrument that measured the 
degree to which patients feel involved in decision-making. Conceptually, the questions were 
based on qualitative work that resulted in 25 commonly observed behaviours being defined 
by the authors during routine primary care visits. These observations were not described and 
it is not clear why published frameworks were not considered. This instrument had 13 items 
with two response categories (0=Disagree or 1=Agree) relate to the sub- scales ‘doctor 
facilitation’, ‘patient doctor information exchange’ and ‘patient decision making’. Higher 
scores reflected a greater degree of perceived patient activity and involvement in the medical 
visit.  It was not possible to assess how the questionnaire domains fitted in with the 
conceptual framework as it was not described. The authors did not report if items reflected 
relevant domains described, or to the overall construct.  
Facilitation of Patient Involvement in Care Scale (FPICS) 
Facilitation of Patient Involvement in Care Scale  (FPICS) (257) is an instrument that measured 
the degree to which patients perceive that their personal doctors actively facilitates or 
encourages them to be involved in their own healthcare. Conceptually, the questions were 
based on a preliminary pool of 18 statements regarding various aspects of doctor behaviour 
that may have been observed by the patient over the course of their relationship. Seventeen 
psychologists reviewed these statements with regards to face validity, content overlap and 
ambiguity. The resulting critique was used to form the construct of the questionnaire. The 
original 18 statements or the final construct were not described and it is not clear why 
published frameworks were not considered.  There were 9 items with a 6-point response 





subscales and higher scores suggested greater perceived doctor facilitation of patient 
involvement. The authors did not report if items reflected the overall construct. 
Dyadic Observing Patient Involvement Scale (OPTION) 
Whilst Observing Patient Involvement scale (OPTION) (253) is an independent observer rated 
instrument that measured how much the doctor involved the patient in the decision, Dyadic 
OPTION(248) is an adaptation that allowed patient reported measures of the same 
underlying construct of doctor competencies required for patient involvement. These 
competencies were derived from patient focus groups and included: 1. Involvement in 
problem definition; 2. Explaining equipoise; 3. Communicating options and risks; 4. 
Conducting the decision process. Based on this construct the Dyadic OPTION was adapted to 
measure perceived patient involvement from the patient’s and doctor’s perspective in a 
single dimension, immediately after the consultation. Three cycles of cognitive debriefing 
were undertaken to refine the content validity in line with the conceptual framework. The 
resulting questionnaire had 12 items with a four-point response scale (1= Strongly disagree 
4=Strongly agree) with higher scores suggested greater perceived patient involvement in the 
decision.  Whilst the authors undertook an extensive process of ensuring high content validity 
they did not report how well each item correlated with the overall construct of shared 
decision making. Only the psychometric evaluation undertaken on the Dyadic OPTION scale 
are reported in the Appendix X – Psychometric properties of SDM instruments, or critiqued 
below. 
Shared Decision Making 9 Question Instrument (SDM-Q9) 
The Shared Decision Making 9 question instrument (SDM-Q9) (258) is a revision of the 
original SDM-Q, designed to be completed by the patient, immediately after their 
consultation, that measured the shared decision making process. As a first step towards a 
theory-driven instrument, the underlying concept of shared decision making (185,259) was 
refined into nine practical steps (260). Through a process of iteration, the group arrived at 
nine questions to measure the nine practical steps of their underlying construct. These 
showed good face validity ratings amongst patients. The resulting questionnaire had nine 





higher scores suggesting their doctor had conducted a shared decision making consultation. 
The 9 items matched the 9 steps identified by the authors in their description of the 
conceptual framework. However, there was no evidence to suggest that individual items 
correlated well with the overall framework of shared decision making.  
Glass(261) and colleagues tested the English version of the 9-item Shared Decision Making 
Questionnaire (SDM-Q-9) in a stratified sample of N = 488 respondents in the US. Scholl(262) 
and colleagues recently adapted the patient-report SDM-Q-9 to a doctor version (SDM-Q-
Doc) in order to allow measurement from both view- points (dyadic approach). This scale was 
tested in medical encounters between 29 doctors and 324 patients in German outpatient 
care.  
Health Care Empowerment Questionnaire (HCEQ) 
Health Care Empowerment Questionnaire (HCEQ)(246) is an instrument designed that 
measured how empowered patients are to take care of their health, in a general sense. The 
authors described the instrument based on three individual empowerment indicators (feeling 
of control; interaction with health professionals, and decisional process) but did not cite the 
literature this comes from.  The instrument consisted of ten statements (3 relating to 
involvement, 3 to control and 4 to interactions) and two response scales. The first response 
scale described perceptions of how empowered they were (e.g. did you feel that you asked 
for explanations?) scored on a four-point scale (1=not at all, 4=extremely). The second 
response scale described how important being empowered was (e.g. how important is asking 
for explanations) scored on a four-point scale (1=not important at all, 4=extremely 
important). Each item was scored as a cross product on these two scales, with highest scores 
indicating the most empowered patients.  The individual items reflect the relevant 
subdomains appropriately, and the subdomains reflect definition of the overall construct of 
empowerment. The individual items also reflect the overall construct; however, an item-total 





The Decisional Conflict Scale (DCS) 
The content of Decisional Conflict Scale (DCS) (263) is based on the construct of decisional 
uncertainty (220), adapted using expert opinion. The DCS has five subscales that have 
developed following testing between groups and broadly based on the conceptual 
framework of decisional uncertainty(220,222,223). Subscales include being informed 
(informed), the decision being reflective of underlying values (values), receiving adequate 
support for the decision (support), how effective the decision is likely to be (effective), and 
uncertainty during the decision (uncertainty). The instrument has 16 items scored on a five-
point scale (0=Strongly agree, 4= stongly disagree). The total score, and subscores, are 
transformed to 0-100 scale, with higher scores associated with greater uncertainty and 
poorer decisions – that is not feeling informed, not feeling the decision reflected your 
values, not feeling supported through the decision, not feeling like the decision will be 
effective and feeling uncertain about your choice. The items reflected the subscales 
described.  
The scale discriminated between those who make and those who delay decisions (effect sizes 
range from 0.4 to 0.8). The instrument had a minimal clinically important difference 
previously established; patients scoring 25 or more are likely to delay decisions, whereas 
those with a score of less than 25 tended to make decisions (264). Patients scoring more than 
25 out of 100 (265) on the total patient DCS has been related to decisional delay, departure 
from active treatment, decision regret, nervousness and a higher intention to sue physicians 
in cases of harms from treatment and has been the score most commonly used to distinguish 
a harmless from a harmful level of decisional conflict (265-268).  
The Provider Decision Process Assessment Instrument (PDPAI (269)) was an adaptation of 
the DCS that is completed by doctors. The tool included 12 items rated on a 5-point Likert 
scale that measure a health care provider’s decisional conflict with a medical decision. Eight 
items were taken unchanged from the DCS, one item was a combination of two DCS items 
(i.e. knowledge regarding benefits and risks) and three new items have been added (i.e. easy 







See Appendix X – Psychometric properties of SDM instruments. 
Overall, the evidence of psychometric robustness for these six questionnaires was limited, 
with studies often only quoting one piece of information to substantiate the instrument’s 
reliability and validity. Tests of reliability and validity varied in quality, and information 
regarding responsiveness was absent in all instruments.  
Only three instrument described a process of item reduction (SDM-Q9, HCEQ and DCS), none 
satisfactorily. Whilst item-total correlation was mentioned by HCEQ and SDM-Q9 authors, 
missing data and item-item correlations were omitted. Therefore, no instrument reports a 
thorough evaluation of items.  
Acceptability was only reported by authors of the DCS who commented that they had less 
than one percent missing data in their overall scores. Floor and ceiling effects could be 
calculated from the data they presented and were less than ten percent. Therefore, the DCS 
was the only instrument that reported sufficient evidence for acceptability.  
Overall, all instruments, except HCEQ, described some of the key processes necessary for 
content validation.  Two of the instruments were based on published conceptual models 
related to constructs described above (Dyadic OPTION – patient involvement, DCS- decisional 
uncertainty). Many others had developed their own framework but then refined it through 
peer-review or cognitive debriefings. SDM-Q, dyadic OPTION and PPICS suggested that their 
content was based on qualitative work, although the details of analysis were not published.  
Internal consistency of all instruments, except the dyadic OPTION, had been reported in the 
original publications: Cronbach’s alpha scores were generally high (0.73-0.94), suggesting that 
items within each instrument were measuring a similar construct. Therefore, all instruments 
(except Dyadic OPTION) met minimum standards for internal consistency.  
Three instruments had a published test-retest reliability score (FPIS, HCEQ and DCS) and all 
showed strong correlation scores between test and retest (>0.70).   Evidence was not 





Inter-rater reliability was only appropriate for the Dyadic OPTION scale as it is the only 
instrument that allowed the measurement of a construct from multiple different perspectives 
(patient, doctor and independent observer). However, the inter-rater reliability for Dyadic 
OPTION was somewhat low and below the recommended criterion (R=0.58). 
All instruments, except two (Dyadic OPTION and HCEQ), reported some evidence of 
convergent validity. Correlation coefficients were not always reported, but when they were 
reported, they were frequently weak associations only (e.g. FPICS to general health 
perception scale r=0.19). Therefore, whilst commonly reported, the strength of the effect 
between the instrument being investigated and instruments that measure similar constructs 
were sub-optimal. DCS was amongst the best performing as its convergence had been tested 
most extensively and scores showed reasonable associations (e.g. correlation between DCS 
and perceived risk questionnaire r=0.48)  
Discriminant validity was not reported for the HCEQ. For the remainder of the instruments it 
was reported as lack of correlation between the instrument and certain patient characteristics 
(age, sex, etc.). No instruments found a relationship between the scale score and these 
characteristics and therefore, all instruments (except HCEQ) were deemed to have sufficient 
discriminant validity.  
Known groups differences was poorly reported in the primary publications. SDM-Q9 and 
PPICS were both shown on two sample t-tests to differentiate between 1 and 2 levels of 
simulated SDM (p<0.001). However, this was in a simulated setting, and therefore, may not 
reflect true differences in shared decision making seen in clinical practice. FPIS failed to 
differentiate between patients who saw female doctors compared with patients that saw 
male doctors (the authors described evidence to suggest female doctors involve patients 
more than their male counterparts). The DCS was the only instrument that has described 
strong differences in magnitude between groups expected to be different, that is those who 
chose to undergo screening and those that delayed their decision.  
Within scale analysis was undertaken for all instruments except HCEQ and was most 





PPICS, exploratory factor analysis showed expected results, with proposed models describing 
more than 60% of the total variance.  
Responsiveness was only reported for DCS:22 studies (4343 participants), involving decisions 
about prostate cancer to IVF (270). The meta-analysis showed those randomized to receive 
a decision aid reported a 7.26 lower mean uninformed sub-score in their DCS compared to 
those randomized to normal decision management (t-test p<0.005).  
 
Summary 
Reporting of psychometric evaluations of scales in the field of SDM is inconsistent.  It could 
be improved and be more consistent by adhering to the now well established psychometric 
criteria advocated by bodies such as MOT, COSMIN, and FDA.  Many of the presented 
instruments show satisfactory, good or even excellent internal consistency, but other 
measures of reliability such as test-retest reliability have not been reported. Validity has in 
several cases not been sufficiently tested, and reported evidence is sometimes weak.  
Responsiveness was not reported in any instrument other than the DCS.  
From the available instruments the DCS appears to be the most psychometrically robust, and 
measures a construct that is very pertinent to surgical rate variation, as discussed in the 
introduction: Decisional conflict scale allows for assessment of decisional uncertainty from 
both the doctors’ (using the PDPAI) and patients’ perspective, and allows a more thorough 
investigation of the decision-making process. Additionally, surgeons’ decision uncertainty 
may be a surrogate marker for professional uncertainty, or at least influenced by it. DCS, 
therefore, it is a strong candidate as an instrument to investigate the drivers of surgical rate 
variation, as they manifest during the consultation.  
Conclusion 
There are many definitions of SDM, with seven main underlying overlapping concepts. Whilst 
there is some evidence that professional uncertainty also has a role regional surgical rate 
variations this has never been measured at the consultation level, and it is plausible that 





Therefore, decisional uncertainty was considered a valid concept to measure in a study of 
regional surgical rate variations. The DCS, as a measure of decisional uncertainty, has 
reasonable evidence of reliability, validity and responsiveness, and is therefore the best 
available questionnaire both conceptually and psychometrically for use in our study on 
regional adult tonsillectomy rate variation. The following chapter will describe measures of 
preference followed by design of an instrument that can elicit treatment preferences for 




CHAPTER SIX: Development of a new instrument to measure patient 














In this chapter I have introduced the standard methods of measuring preferences and 
justified the use of the Analytical Hierarchical Process (AHP).  I have summarised the 
development of a new AHP based instrument to elicit treatment preference in adults with 
recurring tonsillitis. This included a systematic review and critical appraisal of existing studies 
of outcomes for adult tonsillectomy, thematic analysis of new qualitative data about how 
patients make judgements about these outcomes, expert-panel review to arrive at a final set 
of outcomes (reducing days of sore throat, reducing halitosis, reducing visits to the GP, 
reducing risk of bleeding, improving quality of life) for inclusion in the treatment preference 





Treatment preferences (of both patient and surgeon) have been shown (see chapters 1) as 
potentially important constructs that may contribute to regional surgical rate variation.  
Based on a seminal cross sectional study of paediatric tonsillectomy rates by region(16) and 
qualitative study of recurring tonsillitis consultations by region (17), Wennberg (271) 
hypothesised that regional tonsillectomy rate variation resulted from regionally aligned 
surgeon preference, a theory he coined the “Surgical Signature”. If patients who see surgeon 
A are more likely to receive tonsillectomy than if they saw surgeon B, it can be hypothesised 
that surgeon A has a treatment preference for tonsillectomy. However, in the modern health 
care setting of shared decision making, where the surgeon incorporates the patients’ 
preferences, with the best available evidence, to help reach a treatment decision rather than 
paternalistically dictating the treatment, surgeon preference is a complicated construct. 
Consultations with surgeon A could have resulted in tonsillectomy being chosen more 
frequently because the surgeon perceived tonsillectomy was a more effective treatment for 
certain outcomes, perceived patients prioritised these outcomes more than others, proxy 
bias, or the surgeon’s personal preference towards tonsillectomy. Partly due to the 
complexity of this construct surgeon treatment preferences, as they apply in the medical 
consultation, have always been difficult to measure on a scale large enough to inform 
discussions about regional surgical rate variations. Instead they have been implied from 
smaller qualitative studies, especially around the surgical management of breast cancer(26). 
There is no evidence that directly reports on surgeons’ treatment preferences for the 
management of adults with recurring tonsillitis, and how this affects treatment decisions.  
In relation to regional surgical rate variation, whilst surgeon treatment preference has a 
historical context and has been discussed (disproportionately in relation to the level of 
current evidence) patient treatment preferences have only recently come to the fore. There 
is now a growing body of evidence from studies of orthopaedic conditions that regional 
surgical rate variations are associated with regionally aligned patient treatment preferences 
(78). (78,81-83) (85-88), (272) (90) (91). However, due to the difficulties in eliciting patient 
treatment preferences efficiently on a large scale, preferences have been implied by 




not willing to have to treatment”, through to “definitely willing to have treatment”, has never 
been tested with respect to validity or reliability. There is no evidence that directly reports on 
treatment preferences for adults with recurring tonsillitis, and how these patient preferences 
influence the treatment decision.  
The formation of treatment preferences is a complicated process involving the combination 
of an evaluation of the intervention and the choice between alternative interventions based 
on that evaluation. However, as complexity of information increases so does the probability 
that the respondent departs from the rational decision making and employs simplifying 
heuristics to form a preference, and therefore, omits the evaluation phase(234). Therefore, 
it is important that preferences be measured in a reproducible and meaningful manner that 
also takes account of simplifying heuristics. Unfortunately, most preference elicitation 
methods have either not accounted for differing methods of preference generation (rational 
decision versus heuristic decision) or had high cognitive burden for the respondent.  
To undertake a study that allows us to investigate the role of treatment preference for adults 
with recurring tonsillitis it is important to have an instrument that can accurately elicit 
treatment preference. Therefore, this chapter describes the development of an instrument 
designed to quantify treatment preferences in adults with recurring tonsillitis. Initially, I 
evaluated common methods of preference elicitation (i.e. Standard Gamble, Time-Trade-Off, 
Visual Analogue Scales, Conjoint Analysis, Analytical Hierarchical Process) and provided 
rationale for why I selected the Analytical Hierarchical Process for our study. Thereafter, this 
chapter focuses on the development of an instrument designed to elicit treatment 
preferences in adults with recurring tonsillitis based on the Analytical Hierarchical Process 
(AHP).  
Methods of preference elicitation 
The theoretical framework for preference elicitation tends to come from either an economic 
perspective (based on utility theory) or a psychological perspective (based on expectancy 
value theory).  The economic perspective and utility theory is based on the four axioms of the 
rational decision maker described by Von Neumann (233). These axioms are: 1. Completeness 




two alternatives); 2.Transitivity (assumes that an individual always decides consistently); 3. 
Independence (assumes the order of preference cannot be changed by adding an irrelevant 
option); and 4. Continuity (assumes that preference ordering can continue for a new third 
option, based on its preference proximity to a previously preference-defined option).  
Methods based on this theoretical perspective include Standard gamble (SG), Time-trade-off 
(TTO) and Visual Analogue Scales (VAS).  These methods usually aim to obtain consensus 
amongst a large pool of respondents to identify where treatments (or health states) sit on a 
preference scale.  It is hypothesised that preferences elicited using one of these methods 
could be compared across all contexts and studies that used the same method.  
In contrast, expectancy value theory, based on the work of Fishbein  & Ajzen (194) suggests 
that people develop a belief about the action (e.g. that a particular treatment is painful).  The 
belief can be modified if new information becomes available.   People then assign a value to 
that belief (e.g. that pain is a negative attribute and should be avoided) and then an 
expectation is created (or modified) based on the combination of the belief and the value 
(e.g. that the treatment is not a good idea).  In psychology, the concept of preference is similar 
to the idea of attitudes (a disposition of a person to respond favourably or unfavourably to 
an object, person, institution or event(232)).  The two most commonly used methods, based 
on expectation-value theory, are conjoint analysis, CA, which frequently uses the discrete 
choice experiments (DCE) format,(273) and Analytical Hierarchical Process AHP (274-277)  
and studies using these methods for medical purposes has grown substantially in the last 
decade(278). The difference in these techniques relates to how the respondent is presented 
information for comparison. CA uses a holistic approach, presenting all information for a 
single comparison, whereas AHP uses a decomposed method, breaking down the treatment 
into simpler pairwise comparisons. Methods of preference elicitation developed using 
expectancy-value theory tend to indirectly measure preferences and then weight the result 
to transform the scores into ranked preferences. These methods do not require consensus 
amongst respondents, rather the ability to discriminate between them.   
Comparison between Utility Theory and Expectancy-Value Theory  
In contrast to utility theory, expectancy-value theory allows comparisons across all outcomes 




outcomes based on treatments chosen, but would not incorporate differences in the process, 
such as costs, travel times, invasiveness nature of the treatment(279-281). Therefore, the 
expectancy-value theory describes a more complete model of patient treatment preference. 
It must be noted that both theories have failed to consistently predict decision-making 
behaviour and a newer theory of decision making has now emerged that it is argued to more 
accurately describe how people make their decisions – Prospect theory (282). Prospect 
theory is based on the original expectancy value model; it   predicts that individuals tend to 
be risk averse in a domain of gains, or when things are going well, and relatively risk seeking 
in a domain of losses, or when things are not going well. Unfortunately, there are no methods 
of preference elicitation based on prospect theory yet.  
Common methods of eliciting patient treatment preferences 
Standard Gamble (SG) 
SG has been considered the gold standard method for preference measurement. SG is a direct 
measure of preference that requires respondents to choose between two options: The first 
option has a known outcome i.e. the respondent would carry on with their condition the way 
it is for the rest of their life.  The second option includes a gamble: a treatment that has p 
chance of restoring them to complete health and 1-p risk of death. By systematically varying 
the risk of death, a threshold can be calculated that standardises all treatments onto the same 
scale. 
This technique requires respondents to weigh up the probability of the two possibilities and 
come to a decision based on abstract information. This is a complex task that has been shown 
to require a large amount of cognitive effort (283). Partly due to high cognitive burden, SG 
cannot be self-completed requires an interview format to collect the data, it is an expensive 
and time -consuming method to deploy on a large scale.   
The SG uses a ratio scale with death and perfect health as their rational zero or ones, 
respectively and therefore has the advantage that it remains invariant over all 
transformations where the scale is multiplied by a constant. Direct measures assume that 
respondents are internally capable of generating an interval or ratio scale. This means that 




than inches). However, there is evidence that suggests that death may not be an appropriate 
rational zero, since there are some conditions that are considered by some people to be 
worse than death (e.g. constant severe pain or a vegetative state)(284), thus making it 
difficult for respondents to use this method. It has been suggested that error associated with 
these difficulties can be reduced by averaging judgments over respondents(285). 
Time trade-off (TTO) 
TTO was developed as a simple to administer alternative to the standard gamble and involves 
a choice between two certain outcomes (286). The respondent is asked to choose between 
continuing with their condition until death or a treatment that gives them perfect health for 
x years and then death. The interviewer can vary the duration of perfect health until the 
respondent can no longer differentiate between options. Since TTO cannot be self-completed 
(i.e. it relies on an interviewer to administer questions) and is most commonly completed on 
a ratio scale it has similar limitations to SG (i.e time consuming, expensive to deploy in studies 
and assumes respondents can generate preferences on a ratio scale.) 
Visual Analogue scale (VAS) 
Respondents are asked to place their mark of preference for a treatment on a pre-labelled 
scale anchored at either end with markers of best and worst health imaginable (e.g. perfect 
health and death, respectively).   VAS provides interval level information and therefore 
indicates how far apart the treatments are as well as their rank order, but it does not indicate 
the absolute magnitude of preference for any treatment. Another potential disadvantage of 
having only an interval scale is that algebraic operations can only be performed on intervals 
and not on scale values, so it cannot be said, for example, that one health state is twice as 
desirable as another. However, for most practical purposes an interval scale is sufficient. 
Additionally, there is considerable evidence now that shows visual analogue scales for a 
concept as complicated as preference for treatment may lack validity(287,288), partly 





Conjoint Analysis (CA) 
CA asks patients to compare clinical vignettes of potential outcomes. CA elicits treatment 
preference indirectly onto an ordinal scale by asking respondents to make comparisons 
between treatments, in a stepwise fashion, so that the overall ranking of all treatments can 
be calculated. Since each vignette is slightly different from the last, it allows the investigator 
to calculate the decision-maker’s individual priorities(273,292,293). CA approximates a real 
life decision, where the integration of information is down to the respondent, and has been 
shown to imitate the respondents judgement in live decision-making(294)). However, it has 
high cognitive burden related to high volume of information, and need to remember 
information to undertake task effectively  (295)). The ordinal scale is the most primitive form 
of measurement, and requires the respondent to rank order a set of objects (treatments). In 
addition, there is no indication of how much preference each treatment possesses or how far 
apart the treatments are in terms of preference. Ordinal scales provide limited information 
and none of the fundamental operations of algebra may be applied(296).   
Analytical hierarchical process (AHP) 
AHP decomposes treatment into potential outcomes and asks patients to make pairwise 
ratio-comparisons between potential treatment outcomes. Ratios of preference between 
different outcomes are combined with probabilities that outcomes are likely to occur if each 
treatment was chosen in turn to calculate a treatment preference score(274). Therefore, AHP 
indirectly places preferences onto a ratio-scale. Pairwise comparisons required of AHP are 
less cognitively taxing than CA since they involve less information per step and are less time 
consuming compared with composite comparisons of conjoint analysis(297). But it has been 
argued that pairwise comparisons are arbitrary differences in factors that do not model the 
decision making problem(298). AHP can also quantify how inconsistent respondents are with 
regards to the axioms of rational decision making.   
Comparison of methods 
Whilst instruments of preference elicitation have not been formally psychometrically 
evaluated, existing evidence suggests that people exhibit patterns of preference that are 
often incompatible with expected utility theory. For example, a study found (299) that after 




to severe disability), respondents’ evaluations of treatments became unstable, a finding that 
both contradicts expected utility theory and indicates that the standard gamble is internally 
inconsistent. There is now extensive evidence that people violate utility theory when making 
live decisions(300). The idea that tools based on utility theory may lack validity is further seen 
in studies that compare SG, TTO and scaling methods, most of which find no convergent 
validity (287). In using these methods, economists have been chiefly concerned with defining 
the preference location of treatments and diseases on a standardised scale and so require 
large numbers of people to undergo measurement. Errors in measurement of preference 
created at the individual level were considered to be reduced when population aggregates 
were taken.  Evidence suggests that AHP performs better than CA(294,297,301,302). In 
addition, AHP generally relies on the axioms of rational decision-making but allows the 
decision maker to be inconsistent and intransitive to some extent, thereby taking into account 
the difficulty of giving precise preference judgements.  
Which measurement method is best for adults choosing a treatment for their recurring 
tonsillitis? 
Currently, there is no ideal method to elicit treatment preference and no instrument that 
elicits preference with regards to treatment choice of recurring tonsillitis, whether based on 
utility or expectation-value theories. An instrument that elicits preference for adult 
tonsillectomy using the AHP would be advantageous for three main reasons. 
AHP is the only method that not only allows for, but also measures, violations in the axioms 
of rational decision making. Kahneman and Tversky have shown that the axioms of rational 
decision making are frequently broken in people making decisions and so methods of 
measurement based on these axioms fail to validly describe preference (282)).  
The AHP method has amongst the lowest of cognitive burdens, due to the simplicity of 
undertaking pairwise preference comparisons and is preferred by respondents especially 
when there are more than six outcomes to compare. As a result of relatively low cognitive 
burden, the AHP can be easily deployed as a questionnaire with minimal costs and use of 
manpower required for interviews of SG or TTO. The AHP approach has been well 
validated(303) and has been shown to have high predictive validity when compared to 




AHP preference generation process 
AHP requires participants to undertake a series of pairwise comparisons between all potential 
treatment outcomes, based on their personal priorities (that is 7 treatment outcomes would 
require 21 pairwise comparisons).  Comparisons are made on a response scale with semantic 
descriptors (e.g. Equal preference, Moderate preference, Strong Preference, Very Strong 
Preference, Extreme Preference) and later converted to the Saaty scale so that equal 
preference between two outcomes would score: 1, Moderate preference;  3, Strong 
preference;– 5, Very strong preference;- 7 and Extreme preference. - Pairwise scorings are 
entered onto a Saaty matrix (304) which has four final outputs (process described Appendix 
T AHP methodology and Ranking results): Ranked outcome priorities, Outcome preference 
score and consistency score, Treatment preference score  
Ranked outcome priorities are an ordinal rank that relates the preference of outcomes to 
each other. Outcomes with higher ranks show higher preference. Whilst they show the order 
of preference they do not provide the magnitude of preference between outcomes. 
Outcome preference scores provide a value of preference for each outcome on a ratio scale. 
That is the magnitude of difference between outcomes can be calculated using these scores.  
Consistency scores display how consistently participants completed all their comparisons. For 
example, if a participant initially stated that he/she preferred A twice as much as B, and B 
twice as much as C, then he/she should prefer A four times as much as C. Gross deviations 
from this are measured in the AHP consistency score. This score is an internal validity check 
of the process. Scores greater than 0.2 show inconsistent responses, and score greater than 
0.5 equate to random responses.  
Treatment preference score is a weighted score that shows how much their outcome 
preferences line up with a treatment. If a participant has a strong preference for a treatment 
that reduces halitosis, but the evidence suggests that Treatment A has no effect on halitosis, 
then his preference for halitosis will be down-weighted. Alternatively, if a participant has a 
moderate preference for a treatment that reduces sore throat days and the evidence shows 
that Treatment A has a large effect on reducing sore throat days, his preference for reducing 




an overall preference towards Treatment A. If the choice of treatment was between 
Treatment A and Treatment B, and the AHP provided a Treatment A preference of 0.5, it 
would mean that the participant had equal preference for treatments.  
The remainder of this chapter is dedicated to describing how I developed an instrument that 
measures treatment preference for recurring tonsillitis using the AHP approach. 
Development of Preferences in Adults with Recurring Tonsillitis Tool (PARTTS) -- 
Overview  
See Figure 17 Development of the PARTT. 
To develop a new instrument measuring preferences for the treatment of recurring tonsillitis 
I needed to: 1) identify the key outcomes relevant to management of recurring tonsillitis; 2) 
ascertain the relative importance of these outcomes; 3) shortlist the potential outcomes to 
identify a manageable number (Figure 17).   I undertook a systematic review and critical 
appraisal of randomised and non-randomised studies that described outcomes in relation to 
the treatment of recurring tonsillitis. To ensure that these outcomes were important to 
patients making their treatment decisions I presented all identified outcomes to relevant 
patients who were asked to rank them in terms of importance –patient ranking of treatment 
outcomes.  To confirm their rankings a further sample of these patients were invited to a 
focus group to discuss why particular outcomes were considered important. All outcomes 
were considered by an expert panel to identify a manageable number of shortlisted 
outcomes in the final instrument (seven or fewer). Outcomes were chosen based on their 
importance to recurring tonsillitis patients and the reliability of evidence on their expected 
likelihood of occurrence after treatment.  These final set of outcomes were developed into a 
questionnaire using the AHP format.  The instrument was piloted on patients with recurring 
tonsillitis - Pilot.  The following subsections will describe the Methods and Results for each of 







Figure 17 Development of the PARTT 
This shows all the stages involved in the development of PARTT, allowing evaluation of treatment preferences for adults with 
tonsillitis.  
 
Identifying Outcomes (systematic review & critical appraisal) 
 
Systematic review of outcomes 
relevant to the management of 
recurring tonsillitis
Critical appraisal to define effect 
size and reliability of studies of 
outcomes of treatment for 
recurring tonsillitis 
Patient ranking of treatment 
outcomes in terms of personal 
treatment preference
Focus group to discuss why 
particular treatment outcomes 
were considered important, and 
which outcomes were 
understood to be the same
Expert panel to discuss how to 
short list treatment outcomes  
into less than 7 key outcomes 
that were affected by treatment 
choice, the evidence was 
believable, and they were 
important to patients.  
Outcomes developed into a 
questionnaire using AHP format 
and questionniare piloted. 
Changes made according to 
feedback
PARTT (Preferences in Adults 

















I searched the following databases from their inception for published studies that reported 
medium-to-long term outcomes in tonsillectomy undertaken for adults with recurring 
tonsillitis: PubMed, EMBASE and CINAHL. I modelled subject strategies for databases on the 
search strategy by a Cochrane systematic review looking at the effectiveness of tonsillectomy 
(see Appendix E Search strategy for tonsillectomy outcomes), since our study was to 
investigate how patients choose between tonsillectomy and watchful waiting in the 
treatment of recurring tonsillitis.  
Inclusion criteria 
 Adult tonsillectomy for recurring sore throat/tonsillitis 
 Medium-Long term outcomes 
 Randomised and non-randomised studies 
Exclusion criteria 
 Paediatric tonsillectomy 
 Tonsillectomy undertaken for cancer 
 Outcomes that are intraoperative (e.g. blood loss)  
 Outcomes that are perioperative (e.g. post-operative nauseas and vomiting) 
 Outcomes related to the histopathological or microbiological characteristics of the 
excised tonsils 
 Not in the English language 
Data extraction  
Two researchers (NM & LM) independently extracted data from the included studies using 
standardised forms.  
Selection of studies  
Studies were grouped by outcome, i.e. studies reporting on quality of life were grouped with 
other studies relating to quality of life. A study was placed in more than one category if it 




there were higher level studies already in the group (e.g. a case report on quality of life was 
excluded if there was also a systematic review reporting on quality of life after tonsillectomy). 
Three researchers (NM, LM, OR) independently screened titles and abstracts obtained from 
the database searches at different stages of the original review and subsequent updates. 
Similarly, at least two of the three researchers (NM and LM) independently reviewed the full 
text of the potentially relevant titles and abstracts against the inclusion and exclusion criteria. 
Studies were classed as Definite Include, Probably Include, Probably Exclude and Definitely 
Exclude. Studies that were classed as Probably Include or Probably Exclude were discussed to 
decide whether they would be included. Differences in classification were also resolved by 
discussion.  
Remaining studies were critically appraised using the appropriate CASP tools (305-308) and 















2955 records identified through database searching 
1522 duplicates removed 
1433 records screened 
57 full text records assessed for eligibility 
46 full text records excluded because of  
• Adults outcomes from paediatric tonsillectomies 
• Paper already accounted for within  included met-
analysis 































1376 full text records excluded because of  
• Paediatric cohort 
• Cancer cases 
• Case reports 
• Editorials 
• Studies of tonsil histopathology 
• Studies of tonsil microbiology 
• Studies of peri- or early post-operative outcomes 
Figure 18 Systematic review of literature for treatment outcomes related to recurring sore throat 





See Figure 18 Systematic review of literature for treatment outcomes related to recurring 
sore throat.  
The initial search returned 2955 abstracts. Removal of duplicates yielded 1433 abstracts. 
Removal of paediatric cases left 870 abstracts. Removing tonsillectomy for cancer and case 
reports left 175 studies. Removal of editorials and studies that pertain histopathology or 
microbiology left 57 studies. Finally, studies that reported on adult outcomes on patients 
who had undergone a tonsillectomy as a child were removed to leave 19 studies. 
If more than one study reported on the same outcome (e.g. reducing days of sore throat) 
only the study with the highest level of evidence was included and the others excluded (e.g. 
meta-analysis of RCTs examining reducing days of sore throat retained by individual RCTs 
excluded). Exclusion based on highest levels of evidence in outcome groups produced 
eleven studies that had measured different outcomes of tonsillectomy: days of sore-throat; 
the number of episodes of sore-throat, visits to the GP, voice, haemorrhage, snoring, 
halitosis, taste disturbance, alteration to immune profile, quality of life and societal cost.  
 
Whilst I had identified all available tonsillectomy outcomes that had been published, the 
highest level of publication related to those eleven outcomes, I was still not clear how 
believable (reliable, valid) the results of these publications were, or how meaningful they 
were to this study (i.e. effect size and generalisability).   
Therefore, I undertook a critical appraisal to assess the risk of bias for each publication. 
Since the publications ranged from meta-analyses of RCTs through to case series I used the 
Systematic review
Critical appraisal











Critical Appraisal Skills Programme (CASP) risk of bias checklists. These checklists were 
developed to detect risk of bias in RCTs, cohort, case-control, case-series and qualitative 
studies. CASP have provided a robust framework for reporting studies by forcing to 
appraiser to answer 3 key questions: 1. Are the results valid? 2.What are the results? 3. Do 
the results apply to your population?   
To address question number 2 and allow comparisons across studies I calculated 
standardised effect sizes of tonsillectomy on the outcomes (difference in means between 
those who received tonsillectomy and those that did not/pooled standard deviation). The 
effect size of tonsillectomy on each of the eleven outcomes was categorised into small (0.2-
0.49), medium (0.5-0.79) and large (>0.8) (309).  When insufficient data was presented to 
make this calculation (e.g. immunological profile) the results were discussed with two ENT 
surgeons to help categorise the impact. The study was graded based on Oxford Clinical 
Evidence Based Medicine Levels of Evidence(310).  
Based on the critical appraisal of these eleven publications I graded the evidence with 
regards to the outcomes as Strong, Moderate and Weak. Weak was classified as any study 
that was level 3 (case-control), 4(Case series) and 5 (expert opinion). Strong was classified 
for any study that had level 1 (randomised controlled trial) or 2 (cohort) evidence and 
reported a large effect size (Cohen’s D>0.8). Moderate described all other combinations. 
For the full critical appraisal of eleven studies that allowed us to classify the effect size into 
small medium or large, or the strength of study into weak, moderate or strong please see 
Appendix F – Critical appraisal of tonsillectomy outcome studies using CASP and Summary. 
Conclusions 
I identified eleven outcomes of which four had strong evidence (days of sore throat; number 
of episodes; visits to GP; risk of haemorrhage) as outcomes of tonsillectomy.  Evidence 
relating to other outcomes was weaker. It is not clear if any of these outcomes were 
important to the patients making their treatment decisions. Therefore, the next stage was to 






Patient ranking of treatment outcomes (questionnaire ranking and focus group)  
 
Methods 
Ethical approval for this study was granted by Nottingham Research Ethics Committee 
(15/EM/0191) on 8th May 2015.  
I contacted, by email, all patients who had attended ENT clinics with recurring tonsillitis at the 
Royal National Throat Nose and Ear Hospital from 2010 to 2011 and agreed to be part of a 
research register (n=35). Twenty-three patients had previously chosen to treat their condition 
with tonsillectomy, whilst twelve had chosen a non-surgical pathway. (watchful waiting). 
Patients were asked if they would be willing to participate in an online ranking exercise and/or 
attend a focus group to discuss which factors had been important to their treatment decision.  
Twenty-six patients (of the original 35 contacted) agreed to undertake the online ranking 
exercise and were emailed the questionnaire (Appendix G – Online ranking exercise). The 
questionnaire had a description of the 11 outcomes shortlisted from the systematic review 
and a brief description of what each one meant. They were asked to rank the eleven outcomes 
in order of importance to their treatment decision, with number one being the most 
important and number eleven the least. They could rank items with the same number if they 















To develop a better understanding of the importance of the eleven identified outcomes when 
patients make decisions about treatment for recurring tonsillitis I conducted a follow up focus 
group to address the following questions: 
Which factors drive patients’ treatment decisions when they suffer from recurring episodes 
of sore throat?  
What process do respondents go through to rank factors relevant to the treatment of 
recurring sore throat in terms of importance in their decision? 
How well do participants understand terms used to describe evidence based factors relevant 
to the treatment of recurring sore throat? 
The participants were purposively sampled to include those who had chosen to treat their 
condition with a tonsillectomy and those who had not. From the twenty-six participants who 
had agreed to take part in the online exercise, eight agreed to attend two planned focus group 
meetings. All eight patients who had agreed were emailed an information sheet about the 
focus group (Appendix H - Patient Focus group information sheet). Five of the eight patients 
attended on the day and were consented (Appendix I – Consent for focus group) to participate 
in an audio recorded focus group. This meant there was one focus group with four attendees 
(2 who had chosen tonsillectomy and 2 that had chosen watchful waiting) and another focus 
group with only one (who had chosen tonsillectomy). The latter was turned into a semi-
structured interview.  
Two interviewers were present for the focus group and semi-structured interview (NM and 
AD). A semi-structured discussion guide was drawn up (Appendix J – Semi-structured 
interview guide) prior to the meeting to ensure the above three objectives were covered.  
The interviews were audio-recorded, anonymised and later transcribed.  
During the focus group, I asked participants to rank the eleven evidence-based outcomes in 
order of personal importance to their treatment decision. After they had completed the 
exercise, I asked the focus group participants to discuss the process of how they had ranked 




outcomes (such as the likelihood of outcome) and then asked them to repeat the ranking 
exercise.  
Content analysis of each transcript was conducted manually. Two researchers read each 
transcript and independently identified the main themes line by line. Discrepancies within 
these themes were discussed between the researchers until consensus was achieved. 
Discussions led to certain themes being combined whilst others were rephrased. The 
emerging conceptual framework was reviewed by members of the supervisory team who are 
from a multidisciplinary background and is described below.  
Results 
The online ranks given by participants are shown in Table 24.  Respondents ranked improving 
the quality of life as the most important factor in their treatment decision. Reducing days and 
number of sore throats and visits to the GP for a sore throat followed closely behind 
improving the quality of life. Reducing halitosis was the fifth most important outcome to our 
respondents. Respondents ranked reducing the risk of haemorrhage and taste disturbance as 
joint sixth outcomes. Reducing snoring was ranked eighth and reducing the risk of damaging 
the immune system ranked ninth.  Reducing cost of treatment to society and improving voice 




List of factors Average patient rank Rank 
Reducing days of sore throat 3.6 3 
Reducing number of episodes of sore throat 2.2 2 
Reducing visits to the GP for sore throat 4.6 4 
Improving quality of life 1.8 1 
Reducing snoring 5.2 8 
Improving voice 10.6 11 
Reducing halitosis 4 5 




Table 24 Patients' ranked preference of potential treatment outcomes. 
This table shows the patients’ ranked preferences in relation to the treatment outcomes for recurring sore throat. The most 
important three were improving quality of life, followed by reducing the number of episodes of sore throat and the number 
of days of sore throat. n= 26 patients 
 
Which factors drive patients’ treatment decisions when they suffer from recurring episodes 





Thematic analysis of the transcriptions generated four conceptual domains: 
1. Negative aspects of the disease 
2. Hope for improving current situation 
3. Knowledge of potential treatments 









in Adults with 
Recurring Tonsillitis 
Tool) completed
Reducing risk of taste disturbance 7 6 
Reducing risk of haemorrhage 7 6 




Theme 1: Negative impacts of the condition 
Many participants talked about their decision to have treatment as motivated by the negative 
impact of the disease.  This included the intensity of physical symptoms and the psychosocial 
impact of symptoms. 
Physical symptoms 
For some, the intensity of physical symptoms was described in terms of the duration of time 
over which episodes had occurred, “Oh, a good couple of years but it kind of got really bad 
the end of my first year of training, second year, going into my second year”. Other 
participants described the frequency of occurrences “Since I came to this country it was eight 
times since last October. I had tonsillitis eight times!”  Others described the intensity of 
physical symptoms in terms of their perceived severity, using phrases such as “really bad” and 
“awful”.  The sense of deterioration was described by most participants and the phrase 
“getting worse” was frequently used.    
Some participants described their susceptibility to colds as a negative impact of their 
condition “As in like I had it [tonsillitis] a lot, so whenever I had tonsillitis, I have a rubbish 
immune system anyway, but it would be worse, like I’d be so ill and I’d easily get any other 
colds or anything…” 
Many descriptions focussed on the negative impact of other troublesome symptoms in 
addition to sore throat (“snoring”, “difficulty breathing”, “sleep”, “bad breath”, “drooling”) 
on themselves, but often also included the impact of symptoms on others, “...I was snoring 
which affected me like my girlfriend was complaining about it…” or “…Every time I’m sick I’m 
eating tons of chewing gum. I’m shy speaking to people because I think that my breath is so 
bad that no one will talk with me”.  
Psychosocial impact of symptoms 
Later discussions included the psychosocial effect of these symptoms on patients’ everyday 
lives.  This included an impact on both professional and personal lives.  Participants were 
concerned about the numbers of days off that resulted from tonsillitis, which resulted in the 




training when I was getting constant sore throats and tonsillitis, I couldn’t do singing exams, I 
couldn’t…where there were opportunities, producers or casting directors or people that 
would come to the school to hear us sing or perform”. Others described this in relation to 
poor concentration: “I had to be focused and I couldn’t be because I was thinking only about 
my throat and how I’m feeling miserable.” 
Participants also described the way that others did not understand “If someone is not 
suffering from tonsillitis, they will often ask me and they won’t understand.”  The effect of 
this was described in terms of feeling “miserable”.  This effect on participant’s emotional state 
was also seen in relation to social isolation, for example: “….I’ve lost contact with my friends 
because they were going out and I wasn’t able to do everything I want to do, I was thinking in 
terms of tonsillitis…”   
Theme 2: Hope for a positive outcome 
All participants discussed hope during their conversations. Hope for a positive outcome was 
nearly always discussed in the context of loss of hope for spontaneous resolution and the 
need for finality or and ending.  
Nearly all participants agreed that they had lost hope of spontaneous resolution “...they’ve 
been so persistent since 2008 [when] I first noticed them, they’re not going to go away.” All 
participants discussed the need for finality: “I want them gone”, some with a sense of 
anticipation. Most participants talked about the hope of a positive outcome: “It has to work, 
it just has to. It can’t possibly get any worse anyway.” Participants described the positive 
outcome in terms of relief of symptoms such as drooling and snoring.  
Theme 3: Perceived availability of treatment options 
Knowledge of available treatments influences most participants. Some actively sought this 
information from their doctors: “...I went to the doctor and asked if there was something that 
she can do about that and she proposed that she can send a note for tonsillectomy, so I was 
relieved”. Some sought information actively from the internet: “I looked up a lot online what 
I was going to do…” Whilst by others information was passively received “..but as I know, 
because I see some people who took out their tonsils but at least two or three, one of my 




Theme 4: Individual trade-off between risks and benefits 
In the context of receiving information on the availability of treatments participants also 
discussed the individual trade-off between short term risks and long term outcomes “When I 
was thinking about tonsillectomy, I thought that moment of suffering after surgery, it’s better 
than suffering from tonsillitis over and over again, so…”  
Whilst another participant acknowledged that the trade-off is different between patients and 
depends on their disease severity: “I guess when you’re deciding it’s how much they affect 
you, because it can just range from being annoying to it actually affecting your day to day life, 
so I guess it’s where you fall in that spectrum, in that scale, and I think all of us are different 
in different levels, so it would affect us differently, which is why maybe some might not want 
it and some, yes…” 
How do participants rank evidence-based factors relevant to the treatment of recurring sore 
throat in terms of importance in their decision? 
Most participants felt that receiving extra information about the factors made the ranking 
exercise easier: “It was very helpful for me. Now at least I have some information about 
tonsillitis before the operation and after the operation and that is very helpful for this.” 
However, some felt it made it harder. When asked about whether having extra information 
helped with the ranking exercise one participant responded: “I think that all the vague things, 
the general things, aren’t really of help for this [exercise].” 
All participants employed multiple strategies to rank the factors. I coded ranking strategies 
into four broad conceptual domains:  
1. Prioritizing important factors 
2. Trading factors off against each other 
3. Deprioritizing less important factors 





Theme 1 Prioritizing important factors 
Nearly all participants described starting their ranking exercise by prioritizing the most 
important factors: “There were some things that were immediately more important to me 
that I could put as my one and two but then I kind of got lost towards the middle and the 
end.” Prioritization was most frequently discussed in terms of self over society: “I think that 
reducing financial cost to society; it’s mostly irrelevant for most people. It wouldn’t change 
my mind about tonsillectomy.” People frequently and most easily prioritized the negative 
impact of their disease (defined above) over societal benefit citing the personal importance 
of their physical health and quality of life.  
Some participants discussed prioritization in the context of their future health: “My first 
choice is reducing chance of altering the immune system, that was the main reason I wanted 
the tonsillectomy, because I am suffering from tonsillitis very often and I’m taking a lot of 
antibiotics and they are good because they are treating me but they also make harm to my 
body and when I was thinking about the future life, I’m quite afraid that if I will be really, really 
sick, antibiotics won’t work because I will be immune to them and that was the first choice 
for me. ”  
Whilst a few discussed prioritization in terms of unpredictable impact on their careers and 
personal lives. For example, one participant talked about the effect of unexpected episodes 
on their career: “I lost my previous job because I was sick all the time and I was taking days 
off to go to see the GP or go to hospital because I had quinsy and that was awful.”  Some 
discussed loss of opportunity due to the critical timing of the condition. However, tonsillitis 
also seems to have bothered others in a more social context, especially in terms of difficulty 
planning: “I had the same problem with that. I had plans and usually in the most important 
day I had tonsillitis. I was waking up and yes, my tonsils were swollen and I can’t speak, drink, 
eat, whatever. After a while when I was planning something I was thinking what if I will get 




Theme 2 Trade off 
A few participants used the strategy of trading one factor off against another in order to 
complete the ranking exercise. Participants discussed the trade-off in the context of balancing 
knowns and unknowns: 
“For me, this seems to be all important because, on the piece of paper, you have to start from 
one and list them in a certain order, I think they’re all important because even if certain things 
are not, how do you say, they are rare, you never know if you’re going to be that case, so I 
think they are all quite important and things.” 
Theme 3 Reprioritization of less important factors 
Another strategy that participants employed during the task was deprioritizing less important 
factors. Whilst some deprioritized symptoms that they had not personally experienced, 
others deprioritized based on factors they felt were less important.  
When discussing how the lowest ranked items were chosen several participants talked about 
symptoms they had not personally experienced: “Well, last is definitely the sleep problems…” 
or another participant who said: “I think the sleeping problems, I didn’t find it very…because 
most of the time my sleep was well.”  
Some participants deprioritized factors they did not feel were important. This participant 
when talking about why she placed cost as the lowest ranking said: “However much it costs 
every time wouldn’t be that much of a reason to stop me from…that much of a reason for it 
to be more important, that wouldn’t bother me but I can see why it could be a reason for 
other people.” Or this participant when talking about why she placed immune function at the 
bottom of her list: “I mean, it’s interesting but if it (the factor) doesn’t have any impact then 
you just kind of ignore that point because you’ll be thinking about something that does.” 
Theme 4 Clustering of factors based on perceived similarities 
Participants also ranked factors they felt were similar together. The commonest grouping 
strategy was linking factors that were similar semantically or conceptually such as reducing 
episodes of sore throat and days of sore throat: “My second choice was, it’s all under the 
same sort of bracket thing because my second choice was reducing unexpected episodes of a 




participant felt that altering immune system was integral to the quality of life and grouped 
them together: “I’d say improving the overall quality of life and reducing the chance of 
altering the immune system because that’s essentially what it kind of does.” Others had used 
to the same reasoning to group quality of life with sleep, reduced taste with bad breath and 
costs with GP visits.  
Did you have any difficulty with the instructions or terms used to describe the factors in the 
ranking exercise undertaken? 
Most participants completed the prioritisation task with ease and within the 5 minutes. 
However, when probed about how the exercise could have been made easier they felt a more 
visual layout would have helped: “but because it was quite vague to me, I kind of needed it 
to be a bit more outlined and a little bit more, I don’t know, it kind of just felt like there could 
have been lots of different columns. It could have been, oh, mark one to ten before treatment, 
during or after.”  
How well do participants understand terms used to describe evidence based factors 
relevant to the treatment of recurring sore throat? 
When asked more specifically, about whether certain terms were difficult to understand, 
participants discussed three terms repeatedly: 
1. Taste disturbance 
2. Financial cost to community 
3. Immunity 
Taste disturbance  
Half the participants had difficulty with the term taste disturbance: “Yes, the taste 
disturbance, again I just knew that it was something I hadn’t thought of so I didn’t need a 
clarification of what it was to know how important it was to me, but that was the only one I 
thought, well, I think I kind of was relying on thinking I understood it, not actually maybe 
understanding it”. When asked specifically about it participants “Oh, to taste something that 
you don’t necessarily want to…is it like that you don’t necessarily want to taste in your mouth 




Financial cost to the community 
Whilst participants got the basic premise of this term they did not fully understand the full 
implications of the term: “Well, every time you had tonsillitis you had antibiotics right and 
you went to see the GP? Then the financial cost to the community is how much tonsillitis costs 
to treat.” And whilst this statement is true it fails to acknowledge that there is also a cost of 
the tonsillectomy to society and the overall cost can only be calculated when you know the 
difference between these figures.  
Immunity 
The original term was meant to refer to the idea that the tonsils are an important source of 
immune protection from lower respiratory and gastrointestinal infections. Therefore, 
following tonsillectomy you are at potential increased risk having have your immune 
protection affected which may result in respiratory infections or gastroenteritis. However, 
when participants were asked about this term they discussed immunity in terms of tonsillitis 
and not following a tonsillectomy: “As in like I had it a lot, so whenever I had tonsillitis, I have 
a rubbish immune system anyway, but it would be worse, like I’d be so ill and I’d easily get 
any other colds or anything, so how I understand it is just after the tonsillectomy, well, it has 
been for me anyway, when I, because I don’t have it anymore, I haven’t been getting ill as 
often, so it has reduced my immune system weakening, I don’t know if that was the thing…” 
All other terms were understood in their correct context. 
 
  





With regards to the treatment of adults with recurring tonsillitis I now had eleven outcomes 
for which I had 1. A defined effect size 2. An assessment of how credible and applicable the 
evidence based was for our patients, and 3. An assessment of how important they were to 
our patients. However, AHP requires that I have no more than seven outcomes to compare 
between to prevent fatigue(291). In addition, the outcomes should be easily understood by 
the respondent and not so conceptually like each that they prevent respondent 
discrimination.  
Aim 
Our aim was to reduce 11 treatment outcomes to seven or less based on patient importance, 
strength of evidence and effect size, dissimilarity and ease of understanding.   
Method 
An expert group of two ENT surgeons, one public health doctor, an AHP expert and 
psychometrician were presented the combined data from the critical appraisal and patient 















The panel were given the brief that eleven outcomes needed to be reduced to seven or less. 
Criteria for removing outcomes included  
 Insufficient evidence base or poor applicability to our population of interest 
 Small effect of treatment on outcome 
 Low patient priority 
 Conceptually too similar to another outcome for patients to differentiate 
 Difficult concept for patients to understand 
I conducted a structured panel discussion by presenting findings related to 4 key topics and 
asking the panel to discuss with the overall aim of reducing 11 outcomes to seven or less. I 
structured my presentations to help the panel decide which outcomes were 1. more 
important to patients, 2. too similar to each other, 3. Too difficult to understand and 4. Most 
believable given the available evidence.  
The expert panel were presented the results of the thematic analysis to provide insight into 
what themes were important for patients in the management of their recurring tonsillitis and 
how they evaluated the outcomes. For example, reducing days of sore throat, reducing 
episodes of sore throat, reducing days off-work and improving quality of life all mapped to 
three themes patient decision making: negative impacts of the condition, hope for a positive 
outcome, and individual trade off.  These structured discussions helped the panel get a sense 
of which outcomes were more important to patients.  
I presented outcomes that patients felt were clustered together. This helped the panel 
consider which outcomes were considered too similar to each other for valuable comparison, 
for example most patients felt that reducing days of sore throat and episodes of sore throat 
were the same thing.  
I next presented outcomes that the patients had difficulty understanding, to assess whether 
they could be reworded or removed. The above structured discussions allowed the panel to 
appreciate the patients’ perspective with regards to managing their recurring tonsillitis.  
Finally, I presented the 11 studies reporting on their risk of bias (strong, moderate. weak) and 




in relation to these outcomes (e.g. The panel felt that the effect size of tonsillectomy on voice 
was small and the credibility of the study weak).   
Results 
 
Final outcomes to be ranked by 
patients to determine their 
treatment preference 
Reducing days of a sore throat 
Reducing risk of haemorrhage 
Halitosis reduction 
Improvement in quality of life 
Reducing visits to the GP 
Table 25 Tonsillectomy outcomes chosen for inclusion in PARTT 
This table shows the final five tonsillectomy outcomes chosen for inclusion in PARTT as selected by the expert panel, having 
removed six outcomes from the original list. 
Overall 6 outcomes were removed by the expert panel based on conceptual similarity, poor 
evidence credibility or usability, small effect of treatment or low patient priority. The process 
is summarised below. 
Two outcomes (days with sore throat and episodes of a sore throat) were considered too 
similar to each other conceptually based on focus group analysis (Theme 4 – Clustering of 
factors) and so a choice between excluding one or grouping both had to be made. Although 
they were both important, as evidenced by high patient rankings, the panel decided to use 
only one of these outcomes: reducing episodes of a sore throat, as it was ranked higher by 
patients.  
Patients consistently ranked improving voice (11th), societal cost (10th) and immunological 
profile (9th) as the least important outcomes for them. The panel felt the evidence for these 
outcomes was poor and the effect size non-significant and so these three variables were 




patients and the panel felt the evidence for these outcomes was insufficient and so they were 
excluded.  
This left five patient-chosen outcomes that have sufficiently strong evidence: Reducing 
episodes of a sore throat, reducing visits to the GP, improving the quality of life, reducing 
halitosis and reducing haemorrhage risk – see Table 25.  
Summary 
I undertook a systematic review and critical appraisal of randomised and nonrandomised 
studies investigating treatments for recurring tonsillitis in adults to shortlist outcomes that 
were important to patients and had strong evidence. And whilst there were thousands of 
studies investigating outcomes from treatments for recurring tonsillitis, the majority related 
to intra-operative or early postoperative outcomes that I felt were more important to the 
surgeon and anaesthetist than to patients making their decision.  
The evidence of all eleven outcomes from the systematic review and critical appraisal, patient 
rankings and thematic analysis of focus group was discussed with an expert panel. The expert 
panel used the above information to select five outcomes for which there was at least 
moderate supporting evidence and patients also felt were important.  
The following section describes how I converted the patient important five treatment 
outcomes into an AHP based questionnaire, designed to elicit treatment preference for adults 










To design and pilot an AHP based instrument that can be used to elicit treatment preferences 
in adults with recurring tonsillitis.  
Methods 
I designed the Preferences in Adults with Recurring Tonsillitis Tool (PARTT) based on standard 
AHP methodology that asks respondents to undertake pairwise comparisons between 
outcomes, based on their personal preferences. The method required all five outcomes be 
compared to each other on a response scale with semantic response categories (Equal 
preference between two outcomes, Moderate preference, Strong preference, Very strong 
preference and Extreme preference), resulting in 15 pairwise comparisons in total. In the 
introduction, a short explanatory sentence was provided for each outcome so that the 
respondent could weigh up the potential size of the benefit or risk when making their 
preference choice. In addition, I provided instructions of how the exercise should be 
undertaken. Once the PARTT was designed I piloted it with adults with recurring tonsillitis at 
the lead author’s clinic.  
I approached all patients attending a weekly sore throat clinic (which I had organised and ran), 
between 01/11/2013 and 01/12/2013, to help refine the instrument. The study was verbally 
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explained to patients and consent was verbally obtained. Patients were asked to use the think 
aloud technique as they read and completed the questionnaire(311).  
I took notes whilst patients completed the questionnaire and made appropriate changes to 
the instrument based on observations and represented the revised instrument to the next 
batch of patients. The process was repeated until the patients seemed to easily understand 
the instructions and the outcomes that needed to be compared.  
Results 
The draft PARTT is presented in Appendix K - Draft version of PARTT.   
Twelve patients, who had recurring tonsillitis, were approached to take part in the pilot in the 
sore throat clinic by the lead author. All patients agreed to participate and provided verbal 
consent.  
The first three patients had considerable difficulty understanding the instructions. Therefore, 
the lead author verbally explained them so that they could proceed onto the comparisons. 
One patient also found the font on the comparison scale too small to read. An example was 
added into the instructions and the font size was increased.  
The following four patients had no problems with the instructions, although one complained 
that the instruction took him a long time to read, and he lost interest several times. All four 
patients found it tiresome to have to keep returning to the introductory paragraph to 
reference the likely chance of risk or benefit in relation to each outcome. 
Therefore, I changed the example to something more abstract but interesting (i.e. trying to 
find the best way to go to the shops). Additionally, I also added the explanatory sentence of 
the chance of risk or benefit related to each outcome under every comparison.  
The resulting instrument was tested on five patients over two weeks with no changes made 
to it. All patients understood the instructions, felt the example helped, and undertook the 







As described previously the PARTT requires study participants to undertake 15 pairwise 
comparisons between 5 potential treatment outcomes, based on their personal priorities.  
Verbal scale responses are converted to the Saaty scale so that equal preference between 
two outcomes would score one, Moderate preference- 3, Strong preference– 5, Very strong 
preference- 7 and Extreme preference- 9.   
Scores derived from the 15 comparisons are used to calculate preference ranks for each of 
the five potential treatment outcomes using standard AHP techniques(304) (described in 
Appendix T AHP methodology and Ranking results). Higher ranks indicate higher preference, 
hence outcomes ranked number 5 are the most important and those ranked 1 are the least 
important to respondents- these are called the Ranked Outcome Priorities(R.O.P).   
The consistency of participants’ pairwise comparisons is also determined, allowing those who 
had answered questions inconsistently to be removed from the cohort. Consistency scores 
are calculated through standard AHP algorithm (274). 
Finally, a tonsillectomy preference score can be calculated based on standard AHP 
methodology. This is a sum of the participants’ preferences for each outcome, weighted to 
reflect that likelihood of outcome occurrence if tonsillectomy was chosen. For example, if a 
participant has a high preference for reducing halitosis but the likelihood that tonsillectomy 
would reduce halitosis was low, based on the literature, then the impact of halitosis reduction 
on the tonsillectomy preference score would be down-weighted (see Appendix T AHP 
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methodology and Ranking results). Participants’ tonsillectomy preference score is calculated 
on a continuous scale between 0-1, with higher numbers indicating greater preference. The 
participant’s ‘conservative treatment’ preference score is the converse of the tonsillectomy 
preference score, so the greater the preference for one treatment the lower the preference 
for the other. If a participant has given all outcomes equivocal priority than the tonsillectomy 
preference score would be 0.50. 
Consistency checking 
Participants scoring greater than 0.5 on the consistency ratio are excluded from the analysis 
as their comparisons are deemed random. Sensitivity analyses were conducted for subgroups 
if the cohort was restricted by consistency ratios less than 0.2, 0.3, 0.4 and the whole sample.   
Summary 
I designed the PARTT based on the Analytical Hierarchical Process – a method that is based 
on rational decision making, but allows for and quantifies inconsistent decision making that 
is common in real time. The method allows a valid method to measure preferences that is 
easy to deploy and has low cognitive burden.  
I systematically searched and critically evaluated the evidence base to ensure I had detailed 
information on treatment outcomes – in terms of how they are affected based on the 
treatment chosen and how credible and usable the evidence was in relation to our patients 
of interest. The eleven outcomes identified were presented to patients with recurring 
tonsillitis and they were asked to rank them in terms of their importance to their treatment 
decisions. Additionally, I undertook a focus group to better understand how patients were 
making their treatment decisions. The above information was presented to an expert panel 
with the goal of reducing eleven outcomes to seven or less. The panel removed outcomes 
based on patients’ priorities, patients’ conceptually finding outcomes too similar to each 
other, poor quality evidence or small effect of treatment on outcomes. Five outcomes were 





A pilot instrument – PARTT - was designed and sequentially tested on patients with recurring 
tonsillitis and changes made incrementally until it was considered to easily and efficiently 
elicit treatment preferences. 
The following chapter will describe our observational study of the role of treatment 
preference (using PARTT) and decisional uncertainty (using the DCS, described in Chapter 5) 
on decision-making in adults with recurring tonsillitis.     
The following chapter will describe our observational study of the role of treatment 
preference (using PARTT) and decisional uncertainty (using the DCS, described in Chapter 5) 




CHAPTER SEVEN: A cohort study to investigate the roles of decisional 
uncertainty and preferences in explaining regional tonsillectomy 










In this chapter I have presented an observational study investigating treatment decisions for 
adults with recurring tonsillitis. The study investigated the role of patient and surgeons’ 
decisional uncertainty using the Decisional Conflict Scale - DCS) and treatment preference 
(using Preferences in Adults with Recurring Tonsillitis Tool - PARTT) on the management 
chosen for adults with recurring tonsillitis. Overall decisional uncertainty was low for patients 
and ENT surgeons. However, decisional uncertainty was significantly higher for both patients 
and ENT surgeons involved in consultations that resulted in watchful waiting compared with 
those that ended in which tonsillectomy was chosen.  Patient PARTT scores were not 
associated with treatment chosen. However, surgeons’ PARTT scores were related to 





I have shown that the rates of sore throat in the community and in primary care, along with 
tonsillectomy rates in secondary care change with factors that are known to vary between 
regions (specifically age, sex, ethnicity, presence of chronic medical diseases, number of 
people in the household, smoking status and population density).  Controlling for these 
population factors reduced regional tonsillectomy, recurring sore throat and community sore 
throat variations. Following critical review of the literature (17,22,23,39-41,271,312) and 
my subsequent systematic review (100) around this topic, I have hypothesised that factors 
during the medical consultation may also have a part to play in variations observed.  
In relation to recurring tonsillitis and tonsillectomy there is only very preliminary evidence 
from observational studies (17,23) that investigates the role of the consultation on surgical 
rate variation. In general, in relation to other surgical conditions, such as breast cancer, the 
literature suggests that there are two potential drivers related to the medical consultation 
that plays a role in regional surgical rate variation: professional uncertainty and treatment 
preference.  
Professional uncertainty, decisional uncertainty and Decisional Conflict Scale (DCS) 
Observational studies investigating the rates of surgery have shown greater variation for 
procedures which lack professional consensus on how cases should be managed  (24-26), 
with tonsillectomy being one of them(17). Lack of professional consensus has been described 
as professional uncertainty, which has never before been conceptually defined, rather 
inferred from general lack of professional consensus. Additionally, it has never been 
measured directly only inferred through survey studies that show large variation in the 
manner doctors would manage hypothetical patients (see chapter 1).  Currently, there is no 
study that has investigated how professional uncertainty in the management of recurring 
tonsillitis manifests itself during the shared decision making process between ENT surgeon 
and patient to align decisions towards tonsillectomy in some regions more than others. 
It has been hypothesised that in the absence of strong professional consensus surgeons may 
be more uncertain on what to advise and patients may feel more uncertain about what 




itself during shared decision making, between ENT surgeon and patient, specifically as 
decisional uncertainty, for both surgeons and patients. Decisional uncertainty is a well-
defined construct within shared decision-making paradigm and can be measured using the 
Decisional Conflict Scale (DCS) (263) for patients, or Provider’s Decision Process Assessment 
Instrument (PDPAI)(269) for surgeons. The DCS, and surgeon specific DCS called PDPAI, have 
strong psychometric properties with regards to validity and reliability.  
Surgeon treatment preference, patient treatment preference and Preference in Adults with 
Recurring Tonsillitis Tool (PARTT) 
Based on a seminal cross sectional study of paediatric tonsillectomy rates by region (16)and 
qualitative study of recurring tonsillitis consultations by region (23), Wennberg (24) 
hypothesised that regional tonsillectomy rate variation resulted from regionally aligned 
surgeon preference, a theory he coined the “Surgical Signature”. If patients who see surgeon 
A are more likely to receive tonsillectomy than if they saw surgeon B, it can be hypothesised 
that surgeon A has a treatment preference for tonsillectomy. However, in the modern health 
care setting of shared decision making, where the surgeon incorporates the patients’ 
preferences, with the best available evidence, to help reach a treatment decision rather than 
paternalistically dictating the treatment, surgeon preference is a complicated construct. 
Consultations with surgeon A could have resulted in tonsillectomy being chosen more 
frequently because the surgeon perceived tonsillectomy was a more effective treatment for 
certain outcomes, perceived patients prioritised these outcomes more than others, proxy 
bias, or the surgeon’s personal preference towards tonsillectomy. Partly due to the 
complexity of this construct surgeon treatment preferences, as they apply in the medical 
consultation, have always been difficult to measure on a scale large enough to inform 
discussions about regional surgical rate variations. Instead they have been implied from 
smaller qualitative studies, especially around the surgical management of breast cancer (26). 
There is no evidence that directly reports on surgeons’ treatment preferences for the 
management of adults with recurring tonsillitis, and how this affects treatment decisions.  
In relation to regional surgical rate variation, whilst surgeon treatment preference has a 
historical context and has been discussed (disproportionately in relation to the level of 




is now a growing body of evidence from studies of orthopaedic conditions that regional 
surgical rate variations are associated with regionally aligned patient treatment preferences 
(78). (78,81-83) (85-88), (272) (90) (91). However, due to the difficulties in eliciting patient 
treatment preferences efficiently on a large scale, preferences have been implied by 
willingness for treatment based on selecting an ordinal value on a spectrum from “definitely 
not willing to have to treatment”, through to “definitely willing to have treatment”, has never 
been tested with respect to validity or reliability. There is no evidence that directly reports on 
treatment preferences for adults with recurring tonsillitis, and how these patient preferences 
influence the treatment decision.  
Recent advances in decision theory have led to rapid progress in the elicitation of preferences, 
and the analytical hierarchical process (AHP) offers a rapid and reliable method to elicit both 
patient and surgeon treatment preferences. Using outcomes from treatment that are 
important to adults with recurring tonsillitis I designed an instrument based on AHP that is 
capable of eliciting patient treatment preferences – PARTT. By asking a surgeon to complete 
PARTT from a typical recurring tonsillitis patients’ perspective it is possible to approximate 
the surgeon’s treatment preference in the context of the medical consultation, as s/he must 
balance their beliefs around the effectiveness of tonsillectomy with the outcomes they 
perceive are important to their patients. In this way, I can quantify surgeon treatment 
preference, in the context of a medical consultation, without reducing its complexity to 0-10 
visual analogue scale asking surgeons how much they like tonsillectomy.  
 
Aims 
To investigate the role of decisional uncertainty and treatment preference on the treatment 
chosen for adults with recurring tonsillitis  
Objective  
1. To define the relationship between decisional uncertainty and treatment selected for 




2. To define the relationship between ENT surgeons’ decisional uncertainty and the patients’ 
decisional uncertainty 
3. To define the relationship of post-consultation patients’ treatment preference and 
treatment chosen 
4. To define the relationship between pre-consultation surgeons’ treatment preference (in 
the context of a medical consultation) and the treatment chosen by the patient 
Method 
Ethics 
Ethical approval for this study was granted by Nottingham Research Ethics Committee 
(15/EM/0191) on 8th May 2015.  
Sample  
Hospital selection 
Inclusion criteria related to whether a hospital had regular ENT clinics and sufficient volume 
of recurring tonsillitis patients to recruit patients. There was a local and national approach to 
recruiting sites. The national approach was to advertise the study on the NIHR research 
portfolio and send an email out to CRN ENT leads. Locally, I recruited sites by advertising the 
study amongst the regional trainee research collaborative – Otolaryngology Trainee 
Investigators Collaborative (OTIC). OTIC has 46 trainee surgeon members across 14 hospitals 
in the Greater London region.  A total of 17 sites (5 nationally and 12 locally) demonstrated 
interest in participating in the study. They were provided with study protocols, minimum 
recruitment targets per site and asked to discuss recruitment with their Trust’s Research and 
Development departments to assess feasibility. Sites that felt they had the capacity to recruit 
the minimum number of patients were asked to contact me.  
Surgeon selection 
The Principal Investigator (P.I.) was appointed as the Consultant who had shown an interest 
in participating in the study. I briefed the P.I. regarding study etiquette and protocol, 
personally at each site, before recruitment started. The P.I. at each site was asked to discuss 




information sheet about the study and asked to read it (see Appendix M - Detailed Doctor 
Information Sheet). The P.I. explored his/her colleagues’ willingness to participate in the 
study. I sent those who were interested a consent form to complete (see Appendix N - Doctor 
Consent Form). The P.I. recruited a local research team that included junior doctors, research 
trained nurses (depending on local availability) to help conduct the study.  
Patient selection 
Consecutive patients attending ENT clinics were recruited if they were 16 years old and over 
with recurring tonsillitis episodes frequent enough to justify a tonsillectomy (as judged by the 
participating ENT surgeon according to SIGN guidelines). Patients referred for tonsillectomy 
for snoring or halitosis, or with insufficient English language skills to undertake the consent 
process were excluded. The local research team co-ordinated screening of GP referral letters 
to identify potential participants. Potential participants were sent information by the clinical 
team about the study prior to their hospital appointment (see Appendix O - Patient Invitation 
Letter). On the day of their appointment if they were found to meet inclusion criteria, as 
ascertained by their consulting surgeon, they were asked if they were happy to discuss study 
participation with a member of the local research team (defined above). A member of the 
local research team discussed the study in more detail and provided a detailed information 
sheet (see Appendix P – Detailed Patient Information Sheet). Patients who were happy to 
participate were asked to complete a consent form (Appendix Q – Patient Consent Form).  
Sample size calculation 
The study was powered to detect a clinically significant decisional conflict score of 25/100 (or 
an effect size of 0.4).This figure is based on initial validation studies in e adults who were 
offered influenza vaccination showing that the DCS can be used to detect an effect size of 0.4 
(or a DCS score of greater than 25 out of 100) between those who postpone their decision 
and those who actively undertake treatment (313). A subsequent meta-analysis of ten 
randomised controlled trials showed that an effect size of 0.4 (or a total score of greater than 
25 out of 100) in the DCS can differentiate between those who delayed their decisions and 
those that did not, and those who regretted their decision and those that did not(266).  A 
prospective study of 100 aneurysm patients facing a treatment decision showed that an effect 




study to detect a moderate effect (effect size=0.4) based on these studies. I predicted that 
less than one third of patients would choose conservative therapy (3) and estimated the 
standard deviation of the DCS in our population conservatively at 0.8 (314,315). Therefore, 
using two-sided significance level of 0.05, a power of 0.8 I estimated that that I would need 
to recruit 150 patients (100 who chose tonsillectomy and 50 who chose conservative 
therapy). 
Instruments 
Decisional uncertainty (DCS&PDPAI)  
The DCS and the surgeon adapted DCS (PDPAI) both have 16 items scored on a five-point scale 
(0=Strongly agree, 4= strongly disagree). The total score, and sub scores, are transformed to 
0-100 scale, with higher scores associated with greater uncertainty. The scale discriminates 
between those who make and those who delay decisions (effect sizes range from 0.4 to 0.8). 
The instrument has a minimal clinically important difference previously established; patients 
scoring 25 or more are likely to delay decisions, whereas those with a score of less than 25 
tended to make decisions (264). Patients scoring more than 25 out of 100 (265) on the total 
patient DCS has been related to decisional delay, departure from active treatment, decision 
regret, nervousness and a higher intention to sue physicians in cases of harms from treatment 
and has been the score most commonly used to distinguish a harmless from a harmful level 
of decisional conflict (265-268). Decisional uncertainty scores for both patients and surgeons 
were logarithmically transformed to approximate a normal distribution. Parametric analyses 
were conducted on the transformed variables.  
Preference in Adults with Recurring Tonsillitis Tool (PARTT) 
PARTT requires respondents to make a 15 pairwise preference comparisons between 5 
potential treatment outcomes (reducing days of sore throat, reducing risk of haemorrhage, 
halitosis reduction, improvement in quality of life, and reducing visits to the GP) on a verbal 
response scale (Equal preference, Moderate preference, Strong Preference, Very Strong 
Preference, Extreme Preference). There are four final outputs (process described Appendix T 




1. Ranked outcome priorities: Potential treatment outcomes ranked 1-5 in decreasing order 
of preference (e.g. reducing days of sore throat=1, reducing visits to GP=5 suggests 
respondent’s main priority was reducing days of sore throat and lowest priority was reducing 
visits to the GP) 
2. Outcome preference score: Each potential treatment outcome scored between 0-1 to 
demonstrate magnitude of preference between them (e.g. reducing days of sore throat=0.4, 
reducing visits to GP=0.1 suggests that reducing days of sore throat was 4 times more 
important to respondent than reducing visits to the G.P)  
3. Consistency score: Overall score describing how consistently comparisons were completed, 
scored between 0-1, with scores greater than 0.2 suggesting inconsistent comparisons and 
greater than 0.5 suggesting randomly undertaken comparison 
4. Tonsillectomy preference score: Overall score, between 0-1, describing how respondent’s 
values align with tonsillectomy (e.g. respondent A=0.2, respondent B=0.5, respondent C=0.7 
suggests that respondent A has values that do not align tonsillectomy, respondent B has 
values that do not indicate an obvious tonsillectomy preference or aversion, respondent C 
has values that align more closely with tonsillectomy).  
Whilst all four PARTT scores were calculated and analysed with relationship to treatment 
decision chosen only the consistency and tonsillectomy preference scores are presented 
below as they demonstrate key findings. For results relating to the ranked outcome priorities 
see Appendix P.  
Data Collection  
Surgeon data 
Consenting ENT surgeons were given a unique surgeon identifier code by the local research 
team.  Participating ENT surgeons completed a one-time questionnaire booklet that included 
the PARTT, under the hypothetical assumption they were a patient with recurring tonsillitis 
and basic demographic questions (see Appendix R – Doctor pre-consultation questionnaire). 
Immediately, following on from every consultation the surgeon undertook with a study 




consultation questionnaire). Both questionnaires had the ENT surgeon’s unique identifier 
code attached so their scores could be compared later.  
Patient data 
Patients who agreed to participate were given a patient unique identifier and asked to 
complete a questionnaire booklet immediately following on from their ENT consultation, by 
the local research team. The booklet included the DCS, PARTT, satisfaction and basic 
demographic questions. The patient unique identifier and the surgeon unique identifier (of 
the surgeon they had seen) was added to the booklet so that scores could be compared later.  
Analysis 
Sample 
Chi squared testing was used to compare available characteristics of our surgeon participants 
with ENT UK surgeon membership and patient participants with both CALIBER and National 
Prospective Tonsillectomy Audit participants.  
For analyses of patient and surgeon treatment preferences, participants scoring greater than 
0.5 on the PARTT consistency score were excluded from the analysis as their comparisons 
were deemed random. Sensitivity analyses were conducted for subgroups if the cohort was 
restricted by PARTT consistency scores of less than 0.2, 0.3, 0.4 and the whole sample.    
For analyses regarding decisional uncertainty, participants and resulting consultations were 
excluded if either the surgeon or the patient had missing data with regards to the PDPAI or 
DCS, respectively.  
General results 
Patient and surgeon sociodemographic as well as hospital characteristics were investigated 
in relation to the treatment chosen using Chi Squared tests.  
The association between patient and surgeon decisional uncertainty and treatment chosen 
To address the first objective, I developed univariable logistic models that investigated the 
role of the logarithmically transformed decisional uncertainty scores on the likelihood of 
consultation resulting in a tonsillectomy being chosen. I developed multilevel multivariable 




on the treatment chosen, after controlling for disease, patient, surgeon and hospital factors 
that I had considered to be conceptually related to the outcome. I forced consultations to be 
nested within ENT surgeons and ENT surgeons to be clustered within the hospital, to account 
for random variation at these levels. ENT surgeon and hospital variables were added 
sequentially and hierarchically, as random effects to the appropriate level, if they improved 
the model fit (as assessed by Akaike’s information criterion and pseudo-R squared values).  If 
they did not improve upon the model they were added as fixed effects. I developed multi-
level mixed effects linear regression models to assess the role of patient, ENT surgeon and 
hospital variables on the change in patient and then surgeon uncertainty scores 
(logarithmically transformed). Models were developed using the same methodology 
described above.  
The association between ENT surgeon’s decisional uncertainty and patient’s decisional 
uncertainty 
To answer the second objective, I undertook tests of correlation between the patient (DCS) 
and surgeon (PDPAI) uncertainty scores. I used Pearson’s correlation coefficient to describe 
the correlation between patient and surgeon uncertainty scores.  
The association between tonsillectomy preference score and treatment chosen  
I undertook cluster analyses to investigate the role of tonsillectomy preference scores on 
treatment chosen (tonsillectomy or watchful waiting), for surgeons and patients separately. 
The goal of clustering was to assign the respondents into clusters which are grouped with 
similar characteristics (316). Clustering analysis has already been used in many application 
domains such as market research (317), however, the popularity has recently grown in health 
care preferences (318). When clustering, one is interested in grouping respondents that 
cannot be distinguished from each other, and separating those that can(319). 
I chose to undertake cluster analysis as there are no known classifications of tonsillectomy 
preference scores (i.e. we do not know which score identifies high preference and which low 
preference patients, or even if there is moderate preference band). The clustering method 
chosen for this study was Ward’s or minimal increase of sum-of-squares, which used squared 
Euclidean distance between data points. This is the clustering method most commonly used 




clustering methodology (internal validity: Calinski-Harabasz, Silhouette and Duda criteria; 
external validity: True treatment chosen; cross validity: compare clusters grouping created by 
different cluster techniques e.g. median partitioning).  
I undertook multi-variable logistic analyses to assess the relationship of participant cluster 
groupings, for tonsillectomy preference score with actual treatment chosen, for patients and 
ENT surgeons separately. Variables that were associated with treatment choice were added 
sequentially and hierarchically to the model to the patient or surgeon specific models.  
Finally, I added both patient and ENT surgeon preference clusters into the multivariable 
model to investigate the role of both ENT surgeon and patients’ treatment preference score 




Eight sites in the London area and six nationally agreed to participate in the study. 
Geographically the study included sites from Greater Manchester, Oxfordshire, Norwich and 
Norwich, Hertfordshire, Buckinghamshire, Poole and Greater London.  Four (29%) sites were 
teaching hospitals (national proportion 3%) and ten district general hospitals.  
Surgeon selection 
All ENT surgeons of recruiting hospitals, consented to participate. Five surgeons did not 
complete the post consultation questionnaires. Therefore, five consultations lacked surgeons’ 
uncertainty score and were excluded from uncertainty analyses. Ten surgeons had 
inconsistent PARTT responses, and so were excluded from the study (consistency ratio>0.5).  
Therefore, I analysed preferences results from 160 consultations. Two thirds of ENT surgeons 
had a consistency ratio of less than 0.2 and 90% had a ratio of less than 0.4. Sensitivity 
analyses showed no association between outcome rankings and treatment chosen, 
irrespective of consistency ratio cut off threshold.  
Surgeon characteristics are shown in the Table 26. Age, sex and grade of the participating ENT 




However, there were no data available for ENTUK member ethnicity, years of practice or type 
of hospital worked in. 
ENT surgeons’ variables Percentage in this subgroup (n) 
Hospital type  
University 42%(26) 
District General Hospital 58%(36) 

















Staff Grade 11%(7) 
Associate Specialist 10%(6) 
Core trainee 5%(3) 
Missing 3%(2) 







Table 26 ENT surgeons' demographics 








See Figure 19 Patient recruitment flow diagram.  
Screening of GP letters identified 329 potential participants.  Twenty-eight patients did not 
attend their appointments (n=301). One hundred and three patients were excluded as they 
did not meet inclusion criteria (n=198). Eight patients could not be recruited as the research 
team was unavailable on the date of their outpatient appointment (n=190). From the 190 
patients that were eligible for inclusion six patients did not want to participate in the study 
(n=184). Since I successfully recruited 184 patients, our study had a recruitment rate of 98%. 
Only one participant had missing data in their DCS and so their results were excluded from 
the uncertainty analyses. Seven patients did not complete their PARTT completely, whilst 17 
were inconsistent with their responses (consistency ratio>0.5) and so were excluded from 
preference analyses. Two thirds of patients had a consistency ratio of less than 0.2 and 90% 
had a ratio of less than 0.4. Sensitivity analyses showed no association between outcome 
rankings and treatment chosen, irrespective of consistency ratio cut off threshold. Therefore, 
the whole cohort was used for subsequent analyses (Table 29 Sensitivity Analysis for 
consistency ratios).  
Recruited patients were not significantly different from those not recruited in terms of age 
(p=0.51) and sex (p=0.65) - tested using two-sample test of proportions. The distribution of 
patient characteristics across 184 recruited patients was compared to characteristics 
reported in the National Prospective Tonsillectomy Audit (NPTA) (56) (n=33,680) for gender 
and our CPRD-HES study of adult tonsillectomy (n=6830) for age and ethnicity (since this data 
was not available for the NPTA) using two sample test for proportions. Gender distribution in 
our study was comparable to NPTA (83% vs 85% female respectively p=0.45). Age and 
ethnicity distribution were comparable to those who had tonsillectomies recorded on our 
CPRD-HES database (72% vs 68% 16-29-year-old respectively, p=0.25; 77% vs 75% white 





Figure 19 Patient recruitment flow diagram 
This figure shows the number of patients who were initially identified from their GP letters, culminating in the number who 
went on to complete DCS and PARTT. 
From the 184 patients recruited, 36 (20%) chose to treat their recurring tonsillitis non-
surgically (watchful waiting whilst 148 (81%) chose to undergo a tonsillectomy. The 
distribution of patient characteristics across this treatment choice can be seen in Table 27 
below. There was no statistical difference in patient and disease characteristics between the 
two groups.  
Patient variables 
Percentage who chose 
conservative (n) 







Hospital type     
University 22% (13) 78% (47) 
0.67 
33% 
District General 19% (23) 81% (101) 67% 
Age categories     
16-29 18% (24) 82% (109) 
0.39 
72% 
30-59 24% (1) 76% (35) 25% 




Gender     
Male 16% (5) 84% (27) 
0.55 
17% 
Female 20% (30) 79% (118) 80% 
Missing 25% (1) 75% (3)  3% 
Ethnicity     
White 17% (25) 82% (118) 
0.19 
77% 
Non-white 27% (10) 73% (27) 20% 
Missing 25% (1) 75% (3) 2% 
Patient perceived appropriateness of GP referral timing 
Prompt 14% (7) 86% (44) 
0.13 
27% 
Appropriate 25% (23) 74% (67) 49% 
Delayed 13% (5) 87% (33) 20% 
Missing 20% (1) 80% (4) 3% 
No. of tonsillitis episodes in last 12 months 
0-5 22% (13) 78% (17) 
0.83 
12% 
6-7 17% (10) 83% (49) 32% 
>7 19% (12) 81% (50) 33% 
Missing 20% (1) 80% (4) 3% 
No. of days off in last 12 months   
0-5 25% (13) 75% (38) 
0.52 
28% 
6-10 21% (10) 77% (37) 26% 
>11 15% (12) 85% (67) 43% 
Missing 14% (1) 86% (6) 4% 
Total 20% (35) 80% (144) 100% 
Table 27 Patient demographics by treatment chosen 
This table summarises the demographics of the patient groups in both the tonsillectomy and conservative treatment group 
(n=184).  
These patients were sent information sheets prior to their ENT consultation. On the day of 
their ENT appointment the local recruitment officer approached the ENT surgeon to alert 
them of a potential study participant. Twenty-eight patients did not attend their 
appointments. For patients who did attend eligibility of study inclusion was assessed during 
the consultation by the ENT surgeon. One hundred and three patients were excluded as they 
did not meet inclusion criteria. For those who met the inclusion criteria the ENT surgeon asked 




be recruited as the research team was unavailable on the date of their outpatient 
appointment. From the 198 patients that were eligible for inclusion six patients did not want 
to participate in the study. Since I successfully recruited 184 patients, our study had a 
recruitment rate of 98%. 
Recruited patients were not significantly different from those not recruited in terms of age 
(p=0.51) and sex (p=0.65) - tested using two-sample test of proportions.  
The distribution of patient characteristics across 184 recruited patients was compared to 
characteristics reported in the National Prospective Tonsillectomy Audit(NPTA) 
(56)(n=33,680) for gender and our CPRD-HES study of adult tonsillectomy (n=6830) for age 
and ethnicity (since this data was not available for the NPTA) using two sample test for 
proportions. Gender distribution was comparable to National Prospective tonsillectomy audit 
(83% female in our study compared to 85% in NPTA, p=0.45). Age distribution was comparable 
to tonsillectomies recorded on our CPRD-HES database (e.g. 68% in the CPRD-HES database 
compared to compared to 72% in our study sample were 16-29 year olds, p=0.25).  The white 
to non-white ethnicity proportion of our sample was comparable to our CPRD-HES database 
(75% white in CPRD-HES and 77% white in our study, p=0.54).  
General results 
From the 184 patients recruited, 36 (20%) chose to treat their recurring tonsillitis with 
conservative therapy whilst 148 (81%) chose to undergo a tonsillectomy. The distribution of 
patient characteristics across this treatment choice can be seen in Table 27 Patient 
demographics by treatment chosen. There was no statistical difference between patient and 
disease characteristics on treatment chosen.  
The association between patient and surgeon decisional uncertainty and treatment chosen  
Median patient uncertainty was low at 12.2 (interquartile range 0-25), with a skewness score 
of +1.90. Median ENT surgeons’ uncertainty scores were higher than patients at 36.67/100 
(interquartile range 26.67-43.33), with a skewness score of +0.8. Since both patient and ENT 
surgeons’ scores were positively skewed I logarithmically transformed the scores. Therefore, 




There was a moderate effect (Cohen’s D=0.5) of patient decisional uncertainty between those 
who chose tonsillectomy and those who selected watchful waiting – higher uncertainty was 
associated with choosing watchful waiting. ENT surgeons showed a slightly larger effect for 
decisional uncertainty when consultations ended in watchful waiting being selected (Cohen’s 
D=0.7).  
Patients’ (adjusted OR 0.41 95% CI 0.18-0.93) and ENT surgeons’ (adjusted OR 0.0001  95% CI 
<0.001-0.08) uncertainty scores were independently lower when conservative therapy was 
chosen, even after controlling for disease factors (number of tonsillitis episodes and days off 
work in last 12 months), patient factors (age, gender, and ethnicity), ENT surgeon factors 
(surgeon age, sex, ethnicity, grade and years of practice) and hospital factors (type of 
hospital). Whilst the multi-level model showed clustering of results at the ENT surgeon level 
(variance 1.27 95%CI 1.56-10.39), there was no measurable clustering at the hospital level 
(variance <0.001).  
The association between ENT surgeon’s decisional uncertainty and patient’s decisional 
uncertainty 
There was no correlation between patient and surgeon uncertainty scores following tonsillitis 
consultations (Pearson’s correlation coefficient=0.09).  
The association between tonsillectomy preference score and treatment chosen  
ENT surgeons reported a mean tonsillectomy preference score 0.57 (95%C.I 0.54-0.58) and 
patients with recurring tonsillitis reported a mean tonsillectomy preference score of 0.55 
(95% CI 0.54-0.57). Student’s T test did not show any statistical difference in patient 
tonsillectomy preference scores between these two treatment groups (P=0.48).  
Whilst there was no difference in the mean tonsillectomy preference scores between ENT 
surgeons and patients, there was also no correlation between individual preference scores of 
patients and their consulting ENT surgeons: Pearson’s Correlation coefficient 0.14(95% CI: -
0.07-0.35).    
Patients’ tonsillectomy preference scores are displayed in Figure 20 Patients' tonsillectomy 
preference scores. Calinski pseudo F score index (237.93), Duda’s Je(2)/Je(1) index (0.71) and 




these clusters. see Figure 21. Table 30 displays the characteristics of each cluster. The 
proportion of patients who chose tonsillectomy was similar, irrespective of the patients’ 
tonsillectomy preference score group (see Figure 22 Treatment chosen based on patient 
tonsillectomy preference score cluster grouping). 
ENT surgeons’ tonsillectomy preference scores are displayed in Figure 23 ENT surgeons' 
tonsillectomy preference scores. Calinski pseudo F score index (137.80) was greatest for 3 
clusters, wheras Duda’s Je(2)/Je(1) (0.30) index was greatest for 2 clusters. Silhouette score 
was marginally better for 3 clusters (3 clusters : 0.29 vs 2 cluster 0.15) and therefore 3 clusters 
were used – Figure 24 ENT surgeons' cluster groupings based on tonsillectomy preference 
scores. Table 31 shows the how the consultations are divided by ENT surgeons’ cluster. It 
appeared that a greater proportion of patients who saw ENT surgeons’ clustered with a 
stronger preference for tonsillectomy (83%) ended up choosing tonsillectomy compared to 
patients seeing ENT surgeons with a low tonsillectomy preference (60%) see Figure 25 
Proportion of patients choosing tonsillectomy based on ENT surgeons' tonsillectomy 
preference cluster' tonsillectomy preference cluster. This was confirmed on multivariable 
logistic regression testing (Adjusted OR 3.88, 95%CI 1.01-14.97) – see Table 32 Multivariable 
model of predictors of treatment choice. 
 
 


















Patient's age     
15-29 18% (24) 82% (109) 1 
0.56 






Patient's gender     
Male 16% (5) 84% (27) 1 
0.93 
Female 20% (30) 79% (118) 
0.94(0.24-
3.72) 
Patient's ethnicity     
White 17% (25) 82% (118) 1 
0.27 
Non-white 27% (10) 73% (27) 
0.51(0.15-
1.71) 
Self-reported episodes of tonsillitis in last 12 months    
0-5 22% (13) 78% (17) 1 
0.32 
6-7 17% (10) 83% (49) 
1.40(0.38-
5.11) 
>7 19% (12) 81% (50) 
0.52(0.15-
1.82) 
Self-reported days off from work due to tonsillitis in 
last 12 months 
   
0-5 25% (13) 75% (38) 1 
0.6 
6-10 21% (10) 77% (37) 
0.81(0.21-
3.08) 
>10 15% (12) 85% (67) 
1.52(0.44-
5.24) 
Type of hospital     
University 22% (13) 78% (47) 1 
0.85 
District General 19% (23) 81% (101) 
1.15(0.27-
4.86) 
Surgeon's age     
20-29 1(13%) 7(88%) 1 
0.8 
30-39 11(19%) 47(81%) 
0.24(0.01-
4.94) 
40-49 16(26%) 45(74%) 
0.40(0.01-
11.02) 
>50 8(16%) 43(84%) 
0.41(0.01-
13.04) 
Surgeon's sex     




Female 11(21%) 41(79%) 
0.94(0.23-
3.89) 
Surgeon ethnicity     
White 16(19%) 70(81%) 1 
0.69 
Non-white 20(22%) 71(78%) 
1.29(0.37-
4.49) 
Surgeon's grade     
Consultant 21(23%) 72(77%) 1 
0.4 
Registrar 8(18%) 36(82%) 
2.48(0.31-
19.74) 
Staff grade 4(27%) 11(73%) 
0.67(0.10-
4.35) 
Associate Specialist 2(9%) 21(91%) 
5.50(0.52-
57.79) 
Core trainee 1(33%) 2(67%) 
0.29(0.00-
18.93) 
Table 28 Multilevel multivariable model of predictors of choosing tonsillectomy 
This table shows associations between demographics and the probability of tonsillectomy (n=180). 
 
 
Table 29 Sensitivity Analysis for consistency ratios 
Consistency 





































This table shows the mean tonsillectomy preferences for different consistency ratio cut offs, showing no relationship between 












Figure 20 Patients' tonsillectomy preference scores 
This is a graph that describes the tonsillectomy preference scores for patients, ranging from 0 (low preference) to 1 (high preference) for each patient in the study (n=167) This shows the 



















AHP tonsillectomy preference score (1=high preference, 0= low preference) 







Figure 21 Cluster analysis of patient's tonsillectomy preference scores  
This graph shows the results of the cluster analysis of patient tonsillectomy preference. Cluster analysis uses patient’s data to create “preference profiles” which are used to create groups based 
on data, rather than requiring empirical categorisation using arbitrary thresholds. There are 22 patients belonging to the conservative cluster, 58 in the uncertain cluster and 66 in the 





















AHP tonsillectomy preference score (1=high preference, 0= low preference) 










Number of participants 
choosing tonsillectomy 
Number of patients 
altogether 
Odds ratio P 
Patient prefers conservative 0.40(0.38-0.43) 17 (77%) 22 1 0.85 
Patient unsure 0.54(0.53-0.55) 46(80%) 58 1.18(0.31-4.41)  
Patient prefers tonsillectomy 0.63(0.62-0.63) 51(48%) 66 1.03(0.35-3.05)  
 
Table 30 Characteristics patient tonsillectomy preference clusters 





Figure 22 Treatment chosen based on patient tonsillectomy preference score cluster grouping 
This figure illustrates the treatment that was chosen by each patient preference cluster, showing that in all groups the most likely result was tonsillectomy. 
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Figure 23 ENT surgeons' tonsillectomy preference scores 
This is a graph that describes the tonsillectomy preference scores for surgeons, ranging from 0 (low preference) to 1 (high preference) for each patient in the study (n=167) This shows the 
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Figure 24 ENT surgeons' cluster groupings based on tonsillectomy preference scores 
This graph shows the results of the cluster analysis of surgeon tonsillectomy preference. Cluster analysis uses surgeon’s responses to create “preference profiles” which are used to create groups 
based on data, rather than requiring empirical categorisation using arbitrary thresholds. There are 12 surgeons belonging to the conservative cluster, 82 in the uncertain cluster and 73 in the 
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Odds ratio P 
Surgeon aligns 
conservative 
0.38(0.35-0.41) 6(60%) 12 1 0.01 
Surgeon aligns no 
preference 










Table 31 Characteristics of consultations based on ENT surgeon tonsillectomy preference cluster 
This table shows the characteristics of the consultations, separated by their ENT surgeon tonsillectomy cluster, showing 






Figure 25 Proportion of patients choosing tonsillectomy based on ENT surgeons' tonsillectomy preference cluster' tonsillectomy preference cluster 
.   
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Surgeon pref aligns conservative
Surgeon pref unsure
Surgeon pref aligns tonsillectomy







Table 32 Multivariable model of predictors of treatment choice 
This table shows the variables which may predict treatment choice alongside their odds ratio and p-value, illustrating the 
surgeons’ preference is the major predictor of tonsillectomy. 
 
Odds of choosing tonsillectomy Adjusted Odds ratio (95% CI) P-value 
ENT surgeon tonsillectomy preference group   
Aligns conservative therapy 1 
0.01 Unsure 3.74(1.11-12.56) 
Aligns Tonsillectomy 3.88(1.01-14.97) 
Patient tonsillectomy preference group   
Aligns conservative therapy 1 
0.65 Unsure 1.67(0.37-7.62) 
Aligns Tonsillectomy 2.38(0.79-7.13) 












Self-reported episodes of tonsillitis in last 12 months   
0-5 1 
0.06 6-7 7.02(1.34-36.89) 
>7 1.26(0.37-4.38) 
Type of hospital   
University 1 
0.29 



















Table 33 Predictors of belonging to high tonsillectomy preference cluster for surgeons.  
This table shows the predictors of belonging to a high tonsillectomy preference cluster, indicating that being in a DGH and 
age are the strongest predictors of tonsillectomy preference
Predictors of belonging to high ENT surgeons’ 




Hospital type  
University 1 
0.02 
District general 2.90(1.18-7.14) 
Surgeon age  




Surgeon gender  
Male 1  
Female 1.06(0.38-2.95) 0.92 
Surgeon Ethnicity  
White 1 0.61 
Non-white 0.80(0.34-1.87) 
Surgeon grade  
Consultant 1 0.71 
Registrar 1.41(0.32-6.26) 
Staff Grade 2.27(0.40-12.79) 
Associate Specialist 0.39(0.12-1.33) 






I have shown that patients’ decisional uncertainty was generally low, suggesting they felt 
certain about the treatment they had decided on. ENT surgeons reported uncertainty scores 
that are considered clinically important (>25), suggesting they were uncertain, or conflicted, 
with regards to the treatment chosen. Both patients and ENT surgeons reported higher 
uncertainty scores when watchful waiting was chosen. This is understandable given that those 
who are unsure of which treatment to undergo may choose to delay their choice – i.e. 
undergo watchful waiting. I found no association between patient and ENT surgeons’ 
uncertainty.  
Interestingly, whilst patients’ tonsillectomy preference scores were not related to treatment 
chosen, ENT surgeons’ tonsillectomy preference scores were associated with the treatment 
chosen, with patients being nearly four times more likely to choose tonsillectomy if their 
surgeon had a high tonsillectomy preference score. This association remained even after 
controlling for patients’ preferences and other patient and hospital characteristics considered 
to influence the treatment decision. This suggests that surgeons’ pre-consultation 
characteristics have a greater role to play in the decision of whether tonsillectomy is chosen 
than any other patient or disease characteristics that may have been identified during the 
consultation. Hospital characteristics predicted surgeon tonsillectomy preference scores: 
Surgeons who worked in district general hospitals were almost three times more likely to 
report high PARTT scores than surgeons who worked in university hospitals. Whilst the reason 
for this is unclear, it may be due to the fact that teaching hospitals have a more complex 
workload when compared to DGHs. This may result in there being less theatre time dedicated 
to more routine procedures. Further research is needed to investigate this.  
Results in the context of existing literature 
Our patient DCS scores were of a similar magnitude to those described in other studies 
investigating preference sensitive surgical decisions such as male sterilisation (320), trigger 
finger treatment (321) and surgery for breast cancer(322). Our patients reported lower 




hormone replacement therapy when at risk of blood clots(324). Our ENT surgeons reported 
higher uncertainty scores (PDPAI) compared with surgeons managing patients with carpel 
tunnel syndrome(321), which may be reflective of the greater professional uncertainty that 
surrounds the management of recurring tonsillitis.  
When choosing watchful waiting higher uncertainty scores were reported by both surgeons 
and patients. Whilst watchful waiting may have inherently higher uncertainty another 
possibility may relate to differences in the shared decision making (SDM) process. In fact, 
trials of patient decision aids designed to optimise shared decision making were reviewed by 
Cochrane (270) and found to show lower decisional conflict related to feeling unclear about 
personal values (difference -4.81 of 100; 95% -7.23 to -2.40) and lower decisional conflict 
related to feeling uninformed (difference -6.43 of 100; 95% -9.16 to -3.70). It is possible that 
the higher uncertainty scores relate to reduced or ineffective shared decision making during 
the consultation. Alternatively, patients who choose conservative therapy may be more 
appreciative of the risks and benefits of their choice and thus report a higher uncertainty 
score (325). Another explanation could be related to cognitive dissonance. That is, a potential 
mechanism for lower uncertainty scores in patients who choose tonsillectomy, is that they 
may have adjusted their uncertainty score post hoc to justify the decision they just made 
(327). Qualitative studies would help investigate the implications of our findings. 
Our results suggest that patients are more likely to choose treatments based on surgeon 
characteristics, which were established prior to their consultation, rather than their own 
treatment preferences or their disease severity. In part this may be related deferring decisions 
to experts. Qualitative studies of shared decision making that have shown patients see their 
surgeons as occupying expert roles and frequently defer decisions to them(328). In shared-
decision making, it is the role of the surgeon to elicit patient preferences and help them 
choose which treatment will provide outcomes that the patient values.  Surgeon PARTT scores 
elicited refer to surgeon treatment preference in the context of the medical consultation. The 
surgeon PARTT score may be driven by surgeon’s - evaluation of tonsillectomy effectiveness; 
perception of what outcomes the patient values; proxy bias; and personal tonsillectomy 




patient’s preferences differ substantially from the patients’ actual 
preferences(253,329,330).  
Our results may help explain previous findings from studies more specific to the management 
of recurring tonsillitis, albeit in children.  These studies report that ENT surgeons’ treatment 
preference are more deterministic of treatment chosen than the patients’ disease 
characteristics (22,23) and that variations in ENT surgeons’ consultation styles systematically 
predispose to a treatment being selected (17). Both observations may be a result of latent 
surgeons’ preferences towards a treatment. However, these studies were conducted in an 
era when there was little evidence on the effectiveness of tonsillectomy, no national 
guidelines and paternalistic surgeon decision making, all of which would have magnified 
regional tonsillectomy rate variation.  
Whilst it is surprising that ENT surgeons’ treatment preference, in the context of the medical 
consultation, can still be so influential, despite increased patient autonomy, advances in 
psychology over the last four decades have shown that even subtle differences in medical 
consultations can affect treatment choice. Indeed the investigations of framing bias have 
shown that patients are influenced into selecting a treatment depending on how outcome 
information is ‘framed’ by their surgeon: Patients select the risk averse option more 
frequently when the same information is conveyed in terms of harm rather than 
benefit(331) (193).  Psychological theory suggests that the format in which an argument is 
framed occurs subconsciously and is a consequence of the beliefs and values held by people 
presenting the information (332). Alternatively, our findings may suggest how the shared 
decision making process can be more complex than just sharing evidence on treatment 
benefits and risks and eliciting patients’ treatment preferences. Patients may not feel 
equipped, and may not want to make a decision and may defer the decision to the expertise 
of the surgeon. A systematic review of studies that measured patients’ decision role 
preferences showed that 21% of all patients preferred to delegate decision making roles to 
their care givers (333). This number dropped to 14% when the authors analysed decisions 
about surgery only. Additionally, the authors reported that the proportion of patients who 
wish to delegate their medical decisions from 43% in the 1970’s to less than 16% between 




patient to variation in surgeon treatment preferences, with two similar patients being 
offered different treatments based on the surgeon they saw more than their personal 
values or their disease severity. And this response may be associated with the type of 
hospital the patient visited. Qualitative work focusing on the consultation may help 
elucidate how ENT surgeons’ a priori preferences affect the risk of receiving a treatment and 
whether it was undertaken purposefully, due to patient decision paralysis, or unconsciously 
through communication biases.  
Strengths  
Overall, this the largest observational study of decision making in adults with recurring 
tonsillitis using a representative sample. The study measured constructs that had historically 
been associated with regional surgical rate variation, that is decisional uncertainty (as a 
potential surrogate marker of professional uncertainty) and treatment preference in both 
ENT surgeons and patients. PARTT is the only measure available that elicits preferences in 
adults with recurring tonsillitis and was designed using robust methodology that incorporated 
available evidence (using systematic review and critical appraisal) with key-stakeholder views 
(thematic review of focus groups of adults with recurring tonsillitis). AHP is the only 
preference measurement method that can reliably quantify inconsistency. Other methods 
qualitatively judge inconsistency giving the investigators the option to include or exclude 
inconsistent responses- with little transparency to the manner this decision is made.  
PARTT gave little inconsistency in our population compared to other healthcare preference 
studies using AHP measurement methods(334). I used sensitivity analyses to transparently 
assess the impact of inconsistent comparisons (consistency ratio 0.2-0.5) and found they 
made no difference to participants’ rankings, therefore could include them in our analyses. 
This suggests that values may not always be well formed and inconsistency should not 
immediately be used to define lack of validity, as has been found in other AHP studies 
(335,336).  
 
The sample was representative; ENT surgeons recruited were similar to membership profiles 




patients undergoing tonsillectomy in our CPRD-HES database and in the National Prospective 
Tonsillectomy Audit. Given the simplicity of the study, recruitment rate was very high and 
missing data very low. Patients and ENT surgeons completed their questionnaires 
immediately following the consultation, preventing recall bias affecting our scores. I could 
recruit ENT surgeons from all grades and therefore, control for this potential confounding 
variable in our final model.  
Limitations 
More of our sites were teaching hospitals (29%) compared to the national proportion (3%), 
however, there is no evidence to suggest that recurring tonsillitis patients (in patients for 
emergency admissions or in patients for elective referrals) are different between district 
general hospitals and teaching hospitals.  The cross-sectional nature of the study prevents 
deeper understanding of the causal interactions between decisional uncertainty and 
treatment chosen.  
Further limitations of our study can be discussed under two main topics: First, the limitations 
of the instruments used. Second, the power of the sample size to reach the conclusions.   
Potential limitations of instrument used 
Whilst the DCS has been well validated across several clinical conditions, this is its first use in 
recurring tonsillitis. Therefore, I undertook a limited evaluation of its psychometric properties 
in our sample. The DCS had high internal consistency (Cronbach’s alpha= 0.96), good item-
total correlations (0.68-0.83), however, item analysis suggested a floor effect for most items. 
Improved scale response categories may have allowed a more detailed understanding of the 
relationship between treatment and uncertainty score. However, it was not possible to 
evaluate validity or responsiveness in our study. 
PARTT showed that not all respondents were consistent in the manner they completed their 
pairwise comparisons. 13% of patients (23/174) and 16% of ENT surgeons (10/62) were 
inconsistent in the manner they recorded their priorities (consistency ratio>0.2). This may 
reflect an inherent weakness in our measurement process. There are five main reasons 
described for inconsistent responses in AHP questionnaires: Clerical error; use of extreme 




show that the use of extreme values was more common in those who showed inconsistent 
response (consistency ratio >0.2) compared to those who did not. It may have been that these 
participants were using extreme values to support the direction of their preference as 
opposed to strength of their preference e.g. a respondent chooses extreme preference of 
reducing visits to the GP over reducing days of sore throat and then chooses extreme 
preference of reducing days of sore throat over reducing halitosis. Whilst AHP can be used to 
understand that this respondent’s ranked outcome priorities are reducing visits to the GP 
(first), followed by reducing days of sore throat (second), followed by reducing halitosis 
(third), it is difficult to ascertain the strength of the preference between the three outcomes 
(is reducing visits to the GP two or three times as important reducing days of sore throat?).  
Previous AHP studies have dealt with inconsistent reporting in different ways. One way is to 
report inconsistency back to the respondent in real time and allow them to change their 
response. However, in this study I did not want to place further burden on patients. Others 
have addressed inconsistency by excluding participants from the analysis who were 
inconsistent(338-341). However, I felt that this would unnecessarily exclude patients with 
valid responses. I excluded all those who had very high inconsistency from analysis 
(consistency ratio>0.5) and ran sensitivity analyses on those with moderate degrees of 
inconsistency to see if it changed the treatment preference scores for the group. Since there 
were no differences in the overall tonsillectomy preference scores, or the ranked outcome 
priorities I did not exclude those with moderate inconsistency (consistency ratio 0.2-0.5). 
In addition to these observed reasons for inconsistency, a range of publications discuss the 
AHP scale and suggest that the scale itself has limitations (e.g., being bounded, not 
continuous, not representing verbal judgments well, or not delivering balanced judgments) 
(342-346). Alternative scales avoiding this and other potential weaknesses of the AHP scale 
have been proposed (e.g., Lootsma or other geometric scales; Ji’s derived transitive scale; 
different continuous, smaller, or wider scales) and are still being discussed (343,345-348)]. 
Future studies might investigate the extent to which the chosen scale contributes to observed 





Although I recruited more patients than expected, fewer patients chose conservative therapy 
than anticipated (20% versus 33%). Power analysis of our DCS results showed I had sufficient 
participants to detect an effect as small as 0.42, and since the effects I demonstrated were 
larger I feel justified in my conclusions. I also conducted a post-hoc power analysis of our main 
preference finding (i.e. ENT surgeon PARTT score is associated with treatment chosen). I used 
a two tailed Chi squared test with a 5% significance level based on the observed effect 
(adjusted OR 6.34), the sample size between the two surgeon preference groups (n=90) and 
an allocation ratio of 1, to show that I was sufficiently powered (power=81%)(349). 
Therefore, the study was adequately powered to report this finding.  
I repeated this test to examine our finding that there was no relationship between patient 
tonsillectomy preference and treatment chosen. My results showed that the study was 
adequately powered to reach this conclusion (Chi squared showed that 21000 patients would 
need to be recruited to detect (with 80% chance) this observed effect (adjusted odds ratio 
0.94) as significant at the 5% level).   
Conclusions 
Our results suggest patients’ preferences appear to play little role in the treatment decision. 
Conversely, ENT surgeons’ implicit treatment preferences seem to have a greater impact on 
treatment decisions, especially when the surgeon aligns to conservative therapy. This 
observation seems to remain true even after accounting for patients’ preferences and disease 
severity variables. Whilst it can be expected that surgeons develop an implicit preference for 
treatment of adults with recurring tonsillitis based on their personal experience and the 
experience of others (local working environment as well as national and internationally 























In this final chapter I have discussed the key findings of my thesis in the context of the current 
literature and overall strengths and weaknesses of this body of work. I have discussed 
potential avenues for future research, including qualitative studies to better understand my 
findings in relation to surgeons’ proxy rating of patient preference. I have concluded with 
implications for national policy, which include targeting interventions in the community as 




Key findings in the context of current evidence 
There are three key findings of my thesis. Firstly, regional tonsillectomy rate variations reflect 
regional variations in ‘need’ of the population; Second, regional tonsillectomy rate variations 
are greater for children than adults. And finally, treatment decisions for adults with recurring 
tonsillitis are more influenced by surgeon’s treatment preferences than patient preferences 
or severity.   
Regional tonsillectomy rate variations reflect regional variations in ‘need’ of populations 
My studies have shown that there is regional variation in the ‘need’ for tonsillectomy by 
demonstrating regional variations in recurring sore throat in the primary care and self-
reported sore throat in the community. After accounting for regional population 
characteristics related to ‘need’ for tonsillectomy, I found that the regional disparity was 
considerably lower than originally published for children (SCV=2 vs 8.4 (20) ), suggesting that 
a large part of the original variation described relates to the population ‘need’.  
As described in Chapter 1, the term ‘need’ has been defined as the population who could 
benefit from a treatment (60). Variation in surgical ‘need’ has previously been described in 
relation to: 
1.  Regional variations in disease incidence (which may reflect local demographics and 
lifestyle factors) 
2.  Regional variations in disease detection (which may reflect local access to services 
and help seeking behaviour such as GP consultation) 
3. Regional variations in patient treatment preference (which may reflect local social 
norms).  
In relation to tonsillectomy ‘need’ could either be approximated by: 
1.  Sore throat incidence in the community. 
2. Recurring sore throat detection in primary care 
3.  Patient treatment preference measurements in secondary care.  
Whilst there are a handful of studies that report the incidence of sore throat in the community 




primary care, recurring tonsillitis  (351) across settings, there are no studies to date that have 
investigated regional variations in sore throat from the community to primary care, let alone 
patient treatment preferences for recurring tonsillitis. However, my findings support findings 
in other clinical areas which have demonstrated that the community incidence of acute 
respiratory infections (352) (353) (354,355), GP consultation for acute upper respiratory 
tract infections (69) (70-72) (73,75,76) and patients willingness to undergo surgery 
(77,78,83,90,91) are all affected by population characteristics that are known to vary across 
regions. Population characteristics also seem to predict help seeking behaviour more 
generally for urgent care in primary (356) and secondary healthcare centres (357).  
For the first time, I have been able to approximate variations in ‘need’ by reporting regional 
disparities in incidence of community sore throat and detection rates of recurring sore throat 
in secondary care. My findings are strengthened by re-analysis of my results which 
demonstrate similar patterns of variation across all health care settings, initially captured on 
completely independent databases. For example, residents of East Midlands had amongst the 
highest rates of tonsillectomy, as undertaken in secondary care and captured on the HES 
database; this observation appears in part to be explained by the same residents having 
amongst the highest rates of primary care consultations for recurring sore throat, as captured 
on the CPRD database, and self-reported sore throats in the community, as captured on the 
FluWatch database. Bringing this together, my studies suggest that a large component of 
regional tonsillectomy rate variation is generated prior to secondary care visits.  
Indeed, much of the regional variation in tonsillectomy rates may occur even prior to primary 
care attendance for recurring sore throat. My finding that much of regional variation in the 
primary care detection of recurring tonsillitis becomes non-significant once regional 
population characteristics (e.g. age, sex, ethnicity, socioeconomic status etc.) are taken into 
account (SCV=2 for both adults and children). This further demonstrates that regional 
population characteristics, independent of regional health care variables, contribute more 
significantly to regional variations in recurring tonsillitis detection and management than 
previously described. This may, in part, help explain why interventions aimed at healthcare 








Regional variations are greater for children than for adults. 
Whilst regional tonsillectomy rate variations in children are well documented, there are no 
studies, to date, that report on those rate variations in adults despite 40% of all 
tonsillectomies being performed in adults (HES database 1997-2001). My study showed that 
regional tonsillectomy rates varied up to 20% for adults but up to 300% for children. To better 
understand the drivers of this disparity I investigated overall patterns of sore throat from the 
community through to secondary care separately for children and adults, at available time 
points (see Table 34 Incidence and rates of sore throat from community, through recurrence 
in primary care to tonsillectomy in secondary care).   
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0-4 years old 1168 250 104 0.6 
5-15 years old 1679 142 66 2.5 
16-24 years old 1559 116 2.9 1.8 
25-44 years old 2000 80 2.6 0.5 
Table 34 Incidence and rates of sore throat from community, through recurrence in primary care to tonsillectomy in secondary 
care 
This table shows the incidence and rates of sore throat in the community in different age groups, showing the progression 
through the healthcare system. 
Table 34 demonstrates that whilst the incidence of self-reported sore throat was similar 
between ages 5-15 and 16-24, the proportion of those who consulted for sore throat (first 




young adults (116/1159 patient years). A greater proportion of children who see their GP once 
with sore throat go on to have recurring sore throat (66/142 patient years) compared to 
young adults (2.9/116 patient years). This observation may be explained by qualitative studies 
that have shown parents’ decision to bring their children to the GP with acute respiratory 
illness is influenced by a greater perception of threat severity and increased expectation of 
assessment, information, advice or treatment(69-72,168) compared to similar severity levels 
of acute sore throat (167) or respiratory tract infections (169) in adults. Therefore, it seems 
that children are more likely to attend their GP for varying levels of disease severity (as 
observed in my data), whereas adults are more likely to attend for higher levels of disease 
severity. There may be consensus amongst GPs that adults who attend repeatedly for sore 
throat infections are more likely to have severe disease and benefit from referral for 
tonsillectomy. Professional consensus in the management of adults would reduce regional 
variation in this group.  This has never been directly investigated, but can be inferred from my 
results: Many adults (16-24years old) who attended primary care for recurring sore throats 
ended up having a tonsillectomy (62%), whereas only 4% of children (5-15 years old) had a 
tonsillectomy following the same number of consultations.  These results may reflect strongly 
held consensus amongst the medical community of the benefit of tonsillectomy in the adult 
population, which has the effect of reducing regional variation.  
 
 
Surgeon’s treatment preferences influence treatment decisions for adults with recurring 
tonsillitis  
In my study of decision making, I asked surgeons to complete PARTT once, from the 
perspective of an adult patient with recurring tonsillitis, before they saw the first study patient 
at their site.   I found that surgeons who had implicit preference scores that tended towards 
conservative treatment of recurring tonsillitis were 74% less likely to list their patients for a 
tonsillectomy than those whose had an implicit preference towards tonsillectomy; this 
preference was independent of the patients’ preferences (measured using PARTT) or markers 
of disease severity (e.g. episodes in last year, time off routine activities etc.). Surgeons whose 




risk of bleeding compared to surgeons favouring surgery. My study did not have the power to 
investigate if surgeons’ treatment preference scores varied geographically; it did however 
show that surgeons’ treatment preference scores varied with the type of hospital s/he 
worked in. Perhaps due to less capacity for tonsillectomies in teaching hospitals when 
compared with DGHs, as there is more alternative work in tertiary care. 
There is no study to date that examines treatment decision making in adults with recurring 
tonsillitis and therefore I cannot make direct comparisons. In children with recurring tonsillitis 
(n=400), Bloor’s (23) studied treatment decision making and found that there was 
considerable variation in the management of this condition by ENT surgeons.   
Bloor did not directly elicit surgeon treatment preference, but observed that some surgeons 
tended towards tonsillectomy and others watchful waiting, irrespective of patient or disease 
variables{Bloor:1976bm, Bloor:1978vy}. Whilst it is to be expected that surgeons develop 
a personal treatment preference over time based on their personal or local experiences, it 
becomes problematic when patients with the same condition severity and personal 
treatment preference are exposed to different treatments by different surgeons.    
Strengths and Limitations  
The work presented in my thesis is a unique mixed methods study that explores surgical rate 
variation. The work presented is the first time that health care data analysis has been used 
across three health care settings from the community to secondary care to better understand 
regional surgical rate variations and report on findings that have traditionally been missed by 
previous studies since they only investigated variations across one setting. I developed a new 
AHP instrument capable of efficiently eliciting treatment preferences for adults with recurring 
tonsillitis, based on a well validated process (AHP) and created using systematic reviews and 
critical appraisal of available evidence regarding treatment outcomes, and thematic analysis 
of focus groups to define outcomes important to patients.  I used multiple methods to 
develop a better understanding of decision making, including conceptual framework 
mapping, critical appraisal of patient reported outcome measures, design and deployment of 
a multi-centre national observational study of patient and surgeon decisional uncertainty and 




the complexity of the process and difficulty in measuring it, the difficulty inherent to 
preference elicitation and the importance of assessing this process from both the patient’s 
and surgeon’s perspective, which would have been difficult to ascertain in the absence of 
robust and varied methods.  
Previous studies have alluded to the ‘surgical signature’ where consultations with surgeons 
seem to result in one treatment more frequently being chosen compared to another. This has 
frequently been described as surgeon preference. However, surgeon preference in the clinical 
encounter, is a complicated process that involves beliefs around perceived treatment efficacy 
being combined with beliefs around which outcomes are important to their patients, which 
may be further complicated with their personal preferences. Whilst I could have assessed 
surgeon treatment preference by asking surgeons to complete a visual analogue scale from 
0-10 based on their tonsillectomy preference, it would have missed the complexity of this 
construct.   By asking the surgeon to complete a robust preference elicitation instrument from 
the perspective of a typical recurring tonsillitis patient I could capture the complexity of this 
construct without diminishing it.  
However, whilst this may be a strength, there is also a limitation of this method: There is the 
difficulty in interpreting the results. Surgeon PARTT scores, completed from a hypothetical 
patient’s perspective, seem to have more influence on the treatment decision than the real 
patient’s treatment scores. It is difficult to unpick whether this relates to 1. The surgeons’ 
concept of patient important outcomes 2. How effective the surgeon believed tonsillectomy 
was with respect to those outcomes 3. The surgeons’ personal preferences or 4. Proxy bias 
introduced by asking surgeons to complete scores on behalf of someone else.  
A further limitation of my thesis includes the use of only adults in the decision analysis study. 
As shown by the epidemiological investigation, regional tonsillectomy rate variation was 
greater for children than adults, and so analysing decision making for children would have 
been very useful. However, decisions between two agents, when one agent is acting as proxy 
for a third agent would have been difficult to interpret and so I chose, at least in the first 




Since tonsillectomy is a surgical procedure that can be used for both recurring tonsillitis and 
obstructive sleep apnoea, it could be considered a limitation to have not also investigated the 
variations in tonsillectomy rates for patients with obstructive sleep apnoea (OSA). This would 
have provided a more complete picture of all tonsillectomies. However, tracking this 
population through healthcare settings is extremely difficult given the poor coding for this 
population in primary care, in part related to diagnosis of this condition by multiple health 
specialists such as paediatricians and respiratory physicians. Given that OSA is a far less 
frequent reason for tonsillectomy compared to recurring tonsillitis, and the difficulties of 
defining the OSA denominator from the available data I felt it was justified to focus on 
recurring tonsillitis only. However, with OSA becoming a more frequent indication for 
tonsillectomy, care should be taken in devising policy based solely on recurring tonsillitis 
related tonsillectomy variation.  
Whilst having several limitations, my thesis has demonstrated a robust mixed methods 
framework for investigating regional surgical rate variations. Which in relation to 
tonsillectomy I have shown are complicated by regional variations in the ‘need’ and 
potentially even influenced by surgeons during the decision-making process. This 
demonstrates the complexity of the issue that previously has been reduced to a simple 
description of ‘surgical signature’. 
 
Implications for future research 
Developing the evidence base on patient relevant outcomes could help reduce professional 
uncertainty in the management of recurring tonsillitis in adults.  Systematic review 
undertaken to design PARTT revealed a paucity of evidence on key outcomes related to adult 
tonsillectomy. Current research is already being undertaken to further detail the efficacy of 
this procedure (55).  
Whilst I have been able to investigate tonsillectomy rate variations between 10 health 
districts, the data available to me, due to costs and information governance restrictions, did 
not allow me to look at variations between smaller health regions such as primary care trusts. 




and it would have allowed a more direct examination of the impact of local health policy on 
tonsillectomy rates.  So future work should investigate variation at these levels to better help 
understand how local policy influences tonsillectomy rates.  
Whilst I could show that my surgeon proxy ratings of patient treatment preference 
considerably influenced patients’ treatments decisions, the complexity of the construct 
measure makes interpretation difficult as discussed above. Understanding whether surgeon 
treatment preference is based on what surgeons perceive is important to their patients, 
personal preferences, proxy bias or their perception of efficacy of tonsillectomy would help 
devise strategies to align treatment decisions to patients’ treatment preferences. So, future 
work should investigate the drivers of surgeon treatment preference, using qualitative 
analysis of consultations and surgeon interviews.  
It has been shown that effective integration of patient preferences into shared decision 
making has been associated with positive findings in other patient groups(358,359). My 
study showed that patient preferences may not be accurately integrated into the shared 
decision making as much as desired; the elicitation of those preferences may be a first step 
towards integrating them. In this respect PARTT may be able to play a part in elicitation of 
personal patient treatment preferences. Future work will investigate how PARTT can inform 
a patient decision aid, designed to help patients with recurring tonsillitis.  Additionally, its 
role in feedback to surgeons about their latent preferences may help reduce their impact on 
the decision outcome. Future work investigating this may provide insights into the translation 
potential for a preference elicitation in shared decision making, both for the patient and the 
surgeon.  
My thesis used tonsillectomy as an exemplar to investigate regional surgical rate variations. 
These methodologies could be applied to other conditions: 1) using community surveys to 
understand true variations in disease burden and their relationship to variations in treatment 
levels. 2) Using detailed electronic health records to more effectively adjust for the wide range 
of population factors that may affect variation – this is important to prevent wasted effort in 
attempts to reduce variation. 3) analysis of variation stratified by different age groups 




minimal variation), 4) more detailed examination of the role of clinician vs patient preference 
in decision making. 
 
     
Implications for policy  
In a more general sense, there is a strong culture within the NHS of addressing variations of 
all kinds as a means of increasing quality and decreasing cost.  In fact, the current government 
policy is to reduce unwarranted healthcare practice variations to reduce the variations in 
health outcomes(178). There are currently metrics of variation across almost every aspect of 
care (e.g. of Quality Outcome Frameworks, antibiotic prescribing, delays in cancer diagnosis, 
cancer outcomes, cancer screening uptake), however few of these account for patient 
characteristics to the extent that this thesis has, meaning that the initiatives may be a waste 
of effort at best and harmful at worst.  
My study sheds light on what variation is warranted and provides a plausible reason as to why 
the policies to reduce tonsillectomy rate variations may have failed: High rates of 
tonsillectomy in certain regions are related to high rates of recurring sore throats in that 
region. Neither policy nor guidelines were directed at reducing the underlying disease burden 
but rather at aligning medical decision making and so may have failed to address the main 
driver of variation. Our study also shows that the there are many life style factors like smoking, 
population density (possibly acting through access to care) and obesity that increase the risk 
of recurring sore throats. Policy directed at reducing these may have a much greater effect 
on regional variation. Whilst the rate of recurring tonsillitis remains high in certain regions, 
tonsillectomy may be a cost-effective procedure (incremental cost per quality-adjusted life-
year for paediatric tonsillectomy in England ranged from £3129 to £6904 per QALY gained (3) 
and the current problem may be underprovision rather than overprovision.   
My observational study into decision making demonstrated that some patients are being 
exposed to different treatments depending on which surgeon they visit. Regardless of 




with the same condition may end up with different treatments based on who they see during 
their consultation.  
There are 3 potential strategies that could improve shared decision making: 1. Improve the 
evidence on the outcomes of treatment; 2. Implement strategies that reduce the impact of 
surgeon’s proxy rating of patient preference on decision 3. Increase the effect of patient 
preference.  
Firstly, it is not only important to increase the quantity and quality of evidence but also to re-
prioritise studies so that we have information available regarding outcomes that matter to 
patients. In developing PARTT I have noted large disparities between outcomes that patients 
considered important and available studies about those outcomes. Once that information is 
available it will be key to make that knowledge more easily accessible to health care 
professionals and can be integrated into treatment decisions. When this is achieved 
successfully it has been shown to reduce bias in the stages of gathering evidence and choosing 
treatments(360-362).  There are already initiatives like Core Outcome Measures in 
Effectiveness Trials (COMET) in existence that have started collating core outcome sets for 
treatments.  
Secondly,  surgeons’ decision making could be improved by educating them about the 
existence of their biases, on the assumption that an awareness of the biases will permit them 
to avoid being influenced by them (363).  Although informing people about biases is not very 
effective at reducing biased reasoning in non-medical settings (364), there is some indication 
that it can improve surgeons’ reasoning in some respects. For example, Gruppen (326)found 
that informing  surgeons  about  a  specific  bias  —  the  tendency to be influenced by personal 
experience of how effective a treatment was in evaluating future treatment  decisions  —  
reduced its effect. This strategy is not only logical, but it is also justified by research showing 
that continuing medical education in general tends to improve surgeon performance across 
a variety of domains and outcomes (365).  Policy could be directed to re-educating surgeons 
and informing them of their implicit bias towards a treatment, however, this would need to 





Finally, the impact of patient preference on treatment choice could be improved by 
formalising the process of patient preference elicitation and make it an explicit part of the 
shared decision making process. Policy could be directed at empowering patients in their 
treatment decisions. Whilst a recent study has shown more patients want an active part in 
their treatment decision than they did previously(333), there is no currently established 
framework to allow this. The value of understanding and using patient preferences in health 
care is well recognised (366,367). However, eliciting patient preferences is a difficult task 
that involves imagining a future health state, the likelihood of that health state and then the 
desirability of that health state. Finally, patients need to be able to compare amongst 
potential health states. It can be difficult for patients to understand uncertainty and risk or 
abstract constructs such as values and preferences. Additionally, attempting to compare 
values for potential future health states in the clinical consultation may stress the patient’s 
decision making to an even greater extent. PARTT could elicit preferences using simple 
comparisons, but it remains unclear how well treatment preference had been formed prior 
to the use of the instrument.  
Whilst there is evidence that shows skilled interpersonal interactions can elicit patient 
preferences efficiently(368,369), the time limited nature of the contemporary consultation 
rarely allows the opportunity to conduct the intense, interpersonal exploration required for 
preference elicitation. Patients in England are exposed to the second shortest consultation 
times across 10 developed countries(370). When preference elicitation is undertaken as an 
iterative, and deliberate process it can help a person understand and clarify personal values, 
health care situations, treatment options, and likely outcomes(371).Benefiting from 
behavioural decision-making research, an interactive analysis process is used to help an 
individual focus on key components. Whilst historically preference elicitation has been 
conducted by a skilled interviewer using probes and reflection, newer interactive computer 
systems have shown some success when used in addition to a human analyst (372).  
Technology can assist in meeting the challenges inherent in eliciting and incorporating patient 
preferences with high value evidence in routine health care practice. Software developed to 
focus on elicitation and values clarification may help patients think hard about complex, 




have been trialled and are collectively termed patient decision aids(373-376). Systematic 
review of randomised controlled trials that examine the effects of patient decision aids has 
shown that they increase patient knowledge, improve patient perception of risk (relative risk 
1.82, 95% CI 1.52-2.16), and improve congruency between stated values and treatment 
chosen (RR 1.51, 95% CI 1.17-1.97) (270). Additionally, the systematic review that I undertook 
showed that they also have the potential to change regional surgical rates(100).  
A previous study that investigated the influence of the match between patients’ preferences 
for information vs. information received. Authors reported that the trainee and consultant 
surgeons rated patients as adjusting better during surgery when the information provided 
before surgery matched patients preferences for information (377). Patients were also found 
to experience less anxiety and be more adaptive during an invasive medical procedure 
(catheterization) when provided with information matched to patients’ preferences (378). 
Patients’ adjusted better during surgery, had lower self-reported pain and reported better 
satisfaction when their preferences were made explicit(378). Recognising patients’ 
preferences for information (or not), has further been found to have significant effects on 
patients’ symptoms of anxiety and depression. Similarly, the match between patients’ 
preferences for involvement vs. enacted involvement in decision making was found to have 
significant, positive effects on patients’ satisfaction with care processes (379-381)and 
treatment anxiety (382). Therefore, it is important that we devise strategies that improve 
decision making to incorporate patient preferences more closely. 
Whilst the UK government had initially begun to develop patient decision aids (383) in 2011 
only 8 were developed, they were poorly publicised and not user friendly. The King’s Fund 
reported that poor clinician engagement in creating patient decision aids in the UK as a main 
barrier to their use(384). 
Overall, modern technology, if used with purpose and insight, could be deployed to empower 
patients and help doctors ensure the right patient receives the best treatment, based on all 
of the evidence and their patient’s values.  
The use of variation measures in healthcare has been used as a marker of healthcare quality 




of variation, which do not account for population characteristics and underlying disease 
burden, may not provide any valuable information. 
 Additionally, I have shown that we may not be aligning decisions to our patients as well as 
we could. A more appropriate measure for quality of clinical care provided may be related to 
how we share our decisions.  
If all treatment decisions were based around a transparent, robust and reproducible shared 
decision making process it would be likely to reduce unwarranted surgical rate variation. In 
such circumstances, any observed variation would reflect true variation in the preferences of 
patients treated by different general practices and surgical teams. Combining a better shared 
decision making process with a greater insight of regional population ‘need’ for policy makers 
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Appendix A – Fluwatch representativeness 
Table 35 Flu Watch representativeness to national cohort. This table shows the sociodemographic breakdown of 







































N(%) N(%) N(%) N(%) N(%) N(%) 
Age group 
       
 0 to 4 years 6 38 (6) 42 (5) 37 (5) 36 (5) 179 (5) 45 (5) 
 5 to 15 11 87 (14) 110 
(14) 
99 (14) 109 
(14) 
501 (14) 131 (15) 








848 (24) 206 (23) 








1225 (34) 344 (38) 
 65+ 16 123 
(20) 




799 (22) 175 (19) 
Gender 
       








1740 (49) 455 (51) 








1812 (51) 446 (50) 
Region 
       




320 (9) 115 (13) 















1456 (41) 321 (36) 
 London 15 28 (5) 77 (10) 26 (4) 28 (4) 270 (7) 65 (7) 








319 (9) 110 (12) 








1008 (28) 237 (26) 
Vaccination status 




















3159 (89) 715 (79) 
 Unknown 
 
25 (4) 17 (2) 33 (5) 0 (0) 236 (7) 0 (0) 
Index of Multiple 
Deprivation 
quintile 
       
 1 (most 
deprived) 
20 37 (6) 39 (5) 28 (4) 18 (2) 98 (3) 29 (3) 
 2 20 88 (15) 126 
(16) 
91 (13) 62 (8) 310 (9) 82 (9) 








915 (26) 221 (25) 








938 (26) 280 (31) 










1291 (56) 289 (32) 








3306 (98) 846 (98) 
 Non-White 25 5 (2) 3 (5) 6 (1) 7 (1) 78 (2) 19 (2) 
 
Appendix B – Flu Watch Data management 





File A1 (Dailydata.dta) contained daily data on illnesses, including sore throat 
occurrence, severity and additional symptoms. Each row denoted a day of illness. This 
file contained 37,489 rows of data describing events from 3270 patients. These data 
were captured from daily diaries in the first three seasons and online questionnaires 
in the last 2 seasons. File B1 (weeklydata.dta) was the weekly data for all participants, 
whether they had reported an illness during that week or not. Each row related to a 
patient-week. Each row held information of whether the participant had a respiratory 
illness, but not about the specific symptoms. In addition, each contained patient 
information, such as socioeconomic status, ethnicity, age, co-morbidities and smoking 
status derived from the baseline survey. 
File A1 was collapsed by illness, so that each row contained an illness episode, the new 
file was called A2 (illnessdata.dta). File B1 was collapsed by patient ID so each row 
related to one patient only. It held information regarding the dates they entered and 
left the study as well as dates of respiratory illnesses. This new file was labelled B2 
(cohortdata.dta).  
Files A2 and B2 were merged by patient ID to create file C1. This file contained the 
cohort information of File B2 and the collapsed daily symptom illness data of file A2, 
with each row representing a period of illness, or if the patient never reported an 
illness in the daily data file a period of disease free observation. 83 patients were 
removed who had daily illness data but no matching cohort information. There were 
38 illnesses reported in the weekly data for which there was no daily data, so sore 
throat status could not be ascertained. These weeks were not included in the 
denominator. Please refer to Figure B 1 Data Management for visual representation 
of the data management process.  
For patients who reported illnesses I expanded a row prior to their first reported 
illness and following on from their finally reported illness. This created rows for 



















File A1 Daily data File B1 Weekly data 
File A2 Illness data  File B2 Cohort data 
File C1 Platform file 
37,489 days of illness 
3270 patients 






83 patients in 




























































File B2 data (co-variates) 
1 row per patient, 1,051,280 patients 
File B1 data (dates of entry/ exit) 
1 row per patient, 1,151,930 patients 
 
File B3 merged file (dates of entry/exit and covariates) 
1 row per patient, 1,151,930 patients 
Raw File B0 data (dates of entry/ exit) 
1 row per patient, 1,174,764 patients 
 
22,834 patients 
dropped as date 
entry is after 
date exit 
File A2 (co-variates) 
1 row per patient, 2,629,396 patients 
File A1 data (dates of entry/ exit) 
1 row per patient, 3,141,627 patients 
File A3 merged file (dates of entry/exit and covariates) 
1 row per patient, 3,141,627 patients 
Raw File A0 data (dates of entry/ 
exit) 
1 row per patient, 3,528,783 
patients 
387,156 patients 
dropped as date 
entry is after date 
exit 


























Figure C 2 Creating main cohort/denominator file 




File B3  
File G1 (1 row/consultation or 
tonsillectomy, with cohort entry/exit 
and covariate data) 
2,542,555 consultations, 28,043 
tonsillectomies, 1,151,767 patients 
34,171illnesses 
/22,829 patients 
removed as no 
date entry/exit 
File G2 (1 row/consultation or tonsillectomy, with 
cohort entry/exit and covariate data) 
1,440,002 consultations/17,279 tonsillectomies, 
773,890 patients 
1,136,724 illnesses/10,764 
tonsillectomies removed as 
event occurs outside “safe 
observation period” 
File A3 
104,362 illnesses removed 
as occur on the same day 
File E1 (1 row/consultation day) 
2,787,149 illnesses, 1,174,764 
patients 
File F1 (1 row/ 
consultation or 
tonsillectomy) 
1,174,596 patients  
28,046 tonsillectomies, 
2,576,726 consultations 
210,051 illnesses removed 
as occur on within 21 days 
of each other 
File D2  









occur on the 




354,653 patients dropped as 
they don’t have entry-exit 
data 











45,443 patients with 
recurring sore throat 
Added codes ICD-10 codes 
to define tonsillectomies 
for recurring tonsillitis and 
create new variable of 
recurring sore throat (3 


























File H2  
ST set for sore throat, dates of 




outcomes over 21 
million years of 
patient risk 




years of patient risk 
File J1 (Children 
<=15years) 
410,477 outcomes 
over 2.5 million years 
of person at risk 
 
File H3  
Collapsed by patient, 
so each row represents 
a patient 
ST set for recurring sore throat, 
dates of entry and exit from 
being at risk 
File I2 
45443 outcomes 
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years of patient 
risk 
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File J3 (Children 
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18,256 outcomes 
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so each row 
represents a patient 
ST set for tonsillectomy, dates of 
entry and exit from being at risk 
File I3 
16,618 outcomes 
over 21 million 
years of patient 
risk 
File J6 (Adults>15, 
<45 years) 
7,894 outcomes 
over 8.3million years 
of patient risk 
 
File J5 (Children 
<=15years) 
7,849 outcomes over 
2.1 million years of 
person at risk 
 
File H2  





Appendix D – CALIBER tables 
Table 36 Univariable and Multivariable multilevel Poisson analyses of sore throat consultation in children from CALIBER database 
Analysis of sore throat in children 










P Adjusted IRR P 
Gender        
Male 219,640 1,499,044 147 (146-148) 1  1  
Female 256,593 1,492,573 172 (171-173) 
1.17(1.16-
1.18) 
<0.001 1.24(1.23-1.26) <0.001 
Age category        
0-4 years 117,443 469,760 250 (248-252) 1  1  
5-15 years 358,790 2,521,857 142 (141-143) 
0.44(0.43-
0.45) 
<0.001 0.55(0.55-0.56) <0.001 
Ethnic origin        





Indian 2,603 1,5891 164 (154-174) 
0.92(0.87-
0.98) 
 0.87(0.82-0.93)  
Black African 1,794 14,970 120 (111-128) 
0.67(0.63-
0.72) 
 0.63(0.59-0.68)  
Black Caribbean 1,352 11,237 120 (111-131) 
0.68(0.62-
0.74) 
 0.68(0.62-0.74)  
Black other 1,232 9,833 125 (115-136) 
0.70(0.65-
0.76) 
 0.69(0.63-0.75)  
Bangladeshi 870 4,408 197 (175-222) 
1.11(0.98-
1.25) 
 1.01(0.90-1.13)  
Pakistani 2,888 15,023 192 (182-203) 
1.08(1.02-
1.14) 
 0.96(0.91-1.02)  
Other Asian 1,333 8,431 158 (145-172) 
0.89(0.82-
0.96) 
 0.82(0.75-0.89)  
Chinese 442 3,502 126 (109-146) 
0.71(0.61-
0.82) 
 0.72(0.62-0.82)  
Mixed 2,713 21,417 127 (120-134) 
0.71(0.67-
0.75) 





Other 3,965 26,344 151 (143-158) 
0.84(0.80-
0.89) 
 0.85(0.81-0.89)  
Unknown 75,857 489,367 155 (153-157) 
0.87(0.86-
0.88) 
<0.001 0.92(0.90-0.93)  
Social Deprivation        
Least deprived 82,468 494,541 167 (165-169) 1  1  
2nd least deprived 93,744 570,205 164 (163-166) 
0.99(0.97-
1.00) 
 1.02(1.00-1.04)  
3rd least deprived 88,094 536,367 164 (162-166) 
0.98(0.97-
1.00) 
 1.02(1.00-1.04)  
4th least deprived 101,536 651,511 156 (154-157) 
0.93(0.92-
0.95) 
 0.97(0.95-0.97)  
Most deprived 108,186 723,119 150 (148-151) 
0.89(0.88-
0.91) 
<0.001 0.94(0.92-0.96) <0.001 
Respiratory illness        





Present 128,675 54,2115 237 (235-240) 
1.67(1.66-
1.69) 
<0.001 1.79(1.76-1.81) <0.001 
Obstructive sleep 
apnoea 
       
Absent 474,861 2,986,318 159(158-160) 1 <0.001 1 <0.001 
Present 1,363 5,211 262(239-286) 
1.64(1.51-
1.80) 
 1.79(1.76-1.81)  
Obesity        
Not coded 463,220 2,954,201 157 (156-158) 1  1  
Obese 13,013 37,416 348 (338-358) 
2.22(2.15-
2.29) 
<0.001 2.00(1.93-2.08) <0.001 
HIV status        
HIV negative 18204 2100000 159 (158-160) 1  1  
HIV positive 52 4346 214 (196-234) 
1.35(1.23-
1.47) 
<0.001 1.30(1.17-1.45) <0.001 
Eating disorder        





Eating disorder 3,441 10,590 325 (307-343) 
2.05(1.94-
2.17) 
<0.001 1.88(1.76-2.01) <0.001 
Practice region        
North East 2,936 22,103 133 (125-141) 1  1  
North West 82,343 477,419 172 (171-174) 
1.30(1.22-
1.38) 
 1.23(1.15-1.32)  
Yorkshire & The 
Humber 
21,675 137,260 158 (154-161) 
1.19(1.12-
1.27) 
 1.14(1.06-1.23)  
East Midlands 20,633 117,059 176 (172-180) 
1.33(1.25-
1.41) 
 1.32(1.22-1.42)  
West Midlands 69,561 377,557 184 (182-187) 
1.39(1.31-
1.47) 
 1.37(1.27-1.47)  
East of England 65,962 403,374 164 (161-166) 
1.23(1.16-
1.31) 
 1.24(1.16-1.34)  
South West 52,192 356,662 146 (144-148) 
1.10(1.04-
1.17) 
 1.07(0.99-1.15)  
South Central 47,103 360,151 131 (129-132) 
0.98(0.93-
1.05) 





London 59,959 399,297 151 (148-152) 
1.13(1.07-
1.20) 
 1.17(1.09-1.26)  
South East Coast 53,869 340,734 158 (156-160) 
1.19(1.12-
1.27) 






Table 37 Univariable and Multivariable multilevel Poisson analyses of recurring sore throat (as measured by 3 GP sore throat consultations in 1 year) in children from CALIBER database 
Analysis of Rec. sore throat in children 
Characteristic Rate date Univariable analysis Multivariable analysis 
 








P Adjusted IRR P 





Male 8303 1,467,697 62.2(60.9-63.4) 1 <0.001 1 <0.001 
Female 9953 1,457,505 81.6(80.0-83.1) 1.31(1.28-1.35)  1.40(1.36-1.45)  
Age category        
0-4 years 4871 466,907 
104.3(101.4-
109.3) 
1 <0.001 1 <0.001 
5-15 years 16,141 2,458,295 65.7(64.7-66.7) 0.63(0.61-0.65)  0.64(0.62-0.67)  
Ethnic origin        
White British 9,715 1,036,277 93.7(91.9-95.6) 1 <0.001 1  
Indian 104 15,562 66.8(55.1-81.0) 
0.70 (0.58- 
0.86) 
 0.67(0.55- 0.82)  
Black African 66 14,785 44.6(35.1-56.8) 
0.44 (0.35- 
0.57) 
 0.42(0.33- 0.54)  
Black Caribbean 50 11,040 45.3(34.3-59.8) 
0.49 (0.37- 
0.65) 
 0.50(0.38- 0.67)  
Black other 56 9,680 57.8(44.5-75.2) 
0.62 (0.47- 
0.82) 










 1.12(0.84-1.48)  





 0.90(0.76- 1.06)  
Other Asian 64 7,534 77.4(60.6-98.8) 
0.77 (0.60- 
0.98) 
 0.70(0.54- 0.90)  
Chinese 13 8,273 37.7(21.9-65.0) 
0.35 (0.20- 
0.64) 
 0.38(0.21- 0.68)  
Mixed 105 3,446 49.8(41.1-60.3) 
0.48 (0.39- 
0.58) 
 0.45(0.37- 0.55)  
Other 190 21,098 73.8(64.0-85.1) 
0.79 (0.79- 
0.91) 
 0.79(0.68- 0.92)  
Unknown 3,542 25,737 74.2(71.8-76.6) 
0.78 (0.75- 
0.81) 
 0.83(0.80- 0.87)  
Social Deprivation        
Least deprived 3671 483,133 75.9(73.6-78.5) 1 <0.001 1 <0.001 





3rd least deprived 4099 523,682 78.3(75.9-80.7) 1.03(0.99-1.08)  1.06(0.01-1.12)  
4th least deprived 4397 637,016 69.0(67.0-71.1) 0.91(0.99-1.08)  0.93(0.88-0.98)  
Most deprived 4586 708,304 64.7(62.9-66.6) 0.85(0.82-0.89)  0.89(0.84-.094)  
Respiratory illness        
Absent 14669 2,404,546 61.0(60.0-62.0) 1 <0.001 1 <0.001 
Present 6343 520,656 
121.8(118.9-
124.9) 
2.00(1.94-2.06)  2.03(1.95-2.10)  
Obstructive sleep 
apnoea 
       
Absent 20,926 2,920,327 71.7(70.7-72.6) 1  1 <0.001 
Present 86 4,875 
176.4(142.8-
217.9) 
2.46(1.99-3.04) <0.001 2.10(1.69-2.63)  
Obesity        
Not coded 20,289 2,889,942 70.2(69.2-71.2) 1 <0.001 1 <0.001 
Obese 723 35,259 
205.1(190.6-
220.6) 
2.92(2.71-3.15)  2.31(2.12-2.53)  





HIV negative 20,955 2,919,423 71.8(70.8-72.8) 1 0.03 - - 
HIV positive 57 5,959 
95.7(73.8-
124.0) 
1.33(1.03-1.73)  -  
Eating disorder        
Absent 20,823 2,915,165 71.4(70.5-72.4) 1 <0.001 1 <0.001 
Eating disorder 189 10,037 
188.3(163.3-
217.2) 
2.64(2.28-3.04)  2.30(1.95-2.70)  
Practice region        
North East 105 21,729 48.2(39.9-58.5) 1 <0.001 1 <0.001 
North West 3,699 465,631 79.4(76.9-82.0) 
1.64 (1.33- 
2.01) 
 1.41(1.11- 1.78)  
Yorkshire & The 
Humber 
1,026 134,118 76.5(72.0-81.3) 
1.56 (1.26- 
1.94) 
 1.42(1.13-1.79)  
East Midlands 983 113,987 86.2(81.0-91.8) 
1.86 (1.50- 
2.31) 
 1.65(1.31-2.08)  
West Midlands 3,174 367,061 86.5(83.5-89.5) 
1.80 (1.46- 
2.22) 





East of England 2,935 393,646 74.6(71.9-77.3) 
1.55 (1.26- 
1.91) 
 1.49(1.17- 1.88)  
South West 2,241 349,903 64.0(61.4-66.8) 
1.25 (1.01- 
1.54) 
 1.11(0.88- 1.41)  
South Central 1,884 354,759 53.1(50.8-55.6) 
1.05 (0.85- 
1.30) 
 1.01(0.79- 1.28)  
London 2,552 391,228 65.2(62.7-67.8) 
1.29 (1.05- 
1.59) 
 1.29(1.01- 1.63)  
South East Coast 2,413 333,141 72.4(69.6-75.4) 
1.48 (1.20- 
1.83) 
 1.49(1.18- 1.89)  
 
 
Table 38Univariable and Multivariable multilevel Poisson analyses of tonsillectomy in children from CALIBER database 
Analysis of tonsillectomy in children 











P Adjusted IRR P 
Gender        
Male 3077 1,337,792 2.3(2.2-2.4) 1 0.15 1 <0.001 
Female 2847 1,284,218 2.2(2.1-2.3) 
0.96(0.92-
1.01) 
 1.10(1.05-1.16)  
Age category        
0-4 years 208 338,542 0.6(0.5-0.7) 1 <0.001 1 <0.001 
5-15 years 5716 2,283,468 2.5(2.4-2.7) 
4.07(3.55-
4.68) 
 5.34(4.64-6.15)  
Ethnic origin        
White British 4171 935,992 4.5(4.3-4.6) 1 <0.001 1 <0.001 
Indian 53 14,903 3.6(2.7-4.6) 
0.80(0.61-
1.04) 
 0.86(0.66-1.13)  
Black African 41 14,478 2.8(2.1-3.8) 
0.64(0.47-
0.86) 





Black Caribbean 25 10,518 2.4(1.6-3.5) 
0.53(0.36-
0.79) 
 0.50(0.34-0.74)  
Black other 37 9,240 4.0(2.9-5.5) 
0.90(0.65-
1.24) 
 0.86(0.62-1.20)  
Bangladeshi 12 4,186 2.9(1.6-5.0) 
0.64(0.37-
1.12) 
 0.61(0.35-1.06)  
Pakistani 69 14,273 4.8(3.8-6.1) 
1.08(0.86-
1.37) 
 1.01(0.80-1.28)  
Other Asian 29 8,164 3.6(2.5-5.1) 
0.80(0.56-
1.14) 
 0.94(0.65-1.34)  
Chinese 6 3,292 1.8(0.8-4.0) 
0.41(0.19-
0.90) 
 0.47(0.21-1.04)  
Mixed 72 20,228 3.6(2.9-4.5) 
0.80(0.64-
1.00) 
 0.92(0.73-1.16)  
Other 97 24,653 3.9(3.2-4.8) 
0.88(0.72-
1.08) 
 0.89(0.73-1.08)  
Unknown 1312 442,812 3.0(2.8-3.1) 
0.66(0.63-
0.71) 





Social Deprivation        
Least deprived 1197 436,424 2.7(2.6-2.9) 1 <0.001 1 <0.001 
2nd least deprived 1323 498,228 2.7(2.5-2.8) 
0.97(0.90-
1.05) 
 0.98(0.90-1.06)  
3rd least deprived 1112 467,952 2.4(2.2-2.5) 
0.87(0.80-
0.94) 
 0.88(0.81-0.96)  
4th least deprived 1145 569,515 2.0(1.9-2.1) 
0.73(0.68-
0.79) 
 0.76(0.70-0.82)  
Most deprived 1109 635,545 1.7(1.6-1.9) 
0.64(0.59-
0.69) 
 0.68(0.62-0.74)  
Respiratory illness        
Absent 4290 2,202,847 1.9(1.9-2.0) 1 <0.001 1 <0.001 
Present 1634 419,163 3.9(3.7-4.1) 
2.00(1.90-
2.12) 
 1.50(1.42-1.59)  
Obstructive sleep 
apnoea 
       





Present 199 4681 42.5(37.9-47.6) 
19.44(17.30-
21.84) 
 10.99(9.7-12.40)  
Obesity        
Not coded 5777 2,598,203 2.2(2.2-2.3) 1 <0.001 1 <0.001 
Obese 147 23,807 2.2(2.2-2.3) 
2.78(2.37-
3.26) 
 1.96(1.66-2.30)  
HIV status        
HIV negative 5905 2,616,617 2.3(2.2-2.3) 1 0.05 -  
HIV positive 19 5,393 3.5(2.3-5.5) 
1.56(1.00-
2.43) 
 -  
Eating disorder        
Absent 5888 2,615,131 2.3(2.2-2.3) 1 <0.001 1 0.01 
Eating disorder 36 6,879 5.2(3.8-7.2) 
2.32(1.1.69-
3.20) 
 1.54(1.13-2.12)  
Practice region        





North West 1065 406,526 2.6(2.5-2.8) 
2.13(1.42-
3.18) 
 1.92(1.30-2.84)  
Yorkshire & The 
Humber 
289 119,881 2.4(2.2-2.7) 
1.96(1.29-
2.96) 
 1.80(1.20-2.69)  
East Midlands 358 100,056 3.6(3.2-4.0) 
2.90(1.92-
4.38) 
 3.04(2.04-4.54)  
West Midlands 747 324,145 2.3(2.1-2.5) 
1.87(1.25-
2.80) 
 2.01(1.35-2.97)  
East of England 818 351,442 2.3(2.2-2.5) 
1.89(1.26-
2.83) 
 2.27 (1.53-3.36)  
South West 667 313,216 2.1(2.0-2.3) 
1.73(1.15-
2.59) 
 1.72(1.16-2.55)  
South Central 566 321,555 1.8(1.6-1.9) 
1.43(0.95-
2.15) 
 1.77(1.19-2.63)  
London 620 364,800 1.7(1.6-1.8) 
1.38(0.92-
2.07) 
 1.87(1.26-2.78)  
South East Coast 770 300,909 2.6(2.4-2.7) 
2.08(1.39-
3.11) 









Table 39 Univariable and Multivariable multilevel Poisson analyses of GP sore throat consultation in adults 16-44 years old  from CALIBER database 
 
Analysis of sore throat in adults 
 
Characteristic 










P Adjusted IRR P 
Gender        
Male 238,255 3,897,287 61(61-61) 1 <0.001 1 <0.001 
Female 462,300 3,835,896 121(120-121) 1.97(1.96-1.99)  1.75(1.71-1.79)  





16-24 years 268,000 2,316,067 116(115-116) 1 <0.001 1 <0.001 
25-44 years 432,555 5,417,116 80(80-80) 0.69(0.69-0.70)  0.51(0.49-0.52)  
Ethnic origin        
White British 321,006 2,662,499 121(120-122) 1 <0.001 1 <0.001 
Indian 4,681 41,891 112(107-116) 0.93(0.89-0.97)  1.06(0.98-1.14)  
Black African 3,020 33,515 90(86-95) 0.75(0.71-0.79)  0.83(0.72-0.95)  
Black Caribbean 2,617 26,503 99(93-105) 0.82(0.77-0.87)  0.87(0.79-0.97)  
Black other 1,771 19,983 89(83-95) 0.74(0.69-0.79)  0.85(0.75-0.95)  
Bangladeshi 1,028 8,297 124(113-136) 1.03(0.94-1.13)  1.12(0.97-1.29)  
Pakistani 4,012 28,491 141(134-148) 1.17(1.11-1.23)  1.22(1.13-1.32)  
Other Asian 1,752 17,802 98(92-105) 0.82(0.76-0.88)  0.97(0.86-1.10)  
Chinese 772 9,982 77(68-86) 0.64(0.58-0.71)  0.78(0.68-0.90)  
Mixed 2,146 21,632 99(93-106) 0.82(0.77-0.88)  0.80(0.71-0.89)  
Other 5,718 55,433 103(99-107) 0.86(0.82-0.89)  0.99(0.93-1.05)  
Unknown 100,938 937,737 107(107-109) 0.89(0.88-0.90)  0.96(0.93-0.98)  
Social Deprivation        





2nd least deprived 138,642 1,565,682 89(88-90) 1.00(0.99-1.01)  1.01(0.95-1.07)  
3rd least deprived 133,300 1,455,246 92(91-92) 1.03(1.02-1.04)  1.02(0.95-1.10)  
4th least deprived 154,525 1,697,991 91(90-92) 1.03(1.01-1.04)  1.02(0.95-1.10)  
Most deprived 161,441 1,745,740 92(92-93) 1.04(1.03-1.05)  1.09(1.00-1.19)  
Respiratory illness        
Absent 525,725 6,268,955 84(84-84) 1 <0.001 1 <0.001 
Present 174,830 1,454,228 119(119-120) 1.42(1.41-1.44)  1.26(1.23-1.29)  
Obstructive sleep 
apnoea 
       
Absent 698,256 7,717,586 90(90-91) 1 <0.001 1 <0.001 
Present 2,299 15,597 147(139-157) 1.63(1.53-1.73)  1.45(1.31-1.61)  
Obesity        
Not coded 626,511 7,266,361 86(86-87) 1 <0.001 1 <0.001 
Obese 74,044 466,822 159(157-160) 1.84 (1.82-1.86)  1.45(1.26-1.43)  
HIV status        
HIV negative 697,306 7,707,937 90(90-91) 1 <0.001 1 <0.001 





Eating disorder        
Absent 691,868 7,668,696 90(89-91) 1 <0.001 - - 
Eating disorder 8,687 64,488 135(131-139) 1.49(1.45-1.54)  -  
Alcohol        
Non-drinker 101,557 920,847 110(109-111) 1 <0.001 1 <0.001 
Mild-Moderate 
drinker 
160,772 1,411,135 114(113-115) 1.03(1.02-1.05)  1.03(0.99-1.07)  
Heavy drinker 9,052 166,358 54(53-56) 0.49(0.48-0.51)  0.65(0.60-0.71)  
Smoking        
Non-Smoker 384,311 4,941,860 78(77-78) 1 <0.001 1 <0.001 
Ex-smoker 59,408 510,992 116(115-118) 1.49(1.48-1.51)  1.17(1.14-1.21)  
Smoker 256,836 2,280,331 113(112-113) 1.45(1.44-1.46)  1.10(1.08-1.12)  
Diabetes        
No Diabetes coded 690,038 7,661,056 90(88-90) 1 <0.001 1 <0.001 
Diabetes coded 10,517 72,127 146(142-150) 1.62(1.57-1.67)  1.20(1.15-1.26)  







668,963 7,524,266 89(89-89) 1 <0.001 1 <0.001 
Hypertension coded 31,592 208,917 151(149-154) 1.70(1.67-1.73)  1.44(1.39-1.50)  
Practice region        
North East 4,751 58,266 82(78-85) 1 <0.001 1 0.01 
North West 118,007 1,208,414 98(97-99) 1.20(1.15-1.25)  1.13(0.84-1.52)  
Yorkshire & The 
Humber 
32,244 354,395 91(89-93) 1.12(1.07-1.17)  1.07(0.77-1.49)  
East Midlands 30,143 297,100 101(100-103) 1.24(1.19-1.30)  1.18(0.86-1.61)  
West Midlands 101,554 966,445 105(104-106) 1.29(1.24-1.34)  1.23(0.92-1.64)  
East of England 98,107 1,043,158 94(93-95) 1.15(1.11-1.20)  1.14(0.83-1.54)  
South West 85,165 893,425 95(94-96) 1.17(1.12-1.22)  1.12(0.82-1.52)  
South Central 75,475 903,698 84(83-84) 1.02(0.98-1.07)  0.98(0.72-1.32)  
London 84,002 1,176,780 71(71-72) 0.88(0.84-0.91)  0.97(0.71-1.31)  







Table 40 Univariable and Multivariable multilevel Poisson analyses of recurring sore throat (measured by 3 GP GP sore throat consultation in 12 months) in adults 16-44 years old  from CALIBER 
database 
Analysis of rec sore throat in adults 
Characteristic Rate date Univariable analysis Multivariable analysis 
 








P Adjusted IRR P 
Gender        
Male 5,506 3,872,167 1.4(14-15) 1 <0.001 1 <0.001 
Female 14,917 3,773,283 4.0(39-40) 2.78(2.70-2.87)  1.98(1.82-2.15)  
Age category        
16-24 years 5,939 2,065,130 2.9(28-29) 1 <0.001 1 <0.001 
25-44 years 14,484 5,580,320 2.6(26-26) 0.90(0.88-0.93)  0.66(0.61-0.71)  
Ethnic origin        
White British 10,571 2,615,456 4.0(40-41) 1 <0.001 1 0.004 
Indian 144 41,331 3.5(30-41) 0.86(0.73-1.02)  0.95(0.74-1.23)  





Black Caribbean 62 26,239 2.4(18-30) 0.58(0.48-0.75)  0.61(0.45-0.83)  
Black other 50 19,807 2.5(19-33) 0.62(0.47-0.82)  0.78(0.58-1.03)  
Bangladeshi 37 8,179 4.5(33-62) 1.12(0.81-1.54)  1.14(0.75-1.73)  
Pakistani 141 27,984 5.0(43-59) 1.25(1.06-1.47)  1.18(0.99-1.40)  
Other Asian 63 17,626 3.6(30-46) 0.88(0.69-1.13)  1.04(0.74-1.45)  
Chinese 23 9,912 2.3(15-35) 0.57(0.38-0.86)  0.69(0.43-1.13)  
Mixed 72 21,367 3.4(27-42) 0.83(0.66-1.05)  0.92(0.69-1.24)  
Other 173 54,721 3.2(27-37) 0.78(0.67-0.91)  0.82(0.65-1.05)  
Unknown 3,063 924,495 3.3(32-34) 0.82(0.79-0.85)  0.89(0.82-0.96)  
Social Deprivation        
Least deprived 3,263 1,211,570 2.6(26-28) 1 0.69 -  
2nd least deprived 4,084 1,548,093 2.6(26-27) 0.98(0.94-1.03)  -  
3rd least deprived 3,906 1,438,275 2.7(26-28) 1.01(0.96-1.06)  -  
4th least deprived 4,446 1,678,797 2.6(26-27) 0.98(0.94-1.03)  -  
Most deprived 4,616 1,726,382 2.7(26-28) 0.99(0.95-1.04)  -  
Respiratory illness        





Present 5,992 1,437,050 4.2(41-43) 1.79(1.74-1.85)  1.53(1.44-1.63)  
Obstructive sleep 
apnoea 
       
Absent 20,350 7,630,143 2.7(26-27) 1 <0.001 1 <0.001 
Present 73 15,308 4.8(38-60) 1.79(1.42-2.25)  1.82(1.34-2.48)  
Obesity        
Not coded 17,880 7,190,495 2.5(25-25) 1 <0.001 1 <0.001 
Obese 2,543 454,956 5.6(54-58) 2.25(2.16-2.34)  1.55(1.40-1.71)  
HIV status        
HIV negative 20,323 7,620,653 2.7(26-27) 1 <0.001 -  
HIV positive 100 24,798 4.0(33-49) 1.51(1.24-1.84)  -  
Eating disorder        
Absent 20,123 7,582,251 2.7(26-27) 1 <0.001 -  
Eating disorder 300 63,199 4.7(42-53) 1.79(1.60-2.00)  -  
Alcohol        







4,881 1,388,452 3.5(34-36) 0.99(0.94-1.03)  0.94(0.87-1.01)  
Heavy drinker 299 165,285 1.4(12-16) 0.39(0.33-0.44)  0.48(0.40-0.58)  
Smoking        
Non-Smoker 10,877 4,896,800 2.2(22-23) 1 <0.001 1 0.003 
Ex-smoker 1,599 504,568 3.2(30-33) 1.43(1.35-1.50)  1.06(0.96-1.17)  
Smoker 7,947 2,244,082 3.5(35-36) 1.59(1.55-1.64)  1.12(1.06-1.18)  
Diabetes        
No Diabetes coded 20,115 7,574,558 2.7(26-27) 1 <0.001 -  
Diabetes coded 308 70,892 4.3(39-49) 1.64(1.46-1.83)  -  
Hypertension        
No hypertension 
coded 
19,534 7,440,058 2.6(26-27) 1 <0.001 1 <0.001 
Hypertension coded 889 205,392 4.3(41-46) 1.65(1.54-1.76)  1.26(1.13-1.41)  
Practice region        
North East 128 57,664 2.2(19-26) 1 <0.001 1 0.002 





Yorkshire & The 
Humber 
956 350,530 2.7(26-29) 1.23(1.02-1.48)  1.23(0.79-1.92)  
East Midlands 978 292,925 3.3(31-36) 1.50(1.25-1.81)  1.54(1.02-2.31)  
West Midlands 3,130 952,212 3.3(32-34) 1.48(1.24-1.77)  1.44(0.98-2.10)  
East of England 2,948 1,030,596 2.9(28-30) 1.29(1.08-1.54)  1.19(0.80-1.78)  
South West 2,507 882,597 2.8(27-30) 1.28(1.07-1.54)  1.18(0.79-1.78)  
South Central 2,019 895,430 2.3(22-24) 1.02(0.85-1.21)  0.89(0.60-1.32)  
London 2,246 1,168,208 1.9(18-20) 0.87(0.72-1.04)  1.01(0.67-1.51)  
South East Coast 1,970 823,582 2.4(23-25) 1.08(0.90-1.29)  1.03(0.69-1.54)  
 
Analysis of tonsillectomy in adults 
Characteristic Rate date Univariable analysis Multivariable analysis 






P Adjusted IRR P 
Gender        





Female 4,668 3,814,292 1.2(12-13) 2.20(2.09-2.31)  1.39(1.24-1.55)  
Age category        
16-24 years 3,771 2,079,749 1.8(18-19) 1 <0.001 1 <0.001 
25-44 years 3,059 5,620,736 0.5(5-6) 0.30(0.29-0.31)  0.16(0.14-0.17)  
Ethnic origin        
White British 5,115 2,640,103 1.9(19-20) 1 <0.001 1 <0.001 
Indian 43 41,677 1.0(8-14) 0.53(0.39-0.72)  0.85(0.54-1.34)  
Black African 22 33,444 0.7(4-10) 0.34(0.22-0.52)  0.40(0.23-0.69)  
Black Caribbean 30 26,378 1.1(8-16) 0.59(0.41-0.84)  0.66(0.37-1.18)  
Black other 20 19,922 1.0(6-16) 0.52(0.33-0.80)  0.53(0.28-0.99)  
Bangladeshi 16 8,257 1.9(12-32) 1.00(0.61-1.63)  1.63(1.01-2.64)  
Pakistani 35 28,355 1.2(9-17) 0.64(0.46-0.89)  0.85(0.52-1.40)  
Other Asian 23 17,735 1.3(9-20) 0.67(0.44-1.00)  1.16(0.50-2.72)  
Chinese 5 9,965 0.5(2-12) 0.26(0.11-0.62)  0.57(0.21-1.52)  
Mixed 42 21,487 2.0(14-26) 1.01(0.74-1.37)  0.79(0.50-1.27)  
Other 64 55,178 1.2(9-15) 0.60(0.47-0.77)  0.57(0.39-0.85)  





Social Deprivation        
Least deprived 1,125 1,220,412 0.9(9-10) 1 <0.001 1 0.67 
2nd least deprived 1,553 1,558,538 1.0(9-10) 1.08(1.00-1.17)  1.07(0.93-1.21)  
3rd least deprived 1,349 1,448,632 0.9(9-10) 1.01(0.93-1.09)  1.05(0.91-1.20)  
4th least deprived 1,427 1,690,967 0.8(8-9) 0.92(0.85-0.99)  1.11(0.97-1.27)  
Most deprived 1,347 1,739,316 0.7(7-8) 0.84(0.77-0.91)  1.06(0.92-1.22)  
Respiratory illness        
Absent 4,955 6,245,702 0.8(8-8) 1 <0.001 1 <0.001 
Present 1,875 1,454,784 1.3(12-13) 1.62(1.54-1.71)  1.18(1.07-1.29)  
Obstructive sleep 
apnoea 
       
Absent 6,776 7,685,079 0.9(9-9) 1 <0.001 1 <0.001 
Present 54 15,406 3.5(27-46) 3.98(3.04-5.20)  2.59(1.59-4.23)  
Obesity        
Not coded 6,083 7,237,423 0.8(8-9) 1 <0.001 1 <0.001 
Obese 747 463,063 1.6(15-17) 1.92(1.78-2.07)  1.58(1.39-1.80)  





HIV negative 6,805 7,675,332 0.9(9-9) 1 0.57 -  
HIV positive 25 25,153 1.0(7-15) 1.12(0.76-1.66)  -  
Eating disorder        
Absent 6,732 7,636,454 0.9(9-9) 1 <0.001 -  
Eating disorder 98 64,031 1.5(13-19) 1.74(1.42-2.12)  -  
Alcohol        
Non-drinker 880 916,718 1.0(9-10) 1 <0.001 1 <0.001 
Mild-Moderate 
drinker 
1,513 1,404,039 1.1(10-11) 1.12(1.03-1.22)  1.26(1.14-1.40)  
Heavy drinker 71 166,006 0.4(3-5) 0.45(0.35-0.57)  0.61(0.47-0.78)  
Smoking        
Non-Smoker 3,385 4,925,188 0.7(6-7) 1 <0.001 1 <0.001 
Ex-smoker 527 508,724 1.0(10-11) 1.51(1.38-1.65)  1.45(1.24-1.69)  
Smoker 2,918 2,266,573 1.3(12-13) 1.87(1.78-1.97)  1.30(1.20-1.42)  
Diabetes        
No Diabetes coded 6,755 7,628,751 0.9(9-9) 1 0.15 -  





Hypertension        
No hypertension 
coded 
6,618 7,492,583 0.9(9-9) 1 0.04 -  
Hypertension coded 212 207,902 1.0(9-12) 1.15(1.01-1.32)  -  
Practice region        
North East 63 57,950 1.1(8-14) 1 <0.001 1 0.38 
North West 1317 1,201,895 1.1(10-12) 1.01(0.78-1.30)  0.88(0.57-1.38)  
Yorkshire & The 
Humber 
382 352,544 1.1(10-12) 1.00(0.76-1.30)  0.97(0.59-1.59)  
East Midlands 338 295,318 1.3(12-15) 1.21(0.93-1.58)  1.23(0.75-2.02)  
West Midlands 886 961,959 0.9(9-10) 0.85(0.66-1.09)  0.91(0.59-1.40)  
East of England 904 1,038,785 0.9(8-9) 0.80(0.62-1.03)  0.92(0.59-1.45)  
South West 910 888,995 1.0(10-11) 0.94(0.73-1.22)  0.89(0.58-1.39)  
South Central 673 900,495 0.7(7-8) 0.69(0.53-0.89)  0.90(0.56-1.42)  
London 597 1,174,248 0.5(5-6) 0.47(0.36-0.61)  0.78(0.50-1.22)  






Comparison of risk factors across settings, from sore throat in primary care through to tonsillectomy in secondary care 














Gender       
Male 1 1 1 1 1 1 
Female 1.24(1.23-1.26) 1.40(1.36-1.45) 1.10(1.05-1.16) 1.75(1.71-1.79) 1.98(1.82-2.15) 1.39(1.24-1.55) 
Age category       
0-4 years 1 1 1 - - - 
5-15 years 0.55(0.55-0.56) 0.64(0.62-0.67) 5.34(4.64-6.15) - - - 
16-24 years - - - 1 1 1 
25-44 years - - - 0.51(0.49-0.52) 0.66(0.61-0.71) 0.16(0.14-0.17) 
Ethnic origin       
White British 1 1 1 1 1 1 
Indian 0.87(0.82-0.93) 0.67(0.55- 0.82) 0.86(0.66-1.13) 1.06(0.98-1.14) 0.95(0.74-1.23) 0.85(0.54-1.34) 
Black African 0.63(0.59-0.68) 0.42(0.33- 0.54) 0.71(0.52-0.97) 0.83(0.72-0.95) 0.68(0.44-1.03) 0.40(0.23-0.69) 





Black other 0.69(0.63-0.75) 0.61(0.47- 0.81) 0.86(0.62-1.20) 0.85(0.75-0.95) 0.78(0.58-1.03) 0.53(0.28-0.99) 
Bangladeshi 1.01(0.90-1.13) 1.12(0.84-1.48) 0.61(0.35-1.06) 1.12(0.97-1.29) 1.14(0.75-1.73) 1.63(1.01-2.64) 
Pakistani 0.96(0.91-1.02) 0.90(0.76- 1.06) 1.01(0.80-1.28) 1.22(1.13-1.32) 1.18(0.99-1.40) 0.85(0.52-1.40) 
Other Asian 0.82(0.75-0.89) 0.70(0.54- 0.90) 0.94(0.65-1.34) 0.97(0.86-1.10) 1.04(0.74-1.45) 1.16(0.50-2.72) 
Chinese 0.72(0.62-0.82) 0.38(0.21- 0.68) 0.47(0.21-1.04) 0.78(0.68-0.90) 0.69(0.43-1.13) 0.57(0.21-1.52) 
Mixed 0.67(0.63-0.71) 0.45(0.37- 0.55) 0.92(0.73-1.16) 0.80(0.71-0.89) 0.92(0.69-1.24) 0.79(0.50-1.27) 
Other 0.85(0.81-0.89) 0.79(0.68- 0.92) 0.89(0.73-1.08) 0.99(0.93-1.05) 0.82(0.65-1.05) 0.57(0.39-0.85) 
Unknown 0.92(0.90-0.93) 0.83(0.80- 0.87) 0.62(0.58-0.66) 0.96(0.93-0.98) 0.89(0.82-0.96) 0.79(0.70-0.89) 
Social Deprivation       
Least deprived 1 1 1 1 - 1 
2nd least deprived 1.02(1.00-1.04) 1.03(0.97-1.08) 0.98(0.90-1.06) 1.01(0.95-1.07) - 1.07(0.93-1.21) 
3rd least deprived 1.02(1.00-1.04) 1.06(0.01-1.12) 0.88(0.81-0.96) 1.02(0.95-1.10) - 1.05(0.91-1.20) 
4th least deprived 0.97(0.95-0.97) 0.93(0.88-0.98) 0.76(0.70-0.82) 1.02(0.95-1.10) - 1.11(0.97-1.27) 
Most deprived 0.94(0.92-0.96) 0.89(0.84-.094) 0.68(0.62-0.74) 1.09(1.00-1.19) - 1.06(0.92-1.22) 
Respiratory illness       
Absent 1 1 1 1 1 1 







      
Absent 1 1 1 1 1 1 
Present 1.79(1.76-1.81) 2.10(1.69-2.63) 10.99(9.7-12.40) 1.45(1.31-1.61) 1.82(1.34-2.48) 2.59(1.59-4.23) 
Obesity       
Not coded 1 1 1 1 1 1 
Obese 2.00(1.93-2.08) 2.31(2.12-2.53) 1.96(1.66-2.30) 1.45(1.26-1.43) 1.55(1.40-1.71) 1.58(1.39-1.80) 
HIV status       
HIV negative 1 - - 1 - - 
HIV positive 1.30(1.17-1.45) - - 1.37(1.24-1.51) - - 
Eating disorder       
Absent 1 1 1 - - - 
Eating disorder 1.88(1.76-2.01) 2.30(1.95-2.70) 1.54(1.13-2.12) - - - 
Alcohol - - -    
Non-drinker - - - 1 1 1 
Mild-Moderate 
drinker 





Heavy drinker - - - 0.65(0.60-0.71) 0.48(0.40-0.58) 0.61(0.47-0.78) 
Smoking - - -    
Non-Smoker - - - 1 1 1 
Ex-smoker - - - 1.17(1.14-1.21) 1.06(0.96-1.17) 1.45(1.24-1.69) 
Smoker - - - 1.10(1.08-1.12) 1.12(1.06-1.18) 1.30(1.20-1.42) 
Diabetes - - -    
No Diabetes coded - - - 1 - - 
Diabetes coded - - - 1.20(1.15-1.26) - - 
Hypertension - - -    
No hypertension 
coded 
- - - 1 1 - 
Hypertension 
coded 








Appendix E Search strategy for tonsillectomy outcomes 
 
Pubmed 
1. “Tonsillectomy” [Mesh] OR tonsillectom* [ti] OR tonsilectom* [ti] OR adenotonsillectom* [ti] OR adeno-tonsillectom* [ti] 
2. "Palatine Tonsil/surgery"[Mesh] 
3. (Tonsil* [ti] OR adenotonsil* [ti]) AND (SURG* [ti] OR OPERAT* [ti] OR EXCIS* [ti] OR EXTRACT* [ti] OR REMOV* [ti] OR DISSECT* [ti] OR 
ABLAT* [ti] OR COBLAT* [ti] OR LASER* [ti]) 
4. #1 OR #2 OR #3 
EMBASE (Ovid) 
1. exp *tonsillectomy/ 
2. exp tonsil/su [Surgery] 
3. (tonsillectom* or tonsilectom* or adenotonsillectom* or adeno-tonsillectom*).ti. 
4..((Tonsil* or adenotonsil*) and (SURG* or OPERAT* or EXCIS* or EXTRACT* or REMOV* or DISSECT* or ABLAT* or COBLAT* or LASER*)).ti. 






S1 (MH "Tonsillectomy") 
S2 TI tonsillectom* OR tonsilectom* OR adenotonsillectom* OR adeno-tonsillectom* 
S3 TI (tonsil* OR adenotonsil*) AND (surg* OR laser* OR extract* OR resect* OR excis* OR operat* OR dissect* OR remov* OR coblat* OR 
ablat*) 








Appendix F – Critical appraisal of tonsillectomy outcome studies using CASP and Summary 
 
Outcome: Days of sore throat 
Type of study: Meta-analysis Year of publication: 2014 
What did the study involve? Meta-analysis of 2 RCTs investigating effectiveness of tonsillectomy in adults with recurring tonsillitis.  
What was the risk of bias? Inappropriate selection of patients (heterogenous), insufficient follow up (only 6 months) 
What were the results? Pooled mean difference for number of days with sore throat in a follow-up period of about six months was 10.6 days 
fewer in favour of the group receiving surgery (95% CI 5.8 fewer to 15.8 fewer).  
Are the results relevant to my study? The definition used for recurring sore throat (3 episodes of pharyngitis in 6 months or 3 episodes of 
streptococcal pharyngitis in 12 months) seems less stringent to the one I used (7 cases of self-reported tonsillitis in 12 months, or 5 
episodes/year over 2 years or 3 episodes/year over 3 years).  
Outcome: Episodes of sore throat 
Type of study: Meta-analysis  
Year of publication: 2014 





What was the risk of bias? Inappropriate selection of patients (heterogenous), insufficient follow up (only 6 months) 
What were the results? The pooled results of the two adult studies (n=156) showed there were 3.6 fewer sore throat episodes in the group 
receiving tonsillectomy in the first 6 months after treatment (95% CI 7.9 fewer to 0.70 more). 
Are the results relevant to my study? The definition used for recurring sore throat (3 episodes of pharyngitis in 6 months or 3 episodes of 
streptococcal pharyngitis in 12 months) seems less stringent to the one I used (7 cases of self-reported tonsillitis in 12 months, or 5 
episodes/year over 2 years or 3 episodes/year over 3 years).  
Outcome: Quality of life 
Type of study: Systematic review  
Year of publication: 2013 
What did the study involve? Review eight studies investigating the role of tonsillectomy on the quality of life for adults with recurring 
tonsillitis.  
What was the risk of bias? The review authors used only two search engines to identify studies and as a result missed two further studies 
identified through my search strategy (Powell, Skevas). The reported results are based on studies with very low response rates (4 studies had 
less than 50% response rate) and the implication on selection bias. Considerable heterogeneity between studies 
What were the results? Six used the Glasgow Benefit inventory (GBI) and two used Short Form questionnaires (SF12 and SF36). The GBI scale 





administered only once. Six studies that used this tool had between 47 and 187 participants with response rates of 30-89%. Total GBI scores 
ranged from 15.78 to 35.2. Finally, the ages of participants varied considerably from 15-25 or 15-60. One study used the SF36 at one year after 
tonsillectomy whilst another used the SF12 at 6 and 12 months after tonsillectomy. Response rates were between 97% and 56%. Studies 
reported an improvement in the physical component of quality of life (7.6-10.1).  
Are the results relevant to my study? Definitions of recurring/chronic tonsillitis (e.g. 3 episodes in 12 months) were not always similar to those 
used in my study (e.g. 7episodes in 12 months).  
Outcome: GP visits for sore throat 
Type of study: RCT  
Year of publication: 2012 
What did the study involve? Randomised controlled trial of 86 adults with recurring pharyngitis and reported on GP visits as a secondary 
outcome. 
What was the risk of bias? Authors used GP visits as a secondary outcome. This was measured through participant self-reports on days off 
work, upto 5 months after randomisation. The authors do not comment as to whether they were powered to study this. 
What were the results? Four percent pf participants who had a tonsillectomy visited their GP for pharyngitis whereas 43% of the control group 





Are the results relevant to my study? This study was conducted on a Finnish population of patients 13 years and older with recurring 
pharyngitis (>2 episodes in 12 months) and care must be taken when translating the findings to our population of interest (that is adults over 
15 from England who had 7 episodes of tonsillitis over the preceding year). Different healthcare systems could affect whether illness results in 
GP visits and care must be taken in interpreting these results for our study population.  
Outcome: Snoring reduction 
Type of study: Retrospective cohort study 
Year of publication: 2008 
What did the study involve? Cohort comprised of 460 adults recruited from ENT clinics (family members of patients) and hospital employee 
lists. Respondents were asked to recall if they had had a tonsillectomy and whether they currently snore. The authors chose to define their 
cases – habitual snorers – as those who reported their frequency of snoring as always or every night. The graded habitual snoring severity as 
mild, moderate (rarely irritates other people), or severe (roommates choose to sleep in another room). They graded the risk of being a habitual 
snorer of participants who’d had a tonsillectomy compared to those who hadn’t.  
What was the risk of bias? Description of the cohort recruitment is not supplied and therefore it is difficult to conclude on the suitability of 
their recruitment method. Especially, since more than half of their cohort had received a tonsillectomy, which is much higher than in the 
general population.  This data was recorded from patient subjective reports and may not be as accurate as data collected from patient health 





What were the results? After the authors controlled for confounding factors such as age, sex, and body mass index, they found that not 
receiving a tonsillectomy increased the risk of being a habitual snorer (OR 1.18, 95% CI 1.15-2.86).  
Are the results relevant to my study? This study using Turkish adults (18 and over), sourced from ENT clinics and hospitals, who had a 50% 
prevalence rate of tonsillectomy in their population, do not seem comparable to the UK general public, where the rate is less than half that.  
Outcome: Change in voice 
Type of study: Case-control 
Year of publication: 2009 
What did the study involve? Cases were recruited from the local hospital, whilst controls were recruited from a nearby school at a ratio of 1:2. 
Controls were age and sex matched to cases. The authors used objective measures of voice: fundamental frequency, jitter, shimmer, 
harmonic, noise ratio, long-term average spectrum, and nasalance, which were assessed preoperatively and 4 weeks after tonsillectomy in the 
case-group and once only in the control group. 
What was the risk of bias? There was no mention of criteria used to select cases, or what the recruitment rate was. Additionally, the age 
structure of the respondents is not reported. Loss to follow up numbers aren’t reported.   
What were the results?  The authors reported that whilst hypernasality reduced after tonsillectomy, compared to preoperative readings, there 
was no statistical difference in any component of voice measured between pre-operative and post-operative measurements, or between 





Are the results relevant to my study? This is an Indian population with no report of how cases were selected so applicability to our dataset is 
difficult to interpret.  
 
Outcome: Immunological profile 
Type of study: Case series 
Year of publication: 1996 
What did the study involve? The population randomly recruited included adults listed for a tonsillectomy to treat recurring or chronic tonsillitis 
in the local Finnish ENT department. Authors measured pre-operative saliva to quantify markers of immunity. Post-operatively the authors 
took saliva samples at 1 and 6 months after tonsillectomy.  
What was the risk of bias? Selection bias as the patients were not sequentially recruited. Detection bias as measurement used may miss 
significant change in immune system – that is increased rate of infections. 
What were the results? Authors analysed saliva for selected host defence factors, representing both immune (total IgA, IgG, IgM, anti-
Streptococcus mutans, anti-EBV, anti-CMV, and anti-adenovirus IgA and IgG) and nonimmunoglobulin (lysozyme, lactoferrin, salivary 
peroxidases, thiocyanate, hypothiocyanite, and agglutinins) mediators. Following tonsillectomy, a significant (P < 0.04) reduction was observed 
in specific IgG antibodies, suggesting that tonsils participate in local IgG response to oral antigens. Total IgM levels also decreased (P< 0.006), 





nonimmunoglobulin host defence factors, except lactoferrin, which declined significantly, remained normal throughout the study period. The 
authors concluded that tonsillectomy does not seem to lead to any significant long-term impairment of salivary defence capacity.  
Are the results relevant to my study? There is insufficient evidence on the study sample to make reasonable judgments about the 
generalisability of their results to our study population. Additionally, the lack of clinical correlation with their findings makes the translation of 
this information for our study population almost meaningless.  
Outcome: Haemorrhage risk 
Type of study: Case series 
Year of publication: 2005 
What did the study involve? The Royal College of Surgeons of England undertook an audit of all tonsillectomies undertaken in England and 
Northern Ireland between 2002-2004 to ascertain complication rates. This national audit that captured nearly every tonsillectomy undertaken 
in England between 2002-2004 and included 76% of all tonsillectomies undertaken that during that period (i.e. 33,921 patients). 
What was the risk of bias? Detection bias as it is unable to define how many patients managed post-tonsillectomy bleeding without hospital 
presentation. 
What were the results? The report suggested that there was an overall post-operative haemorrhage rate of 3.5%.  






Type of study: Case series 
Year of publication:  
What did the study involve? The study recruited 44 patients with halitosis and chronic tonsillitis. The authors measured halitosis at 4 and 8 
weeks post-operatively using Finklesteins test.  
What was the risk of bias? Selection bias as no report of how patients were selected. Detection bias as test surgeon who performed operation 
is subjectively reporting whether tonsillectomy improved halitosis.  
What were the results? He used subjective measures of halitosis at 4 and 8 weeks following tonsillectomy and reported 79.5% of patients 
reported improved symptoms.   
Are the results relevant to our study? Nigerian population with no description of cohort or inclusion criteria to difficult to ascertain relevance 
to our population.  
Outcome: Taste 
Type of study: Case series  





What did the study involve? The authors recruited 60 adults who did not have a history of olfactory or gustatory disorder. The authors tested 
patients’ ability to discriminate between four tastants on four different regions of the tongue on the 1st post-operative day, 15 days and then 
again at one month.  
What was the risk of bias? Selection bias as patients were not reported as consecutive.  Detection bias as insufficient follow up to define true 
incidence of complication 
What were the results? The final evaluation, 1 month postoperatively, yielded normal results for all the patients except one. Presentation of 
low stimulus quantities resulted in recognition percentages of 95%, while higher stimulus quantities elicited correct responses by all of the 
patients, except one. Results were not reported with measures of precision (standard error, confidence intervals), which brings their reliability 
into question.  
Are the results relevant to our study? Greek population therefore may be different from our study population. 
Outcome: Societal cost 
Type of study: Economic  
Year of publication: 2002 
What did the study involve? This study used a postal survey methodology to assess economic burden. This study used the Glasgow Benefit 
Inventory (GBI) to measure quality of life and thus calculate quality adjusted life years. The study used the costs of surgery, antibiotics, work 






What was the risk of bias? The authors report an extremely low response rate (response rate<30%), and care should be taken in interpreting 
results due to selection bias 
Are the results relevant to our study? The authors reported that for adults with recurring tonsillitis, tonsillectomy has a high up-front cost, but 
within 2.3 years there is no difference in costs between having and not having the operation. 
Are the results relevant to our study? This study conducted on adults with recurring tonsillitis in USA depends, calculates its results based on 
local healthcare costs. There is considerable difference in healthcare costs between England and USA, and the results are not easily 








List of factors 
Type of study (level of 
evidence) 
Specific (non-standardised) effect size 
Standardised 
Effect small/med/large 
Potential impact on decision 
making 
Days of sore throat(54) 
Meta-analysis of RCT 
(1a) 
3.61/6months 1. large 1. Strong 
Number of episodes of sore throat(54) 
Meta-analysis of RCT 
(1a) 
10.64/6months 1. large 1. Strong 
Visits to the GP(7) RCT (1b) 0.9/6months 1. large 1. Strong 
QoL(385) 
Systematic review of 
cohort (2a) 
10% improvement in physical component 
sf 36 
2. medium 1. Moderate 
Snoring reduction(386) Case series (4) 
46% reduction in odds of being a 
severe/habitual snorer if you had a 
tonsillectomy 
1. large 2. Weak 
Voice change (387) Case control (3b) 
17% of peripubescent males had 
hypernasalance preop, and 9% had it post 
tonsillectomy 
2. small 3. Weak 
Halitosis reduction(388) Case series (4) 80% had clearance of halitosis at 2 months 1. large 3. Weak 
Societal cost(8) Case series (4) 12.3 year break even time 2. medium 3. Weak 
Taste disturbance(389) Case series (4) 10%/6months 2. medium 3. Weak 
Haemorrhage risk(56) Cohort (2b) 
4.9% incidence adults (all indication 
tonsillectomy) 





Table 41 Critical appraisal of knowledge related to eleven treatment outcomes for recurring sore throat







Appendix G – Online ranking exercise 
Exercise 
Please rank, in order of importance, which factors about a treatment and outcome are 
most important to you when deciding how best to treat recurring sore throat?  (Order 
the list from 1-10, with 1 meaning most important for you in choosing a treatment, 
and 10 being the least important to you) 
 
Factor Your rank (1-10) of importance 
in your decision 
Reducing days of sore throat   
Reducing unexpected episodes of sore 
throat  
 
Reducing visits to the GP for sore throat   
Improving your overall quality of life   
Improving voice  
Improving snoring    
Reducing bad breath   
Reducing financial cost to your community 
through NHS spending  
 







Reducing risk of bleeding after treatment   




Thank you for taking the time to read this information letter and complete the 
exercise. Our research would not be possible without volunteers 
Appendix H - Patient Focus group information sheet 
 
Dear Patient,  
Doctor –patient communication during medical decision-making: An observational 
study 
Following our conversation I wanted to thank you for agreeing to participate in our 
focus group and attend a meeting on (Insert time and date here). You have been 
selected to participate in this group because you had to make a decision of which 
treatment to choose for recurring sore throat.  The aim of the focus group will be to 
reach a group consensus on which 7 factors are most important when deciding which 
treatment to choose for the treatment of recurring sore throat.  
The focus group will be audio-recorded so that we can analyse the results. All 
information that you provide through the following exercise and during the focus 
group will be kept confidentially. When you arrive you will be asked to sign a consent 
form to say that you agree to participate. Should you have any further questions about 
the study please do not hesitate to contact me on the number at the end of this letter.  
Prior to our meeting I would be grateful if you could complete the following exercise 





During the focus group we will discuss why each of these factors are important for 
you. Then we will ask you to repeat the exercise at the end of the focus group.  
Exercise 
Please rank, in order of importance, which factors about a treatment and outcome are 
most important to you when deciding how best to treat recurring sore throat?  (Order 
the list from 1-10, with 1 meaning most important for you in choosing a treatment, 
and 10 being the least important to you) 
 
Factor Your rank (1-14) of importance 
in your decision 
Reducing days of sore throat   
Reducing number of episodes of sore 
throat 
 
Reducing visits to the GP for sore throat  
Improving your quality of life  
Reducing societal cost burden  
Reducing short term risk to taste 
disturbance (up to 6 months) 
 
Reducing short term risk of bleeding after 
treatment 
 
Reducing chance of altering immune 
system 
 





Reducing halitosis  
 
Thank you for taking the time to read this information letter and complete the 
exercise. Our research would not be possible without volunteers. 
 
Dr Nish Mehta 
Nishchay.mehta.12@ucl.ac.uk 
+44 20 3549 5559 
evidENT  





Appendix I – Consent for focus group 
Study Number: 14/0876 
CONSENT FORM FOR FOCUS GROUP PARTICIPANTS 
Title of Project: Doctor –patient communication during medical decision-making: An 
observational study 
Name of Researcher: Dr Nish Mehta  
Please initial   all boxes  
1. I confirm that I have read and understand the information sheet dated  5th May 
2015 Version 1.1 for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw at 




3. I understand that my information will be kept confidentially at all times and I will 
not be named on any of the reports or publications that result from this study.  
 
 




5. I understand that data collected during the study may be looked  at by individuals 
from the sponsor of the study (University College London Hospitals) to ensure the 
study is conducted to a high standard. I give permission for these individuals to 











6. I agree to take part in the above study.  
 
 
            
Name of Patient    Date    Signature  
 
            
Name of Person taking consent  Date    Signature  
 
 
Nishchay Mehta    21/05/2015   








Appendix J – Semi-structured interview guide 
 
1. House rules 
a. Toilets 
b. Fire escape 
c. Try and speak one at a time 
d. Confidential 
e. Tape recording 
2. Consent 
3. Introductions and Purpose of exercise 
4. Exercise 1: Questions/ comments on the activity/ task  
a. Do you have any questions or comments about this exercise? Or 
activity  
b. How clear did you find it?  
5. Exercise 2: Wording and understanding  
a. What did you understand from the word societal costs? 
b. Immunity 
c. Halitosis 
6. Exercise 2: Justification for ranking - Limiting to top 7 
a. Which factors were the most important to you?  
b. Which factors were least important to you?  
c. Tell me how you went about ranking your top 3? 
d. Tell me about how you ranked the bottom 3?  
e. How did you make your choices? 
7. Exercise 3: Can you add anything to this list of 10 factors? Or anything missed? 
a. Why do you want to add that  





8. Exercise 4: Can each of you now please repeat the ranking exercise 
a. Did you use a different approach? 
b. Did you change any rankings? 
c. Are any of these factors similar to each other?  
d. Group on table 
9. Concluding 
a. Evaluation sheet 
b. Contact if you want to hear how this goes 
Preparation tasks 
 Welcome by me 
 Aneeka to bring expense forms 
 Get name badges/stickers – Aneeka?- yes will bring 
 I will arrange chairs in circles and add low lying table 
 Aneeka to bring tape recorder- confirmed  
 I will bring A4 papers blank and filled with marker pens 
 I will bring 4 small writing pads and pens 
 Aneeka to ask relevant people to complete prioritisation 
exercise if not already done and complete travel expense forms 
 I will facilitate group 





Appendix K - Draft version of PARTT 
Patient Unique Identifier _______   Doctor Unique Identifier ______ 
Investigations into patient –doctor decision making 
This questionnaire is about how you and your doctor came to the decision of how 
best to treat your recurring sore throats (the decision making process). The 
questions are about which factors were important for you when making your 
decision.   
Making Choices about Treatment 
You have just seen your doctor and discussed whether to have an operation under a 
general anaesthetic to remove your tonsils or whether to wait and see if your 
symptoms of recurring sore throat resolve without an operation over time.  
The next set of questions will help us as researchers understand which preferences 
are important to you when you made your decision about your treatment.   
For each question, we ask you to decide which one was most important when you 
decided to have tonsillectomy or not.  Please mark your answer by placing a cross on 
the scale shown below.  If both pieces of information are equally important to you 
then please place your cross in the middle.  
The following information may help you make your choices:  
1. A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 
months.  
2. There is a small chance of bleeding following a tonsillectomy. Bleeding is not 
fatal but would require you to return to hospital for special treatment.  
3. A tonsillectomy can mean you make one less visit to the GP in the first 6 
months after surgery.   
4. After a tonsillectomy, some patients report a large improvement in their 





5. Some people who had bad breath from the recurring sore throats reported 
better breath following tonsillectomy. 
Before you start, here is a simple example of how to answer the questions:  












In this example, the person had a very strong preference for No risk of bleeding 
compared to Fewer days of bleeding so he/she placed a cross on “very strong” at 
the ‘No risk of bleeding’ end of the scale.  
Now please answer the questions below: 
 
Thinking about your decision to have a tonsillectomy or not please answer the 
following questions in the same way. 
1. What is your preference: fewer days of sore throat or no risk of bleeding from a 
treatment?  


































2. What is your preference: fewer visits to the GP or better quality of life? 







3. What is your preference: No risk of bleeding from a treatment or having better 
breath? 













No risk of 
bleeding 

































































4. What is your preference: fewer days of sore throat or better quality of life? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  











5. What is your preference: Fewer days of sore throat or fewer visits to the GP?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  
A tonsillectomy can mean you make one less visit to the GP in the first 6 months 







































6. What is your preference: Fewer days of sore throat or having better breath? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months  
Some people who had bad breath from the recurring sore throats reported better 
breath following tonsillectomy 
 
 







7. What is your preference: Less visits to the GP or no risk of bleeding from a 
treatment? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months 






















































There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal 












8. What is your preference: Fewer visits to the GP or having better breath?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months 
after surgery.   
Some people who had bad breath from the recurring sore throats reported better 
breath following tonsillectomy. 
 





















































9. What is your preference: Better quality of life or No risk of bleeding? 
Before you decide, please consider these two pieces of information: 
After a tonsillectomy, some patients report a large improvement in their quality of 
life 
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal 
but would require you to return to hospital for special medications.  
 
 






10. What is your preference: Better quality of life or better breath?  
Before you decide, please consider these two pieces of information: 
After a tonsillectomy, some patients report a large improvement in their quality of 
































Some people who had bad breath from the recurring sore throats reported better 
breath following tonsillectomy. 
 







































Appendix L – Final PARTT  
Patient Unique Identifier _______   Doctor Unique Identifier ______ 
Investigations into patient –doctor decision making 
This questionnaire is about how you and your doctor came to the decision of how best 
to treat your recurring sore throats (the decision making process). The first set of 
questions are about your certainty during the decision making process, the second set 
of questions relate to your satisfaction with the decision making process, the third set 
of questions are about which factors were important for you when making your 
decision and the final section is about your personal background.   
1. Which treatment option did you and the doctor decide upon (Please tick only one)? 
   
☐ Tonsillectomy   ☐ Watch and Wait 
Thinking about the decision you have just made with your doctor please consider each 










2. I know which options 
are available to me 





3. I know the benefits of 
each option 
☐ ☐ ☐ ☐ ☐ 
4. I know the risks and 
side effects of each 
option 
☐ ☐ ☐ ☐ ☐ 
5. I am clear about which 
benefits matter most to 
me 
☐ ☐ ☐ ☐ ☐ 
6. I am clear about which 
risks and side effects 
matter most to me 
☐ ☐ ☐ ☐ ☐ 
 Strongly 
disagree 




7. I am clear about which 
is more important (the 
benefits or the risks and 
side effects) 
☐ ☐ ☐ ☐ ☐ 
8. I have enough support 
from others to make a 
choice 
☐ ☐ ☐ ☐ ☐ 
9. I am choosing without 
pressure from others 
☐ ☐ ☐ ☐ ☐ 
10. I have enough advice 
to make a choice 
☐ ☐ ☐ ☐ ☐ 
11. I am clear about the 
best choice for me 
☐ ☐ ☐ ☐ ☐ 
12. I feel sure about what 
to choose 








The following questions are about how you reached your treatment decision. For each 
statement, please tick the box that you agree with most.   
13. This decision is easy 
for me to make 
☐ ☐ ☐ ☐ ☐ 
14. I feel I have made an 
informed choice 
☐ ☐ ☐ ☐ ☐ 
15. My decision shows 
what is important to me  
☐ ☐ ☐ ☐ ☐ 
16. I expect to stick to my 
decision 
☐ ☐ ☐ ☐ ☐ 
17. I am satisfied with my 
decision 









18. I am satisfied that I am 
adequately informed 
about the issues 
important to my decision. 






19. The decision I made 
was the best decision 
possible for me 
personally. 
☐ ☐ ☐ ☐ ☐ 
20. I am satisfied that my 
decision was consistent 
with my personal values. 
☐ ☐ ☐ ☐ ☐ 
21. I expect to successfully 
carry out (or continue to 
carry out) the decision I 
made. 
☐ ☐ ☐ ☐ ☐ 
22. I am satisfied that this 
was my decision to make 
☐ ☐ ☐ ☐ ☐ 
23. I am satisfied with my 
decision 





Making Choices about Treatment 
You have just seen your doctor and discussed whether to have an operation under a general 
anaesthetic to remove your tonsils or whether to wait and see if your symptoms of recurring 
sore throat resolve without an operation over time.  
The next set of questions will help us as researchers understand which preferences are 
important to you when you made your decision about your treatment.   
For each question, you will be given two pieces of information. We ask you to compare these 
2 pieces of information and then decide which one was most important when you decided to 
have tonsillectomy or not.  Please mark your answer by placing a cross on the scale shown 
below.  If both pieces of information are equally important to you then please place your 
cross in the middle.  
Before you start, here is a simple example of how to answer the questions:  
Imagine you want to get from your house to the shops and you can go by either bus or bicycle.  
What is your preference: short journey time or low journey cost? 
Before you decide, please consider these two pieces of information: 
Riding a bus will save you 20 minutes in journey time.  
Riding a bicycle will be £4 cheaper.  


































In this example, the person had a very strong preference for short journey time compared 
with low journey cost so he/she placed a cross on “very strong” at the short journey time end 
of the scale. If the person felt that low journey cost was as important to them as short journey 




Thinking about your decision to have a tonsillectomy or not please answer the following 
questions in the same way. 
24. What is your preference: fewer days of sore throat or no risk of bleeding from a 
treatment?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 
require you to return to hospital for special treatment.  
 





































25. What is your preference: fewer visits to the GP or better quality of life? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   
After a tonsillectomy, some patients report a large improvement in their quality of life 







26. What is your preference: No risk of bleeding from a treatment or having better breath? 
Before you decide, please consider these two pieces of information: 
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy. 
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 
require you to return to hospital for special treatment.  






















































27. What is your preference: fewer days of sore throat or better quality of life? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  













28. What is your preference: Fewer days of sore throat or fewer visits to the GP?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  









































29. What is your preference: Fewer days of sore throat or having better breath? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months  
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy 
 





























































30. What is your preference: Less visits to the GP or no risk of bleeding from a treatment? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 
require you to return to hospital for special medications.  
 








31. What is your preference: Fewer visits to the GP or having better breath?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   







































32. What is your preference: Better quality of life or No risk of bleeding? 
Before you decide, please consider these two pieces of information: 
After a tonsillectomy, some patients report a large improvement in their quality of life 
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 



























































33. What is your preference: Better quality of life or better breath?  
Before you decide, please consider these two pieces of information: 
After a tonsillectomy, some patients report a large improvement in their quality of life 
(medium quality research studies) 
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy. 
 











































Now we would like to ask you some background questions.  For each question, tick one box 
only.  
34. How old are you?   
☐ 15-19 ☐ 20-29 ☐ 30-39 ☐ 40-49 ☐ 50-59 ☐ 60-69 
35. What is your sex?  
 ☐ Male     ☐ Female  
36. Which of the following best describes your ethnic group?  
☐ White 
☐ Mixed / Multiple ethnic groups 
☐ Asian / Asian British 
☐ Black / African / Caribbean / Black British 
☐ Any other ethnic group, please describe 
 37. Current occupation (please describe previous if unemployed / retired)?  
 
38. In your opinion, how was the timing of referral from your GP to our ENT services?   
 ☐ Prompt    ☐ Appropriate     ☐ Delayed 
39. How long have you been suffering with severe sore throats? 
 _______Years 
40. How many episodes of sores throat have you had in the last 12 months? 





41. How many days off work/education have you had to take in the last 12 months because 
of sore throats?  
☐ 0-5  ☐ 6-10  ☐ 11-15  ☐ More than 16 







Appendix M - Detailed Doctor Information Sheet 
 
Detailed Doctor Information Sheet 
Doctor –patient communication during medical decision-making: An observational study 
Protocol Reference Number:  14/0876 
We would like to invite you to take part in our research study.  Before you decide we would 
like you to understand why the research is being done and what it would involve for you.  One 
of our team will give a small talk on this study and will answer any questions you may have.  
Part 1 tells you the purpose of this study and what will happen to you if you take part.  Part 2 
gives you more detailed information about the conduct of the study.   
Ask us if there is anything that is not clear.  Take time to decide whether or not you wish to 
take part. 
Part1 
What is the purpose of the study? 
We want patients to be more involved in decisions that will affect their treatment. Currently 
we have little understanding of how decisions about medical treatments are being made. The 
aim of this study is to get a better understanding of how decisions between doctors and 
patients are made when there is no ‘best treatment’ option available. This information will 
then be used to help doctors and patients communicate better when making decisions.  
Why am I being asked to participate in this study? 
We will be recruiting 150 adults who have been considered for a tonsillectomy to treat 
recurring sore throats across 10 hospitals in England (15 patients/hospital) over 6 months. 
We will be asking them questions about their level of certainty when the decision was made 
and their overall satisfaction with it. However, we also want to know the same information 





making process. We are inviting you to participate, as you are likely to see one of these 
patients during a routine outpatient clinic.   
Do I have to take part? 
No. Taking part is completely voluntary. We will describe the study during the talk we give to 
your department. If you agree to take part, we will then ask you to sign a consent form. You 
are free to withdraw at any time without giving a reason.  
 
What will happen to me if I take part? 
If you agree to participate in the study you will be asked to complete a short 5 - minute 
questionnaire on your personal values and sociodemographic details. Subsequently, you will 
be asked to complete a 2-minute paper questionnaire for every patient you see that has also 
been recruited into the study. The questions will relate to decisions made during the 
consultation.  
What are the possible benefits of taking part?  
A decision of which treatment to take can be difficult when the options aren’t clear. We want 
to understand how doctors and patients make these decisions, so that we can make 
information more clear. 
Will my taking part in the study be kept confidential?  
Yes. We will follow ethical and legal practice and all information about you will be handled in 
confidence. The details are included in Part 2.  
 
Contact Details 
Your Local study co-ordinator 







Dr Nish Mehta  Nishchay.mehta.12@ucl.ac.uk    
This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering participation, please 
read the additional information in Part 2 before making any decision.  
Part 2 
Will my data be kept safe?  
If you consent to take part in this study the information you provided will be kept 
confidentially at all times and will be stored at UCL in accordance with the Data Protection 
Act (1998). You will be allocated a code number, which will be used instead of your name to 
identify you on all study forms.  
Only the project team will have access to the information you provide.  The Sponsor (UCLH) 
may also request access to your information to ensure the study is being carried out correctly. 
By signing the consent form you agree to this access by the sponsor for the current study. At 
the end of the study your data will be securely archived for 5 years at UCL.  
 
What will happen to the results of the research study?  
The results of the study will be published in a medical journal and be presented at a scientific 
conference. They will also be written up as part of the PhD thesis of the Chief Investigator. No 
participants will be identified by name in any of the reports or publications. Should you wish 
to see the results, or the publications, please ask your local study co-ordinator (Dr Shilpa 
Ojha).  





This study has been reviewed and given favourable opinion by Nottingham Research Ethics 
Committee.  
Complaints  
If you have a concern about any aspect of this study, you should ask to speak to your local 
study co-ordinator researcher who will do their best to answer your questions (Dr Shilpa Ojha 
details above). If you remain unhappy and wish to complain formally, you can contact the 
Chief Investigator (Mr Nish Mehta Nishchay.mehta.12@ucl.ac.uk).  
Further information and contact details  
If you have any questions about the study, please speak to your local study co-ordinator (Dr 
Shilpa Ojha, details above), who will be able to provide you with up to date information about 
the procedure involved. If you require any further information or have any concerns while 
taking part in the study please contact: 
 
Dr Nishchay Mehta      +44 20 3549 5559 
If you decide you would like to take part then please read and sign the consent form. You will 
be given a copy of the information sheet and the consent form will be filed with the study 
records. 
You can have more time to think this over if you are at all unsure. 







Appendix N - Doctor Consent Form 
 
Centre Number:  1 
Study Number: 14/0876 
Participant Identification Number for this study: 
CONSENT FORM FOR DOCTORS 
Title of Project: Doctor –patient communication during medical decision-making: An 
observational study 
Name of Researcher: Dr Nish Mehta  
Please initial   all boxes  
7. I confirm that I have read and understand the information sheet dated 5th May 2015 
Version 1.1 for the above study.  I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
8. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason legal rights being affected.  
9. I understand that the data collected during the study may be looked at by individuals from 
the sponsor of the trial (University College London Hospitals) to ensure the study is 
conducted to a high standard. I give permission for these individuals to have access to my 
details and questionnaire.  
10. I understand that my information will be kept confidentially at all times and I will not be 
named on any of the reports or publications that result from this study.  
 












            
Name of Participant    Date    Signature  
 
            
Name of Person taking consent  Date    Signature  
 
 Nishchay Mehta    21/05/2015   






Appendix O - Patient Invitation Letter 
 
Dear Patient,  
Doctor –patient communication during medical decision-making: An observational study 
We are currently undertaking a study to see how patients and doctors make decisions related 
to medical problems. 
The goal of this study is to help doctors and patients communicate better to make easier and 
safer decisions in the future. You may be asked to participate in this study when you have 
completed your consultation with the ENT surgeon.  
Why am I being sent this letter? 
We will be recruiting 150 adults who have recurring sore throats throughout hospitals in 
England. The referral letter your GP has sent to our department suggests you may be eligible 
for our study. At the end of your consultation, if your ENT doctor agrees that you are eligible 
for this study you will be asked if you want to participate.  
Do I have to take part? 
No. Taking part is completely voluntary. If your ENT doctor agrees that you are eligible for this 
study it will be up to you to decide whether you want to join or not. If you agree to take part, 
we will then ask you to sign a consent form. You are free to withdraw at any time without 
giving a reason. This would not affect the standard of care you receive.  
Why should I take part? 
A decision of which treatment to take can be difficult when the options aren’t clear. We want 
to understand how doctors and patients make these decisions so that we can make 
information more clear.   





If you agree to participate in the study you will be asked to complete a 10-minute paper 
questionnaire. The questions will be related to the decision you made together with your 
doctor and your satisfaction with it.  In addition you will be asked a few questions about your 
age, gender, education, occupation and ethnicity. This will help us tailor our planned 
improvements to different patient groups. Your treatment will not be affected by how you fill 
in your questionnaire. All the information we collect will be kept confidentially and any 
completed questionnaires will not have your name on them.  
What do I do now? 
Nothing. When you go to your outpatients’ appointment someone from our research team 
may meet and talk to you about this study in more detail. If your ENT doctor feels you are 
appropriate they will ask you if you want to take part.  
Where will the information go? 
The information you provide will be kept confidentially. Your name will be separated from 
your questionnaire. Your name and questionnaire will be linked by a secure code number.   
What will you do with the results? 
The results of the study will be published in a medical journal and be presented at a scientific 
conference. They will also be written up as part of the PhD thesis of the Chief Investigator. No 
participants will be identified by name in any of the reports or publications. Should you wish 
to see the results, or the publications, please ask the research team at the hospital for further 
details.  
Who do I contact if I want more information or have concerns? 
Please contact the Dr Nish Mehta below should you want further information.  
 







330 Grays Inn Rd, London WC1X 8DA 
 
Thank you for taking the time to read this information letter, whether or not you choose to 





Appendix P – Detailed Patient Information Sheet 
 
Detailed Patient Information Sheet 
Doctor –patient communication during medical decision-making: An observational study 
Protocol Reference Number: 14/0876 
We may invite you to take part in our research study depending on which treatment you are 
offered.  If you are invited to participate we would like you to understand why the research 
is being done and what it would involve for you.  One of our team can go through the 
information sheet with you and answer any questions you have.  We‘d suggest this should 
take about 5 minutes.  Talk to others about the study if you wish.   
 
Part 1 tells you the purpose of this study and what will happen to you if you take part.  Part 2 
gives you more detailed information about the conduct of the study.   





What is the purpose of the study? 
 
We want patients to be more involved in decisions that will affect their treatment. Currently 
we have little understanding of how decisions about medical treatments are being made. The 





patients are made when there is no ‘best treatment’ option available. This information will 
then be used to help doctors and patients communicate better.  
 
Why may I be asked to participate in this study? 
 
We will be recruiting 150 adults who have recurring sore throats across 10 hospitals in 
England. The referral letter your GP has sent suggested you may be eligible for our study. 
After your consultation if the ENT doctor agrees that you are eligible for this study you will be 
formally asked if you want to participate.  
 
Do I have to take part? 
 
No. Taking part is entirely voluntary. If your doctor agrees that you are eligible for this study 
it will be up to you to decide whether or not you should participate. If you agree to take part, 
we will then ask you to sign a consent form. You are free to withdraw at any time without 
giving a reason. Whether or not you choose to participate the standard of care you receive 
will not be affected.  
 
What will happen to me if I take part? 
 
If you agree to participate in the study you will be asked to complete a 10-minute paper 
questionnaire. The questions will relate to decisions made during your appointment.  In 
addition you will be asked a few questions about your age, gender, education, occupation and 





the information we collect will be kept confidentially and will not affect the treatment you 
receive from your ENT team.  
 
What are the possible benefits of taking part?  
 
A decision of which treatment to take can be difficult when the options aren’t clear. We want 
to understand how doctors and patients make these decisions so that we can make 
information more clear. 
 
We cannot promise the study will help you personally, but the information we get from this 
study should help improve communication between patients and doctors throughout the 
country.   
 
What if there is a problem?  
 
Any complaint about the way you have been dealt with during the study will be addressed. 
The detailed information concerning this is given in Part 2 of this information sheet. If you 
have any concerns or complaints you should contact the local member of the research team 
in the first instance (details below). 
 
Will my taking part in the study be kept confidential?  
 
Yes. We will follow ethical and legal practice and all information about you will be handled in 







Local Study Co-ordinator 
 
Dr. Shilpa Ojha     shilpa.ojha@uclh.nhs.uk  
 
Chief Investigator 
Dr Nishchay Mehta     Nishchay.mehta.12@ucl.ac.uk  
 
This completes Part 1 of the Information Sheet. 
If the information in Part 1 has interested you and you are considering participation, please 





Will my data be kept safely?  
 
If you consent to take part in this study, the information you provided will be kept 
confidentially at all times and will be stored at your hospital in accordance with the Data 
Protection Act (1998). Your name will not be passed to anyone else outside the research team. 





Only the project team will have access to the information you provide.   The sponsor (UCLH) 
may also request access to your information to ensure the study is being carried out correctly. 
By signing the consent form you agree to this access by the sponsor for the current study. At 
the end of the study your data will be securely archived for 5 years at UCL.  
 
Will my GP be informed of my involvement? 
 
Your GP will not be informed of your participation in this study as we are not changing the 
care you receive. Although your hospital doctor will be aware of your participation he/she will 
not have access to your questionnaire.  
 
What will happen to the results of the research study?  
 
The results of the study will be published in a medical journal and be presented at a scientific 
conference. They will also be written up as part of the PhD thesis of the Chief Investigator. No 
participants will be identified by name in any of the reports or publications. Should you wish 
to see the results, or the publications, please ask your researcher (shilpa.ojha@uclh.nhs.uk). 
 
Who is organising and funding the research?  
 
The research is being organised by the ENT research doctors at UCL hospital in collaboration 
with the ENT doctors at your local hospital. The research is funded by the Wellcome Trust.  
 






All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee, to protect your interests.  This study has been reviewed and given favourable 




If you have a concern about any aspect of this study you should ask to speak to the researcher 
(person who gave you this information sheet). They will do their best to answer your 
questions. If you remain unhappy and wish to complain formally, you can contact your PALS 
team (020 3447 3042). 
 
Further information and contact details  
 
You are encouraged to ask any questions you wish, before, during or after your treatment. If 
you have any questions about the study, please speak to the researcher (person who gave 
you this information sheet), who will be able to provide you with up to date information about 
the procedure involved. If you wish to read the research on which this study is based, please 
ask your researcher. If you require any further information or have any concerns while taking 
part in the study please contact one of the following people: 
Local Study Co-ordinator 







Dr Nishchay Mehta     Nishchay.mehta.12@ucl.ac.uk  
 
 
If you decide you would like to take part then please read and sign the consent form. You will 
be given a copy of this information sheet to keep. The consent form will be filed with the 
study records and a copy may be sent to the Research Sponsor. 
 
You can have more time to think this over if you are at all unsure. 






Appendix Q – Patient Consent Form 
Centre Number:  1 
Study Number: 14/0876 
Participant Identification Number for this trial: 
CONSENT FORM FOR PATIENTS 
Title of Project: Doctor –patient communication during medical decision-making: An 
observational study 
Name of Researcher: Dr Nish Mehta  
Please initial   all boxes  
12. I confirm that I have read and understand the information sheet dated  5th May 2015 
version 1.1 for the above study.  I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
13. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected.  
14. I understand that the data collected during the study may be looked at by individuals from 
the sponsor of the trial (University College London Hospitals) to ensure the study is 
conducted to a high standard. I give permission for these individuals to have access to my 
completed forms. 
15. I understand that my information will be kept confidentially at all times and I will not be 
named on any of the reports or publications that result from this study.  
 
16. I agree to take part in the above study.  
 










Name of Patient    Date    Signature  
 
            
Name of Person taking consent  Date    Signature  
 
Nishchay Mehta              21.05.2015                                    




Appendix R – Doctor pre-consultation questionnaire 
Doctor Unique Identifier _______ 
Doctor’s preferences of treatment factors when deciding how to manage recurrent 
tonsillitis 
The first set of questions are about your demographics and surgical experience. The 
following set of questions are meant to determine which factors you would consider 
important when choosing between tonsillectomy and watchful waiting if you were a 
patient with recurrent tonsillitis.   Please tick only box for each question.  
1. How old are you?   
☐ 20-29 ☐ 30-39 ☐ 40-49 ☐ 50-59 ☐ 60-69 
2. What is your sex?  
 ☐ Male     ☐ Female  
3. Which of the following best describes your ethnic group? 
☐ White 
☐ Mixed / Multiple ethnic groups 
☐ Asian / Asian British 
☐ Black / African / Caribbean / Black 
British 
☐ Any other ethnic group, please 
describe  
 
4. What is your Clinical Grade? 
☐ Consultant   ☐ Registrar  ☐ Staff Grade   
  





5. How many years have you been in ENT practice since leaving medical school? 




Making Choices about Treatment 
You have just seen your doctor and discussed whether to have an operation under a general 
anaesthetic to remove your tonsils or whether to wait and see if your symptoms of recurring 
sore throat resolve without an operation over time.  
The next set of questions will help us as researchers understand which preferences are 
important to you when you made your decision about your treatment.   
For each question, you will be given two pieces of information. We ask you to compare these 
2 pieces of information and then decide which one was most important when you decided to 
have tonsillectomy or not.  Please mark your answer by placing a cross on the scale shown 
below.  If both pieces of information are equally important to you then please place your 
cross in the middle.  
Before you start, here is a simple example of how to answer the questions:  
Imagine you want to get from your house to the shops and you can go by either bus or bicycle.  
What is your preference: short journey time or low journey cost? 
Before you decide, please consider these two pieces of information: 
Riding a bus will save you 20 minutes in journey time.  
Riding a bicycle will be £4 cheaper.  

































In this example, the person had a very strong preference for short journey time compared 
with low journey cost so he/she placed a cross on “very strong” at the short journey time end 
of the scale. If the person felt that low journey cost was as important to them as short journey 




Thinking about your decision to have a tonsillectomy or not please answer the following 
questions in the same way. 
24. What is your preference: fewer days of sore throat or no risk of bleeding from a 
treatment?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 
require you to return to hospital for special treatment.  
 







25. What is your preference: fewer visits to the GP or better quality of life? 





























Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   
After a tonsillectomy, some patients report a large improvement in their quality of life 







26. What is your preference: No risk of bleeding from a treatment or having better breath? 
Before you decide, please consider these two pieces of information: 
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy. 
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 
require you to return to hospital for special treatment.  





















































27. What is your preference: fewer days of sore throat or better quality of life? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  













28. What is your preference: Fewer days of sore throat or fewer visits to the GP?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months.  
A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   
 























































29. What is your preference: Fewer days of sore throat or having better breath? 
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you have up to 11 fewer days of sore throat in 6 months  
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy 
 









30. What is your preference: Less visits to the GP or no risk of bleeding from a treatment? 



































A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 
require you to return to hospital for special medications.  
 








31. What is your preference: Fewer visits to the GP or having better breath?  
Before you decide, please consider these two pieces of information: 
A tonsillectomy can mean you make one less visit to the GP in the first 6 months after surgery.   
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy. 
 
























































32. What is your preference: Better quality of life or No risk of bleeding? 
Before you decide, please consider these two pieces of information: 
After a tonsillectomy, some patients report a large improvement in their quality of life 
There is a small chance of bleeding following a tonsillectomy. Bleeding is not fatal but would 












































33. What is your preference: Better quality of life or better breath?  
Before you decide, please consider these two pieces of information: 
After a tonsillectomy, some patients report a large improvement in their quality of life 
(medium quality research studies) 
Some people who had bad breath from the recurring sore throats reported better breath 
following tonsillectomy. 
 

































Appendix S – Doctor post consultation questionnaire 
Patient Unique Identifier _______   Doctor Unique Identifier ______ 
Doctor satisfaction and certainty following decisions 
Both sets of questions relate to the patient you have just seen and helped reach a decision 
about which treatment they should undertake to treat their recurrent tonsillitis. The first set 
of questions are about your certainty during the decision making process. The second set of 
questions relate to your satisfaction of the decision making process.  Please tick only one box 
per question 
1. Which treatment option did you and the patient decide upon?    
☐ Tonsillectomy   ☐ Watch and Wait 
Thinking about the decision you have just made with your patient please consider each of the 
following statements and tick a box that you most agree with in each row 
 Strongly 
disagree 




2. The decision was hard 
to make 
☐ ☐ ☐ ☐ ☐ 
3. I was unsure what 
treatment would really be 
best for this patient 
☐ ☐ ☐ ☐ ☐ 
4. When making the 
decision, I felt I did not 
know enough about the 
treatment alternatives, 
although the information 
is available in the 
literature 




5. I had trouble making 
the decision because 
important information is 
either unknown or not 
readily available in the 
literature 
☐ ☐ ☐ ☐ ☐ 
 Strongly 
disagree 




6. When I made a decision 
it was hard to decide if the 
benefits of the available 
treatments were more 
important than the risks 
or vice versa 
☐ ☐ ☐ ☐ ☐ 
7. It was easy to identify 
all the considerations that 
affect the decision 
☐ ☐ ☐ ☐ ☐ 
8. I fully understand the 
patient’s views regarding 
the important issues in 
making this decision 
☐ ☐ ☐ ☐ ☐ 
9. I believe that the 
patient fully understands 
the risks and benefits of 
the treatment we chose 





The following questions relate to how you reached the above decision. Please tick a box that 
you most agree with in each row.   
10. I believe that the 
patient will adhere to the 
treatment chosen 
☐ ☐ ☐ ☐ ☐ 
11. I am satisfied with the 
decision that was made 
☐ ☐ ☐ ☐ ☐ 
12. I am satisfied that the 
process used to make the 
decision was as good as 
can be 









13. I am satisfied that I am 
adequately informed 
about the issues 
important to my decision. 
☐ ☐ ☐ ☐ ☐ 
14. The decision I made 
was the best decision 
possible for me 
personally. 
☐ ☐ ☐ ☐ ☐ 
15. I am satisfied that my 
decision was consistent 
with my personal values. 
☐ ☐ ☐ ☐ ☐ 
16. I expect to successfully 
carry out (or continue to 




Thank you completing the questionnaire. Please now give the questionnaire to your 
researcher.  
carry out) the decision I 
made. 
17. I am satisfied that this 
was my decision to make 
☐ ☐ ☐ ☐ ☐ 
18. I am satisfied with 
decision 




Appendix T AHP methodology and Ranking results 
An Eigenvector grid of outcome comparisons was created for each participant. Each row 
represented an outcome.  The matrix was sequentially squared until the normalised row total 
stabilised. The normalised row total allowed the participants preference for that particular 
outcome to be quantified in relation to the other four outcomes. All five row totals always 
summed to one. Participants’ ranks for outcomes were created based on their normalised 
row totals. Therefore, all five outcomes could be ranked in order of priority for the participant 
from one to five, with five being the most important and one the least. Ranked treatment 
priorities were described individually for patients and surgeons. 
 Weights were calculated reflect the likelihood and effect size of each outcome within each 
treatment option. Weights were created by making pairwise comparisons between 
tonsillectomy and conservative therapy, for each of the five above outcomes individually. For 
example tonsillectomy and conservative therapy were compared to each other with regards 
to the likelihood and effect size of bleeding after each treatment: High level evidence shows 
that the risk of bleeding following tonsillectomy is between 4-10%, whilst there is 0% risk of 
bleeding following conservative therapy. Therefore the comparison would ‘extremely’ favour 
conservative therapy in this instance. This was repeated for the other four outcomes and the 
resulting verbal responses converted to the Saaty scale (as described above). Five comparison 
matrixes were created, with each row representing a treatment option (tonsillectomy or 
conservative therapy). The square root of the row product was normalised to create a priority 
vector, or an outcome weight.  
 
The association between Ranked Outcome Priorities (ROP) and treatment chosen 
To assess if higher ranking of an outcome changed the treatment chosen I undertook ordinal 
logistic analyses between patients’ ROP for each of the five outcomes (reducing GP visits, 
reducing days of sore throat, reducing halitosis, improving quality of life, reducing chance of 
bleeding) and treatment chosen (tonsillectomy or watchful waiting). ROPs that were 
significantly related to the treatment choice in univariable analyses were sequentially added 




surgeons. Each ROP was added sequentially and retained if it reached statistical significance 
(p<0.05). A multivariable model of patients’ rankings was created to control for patient age, 
sex, ethnicity and originating hospital. 
The association between Ranked Outcome Priorities and treatment chosen 
Patients’ and ENT surgeons’ ranking of each outcome was calculated using standard analytical 
hierarchy process described above. As two groups, ENT surgeons and patients, both ranked 
potential outcomes identically in terms of their priorities: Patients and ENT surgeons ranked 
quality of life as the most important outcome in making their decision, with reducing days of 
sore throat number 2, reducing bad breath number 3, reducing the risk of bleeding number 4 
and reducing visits to the GP as the least important. These ranking were the same in the group 
of patients who selected tonsillectomy as treatment as well as those who selected 
conservative therapy (higher score shows higher rank and greater preference).  
Ordinal Logistic Regression showed that patients’ priority ranking of outcomes was not 
significantly associated with actual treatment choice. Patients choosing tonsillectomy tended 
to rank improving quality of life highly, however, this result was not statistically significant. 
Logistic analyses of ENT surgeons’ outcome rankings showed that if an ENT surgeon placed a 
high rank on reducing chance of bleeding that consultation was less likely to end in 
tonsillectomy (p=0.03).  
A multivariable model of patients’ rankings confirmed that no outcome ranking score was 
associated with treatment choice, even after accounting for patient characteristics. A 
multivariable mode of ENT surgeons’ rankings showed that after accounting for grade of 
surgeon, type of originating hospital, surgeon’s age and sex there was still a significant 
association between ENT surgeons who ranked reducing the risk of bleeding high and their 






































































logistic OR (95% 
CI) 
P2 
Reducing day of sore throat         
1 (least important) 14 18 1.75 (0.46-6.72) 0.36 19 24 1 0.29 
2 14 18 1.75 (0.46-6.72)  5 5 0.47(0.14-1.66)  
3 35 41 2.92(0.92-9.23)  36 49 1.47(0.07-29.87)  
4 32 38 2.67(0.84-8.47)  48 54 0.36(0.13-1.01)  
5 (Most important) 20 30 1  16 22 0.34(0.1-1.15)  
Reducing visits to the GP         




2 47 55 1.59(0.57-4.42)  64 83 0.75(0.30-1.84)  
3 25 33 0.84(0.29-2.43)  19 21 1.77(0.39-8.02)  
4 4 8 0.27(0.06-1.28)  2 2 1.13(0.05-25.83)  
5 (Most important) 2 2 -  2 3 0.38(0.04-3.27)  
Improving QoL         
1 (least important) 0 1 - 0.16 0 0 - 0.18 
2 1 3 0.08(0.01--0.99)  1 1 1  
3 19 25 0.52(0.17-1.62)  2 4 0.33(0.01-12.82)  
4 34 45 0.51(0.20-1.31)  37 50 0.93(0.04-24.13)  
5 (Most important) 61 71 1  15 84 1.82(0.07-46.68)  
Reducing Bad breath         
1 (least important) 32 39 1 0.5 17 27 1 0.16 




3 16 23 0.5(0.15-1.67)  43 51 3.07(1.06-8.87)  
4 25 28 1.82(0.43-7.77)  24 29 2.67(0.80-8.88)  
5 (Most important) 18 24 0.66(0.19-2.25)  15 16 6.20(0.98-39.13)  
Reducing risk of bleeding         
1 (least important) 32 40 1 0.89 51 58 1 0.03 
2 29 38 0.81(0.27-2.36)  29 34 0.78(0.24-2.57)  
3 20 23 1.67(0.39-7.03)  24 29 0.65(0.20-2.16)  
4 20 26 0.83(0.25-2.76)  13 19 0.30(0.09-1.01)  














Rank of "reduce risk of 
bleeding" 
    
1(Least important) 51 58 1 <0.001 
2 29 34 0.49(0.05-4.9)  
3 24 29 0.78(0.17-3.48)  
4 13 19 0.39(0.07-2.20)  
5(Most important) 7 14 0.05(0.01-0.18)  
Age     
20-29 7 8 1 0.81 
30-39 47 58 0.81(0.08-8.56)  
40-49 45 61 0.87(0.05-15.22)  
50-59 35 41 1.03(0.06-16.90)  
60-69 8 10 1.12(0.07-17.99)  




Male 101 126 1 0.63 
Female 41 52 1.71(0.19-15.33)  
Originating Hospital     
District General Hospital 101 144 3.52(1.09-11.37) 0.04 
University hospital 43 46 1  
Grade     
Consultant 72 93 1 0.01 
Registrar 36 44 5.54(1.51-20.40)  
Staff Grade 11 15 1.13(0.19-6.64)  
Associate Specialist 24 23 4.86(0.91-25.93)  





Appendix U - Sore throat codes 
 
readcode readterm medcode 
14B7.00 History of recurrent tonsillitis 95893 
1C9..00 Sore throat symptom 5755 
1C9..11 Throat soreness 404 
1C92.00 Has a sore throat 5553 
1C93.00 Persistent sore throat 12489 
1C9Z.00 Sore throat symptom NOS 15287 
1CB3.00 Throat pain 386 
1CB3.11 Pain in throat 7366 
2DB..11 O/E - tonsils enlarged 18539 
2DB2.00 O/E - tonsils hyperaemic 22131 
2DB3.00 O/E - tonsils mod. enlarged 6498 




2DB5.00 O/E - tonsils - quinsy present 24596 
2DB6.00 O/E - follicular tonsillitis 7266 
2DB7.00 O/E - exudate on tonsils 25176 
2DC1.00 O/E - pharynx hyperaemic 24664 
2DC2.00 O/E - granular pharyngitis 24788 
2DC3.00 Inflamed throat 14931 
2DE7.00 O/E - throat haemorrhage 71829 
4JF4000 Throat swab culture positive 27014 
7531100 Drainage of peritonsillar abscess 6596 
A34..00 Streptococcal sore throat and scarlatina 54777 
A340.00 Streptococcal sore throat 1765 
A340200 Streptococcal pharyngitis 4902 
A340300 Streptococcal tonsillitis 8496 
A340z00 Streptococcal sore throat NOS 16217 




A383000 Fusobacterial necrotising tonsillitis 58538 
A772.00 Viral pharyngoconjunctivitis 27324 
A912300 Primary tonsil syphilis 48291 
A913400 Secondary syphilis of tonsils 37158 
A986.00 Gonococcal pharynx infection 50882 
AA12.00 Vincent's pharyngitis 31536 
AA1z.12 Vincent's tonsillitis 16954 
AA25.11 Rhinopharyngitis mutilans 53708 
AB63100 Tonsillar aspergillosis 16543 
H00..00 Acute nasopharyngitis 3260 
H02..00 Acute pharyngitis 893 
H02..11 Sore throat NOS 6014 
H02..12 Viral sore throat NOS 6466 
H02..13 Throat infection - pharyngitis 310 




H021.00 Acute phlegmonous pharyngitis 24708 
H022.00 Acute ulcerative pharyngitis 21486 
H023.00 Acute bacterial pharyngitis 17899 
H023000 Acute pneumococcal pharyngitis 92428 
H023100 Acute staphylococcal pharyngitis 29589 
H023z00 Acute bacterial pharyngitis NOS 53395 
H024.00 Acute viral pharyngitis 4868 
H025.00 Allergic pharyngitis 6274 
H02z.00 Acute pharyngitis NOS 407 
H03..00 Acute tonsillitis 138 
H03..11 Throat infection - tonsillitis 11499 
H03..12 Tonsillitis 2125 
H030.00 Acute erythematous tonsillitis 12010 
H031.00 Acute follicular tonsillitis 4061 




H033.00 Acute catarrhal tonsillitis 37409 
H034.00 Acute gangrenous tonsillitis 59986 
H035.00 Acute bacterial tonsillitis 10156 
H035000 Acute pneumococcal tonsillitis 58188 
H035100 Acute staphylococcal tonsillitis 64973 
H035z00 Acute bacterial tonsillitis NOS 15970 
H036.00 Acute viral tonsillitis 9357 
H037.00 Recurrent acute tonsillitis 1747 
H03z.00 Acute tonsillitis NOS 20104 
H12..00 Chronic pharyngitis and nasopharyngitis 10083 
H121.00 Chronic pharyngitis 4324 
H121.11 Sore throat - chronic 16814 
H121000 Simple chronic pharyngitis 47426 
H121100 Atrophic pharyngitis 38879 




H121300 Hypertrophic pharyngitis 15794 
H121400 Pharyngitis keratosa 56361 
H121500 Pharyngitis sicca 30569 
H121600 Chronic follicular pharyngitis 47269 
H121z00 Chronic pharyngitis NOS 14926 
H122.00 Chronic nasopharyngitis 12667 
H12z.00 Chronic pharyngitis and nasopharyngitis NOS 54657 
H14..00 Chronic tonsil and adenoid disease 21000 
H14..12 Tonsil disease - chronic 16864 
H140.00 Chronic tonsillitis 1667 
H141.00 Tonsil and/or adenoid hypertrophy 3549 
H141.12 Enlargement of tonsil or adenoid 18238 
H141000 Hypertrophy of tonsils and adenoids 24164 
H141100 Hypertrophy of tonsils alone 2158 




H143.00 Chronic adenotonsillitis 9328 
H14y.00 Other chronic diseases of tonsils and adenoids 54475 
H14y500 Caseous tonsillitis 36462 
H14y600 Lingular tonsillitis 35249 
H15..00 Peritonsillar abscess - quinsy 3605 
H1y2.00 Other pharyngeal disease NEC 10355 
H1y2100 Pharynx or nasopharynx cellulitis 25156 
H1y2200 Parapharyngeal abscess 12231 
H1y2300 Retropharyngeal abscess 27279 
H1y2400 Pharynx or nasopharynx oedema 19948 
H1y2600 Pharynx or nasopharynx abscess 14710 
H271100 Influenza with pharyngitis 29617 
Hyu0100 
[X]Acute pharyngitis due to other specified 
organisms 93964 




J083600 Uvulitis 8480 
R041.00 [D]Throat pain 15039 
R041.11 [D]Throat discomfort 21060 
14B6.00 History of quinsy 96011 
2DB5.11 O/E - quinsy present 6971 
2DC1.11 O/E - fauces injected 22396 
4JH5000 Mouth swab culture positive 44211 
7531111 Drainage of quinsy 7956 
H15..11 Quinsy 911 
Hyu2500 [X]Other chronic diseases of tonsils and adenoids 3430 
 
Appendix V – Table of Interrelatedness of Concepts 


































































































2. The need 
for workers 
to surrender 
their need for 
control and 
link in with 
support 
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2. The need 
for workers to 
surrender 
their need for 
control and 
link in with 
support 
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This table takes the numbered definitions of SDM constructs in the row (blue) and shows how they have overlap with numbered definitions of 
SDM constructs in the column (red). For example, code 2-1 was entered for row of involvement and column decision support. It meant the 2nd 
numbered definition of the row construct (involvement) – that is “explore all biopsychosocial causes” -  was considered to overlap with the 1st 





Appendix W – Gold standard psychometric properties 
Psychometric property Definition/test 
 
Criteria for acceptability 
 
Item reduction Identification of items for possible 
elimination owing to weak 
psychometric performance; assessed 
on the basis of (1) unrotated principal 
component factor analysis to 
determine whether all items are 
measuring a single factor; and (2) 
item analyses for all items 
 
Principal component factor analysis 
All items should load on the first 
unrotated factor >0.30 
 
Item analyses (applied to all items): 
Missing data <5% No item 
redundancy (inter-item correlations ≤ 
0.75) Item–total correlations >0.25 
Maximum endorsement frequencies ≤ 
80% (i.e. the proportion of 
respondents who endorse each 
response category), including 
floor/ceiling effects <80% (i.e. 
response categories with high 
endorsement rates at the bottom/top 




Aggregate adjacent endorsement 
frequencies ≥ 10 
(391) 
Acceptability The quality of data; assessed by 
completeness of data and score 
distributions 
Missing data for summary scores <5%
 Even distribution of endorsement 
frequencies across response 
categories Floor/ceiling effects for 
summary scores <10% 
Reliability 
Internal consistency The extent to which items comprising 
a scale measure the same construct 
(e.g. homogeneity of the scale); 
assessed by Cronbach’s alpha(392) 
 
Cronbach’s alphas for summary 
scores ≥ 0.70 Inter-item or Item–total 
correlations ≥ 0.20(393) 
Test–retest reliability 
 
The stability of a measuring 
instrument; assessed by 
administering the instrument to 
respondents on two different 
occasions and examining the 
Test–retest reliability correlations for 









Agreement between independent 
raters/observers; assessed by ICCs 
 
ICC ≥ 0.70(394) 
Parallel (alternative) forms reliability 
 
Agreement between two or more 
parallel/alternative forms or different 
versions of the same measure (e.g. 
form A/B, short/long form) that 
indicates that they can be used 
interchangeably; assessed on the 
basis of correlations between 
parallel/alternative forms of a 
measure 
 
High correlation between 
parallel/alternative forms of the 






The extent to which the content of a 
scale is representative of the 
conceptual domain it is intended to 
Qualitative evidence from pre-testing 
with patients, expert opinion and 






cover; assessed qualitatively during 
the questionnaire development stage 
through pre-testing with patients, 
expert opinion and literature review 
scale are representative of the 





Evidence that the scale predicts a 
gold-standard criterion that is 
measured at the same time; assessed 
on the basis of correlations between 
the scale and the criterion measure 
 
High correlation between the scale 





Evidence that the scale predicts a 
gold-standard criterion that is 
measured in the future; assessed on 
the basis of correlations between the 
scale and the criterion measure 
 
High correlation between the scale 





Evidence that a single entity 
(construct) is being measured and 
that items can be combined to form a 
summary score; assessed on the basis 
Internal consistency (Cronbach’s 
alpha) ≥ 0.70 Moderate to high 




of evidence of good internal 
consistency and correlations between 
scale scores (which purport to 







Evidence that the scale is correlated 
with other measures of the same or 
similar constructs; assessed on the 
basis of correlations between the 
measure and other similar measures 
 
Correlations are expected to vary 
according to the degree of similarity 
between the constructs that are being 
measured by each instrument. 
Specific hypotheses are formulated 






Evidence that the scale is not 
correlated with measures of different 
constructs; assessed on the basis of 
correlations with measures of 
different constructs 
 
Low correlations between the 







Known groups differences 
 
The ability of a scale to differentiate 
known groups; assessed by 
comparing scores for subgroups who 
are expected to differ on the 
construct being measured 
 
Significant differences between 





The ability of a scale to detect 
clinically important change over time; 
assessed by comparing scores before 
and after an intervention of known 
efficacy (on the basis of various 
methods including t-tests(395) effect 
sizes(309) standardised response 
means(396) or responsiveness 
statistics(397) 
Significant differences between 
























































No data Pearson’s correlation 
coefficient between 
doctor and observer 
=0.58 (p<0.001) 
Not reported Patient or doctor 
gender did not 
affect scores, values 
not provided 



















Does not have 
differing results 
according to patient 
age, gender, and 
level of education 
(t-test p>025)) 





EFA: 1 factor 
None of the 
items loadings 

























































All items loading 








No data Qual 
evidence 
 
0.73 No data Not relevant Ware satisfaction with 
decision scale (r= 0.26, 
p<0.05) 
Scores do not 
change with age 
Women report 











EFA: 3 factors 
Factor 1 
Cronbachs alpha 
of 5 items >0.50, 
explaining 11% 









of 4 items >0.53 
explaining 25% 
of the variance 
Factor 3 
Cronbachs alpha 
of 4 items >0.37 
explaining 10% 











No data No data 0.83 Retested at 
16 days 
ICC=0.70 
Not relevant No data No data No data EFA: 3 factors 
explaining 69% 
of the variance. 
Cronbach’s 
alpha>0.6 for all 
items belonging 
to a factor and 
<0.51 if not 
















0.92 Retest done 
at 2 weeks 
Pearson’s 
R=0.81 





Perceived Utility of 







Scores do not 

























mean of 7.26 
(Stacey) 








Appendix Y – Tonsillectomy Outcomes Evidence and Patient Ranking 








Days of a sore throat Meta-analysis of RCT 3.61/6months 1. large 1. Strong 3.6 3 
Number of episodes 
of sore throat 
Meta-analysis of RCT 10.64/6months 1. large 1. Strong 2.2 1 
Visits to the GP RCT 0.9/6months 1. large 1. Strong 4.6 4 
QoL Case series 
10% improvement in physical 





Snoring reduction Cohort 
46% reduction in odds of being a 






Voice change Case control 
17% of male children had 
hypernasalance preop, and 9% had 
it post tonsillectomy 
2. medium 3. Weak 10..3 11 
Halitosis reduction Case series 









Societal cost Case series 12.3 year break even time 2. large 4. weak 8.2 10 




Haemorrhage risk Cohort 















Appendix Z – Work in progress 
Do latent surgeon treatment preferences influence treatment decisions in adults 
with recurring tonsillitis?  
Introduction 
There is strong evidence of regional variations in the tonsillectomy rates, with little evidence 
on whether patients’ preferences for tonsillectomy vary by region. Some authors have 
suggested that regional variations in tonsillectomy are the results of regional variation in 
surgeon preferences for tonsillectomy. However, there is very little evidence of whether and 
how surgeons influence treatment decisions at the level of the consultation. In this study we 
aimed to evaluate the role of patient and surgeon treatment preferences in the choice 
between tonsillectomy and conservative therapy in adults with recurring tonsillitis.  
Methods 
Using the Preferences in Adults with Recurring Tonsillitis Tool (PARTT), we undertook a 
multicentre (n=14) observational study of consecutive adults attending ENT clinics with 
recurring tonsillitis. Surgeons (n=54) at participating hospitals were asked to also complete 
PARTT before they saw any patients, from the perspective of a typical adult with recurring 
tonsillitis – surgeon’s proxy preference. Patients (n=160) who consented to participate 
completed the PARTT following their consultation, as well information regarding the 
treatment they had chosen.  
We undertook cluster analyses to assess the impact of surgeons’ proxy preference against the 
patients’. Multivariable logistic models were created to assess the impact of preference 
cluster on treatment actually chosen.  
Results 
We analysed data from 160 consultations between 160 patients and 54 surgeons. PARTT 
responses fell into three clusters: aligning tonsillectomy (n=66 patients, n=16 surgeons), 
aligning conservative therapy n=22 patients, n=8 surgeons) and undecided (n=72 patients, 
n=30 surgeons).Multivariable logistic analysis showed that treatment chosen at the end of 




preference cluster was associated with treatment chosen, even after controlling for markers 
of disease severity and patient preference cluster (Adjusted OR 3.88, 95%CI 1.01-14.97). 
Discussion  
This study adds weight to the argument that surgeon factors may be more consequential in 
treatments chosen than patients’ preferences. In the modern setting where conditions 
frequently have several therapies, all in equipoise, it is important that treatments chosen 
reflect patient’s personal values. Future work should investigate methods that allow 
consultation outcomes to reflect patients’ preferences more closely. Using the PARTT 
routinely, would help to make patients values more explicit whilst making surgeons more 
aware of their implicit preferences that may be unintentionally swaying treatment decisions.  
 
 
 
